0001493152-23-028564.txt : 20230814 0001493152-23-028564.hdr.sgml : 20230814 20230814163920 ACCESSION NUMBER: 0001493152-23-028564 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 83 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEXGEL, INC. CENTRAL INDEX KEY: 0001468929 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 264042544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41173 FILM NUMBER: 231171285 BUSINESS ADDRESS: STREET 1: 2150 CABOT BLVD WEST, STREET 2: SUITE B CITY: LANGHORNE STATE: PA ZIP: 19047 BUSINESS PHONE: 215 702-8550 MAIL ADDRESS: STREET 1: 2150 CABOT BLVD WEST, STREET 2: SUITE B CITY: LANGHORNE STATE: PA ZIP: 19047 FORMER COMPANY: FORMER CONFORMED NAME: AquaMed Technologies, Inc. DATE OF NAME CHANGE: 20090723 10-Q 1 form10-q.htm
0001468929 false Q2 --12-31 0001468929 2023-01-01 2023-06-30 0001468929 NXGL:CommonStockParValue0.001Member 2023-01-01 2023-06-30 0001468929 NXGL:WarrantsToPurchaseCommonStockMember 2023-01-01 2023-06-30 0001468929 2023-08-11 0001468929 2023-06-30 0001468929 2022-12-31 0001468929 2023-04-01 2023-06-30 0001468929 2022-04-01 2022-06-30 0001468929 2022-01-01 2022-06-30 0001468929 us-gaap:CommonStockMember 2022-12-31 0001468929 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001468929 us-gaap:NoncontrollingInterestMember 2022-12-31 0001468929 us-gaap:RetainedEarningsMember 2022-12-31 0001468929 us-gaap:CommonStockMember 2023-03-31 0001468929 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001468929 us-gaap:NoncontrollingInterestMember 2023-03-31 0001468929 us-gaap:RetainedEarningsMember 2023-03-31 0001468929 2023-03-31 0001468929 us-gaap:CommonStockMember 2021-12-31 0001468929 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001468929 us-gaap:RetainedEarningsMember 2021-12-31 0001468929 2021-12-31 0001468929 us-gaap:CommonStockMember 2022-03-31 0001468929 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001468929 us-gaap:RetainedEarningsMember 2022-03-31 0001468929 2022-03-31 0001468929 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001468929 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001468929 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001468929 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001468929 2023-01-01 2023-03-31 0001468929 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001468929 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001468929 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001468929 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001468929 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001468929 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001468929 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001468929 2022-01-01 2022-03-31 0001468929 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001468929 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001468929 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001468929 us-gaap:CommonStockMember 2023-06-30 0001468929 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001468929 us-gaap:NoncontrollingInterestMember 2023-06-30 0001468929 us-gaap:RetainedEarningsMember 2023-06-30 0001468929 us-gaap:CommonStockMember 2022-06-30 0001468929 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001468929 us-gaap:RetainedEarningsMember 2022-06-30 0001468929 2022-06-30 0001468929 NXGL:JointVentureMember 2023-03-01 0001468929 NXGL:CGLabsMember 2023-03-01 0001468929 NXGL:JointVentureMember 2023-06-30 0001468929 us-gaap:USTreasurySecuritiesMember NXGL:FebruraryTwentyThreeTwoThousandAndTwentyThreeMember 2023-06-30 0001468929 us-gaap:USTreasurySecuritiesMember NXGL:FebruraryTwentyThreeTwoThousandAndTwentyThreeMember 2022-12-31 0001468929 us-gaap:USTreasurySecuritiesMember NXGL:AprilTwentySevenTwoThousandAndTwentyThreeMember 2023-06-30 0001468929 us-gaap:USTreasurySecuritiesMember NXGL:AprilTwentySevenTwoThousandAndTwentyThreeMember 2022-12-31 0001468929 us-gaap:USTreasurySecuritiesMember NXGL:JuneFifteenTwoThousandandTwentyThreeMember 2023-06-30 0001468929 us-gaap:USTreasurySecuritiesMember NXGL:JuneFifteenTwoThousandandTwentyThreeMember 2022-12-31 0001468929 us-gaap:USTreasurySecuritiesMember NXGL:JulyThirteenTwoThousandTwentyThreeMember 2023-06-30 0001468929 us-gaap:USTreasurySecuritiesMember NXGL:JulyThirteenTwoThousandTwentyThreeMember 2022-12-31 0001468929 us-gaap:USTreasurySecuritiesMember NXGL:AugustTenTwoThousandTwentyThreeMember 2023-06-30 0001468929 us-gaap:USTreasurySecuritiesMember NXGL:AugustTenTwoThousandTwentyThreeMember 2022-12-31 0001468929 2022-01-01 2022-12-31 0001468929 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2023-06-30 0001468929 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasurySecuritiesMember 2023-06-30 0001468929 us-gaap:FairValueInputsLevel3Member us-gaap:USTreasurySecuritiesMember 2023-06-30 0001468929 us-gaap:USTreasurySecuritiesMember 2023-06-30 0001468929 us-gaap:FairValueInputsLevel1Member 2023-06-30 0001468929 us-gaap:FairValueInputsLevel2Member 2023-06-30 0001468929 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001468929 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2022-12-31 0001468929 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasurySecuritiesMember 2022-12-31 0001468929 us-gaap:FairValueInputsLevel3Member us-gaap:USTreasurySecuritiesMember 2022-12-31 0001468929 us-gaap:USTreasurySecuritiesMember 2022-12-31 0001468929 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001468929 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001468929 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001468929 us-gaap:MachineryAndEquipmentMember srt:MinimumMember 2023-06-30 0001468929 us-gaap:MachineryAndEquipmentMember srt:MaximumMember 2023-06-30 0001468929 us-gaap:MachineryAndEquipmentMember 2023-06-30 0001468929 us-gaap:MachineryAndEquipmentMember 2022-12-31 0001468929 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2023-06-30 0001468929 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2023-06-30 0001468929 us-gaap:FurnitureAndFixturesMember 2023-06-30 0001468929 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001468929 us-gaap:LeaseholdImprovementsMember 2023-06-30 0001468929 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001468929 us-gaap:ConstructionInProgressMember 2023-06-30 0001468929 us-gaap:ConstructionInProgressMember 2022-12-31 0001468929 us-gaap:TechnologyBasedIntangibleAssetsMember 2023-06-30 0001468929 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-12-31 0001468929 us-gaap:CustomerRelatedIntangibleAssetsMember 2023-06-30 0001468929 us-gaap:CustomerRelatedIntangibleAssetsMember 2022-12-31 0001468929 us-gaap:TradeNamesMember 2023-06-30 0001468929 us-gaap:TradeNamesMember 2022-12-31 0001468929 us-gaap:MarketingRelatedIntangibleAssetsMember 2023-06-30 0001468929 us-gaap:MarketingRelatedIntangibleAssetsMember 2022-12-31 0001468929 NXGL:SportDefenseLlcMember NXGL:TechnologyRelatedAndCustomerRelatedIntangiblesMember 2020-05-29 0001468929 NXGL:SportDefenseLlcMember NXGL:TechnologyRelatedAndCustomerRelatedIntangiblesMember 2023-01-01 2023-06-30 0001468929 NXGL:SportDefenseLlcMember NXGL:TechnologyRelatedAndCustomerRelatedIntangiblesMember 2022-01-01 2022-06-30 0001468929 NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember us-gaap:CommonStockMember 2023-06-30 0001468929 NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember srt:ExecutiveOfficerMember 2023-01-01 2023-06-30 0001468929 NXGL:ContractorMember NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2023-03-08 0001468929 NXGL:ContractorMember NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2022-10-01 2022-10-01 0001468929 us-gaap:StockOptionMember NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2023-06-30 0001468929 us-gaap:StockOptionMember NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember srt:MinimumMember 2023-01-01 2023-06-30 0001468929 us-gaap:StockOptionMember NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember srt:MaximumMember 2023-01-01 2023-06-30 0001468929 NXGL:OfficersAndEmployeesMember us-gaap:RestrictedStockMember 2022-08-01 2022-08-01 0001468929 NXGL:OfficersAndEmployeesMember us-gaap:RestrictedStockMember 2022-08-01 0001468929 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2022-01-01 2022-01-01 0001468929 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2022-01-01 0001468929 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2023-01-03 2023-01-03 0001468929 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2023-01-03 0001468929 NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2023-06-30 0001468929 NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2023-01-01 2023-06-30 0001468929 NXGL:AwardsGrantedOutsideOfThe2019PlanMember 2023-06-30 0001468929 NXGL:AwardsGrantedOutsideOfThe2019Member 2023-06-30 0001468929 NXGL:AwardsGrantedOutsideOfThe2019Member 2023-01-01 2023-06-30 0001468929 us-gaap:StockOptionMember NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2022-12-31 0001468929 NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember us-gaap:StockOptionMember 2023-01-01 2023-06-30 0001468929 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001468929 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001468929 us-gaap:RestrictedStockUnitsRSUMember 2023-06-30 0001468929 NXGL:JointVentureMember 2023-03-01 0001468929 NXGL:CGConvertingAndPackagingLLCMember 2023-03-01 0001468929 NXGL:CGLaboratoriesIncMember 2023-03-01 0001468929 2023-03-01 2023-03-01 0001468929 NXGL:CGLaboratoriesMember 2023-01-01 2023-06-30 0001468929 NXGL:CGLabsMember 2023-01-01 2023-06-30 0001468929 NXGL:EconomicInjuryDisasterLoanMember 2020-05-28 0001468929 NXGL:EconomicInjuryDisasterLoanMember 2020-05-27 2020-05-28 0001468929 NXGL:AuctusNoteMember 2021-03-11 0001468929 NXGL:AuctusNoteMember 2021-03-10 2021-03-11 0001468929 2022-03-15 0001468929 NXGL:SecuredConvertiblePromissoryNoteMember us-gaap:PrivatePlacementMember 2021-09-02 0001468929 NXGL:SecuredConvertiblePromissoryNoteMember 2021-09-02 2021-09-02 0001468929 NXGL:SecuredConvertiblePromissoryNoteMember 2022-01-25 0001468929 NXGL:SecuredConvertiblePromissoryNoteMember 2022-01-01 2022-12-31 0001468929 NXGL:SecuredConvertiblePromissoryNoteMember us-gaap:PrivatePlacementMember 2022-09-06 0001468929 us-gaap:PrivatePlacementMember 2021-09-02 0001468929 us-gaap:PrivatePlacementMember 2021-03-11 0001468929 us-gaap:PrivatePlacementMember 2021-02-03 0001468929 us-gaap:PrivatePlacementMember 2020-12-24 0001468929 us-gaap:PrivatePlacementMember 2020-03-18 0001468929 us-gaap:PrivatePlacementMember 2019-09-10 0001468929 us-gaap:PrivatePlacementMember 2019-11-06 0001468929 srt:MinimumMember us-gaap:PrivatePlacementMember 2023-06-30 0001468929 srt:MaximumMember us-gaap:PrivatePlacementMember 2023-06-30 0001468929 us-gaap:WarrantMember 2022-12-31 0001468929 us-gaap:WarrantMember 2023-06-30 0001468929 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001468929 NXGL:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001468929 NXGL:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001468929 NXGL:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001468929 NXGL:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001468929 NXGL:OneOtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001468929 NXGL:TwoOtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001468929 NXGL:ThreeOtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001468929 NXGL:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001468929 NXGL:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001468929 NXGL:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001468929 NXGL:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001468929 NXGL:OneOtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001468929 NXGL:TwoOtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001468929 NXGL:Mr.SteinMember 2021-09-02 0001468929 NXGL:Mr.StefanskyMember 2021-09-02 0001468929 NXGL:Dr.JeromeZeldisMember 2021-09-02 0001468929 NXGL:Dr.JeromeZeldisMember 2023-06-30 0001468929 NXGL:Dr.JeromeZeldisMember 2022-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure NXGL:Segment NXGL:Integer

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: June 30, 2023

 

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to ___________

 

Commission file number: 001-41173

 

NexGel, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   26-4042544
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification Number)
     

2150 Cabot Blvd West, Suite B

Langhorne, PA

   19047
(Address of principal executive office)   (Zip Code)

 

Registrant’s telephone number, including area code: (215) 702-8550

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001   NXGL   The Nasdaq Capital Market LLC
Warrants to Purchase Common Stock   NXGLW   The Nasdaq Capital Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
   
Non-accelerated filer ☒  
   
Smaller reporting company ☒ Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yes ◻ No ☒

 

As of August 11, 2023, the registrant had 5,696,064 shares of common stock outstanding.

 

 

 

 

 

 

nEXGEL, INC.

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION  
     
ITEM 1. Condensed Consolidated Financial Statements (Unaudited) 3
  Condensed Consolidated Balance Sheets as of June 30, 2023 and December 31, 2022 3
  Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2023 and 2022 4
  Condensed Consolidated Statements of Stockholders’ Equity for the Three and Six Months Ended June 30, 2023 and 2022 5
  Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2023 and 2022 6
  Notes to Condensed Consolidated Financial Statements 7
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 23
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk 30
ITEM 4. Controls and Procedures 30
     
PART II – OTHER INFORMATION  
ITEM 1. Legal Proceedings 30
ITEM 1A. Risk Factors 30
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 30
ITEM 3. Defaults Upon Senior Securities 30
ITEM 4. Mine Safety Disclosures 30
ITEM 5. Other Information 30
ITEM 6. Exhibits 31
     
Signatures 32

 

2

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

NEXGEL, INC

CONDENSED CONSOLIDATED BALANCE SHEETS

AS OF JUNE 30, 2023 AND DECEMBER 31, 2022

(Unaudited)

(in thousands, except share and per share data)

 

  

June 30,

2023

  

December 31,

2022

 
ASSETS:          
Current Assets:          
Cash  $3,691   $1,101 
Marketable securities   612    5,508 
Accounts receivable, net   950    222 
Inventory   1,079    502 
Prepaid expenses and other current assets   366    172 
Total current assets   6,698    7,505 
Goodwill   311    311 
Intangibles, net   13    20 
Property and equipment, net   1,413    721 
Operating lease - right of use asset   1,967    1,737 
Other assets   95    63 
Total assets  $10,497   $10,357 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current Liabilities:          
Accounts payable  $1,058   $265 
Accrued expenses and other current liabilities   202    130 
Current portion of note payable   15    15 
Warrant liability   165    242 
Operating lease liability, current portion   232    207 
Total current liabilities   1,672    859 
Operating lease liability, net of current portion   1,819    1,593 
Notes payable, net of current portion   265    268 
Total liabilities   3,756    2,720 
           
Commitments and Contingencies (Note 15)   -    - 
           
STOCKHOLDERS’ EQUITY          
Preferred stock, par value $0.001 per share, 5,000,000 shares authorized, no shares issued and outstanding   -    - 
Common stock, par value $0.001 per share, 25,000,000 shares authorized; 5,696,064 and 5,577,916 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively   6    6 
Additional paid-in capital   19,242    19,189 
Accumulated deficit   (13,067)   (11,558)
Total NexGel stockholders’ equity   6,181    7,637 
Non-controlling interest in joint venture   560    - 
Total stockholders’ equity   6,741    7,637 
Total liabilities and stockholders’ equity  $10,497   $10,357 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3

 

NEXGEL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023 AND 2022

(Unaudited)

(in thousands, except share and per share data)

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Revenues, net  $1,167   $561   $1,786   $956 
                     
Cost of revenues   992    460    1,669    884 
                     
Gross profit   175    101    117    72 
                     
Operating expenses                    
Research and development   55    111    84    135 
Selling, general and administrative   882    708    1,679    1,467 
Total operating expenses   937    819    1,763    1,602 
                     
Loss from operations   (762)   (718)   (1,646)   (1,530)
                     
Other income (expense)                    
Interest expense   (9)   (348)   (10)   (1,092)
Interest income   2    -    2    - 
Loss on debt extinguishment   -    -    -    (150)
Other income   -    2    4    2 
Gain on investments   116    -    124    - 
Changes in fair value of warrant liability   11    29    77    (101)
Total other income (expense), net   120    (317)   197    (1,341)
Loss before income taxes   (642)   (1,035)   (1,449)   (2,871)
Income tax expense   -    -    -    - 
Net loss  $(642)  $(1,035)   (1,449)   (2,871)
Less: Income attributable to non-controlling interest in joint venture   53    -    60    - 
Net loss attributable to NexGel stockholders   (695)   (1,035)   (1,509)   (2,871)
Net loss per common share - basic  $(0.12)  $(0.19)   (0.27)   (0.52)
Net loss per common share - diluted  $(0.12)  $(0.19)   (0.27)   (0.52)
Weighted average shares used in computing net loss per common share - basic   5,662,338    5,572,234    5,624,275    5,572,234 
Weighted average shares used in computing net loss per common share – diluted   5,662,338    5,572,234    5,624,275    5,572,234 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4

 

NEXGEL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023 AND 2022

(Unaudited)

(in thousands, except share data)

 

   Shares   Amount   Capital   Interest   Deficit   Equity 
   Common Stock  

Additional

Paid-in

  

Non-

controlling

   Accumulated  

Total

Stockholders’

 
   Shares   Amount   Capital   Interest   Deficit   Equity 
Balance, January 1, 2023   5,577,916   $6   $19,189   $-   $(11,558)  $7,637 
                               
Restricted stock vesting   5,682    -    24    -    -    24 
                               
Exercise of warrants   30,430    -    -    -    -    - 
                               
Non-controlling interest in JV   -    -    -    500    -    500 
                               
Net income (loss)   -    -    -    7    (814)   (807)
                               
Balance, March 31, 2023   5,614,028   $6   $19,213   $507   $(12,372)  $7,354 
                               
Stock-based compensation   -    -    29    -    -    29 
                               
Exercise of warrants   82,036    -    -    -    -    - 
                               
Net income (loss)   -    -    -    53    (695)   (642)
                               
Balance, June 30, 2023   5,696,064   $6   $19,242   $560   $(13,067)  $6,741 

 

   Shares   Amount   Capital   Deficit)   (Deficit) 
   Common Stock   Additional
Paid-in		   Retained
Earnings
(Accumulated		   Total
Stockholders’
Equity		 
   Shares   Amount   Capital   Deficit)   (Deficit) 
Balance, January 1, 2022   5,572,234   $6   $18,891   $(6,812)  $  12,085 
                          
Stock-based compensation   -    -    55    -    55 
                          
Net loss   -    -    -    (1,836)   (1,836)
                                  
Balance, March 31, 2022   5,572,234   $6   $18,946   $(8,648)  $10,304 
                          
Stock-based compensation   -    -    54    -    54 
                          
Restricted stock vesting   -    -    25    -    25 
                          
Net loss   -    -    -    (1,035)   (1,035)
                          
Balance, June 30, 2022   5,572,234   $6   $19,025   $(9,683)  $9,348 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5

 

NEXGEL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2023 AND 2022

(Unaudited)

(in thousands)

 

   2023   2022 
   Six Months Ended June 30, 
   2023   2022 
Operating Activities          
Net loss  $(1,509)  $(2,871)
Adjustments to reconcile net loss to net cash used in operating activities:          
Income attributable to non-controlling interest in joint venture   60    - 
Depreciation and amortization   68    57 
Changes in ROU asset and operating lease liability   21    19 
Share-based compensation and restricted stock vesting   53    134 
Gain on investment in marketable securities   124    - 
Changes in fair value of warrant liability and warrant modification   (77)   101 
Amortization of deferred financing costs   -    1,086 
Loss on extinguishment of debt   -    150 
           
Changes in operating assets and liabilities:          
Accounts receivable   (728)   (91)
Inventory   (577)   (90)
Prepaid expenses and other assets   (226)   (286)
Accounts payable   793    268 
Accrued expenses and other current liabilities   72    28 
Net Cash Used in Operating Activities   (1,926)   (1,495)
           
Investing Activities          
Proceeds from sales of marketable securities   4,772    - 
Investment in marketable securities   -    (5,371)
Capital expenditures   (253)   (31)
Net Cash Provided by Investing Activities   4,519    (5,402)
           
Financing Activities          
Principle payments of notes payable   (3)   (2,033)
Net Cash Used in Financing Activities   (3)   (2,033)
Net Decrease in Cash   2,590    (8,930)
Cash – Beginning of period   1,101    13,350 
Cash – End of period  $3,691   $4,420 
Supplemental Disclosure of Cash Flows Information          
Cash paid during the year for:          
Interest  $-   $- 
Taxes  $-   $- 
           
Supplemental Non-cash Investing and Financing activities          
Property and equipment contributed as capital investment to JV  $500   $- 
ROU asset and operating lease liabilities recognized upon consolidation of JV  $334   $- 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

6

 

NEXGEL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share data)

 

1. Description of Business, Stock Split and Basis of Presentation

 

NexGel, Inc. (“NexGel” or the “Company”) manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. The Company specializes in custom gels by capitalizing on proprietary manufacturing technologies. NexGel has historically served as a contract manufacturer, supplying our gels to third parties who incorporate them into their own products, and has recently began producing the Company’s own consumer products using our gels focused on proprietary branded products and white label opportunities. Both the Company’s gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies. Together, these technologies enable NexGel to produce gels that can satisfy rigid tolerance specifications with respect to a wide range of physical characteristics (e.g., thickness, water content, adherence, absorption, moisture vapor transmission rate (a measure of the passage of water vapor through a substance) and release rate) while maintaining product integrity. Additionally, the Company has the manufacturing capability to offer broad choices in the selection of liners onto which the gels are coated. Consequently, NexGel and our customers are able to determine tolerances in moisture vapor transmission rate and active ingredient release rates while personalizing color and texture.

 

NexGel was previously known as AquaMed Technologies, Inc. (“AquaMed”) before changing its name to NexGel, Inc. on November 14, 2019.

 

On March 1, 2023, the Company acquired a 50% interest in a newly formed joint venture (“JV”), CG Converting and Packaging, LLC, with C.G. Laboratories Inc. (“CG Labs”) for its converting and packaging business. The agreement is effective March 1, 2023. As a result of this transaction, the Company owns 50% of the JV, with the remaining 50% held by CG Labs.

 

Basis of Presentation

 

The accompanying interim unaudited condensed consolidated financial statements and footnotes of NexGel have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and the instructions to Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, these unaudited condensed consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation of the results of the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full year ending December 31, 2023. These condensed consolidated financial statements should be read in conjunction with the audited financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

 

Principles of Consolidation

 

The accompanying condensed consolidated financial statements include the accounts of the Company and its consolidated wholly-owned subsidiary, NexGelRx, Inc. and the fifty percent (50%) owned JV (see Note 11).

 

7

 

2. Going Concern

 

As of June 30, 2023, the Company had a cash balance of $3.7 million (including cash equivalents) and $612 thousand of marketable securities (see Note 3 for details of our marketable securities). For the six months ended June 30, 2023, the Company incurred a net loss of $1.5 million and had a net usage of cash in operating activities of $1.9 million. In addition, the Company had a working capital of $5.0 million as of June 30, 2023. We believe we have sufficient cash and marketable securities to operate our business plan through 2025.

 

Management is exploring new product channel sales in adjacent industries, such as cosmetics, athletic products, and proprietary medical devices. The Company has increased its focus on sales and developing a sales pipeline for potential customers. This customer base expansion will enable us to provide financial stability for the foreseeable future, expand our current processes, and position us for long-term shareholder value creation.

 

We have sufficient capital to maintain as a going concern due to the capital raise that occurred on December 27, 2021. We intend to maintain and attempt to grow our existing contract manufacturing business. We also plan to continue building and developing our catalog of consumer products for sale to branding partners and to use our in-house capabilities to create and test market additional branded products. These products will be target marketed and sold online through social media, television and online marketplaces. Furthermore, the Company plans to develop its own proprietary medical devices and explore drug delivery programs for its technology. Additionally, the Company continues to evaluate strategic initiatives (e.g., acquisitions) and additional capital raises through debt or equity may be necessary to achieve these objectives.

 

We expect to continue incurring losses for the near-term future. Our ability to continue to operate as a going concern in the long-term is dependent upon our ability to manage and grow our current products and to ultimately achieve profitable operations. Management may consider various options to raise capital to fund potential acquisitions through equity or debt offerings. There can be no assurances, however, that management will be able to obtain sufficient additional funds, if needed, or that such funds, if available, will be obtained on terms satisfactory to us. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets and liabilities that might be necessary should we be unable to continue as a going concern. Additionally, it is reasonably possible that estimates made in the condensed consolidated financial statements have been, or will be, materially and adversely impacted in the near term as a result of these conditions, including the recoverability of long-lived assets.

 

8

 

3. Significant Accounting Policies and Estimates

 

Use of Estimates

 

The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. These estimates and assumptions include allowances for doubtful accounts, inventory reserves, deferred taxes, share-based compensation and related valuation allowances and fair value of long-lived assets. Actual results could differ from the estimates.

 

Cash

 

Cash is comprised of cash in banks and highly liquid investments, including U.S. treasury bills purchased with an original maturity of three months or less as well as investments in money market funds for which the carrying amount approximates fair value, due to the short maturities of these investments.

 

Marketable Securities

 

The Company classifies its marketable securities as held-to-maturity, which include U.S. treasury bills with original maturities of greater than three months. These securities are carried at fair value with any change in fair value recorded as an unrealized gain (loss) in the consolidated statement of operations of the period in which such change occurs.

 

The Company had the following marketable securities as of June 30, 2023 and December 31, 2022:

Schedule of Marketable Securities  

   June 30,   December 31, 
   2023   2022 
Marketable Securities          
United States treasury bills (due February 23, 2023)  $-   $492 
United States treasury bills (due April 27, 2023)   -    20 
United States treasury bills (due June 15, 2023)   -    4,384 
United States treasury bills (due July 13, 2023)   127    127 
United States treasury bills (due August 10, 2023)   485    485 
Total  $612   $5,508 

 

Accounts Receivable, net

 

Trade accounts receivable are stated at the amount the Company expects to collect and do not bear interest. The Company evaluates the collectability of accounts receivable and records a provision to the allowance for doubtful accounts based on factors including the length of time the receivables are past due, the current business environment and the Company’s historical experience. Provisions to the allowances for doubtful accounts are recorded in selling, general, and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered. The allowance for doubtful accounts was $17 thousand as of June 30, 2023, and $9 thousand as of December 31, 2022.

 

Inventory and Cost of Goods Sold

 

Inventory is stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. The Company evaluates inventories for excess quantities, obsolescence, and shelf-life expiration. This evaluation includes an analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, and a review of the shelf-life expiration dates for products. These factors determine when, and if, the Company adjusts the carrying value of inventory to estimated net realizable value.

 

9

 

The Company produces proprietary branded products and white label opportunities in our manufacturing of consumer products. In our contract manufacturing, the Company builds its products based on customer orders and immediately ships the products upon completion of the production process.

 

The balance is made up of raw materials, work-in-progress, and finished goods. Inventory is maintained primarily at the Company’s warehouse and at an Amazon fulfillment center.

 

The “Cost of revenues” line item in the condensed consolidated statements of operations is comprised of the book value of inventory sold to customers during the reporting period. When circumstances dictate that we use net realizable value as the basis for recording inventory, we base our estimates on expected future selling prices less expected disposal costs.

 

Research and Development

 

Our research and development activities focus on new and innovative products designed to support revenue growth. Research and development expenses consist primarily of contracted development and testing efforts associated with development of products.

 

Shipping and Handling Revenue and Expense

 

Shipping and handling revenue and expense are included in our condensed consolidated statements of operations in revenues and cost of revenues, respectively. This is primarily through shipping fees incurred in the Amazon marketplace.

 

Property and Equipment, net

 

Property and equipment is recorded at historical cost, net of accumulated depreciation and amortization. Depreciation is provided over the assets’ useful lives on a straight-line basis. Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or lease terms. Repairs and maintenance costs are expensed as incurred.

 

Management periodically assesses the estimated useful life over which assets are depreciated or amortized. If the analysis warrants a change in the estimated useful life of property and equipment, management will reduce the estimated useful life and depreciate or amortize the carrying value prospectively over the shorter remaining useful life.

 

The carrying amounts of assets sold or retired and the related accumulated depreciation are eliminated in the period of disposal and the resulting gains and losses are included in the results of operations during the same period.

 

Impairment of Long-Lived Assets

 

The Company reviews its property and equipment and any identifiable intangibles for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted operating cash flow expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell.

 

Goodwill and Intangible Assets

 

In applying the acquisition method of accounting, amounts assigned to identifiable assets and liabilities acquired were based on estimated fair values as of the date of acquisition, with the remainder recorded as goodwill. Identifiable intangible assets are initially recorded at fair value using generally accepted valuation methods appropriate for the type of intangible asset. Identifiable intangible assets with definite lives are amortized over their estimated useful lives and are reviewed for impairment if indicators of impairment arise. Intangible assets with indefinite lives are tested for impairment within one year of acquisitions or annually as of December 31, and whenever indicators of impairment exist. The fair value of intangible assets is compared with their carrying values, and an impairment loss would be recognized for the amount by which a carrying amount exceeds its fair value.

 

10

 

The Company performed the annual assessment and concluded it is more likely than not that the fair value exceeds the carrying value and no impairments were recognized in the year ended December 31, 2022.

 

Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets are recorded at historical cost and is primarily made up of $96 thousand and $63 thousand of prepaid insurance, and $270 thousand and $109 thousand general prepaid expenses and other current assets as of June 30, 2023, and December 31, 2022, respectively.

 

Other Assets

 

Other assets are recorded at historical costs, and as of June 30, 2023, and December 31, 2022, the balance is primarily comprised of spare parts for manufacturing equipment. Other assets are not subject to depreciation until such time that they are placed into service and the part that is being replaced is disposed.

 

Fair Value Measurements

 

The Company utilizes the fair value hierarchy to apply fair value measurements. The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair values that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources, while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions. The basis for fair value measurements for each level within the hierarchy is described below:

 

Level 1 — Quoted prices for identical assets or liabilities in active markets.

 

Level 2 — Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable.

 

Level 3 — Valuations derived from valuation techniques in which one or more significant inputs to the valuation model are unobservable.

 

The Company considers the carrying amounts of its financial instruments (cash, accounts receivable and accounts payable, notes payable and convertible notes payable) in the balance sheet to approximate fair value because of the short-term or highly liquid nature of these financial instruments.

 

The following table sets forth the fair value of the Company’s financial assets within the fair value hierarchy:

 

   Level 1   Level 2   Level 3   Fair Value 
       June 30, 2023     
   Level 1   Level 2   Level 3   Fair Value 
Assets                    
Marketable securities:                          
United States treasury bills  $612   $     -   $-   $612 
Total  $612   $-   $-   $612 

 

   Level 1   Level 2   Level 3   Fair Value 
       December 31, 2022     
   Level 1   Level 2   Level 3   Fair Value 
Assets                    
Marketable securities:                    
United States treasury bills  $5,508   $      -   $     -   $5,508 
Total  $5,508   $-   $-   $5,508 

 

11

 

Warrant Liability

 

Warrants to purchase common stock were issued in connection with equity financing raises, which occurred during 2019 through 2021. The fair values of the warrants are estimated as of the date of issuance and again at each year end using a Black-Scholes option valuation model. At issuance, the fair values of the warrants are recognized as an equity issuance cost within additional paid-in-capital. Fair value adjustments to the warrant liability are recognized in other income (expense) in the accompanying condensed consolidated statements of operations.

 

Revenue Recognition

 

On January 1, 2018, the Company adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted ASC 606 for all applicable contracts using the modified retrospective method, which would have required a cumulative-effect adjustment, if any, as of the date of adoption.

 

The Company currently recognizes revenue predominately from three types of revenue, contract manufacturing, custom and white label finished goods manufacturing and our branded products. Revenues from manufactured and branded products are recognized at the point where the customer obtains control of the goods and the Company satisfies its performance obligation, which generally is at the time the customer receives the product.

 

The Company’s customers consist of other life sciences companies and Amazon retail customers. Revenues are entirely concentrated in the United States. Payment terms vary by the type and location of customer and may differ by jurisdiction and customer, but payment is generally required in a term ranging from 30 to 60 days from date of shipment.

 

Estimates for product returns, allowances and discounts are recorded as a reduction of revenue and are established at the time of sale. Returns are estimated through a comparison of historical return data and are determined for each product and adjusted for known or expected changes in the marketplace specific to each product, when appropriate. Historically, sales return provisions have not been material. Amounts accrued for sales allowances and discounts are based on estimates of amounts that are expected to be claimed on the related sales and are based on historical data. Payments for allowances and discounts have historically been immaterial.

 

Disaggregated revenue by sales type:

  

   2023   2022 
   Three months ended 
   June 30, 
   2023   2022 
Contract manufacturing  $887   $324 
Custom and white label finished goods manufacturing   —    19 
NexGel branded consumer products   259    180 
Other   21    38 
Total  $1,167   $561 

 

12

 

   2023   2022 
   Six months ended 
   June 30, 
   2023   2022 
Contract manufacturing  $1,267   $459 
Custom and white label finished goods manufacturing   4    19 
NexGel branded consumer products   493    392 
Other   22    86 
Total  $1,786   $956 

 

As of June 30, 2023, and December 31, 2022, the Company did not have any contract assets or contract liabilities from contracts with customers. As of June 30, 2023, and December 31, 2022, there were no remaining performance obligations that the Company had not satisfied.

 

The Company has four distinct lines of business; Contract Manufacturing, Custom & White Label, Consumer Branded Products, and Medical Devices.

 

Contract Manufacturing

 

Customers order rolls of gel (“rollstock”). The rollstock is shipped to our customers, which they package into finished goods. Historically, this has been the Company’s primary source of revenue.

 

Custom & White Label

 

These products often infuse various ingredients into our base gel to develop unique product offerings to satisfy market demand (e.g. aloe infused into the gel for a beauty mask). The rollstock is converted and packaged into salable units. The finished goods are shipped to the customer, who is ultimately responsible for product distribution. Frequently these products started as development deals, in which the customer paid the Company a small fee to develop a specific product. Once completed, the customer places a large order for newly developed product.

 

Consumer Branded Products

 

These products are finished goods marketed and sold directly to the customer by the Company through online and retail channels. The Company is responsible for sales, marketing, and distribution. These products carry the Company’s brand names.

 

Medical Devices

 

Medical Devices are a hybrid business, combining elements of Custom & White Label and Consumer Branded Products. Medical Devices, which are not yet marketed, are expected to be distributed through strategic partnerships. The Company will manufacture and possibly convert/package the device while the strategic partner brings the product to market. Small market Medical Devices could be launched by the Company, but also be offered to a distributor to reach the full scale of the market.

 

Share-based Compensation

 

On August 28, 2019, the Company adopted the 2019 Long-Term Incentive Plan, as amended (the “2019 Plan”). See Note 10 below for further details regarding the 2019 Plan.

 

The 2019 Plan provides certain employees, contractors, and outside directors with share-based compensation in the form of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalent rights and other awards. The fair values of incentive stock option award grants are estimated as of the date of grant using a Black-Scholes option valuation model. Compensation expense is recognized in the statements of operations on a straight-line basis over the requisite service period, which is generally the vesting period required to obtain full vesting. Forfeitures are accounted for when they occur.

 

13

 

In June 2018, FASB issued Accounting Standards Update (“ASU”) No. 2018-07, Compensation - Stock Compensation (Topic 718) - Improvements to Nonemployee Share-Based Payment Accounting. These amendments expand the scope of Topic 718, Compensation - Stock Compensation, to include share-based payments issued to non-employees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. This new standard was effective for the Company on January 1, 2020. The Company adopted this new standard early in the third quarter of 2019 and it did not have a material impact to its condensed consolidated financial statements.

 

Income Taxes

 

Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax bases of assets and liabilities at the applicable tax rates. Deferred tax assets are reduced by a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates.

 

Tax benefits are recognized from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by a tax authority and based upon the technical merits of the tax position. The tax benefit recognized in the condensed consolidated financial statements for a particular tax position is based on the largest benefit that is more likely than not to be realized upon settlement. An unrecognized tax benefit, or a portion thereof, is presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed.

 

Leases

 

ASC 842, Leases, requires recognition of leases on the condensed consolidated balance sheets as right-of-use (“ROU”) assets and lease liabilities. ROU assets represent the Company’s right to use underlying assets for the lease terms and lease liabilities represent the Company’s obligation to make lease payments arising from the leases. Operating lease ROU assets and operating lease liabilities are recognized based on the present value and future minimum lease payments over the lease term at commencement date. As the Company’s leases do not provide an implicit rate, the Company used its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. A number of the lease agreements contain options to renew and options to terminate the leases early. The lease term used to calculate ROU assets and lease liabilities only includes renewal and termination options that are deemed reasonably certain to be exercised.

 

The Company recognized lease liabilities, with corresponding ROU assets, based on the present value of unpaid lease payments for existing operating leases longer than twelve months. The ROU assets were adjusted per ASC 842 transition guidance for existing lease-related balances of accrued and prepaid rent, and unamortized lease incentives provided by lessors. Operating lease cost is recognized as a single lease cost on a straight-line basis over the lease term and is recorded in selling, general and administrative expenses. Variable lease payments for common area maintenance, property taxes and other operating expenses are recognized as expense in the period when the changes in facts and circumstances on which the variable lease payments are based occur. The Company has elected not to separate lease and non-lease components for all property leases for the purposes of calculating ROU assets and lease liabilities.

 

Segment Reporting

 

The Company operates in one business segment as a contract manufacturer of aqueous polymer hydrogels. As a result, the Company’s operations are a single reportable segment, which is consistent with the Company’s internal management reporting.

 

14

 

Recently Issued Accounting Standards

 

From time to time, new accounting pronouncements are issued by FASB, or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption.

 

In June 2016, FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 significantly changes the impairment model for most financial assets and certain other instruments. ASU 2016-13 will require immediate recognition of estimated credit losses expected to occur over the remaining life of many financial assets, which will generally result in earlier recognition of allowances for credit losses on loans and other financial instruments. ASU 2016-13 is effective for the Company’s fiscal year beginning January 1, 2023 and subsequent interim periods. The Company is currently evaluating the impact the adoption of ASU 2016-13 will have on the Company’s condensed consolidated financial statements.

 

4. Leases

 

The Company has one operating lease for a commercial manufacturing facility and administrative offices located in Langhorne, Pennsylvania that runs through January 2031. There are two options that can extend the lease term for five years each. The exercise of the lease options to renew is solely at the Company’s discretion.

 

The following table presents information about the amount and timing of the liability arising from the Company’s operating lease as of June 30, 2023 ($ in thousands):

  

   Operating 
   Lease 
Maturity of Lease Liability  Liability 
2023  $122 
2024   245 
2025   245 
2026   301 
2027   315 
Thereafter   1,115 
Total undiscounted operating lease payments   2,343 
Less: Imputed interest   (292)
Present value of operating lease liability  $2,051 
Weighted average remaining lease term   8.6 years  
Weighted average discount rate   3.5%

 

Total operating lease expense for the six months ended June 30, 2023, and 2022, was $136 thousand and $103 thousand, respectively, and is recorded in cost of goods sold and selling, general, and administrative expenses in the accompanying condensed consolidated statement of operations.

 

Supplemental cash flows information related to leases was as follows ($ in thousands):

  

   June 30, 
   2023 
Cash paid for amounts included in the measurement of lease liability:     
Operating cash flows from operating lease  $136 

 

15

 

5. Inventory

 

Inventory consists of the following ($ in thousands):

  

   June 30,   December 31, 
   2023   2022 
Raw materials  $638   $295 
Work-in-progress   43    51 
Finished goods   398    156 
Inventory, gross   1,079    502 
Less: Inventory reserve for excess and slow moving inventory   —    — 
Total  $1,079   $502 

 

Inventory is maintained at the Company’s warehouse, an outsourced third-party contract manufacturing vendor, and at Amazon fulfillment centers. The Company builds its contract manufacturing products based on customer orders and immediately ships the products upon completion of the production process.

 

6. Property and Equipment, Net

 

Property and equipment consist of the following ($ in thousands):

  

   Useful Life   June 30,   December 31, 
   (Years)   2023   2022 
Machinery and equipment  3 - 10   $1,530   $973 
Office furniture and equipment  3 - 10    159    59 
Leasehold improvements  6    261    228 
Construction in progress  N/A    118    55 
Total property and equipment       2,068    1,315 
Less: accumulated depreciation and amortization       (655)   (594)
Property and equipment, net      $1,413   $721 

 

Depreciation expense for the six months ended June 30, 2023, and 2022 was $61 thousand and $49 thousand, respectively.

 

7. Intangible Assets

 

The following provides a breakdown of identifiable intangible assets as of June 30, 2023 and December 31, 2022:

  

   June 30,   December 31, 
   2023   2022 
Product/Technology Related          
Identifiable intangible assets, gross  $31   $31 
Accumulated amortization   (31)   (26)
Product/Technology Related identifiable intangible assets, net   -    5 
Marketing Related          
Customer related intangible asset, gross   17    17 
Tradename related intangible asset, gross   7    7 
Accumulated amortization   (11)   (9)
Marketing related identifiable intangible assets, net   13    15 
Total Identifiable intangible assets, net  $13   $20 

 

In connection with the May 29, 2020, acquisition of Sports Defense, the Company identified intangible assets of $55 thousand representing technology related and customer related intangibles. These assets are being amortized on a straight-line basis over their weighted average estimated useful life of 5.7 years and amortization expense amounted to $7 thousand for the six months ended June 30, 2023, and 2022, respectively.

 

16

 

As of June 30, 2023, the estimated annual amortization expense for each of the next five fiscal years is as follows:

  

      
($ in thousands):     
2023  $2 
2024   2 
2025   2 
2026   2 
2027   2 
Thereafter   3 
Total  $13 

 

8. Accrued Expenses and Other Current Liabilities

 

Accrued expenses and other current liabilities consist of the following ($ in thousands):

 

   June 30,   December 31, 
   2023   2022 
Salaries, benefits, and incentive compensation  $72   $56 
Franchise tax accrual   64    52 
Other   66    22 
Total accrued expenses and other current liabilities  $202   $130 

 

9. Common Stock

 

At June 30, 2023, the Company has reserved common stock for issued securities in relation to the following:

 

Share-based compensation plan   528,182 
Warrants to purchase common stock   3,442,904 
Restricted stock units   121,787 

 

10. Share-based Compensation

 

The 2019 Plan provides for the granting of incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights (“SARs”), restricted stock units, performance awards, dividend equivalent rights and other awards, which may be granted singly, in combination, or in tandem, and which may be paid in cash, shares of common stock of the Company or a combination of cash and shares of common stock of the Company up to an amount of 871,429 shares of common stock, all of which may be delivered pursuant to incentive stock options. Subject to adjustments pursuant to the 2019 Plan, the maximum number of shares of common stock with respect to which stock option or SARs may be granted to an executive officer during any calendar year is 14,286 shares of common stock.

 

Incentive stock options

 

On March 8, 2023, the Company granted a contractor an option to purchase up to 17,532 shares of the Company’s common stock at a per share exercise price of $2.00 under the Company’s 2019 Plan. This option award vests over a period of 12 months.

 

17

 

The following table contains information about the 2019 Plan as of June 30, 2023:

 

   Awards   Awards       Awards 
  

Reserved for

Issuance

   Issued & Outstanding  

Awards

Exercised

  

Available for

Grant

 
2019 Plan(1)   871,429    612,932    7,183    251,314 
Awards granted outside of the 2019 Plan(2)   -    37,037    11,364    - 

 

(1) Includes incentive stock options and restricted stock units discussed below.
   
(2) Includes shares of restricted common stock granted outside of the 2019 Plan to our Chief Executive Officer, Adam Levy.

 

The following table summarizes the Company’s incentive stock option activity and related information for the period ended June 30, 2023:

 

           Weighted 
       Weighted   Average 
       Average   Contractual 
   Number of   Exercise   Term in 
   Options   Price   Years 
Outstanding at January 1, 2023   524,937   $2.351416    8.38 
Granted   17,532    2.00    10.0 
Exercised   —    —    — 
Forfeited   —    —    — 
Cancelled   (10,000)   1.75    — 
Expired   (4,287)   1.40    — 
Outstanding at June 30, 2023   528,182   $2.35886    7.99 
Exercisable at June 30, 2023   337,111   $1.774915    7.21 

 

As of June 30, 2023, vested outstanding stock options had $129 thousand intrinsic value as the exercise price is greater than the estimated fair value of the underlying common stock, respectively. As of June 30, 2023, there was approximately $17 thousand of total unrecognized share-based compensation related to unvested stock options, which the Company expects to recognize over the next 11 months excluding options fully contingent upon certain sales-based milestones being achieved within 18 to 36 months of commercial release.

 

The Company recognizes compensation expense for stock option awards on a straight-line basis over the applicable service period of the award. The service period is generally the vesting period. The following assumptions were used to calculate share-based compensation expense for the period ended June 30, 2023:

 

Volatility   257.64%
Risk-free interest rate   4.21%
Dividend yield   0.0%
Expected term   5.50 years 

 

The Company does not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. Accordingly, the Company has elected to use the “simplified method” to estimate the expected term of its share-based awards. The simplified method computes the expected term as the sum of the award’s vesting term plus the original contractual term divided by two.

 

Based on the lack of historical data of volatility for the Company’s common stock, the Company based its estimate of expected volatility on a weighted-average of the historical volatility of comparable public companies that manufacture similar products and are similar in size, stage of life cycle, and financial leverage.

 

Restrictive Stock Awards

 

Effective as of August 1, 2022, the Company granted a restricted stock award of 84,750 shares of the Company’s common stock to certain officers and employees, all of which shares vest in four equal installments on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. Under ASC 718, the Company has measured the value of the 84,750 shares granted based on a closing price of the closing price of the Company’s stock at the grant date of the RSU Grant ($1.82 per share).

 

18

 

Effective as of January 1, 2022, the Company granted a restricted stock award of 11,364 shares of the Company’s common stock to Adam Levy for his service as our Chief Executive Officer pursuant to the terms of his Executive Employment Agreement dated November 4, 2021, all of which shares vested monthly from January 1, 2022 through December 31, 2022. Under ASC 718, the Company has measured the value of the 11,364 shares granted based on the closing price of the Company’s stock at the grant date of the RSU Grant ($4.40 per share).

 

Effective as of January 3, 2023, the Company granted a restricted stock award of 37,037 shares of the Company’s common stock to Adam Levy for his service as our Chief Executive Officer pursuant to the terms of his Executive Employment Agreement dated December 30, 2022, all of which shares vested monthly from January 3, 2023 through December 31, 2023. Under ASC 718, the Company has measured the value of the 37,037 shares granted based on the closing price of the Company’s stock at the grant date of the RSU Grant ($1.35 per share).

       Weighted 
       Average 
   Number of   Grant Date 
   Units   Fair Value 
Outstanding at January 1, 2023   90,432   $1.43 
Granted   37,037    1.35 
Exercised and converted to common shares   (5,682)   4.40 
Forfeited   —    — 
Outstanding at June 30, 2023   121,787   $1.68 
Exercisable at June 30, 2023   30,466   $1.68 

 

Compensation expense will be recognized ratably over the total vesting schedule. The Company will periodically adjust the cumulative compensation expense for forfeited awards. As of June 30, 2023, there was $121 thousand unrecognized share-based compensation related to unvested RSUs, which the Company expects to recognize over the next 3 years.

 

Stock based compensation and restricted stock vesting of $53 thousand and $134 thousand has been recorded for the six months ended June 30, 2023, and 2022, respectively.

 

Warrants

 

The following table shows a summary of common stock warrants through June 30, 2023:

 

       Weighted   Weighted 
       Average   Average 
   Number of   Exercise   Contractual 
   Warrants   Price   Term in Years 
Outstanding at January 1, 2023   3,637,190   $5.16281    3.65 
Granted   —    —    — 
Exercised   (112,466)   0.55    — 
Forfeited   —    —    — 
Cancelled   (81,820)   0.91    — 
Expired   —    —    — 
Outstanding at June 30, 2023   3,442,904   $5.414793    3.35 
Exercisable at June 30, 2023   3,442,904   $5.414793    3.35 

 

As of June 30, 2023, vested outstanding warrants had $0 intrinsic value as the exercise price is greater than the estimated fair value of the underlying common stock.

 

11. Noncontrolling Interest in Joint Venture

 

On March 1, 2023, the Company acquired a 50% interest in a JV, named CG Converting and Packaging, LLC, with C.G. Laboratories Inc. (“CG Labs”) for its converting and packaging business (see Note 1). The JV is owned 50% by the Company and 50% by CG Labs. CG Labs contributed its existing converting and packaging division to the JV, including, but not limited to, its facilities, equipment, employees, and customers. The Company will contribute $500,000 to the JV, on a schedule to be determined, to be used for equipment and facility upgrades as well as general corporate purposes for JV. As of June 30, 2023, the Company has contributed $350,000 of its $500,000 commitment.

 

19

 

The JV is considered to be a variable interest entity (“VIE”), as defined by authoritative accounting guidance. A VIE must be consolidated by a reporting entity if the reporting entity is the primary beneficiary because it has (i) the power to direct the VIE’s activities that most significantly impact the VIE’s economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE. All major decisions related to the JV that most significantly impact its economic performance, including but not limited to operating procedures with respect to business affairs. Therefore, we have consolidated the JV.

 

12. Notes Payable

 

Economic Injury Disaster Loan

 

On May 28, 2020, the Company entered into the standard loan documents required for securing a loan (the “EIDL Loan”) from the SBA under its Economic Injury Disaster Loan (“EIDL”) assistance program in light of the impact of the COVID-19 pandemic on the Company’s business. Pursuant to that certain Loan Authorization and Agreement (the “SBA Loan Agreement”), the principal amount of the EIDL Loan is up to $260,500, with proceeds to be used for working capital purposes. Interest accrues at the rate of 3.75% per annum. Installment payments, including principal and interest, are due monthly which the Company began paying in December 2022 (thirty months from the date of the SBA Note) in the amount of $1,270. The balance of principal and interest is payable thirty years from the date of the SBA Note. In connection therewith, the Company received an $8,000 advance, which does not have to be repaid. The balances of the principal and accrued interest amounted to $280 thousand and $283 thousand as of June 30, 2023 and December 31, 2022, respectively.

 

The future annual principal amounts and accrued interest to be paid as of June 30, 2023 are as follows:

 

   Amount 
For the year ending December 31 ($ in thousands):     
2023 (remainder of the year)  $3 
2024   5 
2025   5 
2026   5 
2027   6 
Thereafter   256 
Total  $280 

 

13. Convertible Notes Payable

 

On March 11, 2021, the Company issued Auctus Fund, LLC, a Delaware limited liability company a one-year senior secured convertible promissory note in the principal amount of $1.68 million, which included $180 thousand of interest which was deemed fully earned as of the issuance date (the “Auctus Note”). The Auctus Note was fully repaid (including all principal and interest) on March 15, 2022 with a one-time cash payment of $1.68 million.

 

On September 2, 2021, the Company issued to certain holders one-year subordinated secured convertible promissory notes in the aggregate principal amount of $1,814 thousand, which included $194 thousand of interest which was deemed fully earned as of the issuance date (the “September 2 Notes”). On January 25, 2022, the Company repaid one of the September 2 Notes in full with a one-time cash payment of $300 thousand of outstanding principal and accrued but unpaid interest. The Company incurred pre-payment penalty of $17 thousand with respect to the repayment of the note and the remaining unamortized debt discount in the amount of $133 thousand was written off and both amounts were recorded as a loss on extinguishment of debt of $150 thousand in accompany condensed consolidated statement of operations during 2022. The repayment extinguished the note in its entirety. On September 6, 2022, the outstanding balance on the remaining September 2 Notes’ was repaid in full which consisted of principal of $1,478 thousand.

 

20

 

14. Warrant Liability

 

On September 2, 2021, March 11, 2021, February 3, 2021, December 24, 2020, March 18, 2020, September 10, 2019, and November 6, 2019, the Company issued 22,019, 34,286, 7,429, 7,286, 44,286, 35,715 and 114,286 warrants, respectively, as equity issuance consideration, in connection with a private placement of the Company’s common stock. The warrants entitle the holder to purchase one share of our common stock at an exercise price equal to $0.49 to $5.25 per share at any time on or after their issuance date and on or prior to the close of business 3 or 5 years, as applicable, after the issuance date (the “Termination Date”). The Company determined that these warrants are free standing financial instruments that are legally detachable and separately exercisable from the common stock included in the public share offering. Management also determined that the warrants required classification as a liability pursuant to ASC 815. In accordance with the accounting guidance, the outstanding warrants are recognized as a warrant liability on the balance sheet and are measured at their inception date fair value and subsequently re-measured at each reporting period with changes being recorded as a component of other income in the statement of operations.

 

The warrants outstanding and fair values at each of the respective valuation dates are summarized below:

 

Warrant Liability  Warrants Outstanding   Fair Value per Share   Fair Value 
Fair value as of year ended 12/31/2022   265,305       $242 
Exercise of warrants   (194,286)             (154)
Change in fair value of warrant liability   -        77 
Fair value as of period ended 6/30/2023   71,019        $165 

 

The warrant liabilities are considered Level 3 liabilities on the fair value hierarchy as the determination of fair value includes various assumptions about of future activities and the Company’s stock prices and historical volatility of Guideline Public Companies as inputs.

 

15. Commitments and Contingencies

 

Litigation

 

The Company may be subject to legal proceedings and claims that arise in the ordinary course of business. Management is not currently aware of any matters that will have a material effect on the financial position, results of operations, or cash flows of the Company.

 

Service Agreement

 

On March 21, 2023, the Company entered into a Services Agreement with GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (“Haleon”) to supply material for a consumer product to be developed and released in the future. There can be no guaranty that a consumer product will be released or, if released, that it will be successful. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC is a Haleon group company.

 

16. Concentrations of Risk

 

The Company’s revenues are concentrated in a small group of customers with some individually having more than 10% of total revenues.

 

Revenues from two customers that exceeded 10% of total revenues for the six months ended June 30, 2023, were 40% and 14%. The accounts receivable from those top two customers were 0% and 22% as well as 13%, 15%, and 16% from three other customers of the total accounts receivable as of June 30, 2023.

 

21

 

Revenues from two customers that exceeded 10% of total revenues for the six months ended June 30, 2022, were 40% and 25%. The accounts receivable from those top two customers by revenue were 6% and 46% as well as 15% and 22% from two other customers of the total accounts receivable as of June 30, 2022.

 

The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash, cash equivalents and marketable securities. Cash balances are maintained principally at major U.S. financial institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to regulatory limits. Such cash balances are currently in excess of the FDIC insurance limit of $250 thousand. As of June 30, 2023, the total amount exceeding such limit was $3 million. The Company has not experienced any credit losses associated with its cash balances in the past. The Company invests its cash equivalents in U.S. treasury bills with original maturities of three months or less.

 

Marketable securities are comprised of U.S. treasury bills with original maturities greater than three months. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents, and marketable securities and performs periodic evaluations of the credit standing of such institutions.

 

17. Related Party Transactions

 

Convertible Promissory Note

 

On September 2, 2021, the Company issued three Secured Convertible Promissory Notes to members of the board of directors in aggregate amounts of $150,000 to Mr. Stein, $150,000 to Mr. Stefansky (Bezalel Partners, LLC), and $50,000 to Dr. Zeldis as part of the September 2 Notes. The notes were repaid in full in 2022.

 

Advances

 

Dr. Jerome Zeldis, a member of the Company board of directors, has an outstanding balance due of $25,000 for services as of June 30, 2023 and $40,000 as of December 31, 2022, included in accounts payable in the accompanying condensed consolidated balance sheets.

 

18. Subsequent Events

 

Management of the Company has performed a review of events and transactions occurring after the condensed consolidated balance sheet date to determine if there were any such events or transactions requiring adjustment to or disclosure in the accompanying condensed consolidated financial statements and has noted none except as follows.

 

In July 2023, the Company announced a new strategic relationship with Enigma Health, a new joint venture company, for retail distribution and marketing services in North America. In addition to the Company, Enigma Health will also be providing services for Moiety, Inc., a topical lotion and creams manufacturer.

 

22

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis are intended to help prospective investors understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with our financial statements and related notes thereto included elsewhere in this information statement.

 

The statements in this discussion regarding industry outlook, expectations regarding our future performance, liquidity and capital resources and other non-historical statements are forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to, the risks and uncertainties described in “Special Note Regarding Forward-Looking Statements.” Actual results may differ materially from those contained in any forward-looking statements.

 

The NexGel Financial Statements, discussed below, reflect the NexGel financial condition, results of operations, and cash flows. The financial information discussed below and included in this information statement, however, may not necessarily reflect what the NexGel financial condition, results of operations, or cash flows would have been had NexGel been operated as a separate, independent entity during the years presented, or what the NexGel financial condition, results of operations, and cash flows may be in the future.

 

Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains “forward-looking statements,” which include information relating to future events, future financial performance, strategies, expectations, competitive environment and regulation. Words such as “may,” “should,” “could,” “would,” “predict,” “potential,” “continue,” “expect,” “anticipate,” “future,” “intend,” “plan,” “believe,” “estimate,” and similar expressions, as well as statements in future tense, identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will actually be achieved. Forward-looking statements are based on information we have when those statements are made or our management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to:

 

  ● our ability to continue as a going concern;
     
  ● inadequate capital;
     
  ● inadequate or an inability to raise sufficient capital to execute our business plan;
     
  ● our ability to comply with current good manufacturing practices;
     
  ● loss or retirement of key executives;
     
  ● our plans to make significant additional outlays of working capital before we expect to generate significant revenues and the uncertainty regarding when we will begin to generate significant revenues, if we are able to do so;
     
  ● adverse economic conditions and/or intense competition;
     
  ● loss of a key customer or supplier;
     
  ● entry of new competitors;
     
  ● adverse federal, state and local government regulation;
     
  ● technological obsolescence of our manufacturing process and equipment;
     
  ● technical problems with our research and products;
     
  ● risks of mergers and acquisitions including the time and cost of implementing transactions and the potential failure to achieve expected gains, revenue growth or expense savings;
     
  ● price increases for supplies and components; and
     
  ● the inability to carry out our business plans.

 

23

 

For a discussion of these and other risks that relate to our business and investing in shares of our common stock, you should carefully review the risks and uncertainties described elsewhere in this Quarterly Report on Form 10-Q. The forward-looking statements contained in this Quarterly Report on Form 10-Q are expressly qualified in their entirety by this cautionary statement. We do not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

 

Overview

 

We manufacture high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. We specialize in custom gels by capitalizing on proprietary manufacturing technologies. We have historically served as a contract manufacturer, supplying our gels to third parties who incorporate them into their own products and have recently began producing our own consumer products using our gels focused on proprietary branded products and white label opportunities. Both our gels and our consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies. Together, these technologies enable us to produce gels that can satisfy rigid tolerance specifications with respect to a wide range of physical characteristics (e.g., thickness, water content, adherence, absorption, moisture vapor transmission rate [a measure of the passage of water vapor through a substance] and release rate) while maintaining product integrity. Additionally, we have the manufacturing ability to offer broad choices in the selection of liners onto which the gels are coated. Consequently, we and our customers are able to determine tolerances in moisture vapor transmission rate and active ingredient release rates while personalizing color and texture.

 

Joint Venture

 

On March 1, 2023, the Company acquired of 50% interest in a newly formed joint venture (“JV”), CG Converting and Packaging, LLC, with C.G. Laboratories Inc. (“CG Labs”) for its converting and packaging business. The agreement is effective March 1, 2023. As a result of this transaction, the Company owns 50% of the JV, with the remaining 50% held by CG Labs.

 

Results of Operations

 

The following sections discuss and analyze the changes in the significant line items in our condensed consolidated statements of operations for the comparison periods identified.

 

Comparison of the Three Months ended June 30, 2023, and 2022

 

Revenues, net.

 

For the three months ended June 30, 2023, revenues were $1.17 million and increased by $606 thousand, or 108.0%, when compared to $561 thousand for the three months ended June 30, 2022. The increase in our overall revenues was primarily due to sales growth in both our contract manufacturing and branded products, including the revenue from CG Labs from April 1, 2023 through June 30, 2023 of $602 thousand.

 

The Company has four distinct lines of business; Contract Manufacturing, Custom & White Label, Consumer Branded Products, and Medical Devices as further described below.

 

Contract Manufacturing

 

Customers order rolls of gel (“rollstock”). The rollstock is shipped to our customers, which they package into finished goods. Historically, this has been the Company’s primary source of revenue.

 

Custom & White Label

 

These products often infuse various ingredients into our base gel to develop unique product offerings to satisfy market demand (e.g. aloe infused into the gel for a beauty mask). The rollstock is converted and packaged into salable units. The finished goods are shipped to the customer, who is ultimately responsible for product distribution. Frequently these products started as development deals, in which the customer paid the company a small fee to develop a specific product. Once completed, the customer places a large order for newly developed product.

 

24

 

Consumer Branded Products

 

These products are finished goods marketed and sold directly to the customer by the Company through online and retail channels. The Company is responsible for sales, marketing, and distribution. These products carry the Company’s brand names.

 

Medical Devices

 

Medical Devices are a hybrid business, combining elements of Custom & White Label and Consumer Branded Products. Medical Devices, which are not yet marketed, are expected to be distributed through strategic partnerships. The Company will manufacture and possibly convert/package the device while the strategic partner brings the product to market. Small market Medical Devices could be launched by the Company, but also be offered to a distributor to reach the full scale of the market.

 

Gross profit. Our gross profit was $175 thousand for the three months ended June 30, 2023, compared to a gross profit of $101 thousand for the three months ended June 30, 2022. The increase of $74 thousand in gross profit quarter over quarter was primarily due to the higher volume of contract manufacturing sales against fixed costs partially offset by higher manufacturing labor costs and increased manufacturing of promotional materials, customer product samples and other marketing materials to support our new product launches. Gross profit was approximately 15% for the three months ended June 30, 2023, compared to a gross profit of 18% for the three months ended June 30, 2022.

 

The components of cost of revenues are as follows for the three months ended June 30, 2023 and 2022 ($ in thousands):

 

   Three Months Ended 
   June 30, 
   2023   2022 
Cost of revenues          
Materials and finished products  $594   $196 
Compensation and benefits   163    163 
Depreciation and amortization   21    22 
Equipment, production and other expenses   214    79 
Total cost of revenues  $992   $460 

 

Cost of revenues increased by $532 thousand, or 115.7%, to $992 thousand for the three months ended June 30, 2023, as compared to $460 thousand for the three months ended June 30, 2022. The increase in cost of revenues is pertains to and increase in materials and finished products and equipment, production and other expenses. These increases primarily align with the new product line growth and increased amounts of promotional materials, customer product samples and other marketing materials to support our new product launches.

 

Selling, general, and administrative expenses. The following table highlights selling, general, and administrative expenses by type for the three months ended June 30, 2023 and 2022 ($ in thousands):

 

   Three Months Ended 
   June 30, 
   2023   2022 
Selling, general and administrative expenses          
Compensation and benefits  $176   $121 
Share-based compensation   23    43 
Depreciation and amortization   16    7 
Advertising, marketing, & Amazon fees   166    80 
Investor & shareholder services   140    129 
Franchise tax & corporate insurance   63    48 
Professional & consulting fees   246    217 
Other expenses and professional fees   52    63 
Total selling, general and administrative expenses  $882   $708 

 

25

 

Selling, general and administrative expenses increased by $174 thousand, or 24.6%, to $882 thousand for the three months ended June 30, 2023, as compared to $708 thousand for the three months ended June 30, 2022. The increase in Selling, general and administrative expenses is primarily attributable to the factors described below.

 

Compensation and benefits increased by $55 thousand, or 45.5%, to $176 thousand for the three months ended June 30, 2023, as compared to $121 thousand for the three months ended June 30, 2022. The number of employees increased compared to the prior period and officer compensation increased in conjunction with contract renewals.

 

Share-based compensation decreased by $20 thousand, or 46.5%, to $23 thousand for the three months ended June 30, 2023, as compared to $43 thousand for the three months ended June 30, 2022. The decrease in share-based compensation related to the issuance of stock options and restricted awards to our officers, employees, and advisors in the prior year period that were not issued in the current period.

 

Advertising, marketing, Amazon fees increased by $86 thousand, or 107.5% to $166 thousand for the three months ended June 30, 2023, as compared to $80 thousand for the three months ended June 30, 2022. The increase is due to the increased Amazon selling fees and Amazon Advertising, which correlates with our increase in Branded Sales, as well as an increase in advertising and marketing in channels outside of Amazon.

 

Investor and shareholder services increased by $11 thousand, or 8.5% to $140 thousand for the three months ended June 30, 2023, as compared to $129 thousand for the three months ended June 30, 2022. The increase is due to an increase in investor outreach.

 

Franchise taxes and corporate insurance increased by $15 thousand, or 31.3% to $63 thousand for the three months ended June 30, 2023, as compared to $48 thousand for the three months ended June 30, 2022.

 

Professional and consulting fees increased by $29 thousand, or 13.4% to $246 thousand for the three months ended June 30, 2023, as compared to $217 thousand for the three months ended June 30, 2022. We continued to incur accounting and consulting fees associated with public company governance requirements.

 

Other expenses decreased by $11 thousand, or 17.5%, to $52 thousand for the three months ended June 30, 2023 from $63 thousand for the three months ended June 30, 2022. Other selling, general and administrative expenses generally consist of costs associated with our selling efforts and general management, including information technology, travel, training and recruiting.

 

Research and development expenses. Research and development expenses were $55 thousand and $111 thousand for the three months ended June 30, 2023 and June 30, 2022, respectively.

 

Comparison of the Six Months ended June 30, 2023 and 2022

 

Revenues, net.

 

For the six months ended June 30, 2023, revenues were $1.79 million and increased by $830 thousand, or 86.8%, when compared to $956 thousand for the six months ended June 30, 2022. The increase in our overall revenues was primarily due to sales growth in both our contract manufacturing and branded products, including the revenue from CG Labs from April 1, 2023 through June 30, 2023 of $792 thousand.

 

Gross profit. Our gross profit was $117 thousand for the six months ended June 30, 2023, compared to a gross profit of $72 thousand for the six months ended June 30, 2022. The increase in profit recorded for the six months ended June 30, 2023, as compared to the six months ended June 30, 2022, was primarily due to the higher volume of contract manufacturing sales against fixed costs, partially offset by increased manufacturing of promotional materials, customer product samples and other marketing materials to support our new product launches. Gross profit was approximately 7% for the six months ended June 30, 2023, compared to a gross profit of 8% for the six months ended June 30, 2022. The components of cost of revenues are as follows for the six months ended June 30, 2023 and 2022 ($ in thousands):

 

  

Six Months Ended

June 30,

 
   2023   2022 
Cost of revenues          
Materials and finished products  $949   $290 
Compensation and benefits   334    342 
Depreciation and amortization   42    43 
Equipment, production, and other expenses   344    209 
Total cost of revenues  $1,669   $884 

 

26

 

Cost of revenues increased by $785 thousand, or 88.8%, to $1.67 million for the six months ended June 30, 2023, as compared to $884 thousand for the six months ended June 30, 2022. The increase in cost of revenues pertains to and increase in materials and finished products and equipment, production and other expenses. These increases primarily align with the new product line growth and increased amounts of promotional materials, customer product samples and other marketing materials to support our new product launches.

 

Selling, general, and administrative expenses. The following table highlights selling, general, and administrative expenses by type for the six months ended June 30, 2023 and 2022 ($ in thousands):

 

  

Six Months Ended

June 30,

 
   2023   2022 
Selling, general, and administrative expenses          
Compensation and benefits  $321   $233 
Share-based compensation   42    61 
Depreciation and amortization   26    14 
Advertising, marketing, & Amazon fees   260    119 
Investor & shareholder services   237    278 
Franchise tax & corporate insurance   122    97 
Professional & consulting fees   552    443 
Other expenses   119    222 
Total selling, general and administrative expenses  $1,679   $1,467 

 

Selling, general, and administrative expenses increased by $212 thousand, or 14.5%, to $1.68 million for the six months ended June 30, 2023, as compared to $1.47 million for the six months ended June 30, 2022. The increase in selling, general, and administrative expenses is primarily attributable to our costs for professional fees and other administrative expenses in the current period associated with public company governance requirements.

 

Compensation and benefits increased by $88 thousand, or 37.8%, to $321 thousand for the six months ended June 30, 2023, as compared to $233 thousand for the six months ended June 30, 2022. The number of employees increased compared to the prior period and officer compensation increased in conjunction with contract renewals.

 

Share-based compensation decreased by $19 thousand, or 31.1%, to $42 thousand for the six months ended June 30, 2023, as compared to $61 thousand for the six months ended June 30, 2022. The share-based compensation related to the issuance of stock restricted stock awards and options to our CEO and options to board members, employees, and advisors.

 

Advertising, marketing, Amazon fees increased by $141 thousand or 118.5%, to $260 thousand for the six months ended June 30, 2023, as compared to $119 thousand for the six months ended June 30, 2022. The increase is due to the increased Amazon selling fees as well as an increase in advertising and marketing.

 

Investor and shareholder services decreased by $41 thousand or 14.7%, to $237 thousand for the six months ended June 30, 2023, as compared to $278 thousand for the six months ended June 30, 2022. The decrease is due to initial fees related to the Nasdaq listing in 2022 upon the IPO occurring on December 27, 2021.

 

Franchise taxes and corporate insurance increased by $25 thousand or 25.8%, to $122 thousand for the six months ended June 30, 2023, as compared to $97 thousand for the six months ended June 30, 2022.

 

27

 

Professional and consulting fees increased by $109 thousand or 24.6% to $552 thousand for the six months ended June 30, 2023, as compared to $443 thousand for the six months ended June 30, 2022. We continued to incur accounting and consulting fees associated with public company governance requirements.

 

Other expenses decreased by $103 thousand, or 46.4%, to $119 thousand for the six months ended June 30, 2023 from $222 thousand for the six months ended June 30, 2022. Other selling, general and administrative expenses generally consist of costs associated with our selling efforts and general management, including information technology, travel, training and recruiting.

 

Research and development expenses. Research and development expenses decreased by $51 thousand to $84 thousand for the six months ended June 30, 2023 from $135 thousand for the six months ended June 30, 2022. The decrease is due to the completion of development efforts of two proof of concept studies for drug delivery candidates utilizing our hydrogel technology.

 

Liquidity and Capital Resources

 

Cash Flow

(in thousands)

 

   June 30,   June 30, 
   2023   2022 
Net cash used in operating activities  $(1,926)  $(1,495)
Net cash provided by investing activities   4,519    (5,402)
Net cash used in financing activities   (3)   (2,033)
Net increase (decrease) in cash and cash equivalents   2,590    (8,930)
Cash and cash equivalents at beginning of year   1,101    13,350 
Cash and cash equivalent at end of quarter  $3,691   $4,420 

 

As of June 30, 2023, we had $3.7 million of cash and $612 thousand of marketable securities, compared to $1.1 million of cash and $5.5 million of marketable securities at December 31, 2022. Net cash used in operating activities was $1.9 million and $1.5 million for the six months ended June 30, 2023 and 2022, respectively.

 

Net cash provided by investing activities was $4.5 million and net cash used in investing activities was $5.4 million for the six months ended June 30, 2023 and 2022, respectively, consisting of the sales of marketable securities of $4.8 million and purchases of capital equipment of $253 thousand for six months ended June 30, 2023.

 

Net cash used in financing activities for the six months ended June 30, 2023 and 2022 was $3 thousand and $2 million and is attributable to the principal payments of notes payable and convertible notes, respectively.

 

At June 30, 2023, current assets totaled $6.7 million and current liabilities totaled $1.7 million, as compared to current assets totaling $7.5 million and current liabilities totaling $859 thousand at December 31, 2022. As a result, we had working capital of $5.0 million at June 30, 2023, compared to a working capital of $6.6 million at December 31, 2022. The decrease in the working capital as of June 30, 2023 is primarily attributable to the loss from operations of $1.6 million.

 

We have never declared or paid any cash dividends on our common stock. For the foreseeable future, we anticipate that all available funds and any earnings generated in our business will be used to finance the growth of our business and will not be paid out as dividends to our shareholders. Any future determination related to our dividend policy will be made at the discretion of our Board of Directors and will depend upon, among other factors, our results of operations, financial condition, capital requirements, contractual restrictions, business prospects and other factors our Board of Directors may deem relevant.

 

Management is exploring new product channel sales in consumer products, such as cosmetics, athletic products, and proprietary medical devices. The Company has increased its focus on sales and developing a sales pipeline for potential customers. This customer base expansion will enable us to provide financial stability for the foreseeable future, expand our current processes, and position us for long-term shareholder value creation.

 

We have sufficient capital to maintain as a going concern due to the capital raise that occurred on December 27, 2021. We intend to maintain and attempt to grow our existing contract manufacturing business. We also plan to continue building and developing its catalog of consumer products for sale to branding partners and to use our in-house capabilities to create and test market additional branded products. These products will be target marketed and sold online through social media, television and online marketplaces. Furthermore, the Company plans to develop its own proprietary medical devices and explore drug delivery programs for its technology. Additionally, the Company continues to evaluate strategic initiatives (e.g., acquisitions) and additional capital raises through debt or equity may be necessary to achieve these objectives.

 

28

 

We expect to continue incurring losses for the near-term future. Our ability to continue to operate as a going concern in the long-term is dependent upon our ability to manage and grow our current products and to ultimately achieve profitable operations. Management may consider various options to raise capital to fund potential acquisitions through equity or debt offerings. There can be no assurances, however, that management will be able to obtain sufficient additional funds, if needed, or that such funds, if available, will be obtained on terms satisfactory to us. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets and liabilities that might be necessary should we be unable to continue as a going concern.

 

Additionally, it is reasonably possible that estimates made in the financial statements have been, or will be, materially and adversely impacted in the near term as a result of these conditions, including the recoverability of long-lived assets.

 

Off Balance Sheet Arrangements

 

As of June 30, 2023, we had no off-balance sheet arrangements in the nature of guarantee contracts, retained or contingent interests in assets transferred to entities (or similar arrangements serving as credit, liquidity or market risk support to entities for any such assets), or obligations (including contingent obligations) arising out of variable interests in entities providing financing, liquidity, market risk or credit risk support to us, or that engage in leasing, hedging or research and development services with us.

 

Critical Accounting Policies and Estimates

 

The preparation of our Financial Statements in accordance with generally accepted accounting principles is based on the selection and application of accounting policies that require us to make significant estimates and assumptions about the effects of matters that are inherently uncertain. We consider the accounting policies discussed below to be critical to the understanding of our Financial Statements. Actual results could differ from our estimates and assumptions, and any such differences could be material to our Financial Statements.

 

Share-based compensation – We utilize share-based compensation in the form of incentive stock options. The fair values of incentive stock option award grants are estimated as of the date of grant using a Black-Scholes option valuation model. Compensation expense is recognized in the statements of operations on a straight-line basis over the requisite service period, which is generally the vesting period required to obtain full vesting. The expected term of the awards granted is estimated using the simplified method which computes the expected term as the sum of the award’s vesting term plus the original contractual term divided by two.

 

Warrant Liability – Warrants to purchase common stock were issued in connection with equity financing raises which occurred during 2019 through 2021. The fair values of the warrants are estimated as of the date of issuance and again at each year end using a Black-Scholes option valuation model. At issuance, the fair value of the warrant is recognized as an equity issuance cost within additional paid-in-capital. Fair value adjustments to the warrant liability are recognized in other income (expense) in the statements of operations. The expected term of the awards granted are based on either the three-year or five-year contractual expiration date.

 

Black Scholes Inputs - The fair value of each stock option award and warrant issued was estimated on the date of grant using a Black-Scholes option-valuation model, which requires management to make certain assumptions regarding: (i) fair value of the common stock that underlies the stock option; (ii) the expected volatility in the market price of our common stock; (iii) dividend yield; (iv) risk-free interest rates; and (iv) the period of time employees are expected to hold the award prior to exercise (referred to as the expected term). Under the Black-Scholes option-valuation model, entities typically estimate the expected volatility based on historical volatilities of the entity’s own common stock. Based on the lack of historical data of volatility for the Company’s common stock, the Company based its estimate of expected volatility on a weighted average of the historical volatility of comparable public companies that manufacture similar products and are similar in size, stage of life cycle, and financial leverage. The fair value of the common stock that underlies the stock option is estimated by the Company considering the price of the most recent issuance of the Company’s common stock. The dividend yield is based upon the assumption that the Company will not declare a dividend over the life of the options. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for bonds with maturities consistent with the expected term of the related award.

 

29

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not required.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures.

 

As of June 30, 2023, we conducted an evaluation of the effectiveness of our “disclosure controls and procedures” (“Disclosure Controls”), as defined by Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Disclosure Controls evaluation was done under the supervision and with the participation of management, including our chief executive officer and chief financial officer. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based upon this evaluation, our chief executive officer and chief financial officer have concluded that our Disclosure Controls and Procedures were effective as of June 30, 2023 at a reasonable level of assurance.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting during the fiscal quarter ended June 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims.

 

There are no material proceedings in which any of our directors, officers or affiliates or any registered or beneficial shareholder of more than 5% of our common stock is an adverse party or has a material interest adverse to our interest

 

ITEM 1A. RISK FACTORS

 

Not required for smaller reporting companies.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

(a) Sales of Unregistered Securities during the three months ended June 30, 2023

 

The Company did not sell any unregistered securities during the three months ended June 30, 2023.

 

(b) Issuer Repurchases of Securities during the three months ended June 30, 2023

 

The Company did not repurchase any of its securities during the three months ended June 30, 2023.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

Not applicable.

 

30

 

ITEM 6. EXHIBITS

 

See “Index to Exhibits” for a description of our exhibits.

 

Index to Exhibits

 

Exhibit No.   Description
3.1   Certificate of Incorporation of AquaMed Technologies, Inc. (incorporated by reference to Exhibit 3.1 to Form S-1, filed with the SEC on January 9, 2019).
3.2   Certificate of Amendment to Certificate of Incorporation of AquaMed Technologies, Inc. (incorporated by reference to Exhibit 3.2 to Form S-1, filed with the SEC on January 9, 2019).
3.3   Amended and Restated Certificate of Incorporation of AquaMed Technologies, Inc. (incorporated by reference to Exhibit 3.3 to Amendment No. 1 to Form S-1, filed with the SEC on March 11, 2019).
3.4   Certificate of Amendment to the Amended and Restated Certificate of Incorporation of AquaMed Technologies, Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on November 14, 2019)
3.5   Certificate of Amendment to the Amended and Restated Certificate of Incorporation of NexGel, Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on May 29, 2020)
3.6   Certificate of Amendment to the Amended and Restated Certificate of Incorporation of NexGel, Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on August 2, 2021)
3.7   Amended and Restated Bylaws of AquaMed Technologies, Inc. (incorporated by reference to Exhibit 3.5 to Amendment No. 1 to Form S-1, filed with the SEC on March 11, 2019).
31.1*   Certification of Chief Executive Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.
31.2*   Certification of Chief Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.
32.1*   Certification of Chief Executive Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*   Certification of Chief Financial Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101*   The following materials from the Company’s Quarterly Report on Form 10-Q for the fiscal quarter June 30, 2022, formatted in iXBRL (Inline eXtensible Business Reporting Language), (i) Balance Sheets, (ii) Statements of Operations, (iii) Statements of Stockholders’ Equity, (iv) Statements of Cash Flows, and (v) Notes to the Financial Statements.
104*   Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit).

 

* Filed herewith.
   
** Certain exhibits and schedules have been omitted and the Company agrees to furnish supplementary to the Securities and Exchange Commission a copy of any omitted exhibits upon request.

 

31

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  NEXGEL, INC.
     
Date:August 14, 2023 By: /s/ Adam Levy
  Name: Adam Levy
  Title: Chief Executive Officer
    (Principal Executive Officer)
     
  By: /s/ Adam E. Drapczuk III
  Name: Adam E. Drapczuk III
  Title: Chief Financial Officer
    (Principal Financial Officer)

 

32

 

 EX-31.1 2 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULES 13a-14(A) AND 15d-14(A)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

I, Adam Levy, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of NexGel, Inc. (the “registrant”);
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15I and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
b. designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
c. evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
d. disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 14, 2023 By: /s/ Adam Levy
    Adam Levy
    Chief Executive Officer
    (Principal Executive Officer)

 

 

 

 EX-31.2 3 ex31-2.htm

 

EXHIBIT 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULES 13a-14(A) AND 15d-14(A)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

I, Adam E. Drapczuk III, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of NexGel, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 14, 2023 By: /s/ Adam E. Drapczuk III
    Adam E. Drapczuk III
    Chief Financial Officer
    (Principal Financial Officer)

 

 

 

 EX-32.1 4 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

This certification is furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350) and accompanies the Quarterly Report on Form 10-Q (the “Form 10-Q”) for the six months ended June 30, 2023, of NexGel, Inc. (the “Company”). I, Adam Levy, the Chief Executive Officer and Principal Executive Officer of the Company, certify that, based on my knowledge:

 

(1) The Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
   
(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the periods covered in this report.

 

Date: August 14, 2023 By: /s/ Adam Levy
  Name: Adam Levy
  Title: Chief Executive Officer
    (Principal Executive Officer)

 

The foregoing certification is being furnished as an exhibit to the Form 10-Q pursuant to Item 601(b)(32) of Regulation S-K and Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and, accordingly, is not being filed as part of the Form 10-Q for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

 

 

 EX-32.2 5 ex32-2.htm

 

EXHIBIT 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

This certification is furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350) and accompanies the Quarterly Report on Form 10-Q (the “Form 10-Q”) for the six months ended June 30, 2023 of NexGel, Inc. (the “Company”). I, Adam E. Drapczuk III, the Chief Financial Officer and Principal Financial Officer of the Company, certify that, based on my knowledge:

 

(1) The Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
   
(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the periods covered in this report.

 

Date: August 14, 2023 By: /s/ Adam E. Drapczuk III
  Name: Adam E. Drapczuk III
  Title: Chief Financial Officer
    (Principal Financial Officer)

 

The foregoing certification is being furnished as an exhibit to the Form 10-Q pursuant to Item 601(b)(32) of Regulation S-K and Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and, accordingly, is not being filed as part of the Form 10-Q for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

 

 

 EX-101.SCH 6 nxgl-20230630.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Description of Business, Stock Split and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Significant Accounting Policies and Estimates link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Accrued Expenses and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Common Stock link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Share-based Compensation link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Noncontrolling Interest in Joint Venture link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Convertible Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Warrant Liability link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Concentrations of Risk link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Significant Accounting Policies and Estimates (Policies) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Significant Accounting Policies and Estimates (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Common Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Share-based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Warrant Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Description of Business, Stock Split and Basis of Presentation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Schedule of Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Schedule of Fair Value of Financial Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Schedule of Disaggregated Revenue by Sales Type (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Significant Accounting Policies and Estimates (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Schedule of Future Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Schedule of Supplemental Cash Flows Information Related to Leases (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Leases (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Property and Equipment, Net (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Schedule of Breakdown of Identifiable Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Schedule of Estimated Annual Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Schedule of Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Schedule of Reserved Common Stock For Issued Securities in Relation (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Schedule of Information about Incentive Plan (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Schedule of Incentive Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Schedule of Assumptions used in Share-based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Schedule of Restricted Stock Units Granted (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Summary of Common Stock Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - Share-based Compensation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - Noncontrolling Interest in Joint Venture (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - Schedule of Debt Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - Convertible Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - Schedule of Warrant Liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - Warrant Liability (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - Concentrations of Risk (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 nxgl-20230630_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 nxgl-20230630_def.xml XBRL DEFINITION FILE EX-101.LAB 9 nxgl-20230630_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, par value 0.001 [Member] Warrants to Purchase Common Stock [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Noncontrolling Interest [Member] Retained Earnings [Member] Business Acquisition [Axis] Joint Venture [Member] CG Labs [Member] Ownership [Axis] Financial Instrument [Axis] US Treasury Securities [Member] Award Date [Axis] February 23, 2023 [Member] April 27, 2023 [Member] June 15, 2023 [Member] July 13, 2023 [Member] August 10, 2023 [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Long-Lived Tangible Asset [Axis] Machinery and Equipment [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Furniture and Fixtures [Member] Leasehold Improvements [Member] Construction in Progress [Member] Finite-Lived Intangible Assets by Major Class [Axis] Technology-Based Intangible Assets [Member] Customer-Related Intangible Assets [Member] Trade Names [Member] Marketing-Related Intangible Assets [Member] Sport Defense LLC [Member] Technology Related and Customer Related Intangibles [Member] Plan Name [Axis] 2019 Plan [Member] Title of Individual [Axis] Executive Officer [Member] Contractor [Member] Award Type [Axis] Equity Option [Member] Officers and Employees [Member Restricted Stock [Member] Chief Executive Officer [Member] Awards Granted Outside Of The 2019 Plan [Member] Awards Granted Outside Of The 2019 [Member] Restricted Stock Units (RSUs) [Member] CG Converting And Packaging LLC [Member] CG Laboratories Inc [Member] CG Laboratories [Member] Debt Instrument [Axis] Economic Injury Disaster Loan [Member] Class of Warrant or Right [Axis] Auctus Note [Member] Secured Convertible Promissory Note [Member] Sale of Stock [Axis] Private Placement [Member] Warrant [Member] Customer [Axis] Customer One [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer Two [Member] Accounts Receivable [Member] One Other Customer [Member] Two Other Customer [Member] Three Other Customer [Member] Related Party, Type [Axis] Mr. Stein [Member] Mr.Stefansky [Member] Dr.Jerome Zeldis [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS: Current Assets: Cash Marketable securities Accounts receivable, net Inventory Prepaid expenses and other current assets Total current assets Goodwill Intangibles, net Property and equipment, net Operating lease - right of use asset Other assets Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities: Accounts payable Accrued expenses and other current liabilities Current portion of note payable Warrant liability Operating lease liability, current portion Total current liabilities Operating lease liability, net of current portion Notes payable, net of current portion Total liabilities Commitments and Contingencies (Note 15) STOCKHOLDERS’ EQUITY Preferred stock, par value $0.001 per share, 5,000,000 shares authorized, no shares issued and outstanding Common stock, par value $0.001 per share, 25,000,000 shares authorized; 5,696,064 and 5,577,916 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively Additional paid-in capital Accumulated deficit Total NexGel stockholders’ equity Non-controlling interest in joint venture Total stockholders’ equity Total liabilities and stockholders’ equity Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues, net Cost of revenues Gross profit Operating expenses Research and development Selling, general and administrative Total operating expenses Loss from operations Other income (expense) Interest expense Interest income Loss on debt extinguishment Other income Gain on investments Changes in fair value of warrant liability Total other income (expense), net Loss before income taxes Income tax expense Net loss Less: Income attributable to non-controlling interest in joint venture Net loss attributable to NexGel stockholders Net loss per common share - basic Net loss per common share - diluted Weighted average shares used in computing net loss per common share - basic Weighted average shares used in computing net loss per common share – diluted Balance Balance, shares Restricted stock vesting Restricted stock vesting, shares Exercise of warrants Exercise of stock warrants, shares Non-controlling interest in JV Net income (loss) Stock-based compensation Balance Balance, shares Statement of Cash Flows [Abstract] Operating Activities Net loss Adjustments to reconcile net loss to net cash used in operating activities: Income attributable to non-controlling interest in joint venture Depreciation and amortization Changes in ROU asset and operating lease liability Share-based compensation and restricted stock vesting Gain on investment in marketable securities Changes in fair value of warrant liability and warrant modification Amortization of deferred financing costs Loss on extinguishment of debt Changes in operating assets and liabilities: Accounts receivable Inventory Prepaid expenses and other assets Accounts payable Accrued expenses and other current liabilities Net Cash Used in Operating Activities Investing Activities Proceeds from sales of marketable securities Investment in marketable securities Capital expenditures Net Cash Provided by Investing Activities Financing Activities Principle payments of notes payable Net Cash Used in Financing Activities Net Decrease in Cash Cash – Beginning of period Cash – End of period Supplemental Disclosure of Cash Flows Information Cash paid during the year for: Interest Taxes Supplemental Non-cash Investing and Financing activities Property and equipment contributed as capital investment to JV ROU asset and operating lease liabilities recognized upon consolidation of JV Organization, Consolidation and Presentation of Financial Statements [Abstract] Description of Business, Stock Split and Basis of Presentation Going Concern Accounting Policies [Abstract] Significant Accounting Policies and Estimates Leases Leases Inventory Disclosure [Abstract] Inventory Property, Plant and Equipment [Abstract] Property and Equipment, Net Goodwill and Intangible Assets Disclosure [Abstract] Intangible Assets Payables and Accruals [Abstract] Accrued Expenses and Other Current Liabilities Equity [Abstract] Common Stock Share-Based Payment Arrangement [Abstract] Share-based Compensation Equity Method Investments and Joint Ventures [Abstract] Noncontrolling Interest in Joint Venture Debt Disclosure [Abstract] Notes Payable Convertible Notes Payable Warrant Liability Warrant Liability Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Risks and Uncertainties [Abstract] Concentrations of Risk Related Party Transactions [Abstract] Related Party Transactions Subsequent Events [Abstract] Subsequent Events Use of Estimates Cash Marketable Securities Accounts Receivable, net Inventory and Cost of Goods Sold Research and Development Shipping and Handling Revenue and Expense Property and Equipment, net Impairment of Long-Lived Assets Goodwill and Intangible Assets Prepaid Expenses and Other Current Assets Other Assets Fair Value Measurements Warrant Liability Revenue Recognition Share-based Compensation Income Taxes Leases Segment Reporting Recently Issued Accounting Standards Schedule of Marketable Securities Schedule of Fair Value of Financial Assets Schedule of Disaggregated Revenue by Sales Type Schedule of Future Minimum Lease Payments Schedule of Supplemental Cash Flows Information Related to Leases Schedule of Inventory Schedule of Property and Equipment Schedule of Breakdown of Identifiable Intangible Assets Schedule of Estimated Annual Amortization Expense Schedule of Accrued Expenses and Other Current Liabilities Schedule of Reserved Common Stock For Issued Securities in Relation Schedule of Information about Incentive Plan Schedule of Incentive Stock Option Activity Schedule of Assumptions used in Share-based Compensation Schedule of Restricted Stock Units Granted Summary of Common Stock Warrants Schedule of Debt Instruments Schedule of Warrant Liability Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Acquisition percentage Minority percentage Net loss Net cash used in operating activities Working capital Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table] Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] Total Platform Operator, Crypto-Asset [Table] Platform Operator, Crypto-Asset [Line Items] Contract manufacturing Custom and white label finished goods manufacturing NexGel branded consumer products Other Total Allowance for doubtful accounts Asset impairment charges Prepaid insurance General prepaid expenses Remaining performance obligations Number of operating segments Schedule Of Future Minimum Lease Payments 2023 2024 2025 2026 2027 Thereafter Total undiscounted operating lease payments Less: Imputed interest Present value of operating lease liability Weighted average remaining lease term Weighted average discount rate Schedule Of Supplemental Cash Flows Information Related To Leases Operating cash flows from operating lease Operating lease expense Raw materials Work-in-progress Finished goods Inventory, gross Less: Inventory reserve for excess and slow moving inventory Total Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Useful Life (Years) Total property and equipment Less: accumulated depreciation and amortization Property and equipment, net Depreciation expense Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Identifiable intangible assets, gross Accumulated amortization Total 2023 2024 2025 2026 2027 Thereafter Total Intangibles Expected life Amortization expense Salaries, benefits, and incentive compensation Franchise tax accrual Other Total accrued expenses and other current liabilities Share-based compensation plan Warrants to purchase common Stock Restricted stock units Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Awards Reserved For Issuance Awards Issued Awards Exercised Awards Available for Grant Number of options, outstanding, beginning balance Weighted average exercise price, outstanding beginning balance Weighted average remaining contractual term Number of options, granted Weighted average exercise price, granted Weighted average remaining contractual term, Granted Number of options, exercised Weighted average exercise price, exercised Number of options, forfeited Weighted average exercise price, forfeited Number of options, cancelled Weighted average exercise price, cancelled Number of options, expired Weighted average exercise price, expired Number of options, outstanding, ending balance Weighted average exercise price, outstanding ending balance Weighted average remaining contractual term Number of options, exercisable Weighted average exercise price, exercisable Weighted average remaining contractual term, exercisable Volatility Risk-free interest rate Dividend yield Expected term Number of units outstanding beginning Weighted average grant date fair value outstanding beginning Number of units, granted Weighted average grant date fair value, granted Number of units, exercised and converted to common shares Weighted average grant date fair value, exercised and converted to common shares Number of units, forfeited Weighted average grant date fair value, forfeited Number of units outstanding beginning Weighted average grant date fair value outstanding ending Number of units exercisable Weighted average grant date fair value exercisable Number of warrants, outstanding beginning balance Weighted average exercise price, outstanding beginning balance Weighted average remaining contractual term Number of warrants, granted Weighted average exercise price, granted Number of warrants, exercised Weighted average exercise price, exercised Number of warrants, forfeited Weighted average exercise price, forfeited Number of warrants, cancelled Weighted average exercise price, cancelled Number of warrants, expired Weighted average exercise price, expired Number of warrants, outstanding ending balance Weighted average exercise price, outstanding ending balance Weighted average remaining contractual term Number of warrants, exercisable Weighted average exercise price, exercisable Weighted average remaining contractual term, exercisable Number of options, granted Number of shares granted Exercise price of options Intrinsic value Unrecognized share-based compensation expense Period of recognition of stock based compensation expense Share price [custom:UnrecognizedShareBasedCompensationExpense] Stock based compensation and restricted stock vesting Intrinsic value of vested outstanding warrants Payment to acquire business Payment to acquire business 2023 (remainder of the year) 2024 2025 2026 2027 Thereafter Total Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Borrowing capacity Interest rate DebtInstrument periodic payment Loan advance Accrued interest Principal amount of debt Debt Instrument, Periodic Payment, Interest Interest expense Outstanding principal and accrued unpaid interest Pre payment penalty Unamortized debt discount Gains loss on extinguishment of debt Warrants outstanding Fair value Number of warrants, exercised Exercise of wararnts Change in fair value of warrant liability Change in fair value of warrant liability Warrants outstanding Fair value Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary, Sale of Stock [Line Items] Warrants outstanding Exercise price Concentration Risk [Table] Concentration Risk [Line Items] Concentration risk, percentage Cash, FDIC insured amount Cash, exceeding Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Number Of Debt Instruments Debt instrument face amount Due from related parties, current Warrants to Purchase Common Stock [Member] Common Stock, par value 0.001 [Member] Warrant liability current. Change in fair value of warrant liability. Noncontrolling interest. Change in right of use asset and operating lease liability. Property and equipment contributed as capital investment to JV. Rou asset and operating lease liabilities recognized upon consolidation of jv. Joint Venture [Member] CG Labs [Member] Working capital deficit. Shipping And Handling Revenue And Expense Policy [Policy Text Block] Prepaid Expenses And Other Current Assets Policy [Policy Text Block] Other Assets Policy [Policy Text Block] Warrant Liability Policy [Policy Text Block] Revenue from contract manufacturing. Revenue from finished goods. Revenue from consumer products. Revenue classified as others. The tabular disclosure of supplemental cash flows information related to leases. Sport Defense LLC [Member] Technology Related and Customer Related Intangibles [Member] Warrant to purchase common stock. Contractor [Member] 2019 Plan [Member] Share based compensation arrangement by share based payment award number of shares available for exercised. Awards Granted Outside Of The 2019 Plan [Member] Awards Granted Outside Of The 2019 [Member] Share based compensation arrangement by share based payment award options cancelled in period. Share based compensation arrangement by share based payment award options grants in period. Share based compensation arrangement by share based payment award options granted weighted average remaining contractual term 2. Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term 1. Officers and Employees [Member Share based compensation arrangement by share based payment award equity instruments other than options exercisable non vested number. Share based compensation arrangement by share based payment award equity instruments other than options exercises in period weighted average grant date fair value. Share based compensation arrangement by share based payment award equity instruments other than options non vested exercisable weighted average grant date fair value. Unrecognized share based compensation expense. Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. The number of shares into which fully or partially vested warrants outstanding as of the balance sheet date can be currently converted under the option plan. Weighted average price at which grantees can acquire the shares reserved for issuance under the warrants plan. Weighted average per share amount at which grantees can acquire shares of common stock by exercise of warrants. Weighted average price at which option holders acquired shares when converting their warrants into shares. Weighted average price at which grantees could have acquired the underlying shares with respect to warrants that were terminated. Weighted average price at which grantees could have acquired the underlying shares with respect to warrants that were terminated. Weighted average price at which grantees could have acquired the underlying shares with respect to warrants of the plan that expired. The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of warrants outstanding and currently exercisable under the warrants plan. Weighted average remaining contractual term for non option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share based compensation arrangement by share based payment award non options outstanding weighted average remaining contractual term 1. Weighted average remaining contractual term, exercisable. Intrinsic value of vested outstanding warrants. CG Laboratories Inc [Member] CG Converting And Packaging LLC [Member] CG Laboratories [Member] Economic Injury Disaster Loan [Member] Auctus Note [Member] Secured Convertible Promissory Note [Member] Outstanding Principal And Accrued Unpaid Interest. Pre Payment Penalty Warrants Liability Disclosure [Text Block] Fair Value Adjustment Of Warrants Shares Customer One [Member] Customer Two [Member] One Other Customer [Member] Two Other Customer [Member] Three Other Customer [Member] Number of debt instruments. Mr. Stein [Member] Dr.Jerome Zeldis [Member] Stock issued during period value stock warrants exercised. Stock issued during period shares stock warrants exercised. Lessee operating lease liability payments due after year four. Finite lived intangible assets amortization expense after year four. February 23, 2023 [Member] April 27, 2023 [Member] June 15, 2023 [Member] July 13, 2023 [Member] August 10, 2023 [Member] Finance lease liability payments due after year four. Schedule Of Fair Value Warrant Liability [Text Block] Mr.Stefansky [Member] Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) ChangeInFairValueOfWarrantLiability Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares, Outstanding Marketable Security, Gain (Loss) Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Marketable Securities Payments to Acquire Productive Assets Net Cash Provided by (Used in) Investing Activities Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Lessee, Operating Leases [Text Block] Inventory Disclosure [Text Block] WarrantsLiabilityDisclosureTextBlock Cash and Cash Equivalents, Policy [Policy Text Block] Warrant Liability Policy [Policy Text Block] Share-Based Payment Arrangement [Policy Text Block] Lessee, Leases [Policy Text Block] Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Finite-Lived Intangible Assets, Net Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Finite-Lived Intangible Asset, Expected Amortization, Year One Finite-Lived Intangible Asset, Expected Amortization, Year Two Finite-Lived Intangible Asset, Expected Amortization, Year Three Finite-Lived Intangible Asset, Expected Amortization, Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour Other Liabilities, Current Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNonvestedNumber ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2 ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageCancelledPrice ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm1 Payments to Acquire Businesses, Gross Long-Term Debt, Maturity, Year One Long-Term Debt, Maturity, Year Two Long-Term Debt, Maturity, Year Three Long-Term Debt, Maturity, Year Four FinanceLeaseLiabilityPaymentsDueAfterYearFour Long-Term Debt Warrants and Rights Outstanding Class of Warrant or Right, Number of Securities Called by Warrants or Rights EX-101.PRE 10 nxgl-20230630_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover - shares
 6 Months Ended
Jun. 30, 2023
Aug. 11, 2023
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2023  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 001-41173  
Entity Registrant Name NexGel, Inc.  
Entity Central Index Key 0001468929  
Entity Tax Identification Number 26-4042544  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 2150 Cabot Blvd West  
Entity Address, Address Line Two Suite B  
Entity Address, City or Town Langhorne  
Entity Address, State or Province PA  
Entity Address, Postal Zip Code 19047  
City Area Code (215)  
Local Phone Number 702-8550  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   5,696,064
Common Stock, par value 0.001 [Member]    
Title of 12(b) Security Common Stock, par value $0.001  
Trading Symbol NXGL  
Security Exchange Name NASDAQ  
Warrants to Purchase Common Stock [Member]    
Title of 12(b) Security Warrants to Purchase Common Stock  
Trading Symbol NXGLW  
Security Exchange Name NASDAQ  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current Assets:    
Cash $ 3,691 $ 1,101
Marketable securities 612 5,508
Accounts receivable, net 950 222
Inventory 1,079 502
Prepaid expenses and other current assets 366 172
Total current assets 6,698 7,505
Goodwill 311 311
Intangibles, net 13 20
Property and equipment, net 1,413 721
Operating lease - right of use asset 1,967 1,737
Other assets 95 63
Total assets 10,497 10,357
Current Liabilities:    
Accounts payable 1,058 265
Accrued expenses and other current liabilities 202 130
Current portion of note payable 15 15
Warrant liability 165 242
Operating lease liability, current portion 232 207
Total current liabilities 1,672 859
Operating lease liability, net of current portion 1,819 1,593
Notes payable, net of current portion 265 268
Total liabilities 3,756 2,720
Commitments and Contingencies (Note 15)
STOCKHOLDERS’ EQUITY    
Preferred stock, par value $0.001 per share, 5,000,000 shares authorized, no shares issued and outstanding
Common stock, par value $0.001 per share, 25,000,000 shares authorized; 5,696,064 and 5,577,916 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively 6 6
Additional paid-in capital 19,242 19,189
Accumulated deficit (13,067) (11,558)
Total NexGel stockholders’ equity 6,181 7,637
Non-controlling interest in joint venture 560
Total stockholders’ equity 6,741 7,637
Total liabilities and stockholders’ equity $ 10,497 $ 10,357
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 25,000,000 25,000,000
Common stock, shares issued 5,696,064 5,577,916
Common stock, shares outstanding 5,696,064 5,577,916
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenues, net $ 1,167 $ 561 $ 1,786 $ 956
Cost of revenues 992 460 1,669 884
Gross profit 175 101 117 72
Operating expenses        
Research and development 55 111 84 135
Selling, general and administrative 882 708 1,679 1,467
Total operating expenses 937 819 1,763 1,602
Loss from operations (762) (718) (1,646) (1,530)
Other income (expense)        
Interest expense (9) (348) (10) (1,092)
Interest income 2 2
Loss on debt extinguishment (150)
Other income 2 4 2
Gain on investments 116 124
Changes in fair value of warrant liability 11 29 77 (101)
Total other income (expense), net 120 (317) 197 (1,341)
Loss before income taxes (642) (1,035) (1,449) (2,871)
Income tax expense
Net loss (642) (1,035) (1,449) (2,871)
Less: Income attributable to non-controlling interest in joint venture 53 60
Net loss attributable to NexGel stockholders $ (695) $ (1,035) $ (1,509) $ (2,871)
Net loss per common share - basic $ (0.12) $ (0.19) $ (0.27) $ (0.52)
Net loss per common share - diluted $ (0.12) $ (0.19) $ (0.27) $ (0.52)
Weighted average shares used in computing net loss per common share - basic 5,662,338 5,572,234 5,624,275 5,572,234
Weighted average shares used in computing net loss per common share – diluted 5,662,338 5,572,234 5,624,275 5,572,234
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Noncontrolling Interest [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2021 $ 6 $ 18,891   $ (6,812) $ 12,085
Balance, shares at Dec. 31, 2021 5,572,234        
Net income (loss)   (1,836) (1,836)
Stock-based compensation 55   55
Balance at Mar. 31, 2022 $ 6 18,946   (8,648) 10,304
Balance, shares at Mar. 31, 2022 5,572,234        
Balance at Dec. 31, 2021 $ 6 18,891   (6,812) 12,085
Balance, shares at Dec. 31, 2021 5,572,234        
Net income (loss)         (2,871)
Balance at Jun. 30, 2022 $ 6 19,025   (9,683) 9,348
Balance, shares at Jun. 30, 2022 5,572,234        
Balance at Mar. 31, 2022 $ 6 18,946   (8,648) 10,304
Balance, shares at Mar. 31, 2022 5,572,234        
Restricted stock vesting 25   25
Net income (loss)   (1,035) (1,035)
Stock-based compensation 54   54
Balance at Jun. 30, 2022 $ 6 19,025   (9,683) 9,348
Balance, shares at Jun. 30, 2022 5,572,234        
Balance at Dec. 31, 2022 $ 6 19,189 (11,558) 7,637
Balance, shares at Dec. 31, 2022 5,577,916        
Restricted stock vesting 24 24
Restricted stock vesting, shares 5,682        
Exercise of warrants
Exercise of stock warrants, shares 30,430        
Non-controlling interest in JV 500 500
Net income (loss) 7 (814) (807)
Balance at Mar. 31, 2023 $ 6 19,213 507 (12,372) 7,354
Balance, shares at Mar. 31, 2023 5,614,028        
Balance at Dec. 31, 2022 $ 6 19,189 (11,558) $ 7,637
Balance, shares at Dec. 31, 2022 5,577,916        
Restricted stock vesting, shares         121,787
Net income (loss)         $ (1,449)
Balance at Jun. 30, 2023 $ 6 19,242 560 (13,067) 6,741
Balance, shares at Jun. 30, 2023 5,696,064        
Balance at Mar. 31, 2023 $ 6 19,213 507 (12,372) 7,354
Balance, shares at Mar. 31, 2023 5,614,028        
Exercise of warrants
Exercise of stock warrants, shares 82,036        
Net income (loss) 53 (695) (642)
Stock-based compensation 29 29
Balance at Jun. 30, 2023 $ 6 $ 19,242 $ 560 $ (13,067) $ 6,741
Balance, shares at Jun. 30, 2023 5,696,064        
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Operating Activities          
Net loss $ (695) $ (1,035) $ (1,509) $ (2,871)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Income attributable to non-controlling interest in joint venture     60  
Depreciation and amortization     68 57  
Changes in ROU asset and operating lease liability     21 19  
Share-based compensation and restricted stock vesting     53 134  
Gain on investment in marketable securities     124  
Changes in fair value of warrant liability and warrant modification     (77) 101  
Amortization of deferred financing costs     1,086  
Loss on extinguishment of debt 150  
Changes in operating assets and liabilities:          
Accounts receivable     (728) (91)  
Inventory     (577) (90)  
Prepaid expenses and other assets     (226) (286)  
Accounts payable     793 268  
Accrued expenses and other current liabilities     72 28  
Net Cash Used in Operating Activities     (1,926) (1,495)  
Investing Activities          
Proceeds from sales of marketable securities     4,772  
Investment in marketable securities     (5,371)  
Capital expenditures     (253) (31)  
Net Cash Provided by Investing Activities     4,519 (5,402)  
Financing Activities          
Principle payments of notes payable     (3) (2,033)  
Net Cash Used in Financing Activities     (3) (2,033)  
Net Decrease in Cash     2,590 (8,930)  
Cash – Beginning of period     1,101 13,350 $ 13,350
Cash – End of period $ 3,691 $ 4,420 3,691 4,420 $ 1,101
Cash paid during the year for:          
Interest      
Taxes      
Supplemental Non-cash Investing and Financing activities          
Property and equipment contributed as capital investment to JV     500  
ROU asset and operating lease liabilities recognized upon consolidation of JV     $ 334  
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Description of Business, Stock Split and Basis of Presentation
 6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business, Stock Split and Basis of Presentation

1. Description of Business, Stock Split and Basis of Presentation

 

NexGel, Inc. (“NexGel” or the “Company”) manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. The Company specializes in custom gels by capitalizing on proprietary manufacturing technologies. NexGel has historically served as a contract manufacturer, supplying our gels to third parties who incorporate them into their own products, and has recently began producing the Company’s own consumer products using our gels focused on proprietary branded products and white label opportunities. Both the Company’s gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies. Together, these technologies enable NexGel to produce gels that can satisfy rigid tolerance specifications with respect to a wide range of physical characteristics (e.g., thickness, water content, adherence, absorption, moisture vapor transmission rate (a measure of the passage of water vapor through a substance) and release rate) while maintaining product integrity. Additionally, the Company has the manufacturing capability to offer broad choices in the selection of liners onto which the gels are coated. Consequently, NexGel and our customers are able to determine tolerances in moisture vapor transmission rate and active ingredient release rates while personalizing color and texture.

 

NexGel was previously known as AquaMed Technologies, Inc. (“AquaMed”) before changing its name to NexGel, Inc. on November 14, 2019.

 

On March 1, 2023, the Company acquired a 50% interest in a newly formed joint venture (“JV”), CG Converting and Packaging, LLC, with C.G. Laboratories Inc. (“CG Labs”) for its converting and packaging business. The agreement is effective March 1, 2023. As a result of this transaction, the Company owns 50% of the JV, with the remaining 50% held by CG Labs.

 

Basis of Presentation

 

The accompanying interim unaudited condensed consolidated financial statements and footnotes of NexGel have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and the instructions to Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, these unaudited condensed consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation of the results of the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full year ending December 31, 2023. These condensed consolidated financial statements should be read in conjunction with the audited financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

 

Principles of Consolidation

 

The accompanying condensed consolidated financial statements include the accounts of the Company and its consolidated wholly-owned subsidiary, NexGelRx, Inc. and the fifty percent (50%) owned JV (see Note 11).

 

 
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Going Concern
 6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Going Concern

2. Going Concern

 

As of June 30, 2023, the Company had a cash balance of $3.7 million (including cash equivalents) and $612 thousand of marketable securities (see Note 3 for details of our marketable securities). For the six months ended June 30, 2023, the Company incurred a net loss of $1.5 million and had a net usage of cash in operating activities of $1.9 million. In addition, the Company had a working capital of $5.0 million as of June 30, 2023. We believe we have sufficient cash and marketable securities to operate our business plan through 2025.

 

Management is exploring new product channel sales in adjacent industries, such as cosmetics, athletic products, and proprietary medical devices. The Company has increased its focus on sales and developing a sales pipeline for potential customers. This customer base expansion will enable us to provide financial stability for the foreseeable future, expand our current processes, and position us for long-term shareholder value creation.

 

We have sufficient capital to maintain as a going concern due to the capital raise that occurred on December 27, 2021. We intend to maintain and attempt to grow our existing contract manufacturing business. We also plan to continue building and developing our catalog of consumer products for sale to branding partners and to use our in-house capabilities to create and test market additional branded products. These products will be target marketed and sold online through social media, television and online marketplaces. Furthermore, the Company plans to develop its own proprietary medical devices and explore drug delivery programs for its technology. Additionally, the Company continues to evaluate strategic initiatives (e.g., acquisitions) and additional capital raises through debt or equity may be necessary to achieve these objectives.

 

We expect to continue incurring losses for the near-term future. Our ability to continue to operate as a going concern in the long-term is dependent upon our ability to manage and grow our current products and to ultimately achieve profitable operations. Management may consider various options to raise capital to fund potential acquisitions through equity or debt offerings. There can be no assurances, however, that management will be able to obtain sufficient additional funds, if needed, or that such funds, if available, will be obtained on terms satisfactory to us. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets and liabilities that might be necessary should we be unable to continue as a going concern. Additionally, it is reasonably possible that estimates made in the condensed consolidated financial statements have been, or will be, materially and adversely impacted in the near term as a result of these conditions, including the recoverability of long-lived assets.

 

 
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Significant Accounting Policies and Estimates
 6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Significant Accounting Policies and Estimates

3. Significant Accounting Policies and Estimates

 

Use of Estimates

 

The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. These estimates and assumptions include allowances for doubtful accounts, inventory reserves, deferred taxes, share-based compensation and related valuation allowances and fair value of long-lived assets. Actual results could differ from the estimates.

 

Cash

 

Cash is comprised of cash in banks and highly liquid investments, including U.S. treasury bills purchased with an original maturity of three months or less as well as investments in money market funds for which the carrying amount approximates fair value, due to the short maturities of these investments.

 

Marketable Securities

 

The Company classifies its marketable securities as held-to-maturity, which include U.S. treasury bills with original maturities of greater than three months. These securities are carried at fair value with any change in fair value recorded as an unrealized gain (loss) in the consolidated statement of operations of the period in which such change occurs.

 

The Company had the following marketable securities as of June 30, 2023 and December 31, 2022:

Schedule of Marketable Securities  

   June 30,   December 31, 
   2023   2022 
Marketable Securities          
United States treasury bills (due February 23, 2023)  $-   $492 
United States treasury bills (due April 27, 2023)   -    20 
United States treasury bills (due June 15, 2023)   -    4,384 
United States treasury bills (due July 13, 2023)   127    127 
United States treasury bills (due August 10, 2023)   485    485 
Total  $612   $5,508 

 

Accounts Receivable, net

 

Trade accounts receivable are stated at the amount the Company expects to collect and do not bear interest. The Company evaluates the collectability of accounts receivable and records a provision to the allowance for doubtful accounts based on factors including the length of time the receivables are past due, the current business environment and the Company’s historical experience. Provisions to the allowances for doubtful accounts are recorded in selling, general, and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered. The allowance for doubtful accounts was $17 thousand as of June 30, 2023, and $9 thousand as of December 31, 2022.

 

Inventory and Cost of Goods Sold

 

Inventory is stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. The Company evaluates inventories for excess quantities, obsolescence, and shelf-life expiration. This evaluation includes an analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, and a review of the shelf-life expiration dates for products. These factors determine when, and if, the Company adjusts the carrying value of inventory to estimated net realizable value.

 

 

The Company produces proprietary branded products and white label opportunities in our manufacturing of consumer products. In our contract manufacturing, the Company builds its products based on customer orders and immediately ships the products upon completion of the production process.

 

The balance is made up of raw materials, work-in-progress, and finished goods. Inventory is maintained primarily at the Company’s warehouse and at an Amazon fulfillment center.

 

The “Cost of revenues” line item in the condensed consolidated statements of operations is comprised of the book value of inventory sold to customers during the reporting period. When circumstances dictate that we use net realizable value as the basis for recording inventory, we base our estimates on expected future selling prices less expected disposal costs.

 

Research and Development

 

Our research and development activities focus on new and innovative products designed to support revenue growth. Research and development expenses consist primarily of contracted development and testing efforts associated with development of products.

 

Shipping and Handling Revenue and Expense

 

Shipping and handling revenue and expense are included in our condensed consolidated statements of operations in revenues and cost of revenues, respectively. This is primarily through shipping fees incurred in the Amazon marketplace.

 

Property and Equipment, net

 

Property and equipment is recorded at historical cost, net of accumulated depreciation and amortization. Depreciation is provided over the assets’ useful lives on a straight-line basis. Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or lease terms. Repairs and maintenance costs are expensed as incurred.

 

Management periodically assesses the estimated useful life over which assets are depreciated or amortized. If the analysis warrants a change in the estimated useful life of property and equipment, management will reduce the estimated useful life and depreciate or amortize the carrying value prospectively over the shorter remaining useful life.

 

The carrying amounts of assets sold or retired and the related accumulated depreciation are eliminated in the period of disposal and the resulting gains and losses are included in the results of operations during the same period.

 

Impairment of Long-Lived Assets

 

The Company reviews its property and equipment and any identifiable intangibles for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted operating cash flow expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell.

 

Goodwill and Intangible Assets

 

In applying the acquisition method of accounting, amounts assigned to identifiable assets and liabilities acquired were based on estimated fair values as of the date of acquisition, with the remainder recorded as goodwill. Identifiable intangible assets are initially recorded at fair value using generally accepted valuation methods appropriate for the type of intangible asset. Identifiable intangible assets with definite lives are amortized over their estimated useful lives and are reviewed for impairment if indicators of impairment arise. Intangible assets with indefinite lives are tested for impairment within one year of acquisitions or annually as of December 31, and whenever indicators of impairment exist. The fair value of intangible assets is compared with their carrying values, and an impairment loss would be recognized for the amount by which a carrying amount exceeds its fair value.

 

 

The Company performed the annual assessment and concluded it is more likely than not that the fair value exceeds the carrying value and no impairments were recognized in the year ended December 31, 2022.

 

Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets are recorded at historical cost and is primarily made up of $96 thousand and $63 thousand of prepaid insurance, and $270 thousand and $109 thousand general prepaid expenses and other current assets as of June 30, 2023, and December 31, 2022, respectively.

 

Other Assets

 

Other assets are recorded at historical costs, and as of June 30, 2023, and December 31, 2022, the balance is primarily comprised of spare parts for manufacturing equipment. Other assets are not subject to depreciation until such time that they are placed into service and the part that is being replaced is disposed.

 

Fair Value Measurements

 

The Company utilizes the fair value hierarchy to apply fair value measurements. The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair values that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources, while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions. The basis for fair value measurements for each level within the hierarchy is described below:

 

Level 1 — Quoted prices for identical assets or liabilities in active markets.

 

Level 2 — Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable.

 

Level 3 — Valuations derived from valuation techniques in which one or more significant inputs to the valuation model are unobservable.

 

The Company considers the carrying amounts of its financial instruments (cash, accounts receivable and accounts payable, notes payable and convertible notes payable) in the balance sheet to approximate fair value because of the short-term or highly liquid nature of these financial instruments.

 

The following table sets forth the fair value of the Company’s financial assets within the fair value hierarchy:

 

   Level 1   Level 2   Level 3   Fair Value 
       June 30, 2023     
   Level 1   Level 2   Level 3   Fair Value 
Assets                    
Marketable securities:                          
United States treasury bills  $612   $     -   $-   $612 
Total  $612   $-   $-   $612 

 

   Level 1   Level 2   Level 3   Fair Value 
       December 31, 2022     
   Level 1   Level 2   Level 3   Fair Value 
Assets                    
Marketable securities:                    
United States treasury bills  $5,508   $      -   $     -   $5,508 
Total  $5,508   $-   $-   $5,508 

 

 

Warrant Liability

 

Warrants to purchase common stock were issued in connection with equity financing raises, which occurred during 2019 through 2021. The fair values of the warrants are estimated as of the date of issuance and again at each year end using a Black-Scholes option valuation model. At issuance, the fair values of the warrants are recognized as an equity issuance cost within additional paid-in-capital. Fair value adjustments to the warrant liability are recognized in other income (expense) in the accompanying condensed consolidated statements of operations.

 

Revenue Recognition

 

On January 1, 2018, the Company adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted ASC 606 for all applicable contracts using the modified retrospective method, which would have required a cumulative-effect adjustment, if any, as of the date of adoption.

 

The Company currently recognizes revenue predominately from three types of revenue, contract manufacturing, custom and white label finished goods manufacturing and our branded products. Revenues from manufactured and branded products are recognized at the point where the customer obtains control of the goods and the Company satisfies its performance obligation, which generally is at the time the customer receives the product.

 

The Company’s customers consist of other life sciences companies and Amazon retail customers. Revenues are entirely concentrated in the United States. Payment terms vary by the type and location of customer and may differ by jurisdiction and customer, but payment is generally required in a term ranging from 30 to 60 days from date of shipment.

 

Estimates for product returns, allowances and discounts are recorded as a reduction of revenue and are established at the time of sale. Returns are estimated through a comparison of historical return data and are determined for each product and adjusted for known or expected changes in the marketplace specific to each product, when appropriate. Historically, sales return provisions have not been material. Amounts accrued for sales allowances and discounts are based on estimates of amounts that are expected to be claimed on the related sales and are based on historical data. Payments for allowances and discounts have historically been immaterial.

 

Disaggregated revenue by sales type:

  

   2023   2022 
   Three months ended 
   June 30, 
   2023   2022 
Contract manufacturing  $887   $324 
Custom and white label finished goods manufacturing   —    19 
NexGel branded consumer products   259    180 
Other   21    38 
Total  $1,167   $561 

 

 

   2023   2022 
   Six months ended 
   June 30, 
   2023   2022 
Contract manufacturing  $1,267   $459 
Custom and white label finished goods manufacturing   4    19 
NexGel branded consumer products   493    392 
Other   22    86 
Total  $1,786   $956 

 

As of June 30, 2023, and December 31, 2022, the Company did not have any contract assets or contract liabilities from contracts with customers. As of June 30, 2023, and December 31, 2022, there were no remaining performance obligations that the Company had not satisfied.

 

The Company has four distinct lines of business; Contract Manufacturing, Custom & White Label, Consumer Branded Products, and Medical Devices.

 

Contract Manufacturing

 

Customers order rolls of gel (“rollstock”). The rollstock is shipped to our customers, which they package into finished goods. Historically, this has been the Company’s primary source of revenue.

 

Custom & White Label

 

These products often infuse various ingredients into our base gel to develop unique product offerings to satisfy market demand (e.g. aloe infused into the gel for a beauty mask). The rollstock is converted and packaged into salable units. The finished goods are shipped to the customer, who is ultimately responsible for product distribution. Frequently these products started as development deals, in which the customer paid the Company a small fee to develop a specific product. Once completed, the customer places a large order for newly developed product.

 

Consumer Branded Products

 

These products are finished goods marketed and sold directly to the customer by the Company through online and retail channels. The Company is responsible for sales, marketing, and distribution. These products carry the Company’s brand names.

 

Medical Devices

 

Medical Devices are a hybrid business, combining elements of Custom & White Label and Consumer Branded Products. Medical Devices, which are not yet marketed, are expected to be distributed through strategic partnerships. The Company will manufacture and possibly convert/package the device while the strategic partner brings the product to market. Small market Medical Devices could be launched by the Company, but also be offered to a distributor to reach the full scale of the market.

 

Share-based Compensation

 

On August 28, 2019, the Company adopted the 2019 Long-Term Incentive Plan, as amended (the “2019 Plan”). See Note 10 below for further details regarding the 2019 Plan.

 

The 2019 Plan provides certain employees, contractors, and outside directors with share-based compensation in the form of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalent rights and other awards. The fair values of incentive stock option award grants are estimated as of the date of grant using a Black-Scholes option valuation model. Compensation expense is recognized in the statements of operations on a straight-line basis over the requisite service period, which is generally the vesting period required to obtain full vesting. Forfeitures are accounted for when they occur.

 

 

In June 2018, FASB issued Accounting Standards Update (“ASU”) No. 2018-07, Compensation - Stock Compensation (Topic 718) - Improvements to Nonemployee Share-Based Payment Accounting. These amendments expand the scope of Topic 718, Compensation - Stock Compensation, to include share-based payments issued to non-employees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. This new standard was effective for the Company on January 1, 2020. The Company adopted this new standard early in the third quarter of 2019 and it did not have a material impact to its condensed consolidated financial statements.

 

Income Taxes

 

Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax bases of assets and liabilities at the applicable tax rates. Deferred tax assets are reduced by a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates.

 

Tax benefits are recognized from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by a tax authority and based upon the technical merits of the tax position. The tax benefit recognized in the condensed consolidated financial statements for a particular tax position is based on the largest benefit that is more likely than not to be realized upon settlement. An unrecognized tax benefit, or a portion thereof, is presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed.

 

Leases

 

ASC 842, Leases, requires recognition of leases on the condensed consolidated balance sheets as right-of-use (“ROU”) assets and lease liabilities. ROU assets represent the Company’s right to use underlying assets for the lease terms and lease liabilities represent the Company’s obligation to make lease payments arising from the leases. Operating lease ROU assets and operating lease liabilities are recognized based on the present value and future minimum lease payments over the lease term at commencement date. As the Company’s leases do not provide an implicit rate, the Company used its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. A number of the lease agreements contain options to renew and options to terminate the leases early. The lease term used to calculate ROU assets and lease liabilities only includes renewal and termination options that are deemed reasonably certain to be exercised.

 

The Company recognized lease liabilities, with corresponding ROU assets, based on the present value of unpaid lease payments for existing operating leases longer than twelve months. The ROU assets were adjusted per ASC 842 transition guidance for existing lease-related balances of accrued and prepaid rent, and unamortized lease incentives provided by lessors. Operating lease cost is recognized as a single lease cost on a straight-line basis over the lease term and is recorded in selling, general and administrative expenses. Variable lease payments for common area maintenance, property taxes and other operating expenses are recognized as expense in the period when the changes in facts and circumstances on which the variable lease payments are based occur. The Company has elected not to separate lease and non-lease components for all property leases for the purposes of calculating ROU assets and lease liabilities.

 

Segment Reporting

 

The Company operates in one business segment as a contract manufacturer of aqueous polymer hydrogels. As a result, the Company’s operations are a single reportable segment, which is consistent with the Company’s internal management reporting.

 

 

Recently Issued Accounting Standards

 

From time to time, new accounting pronouncements are issued by FASB, or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption.

 

In June 2016, FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 significantly changes the impairment model for most financial assets and certain other instruments. ASU 2016-13 will require immediate recognition of estimated credit losses expected to occur over the remaining life of many financial assets, which will generally result in earlier recognition of allowances for credit losses on loans and other financial instruments. ASU 2016-13 is effective for the Company’s fiscal year beginning January 1, 2023 and subsequent interim periods. The Company is currently evaluating the impact the adoption of ASU 2016-13 will have on the Company’s condensed consolidated financial statements.

 
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Leases
 6 Months Ended
Jun. 30, 2023
Leases  
Leases

4. Leases

 

The Company has one operating lease for a commercial manufacturing facility and administrative offices located in Langhorne, Pennsylvania that runs through January 2031. There are two options that can extend the lease term for five years each. The exercise of the lease options to renew is solely at the Company’s discretion.

 

The following table presents information about the amount and timing of the liability arising from the Company’s operating lease as of June 30, 2023 ($ in thousands):

  

   Operating 
   Lease 
Maturity of Lease Liability  Liability 
2023  $122 
2024   245 
2025   245 
2026   301 
2027   315 
Thereafter   1,115 
Total undiscounted operating lease payments   2,343 
Less: Imputed interest   (292)
Present value of operating lease liability  $2,051 
Weighted average remaining lease term   8.6 years  
Weighted average discount rate   3.5%

 

Total operating lease expense for the six months ended June 30, 2023, and 2022, was $136 thousand and $103 thousand, respectively, and is recorded in cost of goods sold and selling, general, and administrative expenses in the accompanying condensed consolidated statement of operations.

 

Supplemental cash flows information related to leases was as follows ($ in thousands):

  

   June 30, 
   2023 
Cash paid for amounts included in the measurement of lease liability:     
Operating cash flows from operating lease  $136 

 

 
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Inventory
 6 Months Ended
Jun. 30, 2023
Inventory Disclosure [Abstract]  
Inventory

5. Inventory

 

Inventory consists of the following ($ in thousands):

  

   June 30,   December 31, 
   2023   2022 
Raw materials  $638   $295 
Work-in-progress   43    51 
Finished goods   398    156 
Inventory, gross   1,079    502 
Less: Inventory reserve for excess and slow moving inventory   —    — 
Total  $1,079   $502 

 

Inventory is maintained at the Company’s warehouse, an outsourced third-party contract manufacturing vendor, and at Amazon fulfillment centers. The Company builds its contract manufacturing products based on customer orders and immediately ships the products upon completion of the production process.

 
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Property and Equipment, Net
 6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
Property and Equipment, Net

6. Property and Equipment, Net

 

Property and equipment consist of the following ($ in thousands):

  

   Useful Life   June 30,   December 31, 
   (Years)   2023   2022 
Machinery and equipment  3 - 10   $1,530   $973 
Office furniture and equipment  3 - 10    159    59 
Leasehold improvements  6    261    228 
Construction in progress  N/A    118    55 
Total property and equipment       2,068    1,315 
Less: accumulated depreciation and amortization       (655)   (594)
Property and equipment, net      $1,413   $721 

 

Depreciation expense for the six months ended June 30, 2023, and 2022 was $61 thousand and $49 thousand, respectively.

 
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Intangible Assets
 6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets

7. Intangible Assets

 

The following provides a breakdown of identifiable intangible assets as of June 30, 2023 and December 31, 2022:

  

   June 30,   December 31, 
   2023   2022 
Product/Technology Related          
Identifiable intangible assets, gross  $31   $31 
Accumulated amortization   (31)   (26)
Product/Technology Related identifiable intangible assets, net   -    5 
Marketing Related          
Customer related intangible asset, gross   17    17 
Tradename related intangible asset, gross   7    7 
Accumulated amortization   (11)   (9)
Marketing related identifiable intangible assets, net   13    15 
Total Identifiable intangible assets, net  $13   $20 

 

In connection with the May 29, 2020, acquisition of Sports Defense, the Company identified intangible assets of $55 thousand representing technology related and customer related intangibles. These assets are being amortized on a straight-line basis over their weighted average estimated useful life of 5.7 years and amortization expense amounted to $7 thousand for the six months ended June 30, 2023, and 2022, respectively.

 

 

As of June 30, 2023, the estimated annual amortization expense for each of the next five fiscal years is as follows:

  

      
($ in thousands):     
2023  $2 
2024   2 
2025   2 
2026   2 
2027   2 
Thereafter   3 
Total  $13 

 
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.2
Accrued Expenses and Other Current Liabilities
 6 Months Ended
Jun. 30, 2023
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities

8. Accrued Expenses and Other Current Liabilities

 

Accrued expenses and other current liabilities consist of the following ($ in thousands):

 

   June 30,   December 31, 
   2023   2022 
Salaries, benefits, and incentive compensation  $72   $56 
Franchise tax accrual   64    52 
Other   66    22 
Total accrued expenses and other current liabilities  $202   $130 

 
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Common Stock
 6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Common Stock

9. Common Stock

 

At June 30, 2023, the Company has reserved common stock for issued securities in relation to the following:

 

Share-based compensation plan   528,182 
Warrants to purchase common stock   3,442,904 
Restricted stock units   121,787 

 
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based Compensation
 6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Share-based Compensation

10. Share-based Compensation

 

The 2019 Plan provides for the granting of incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights (“SARs”), restricted stock units, performance awards, dividend equivalent rights and other awards, which may be granted singly, in combination, or in tandem, and which may be paid in cash, shares of common stock of the Company or a combination of cash and shares of common stock of the Company up to an amount of 871,429 shares of common stock, all of which may be delivered pursuant to incentive stock options. Subject to adjustments pursuant to the 2019 Plan, the maximum number of shares of common stock with respect to which stock option or SARs may be granted to an executive officer during any calendar year is 14,286 shares of common stock.

 

Incentive stock options

 

On March 8, 2023, the Company granted a contractor an option to purchase up to 17,532 shares of the Company’s common stock at a per share exercise price of $2.00 under the Company’s 2019 Plan. This option award vests over a period of 12 months.

 

 

The following table contains information about the 2019 Plan as of June 30, 2023:

 

   Awards   Awards       Awards 
  

Reserved for

Issuance

   Issued & Outstanding  

Awards

Exercised

  

Available for

Grant

 
2019 Plan(1)   871,429    612,932    7,183    251,314 
Awards granted outside of the 2019 Plan(2)   -    37,037    11,364    - 

 

(1) Includes incentive stock options and restricted stock units discussed below.
   
(2) Includes shares of restricted common stock granted outside of the 2019 Plan to our Chief Executive Officer, Adam Levy.

 

The following table summarizes the Company’s incentive stock option activity and related information for the period ended June 30, 2023:

 

           Weighted 
       Weighted   Average 
       Average   Contractual 
   Number of   Exercise   Term in 
   Options   Price   Years 
Outstanding at January 1, 2023   524,937   $2.351416    8.38 
Granted   17,532    2.00    10.0 
Exercised   —    —    — 
Forfeited   —    —    — 
Cancelled   (10,000)   1.75    — 
Expired   (4,287)   1.40    — 
Outstanding at June 30, 2023   528,182   $2.35886    7.99 
Exercisable at June 30, 2023   337,111   $1.774915    7.21 

 

As of June 30, 2023, vested outstanding stock options had $129 thousand intrinsic value as the exercise price is greater than the estimated fair value of the underlying common stock, respectively. As of June 30, 2023, there was approximately $17 thousand of total unrecognized share-based compensation related to unvested stock options, which the Company expects to recognize over the next 11 months excluding options fully contingent upon certain sales-based milestones being achieved within 18 to 36 months of commercial release.

 

The Company recognizes compensation expense for stock option awards on a straight-line basis over the applicable service period of the award. The service period is generally the vesting period. The following assumptions were used to calculate share-based compensation expense for the period ended June 30, 2023:

 

Volatility   257.64%
Risk-free interest rate   4.21%
Dividend yield   0.0%
Expected term   5.50 years 

 

The Company does not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. Accordingly, the Company has elected to use the “simplified method” to estimate the expected term of its share-based awards. The simplified method computes the expected term as the sum of the award’s vesting term plus the original contractual term divided by two.

 

Based on the lack of historical data of volatility for the Company’s common stock, the Company based its estimate of expected volatility on a weighted-average of the historical volatility of comparable public companies that manufacture similar products and are similar in size, stage of life cycle, and financial leverage.

 

Restrictive Stock Awards

 

Effective as of August 1, 2022, the Company granted a restricted stock award of 84,750 shares of the Company’s common stock to certain officers and employees, all of which shares vest in four equal installments on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. Under ASC 718, the Company has measured the value of the 84,750 shares granted based on a closing price of the closing price of the Company’s stock at the grant date of the RSU Grant ($1.82 per share).

 

 

Effective as of January 1, 2022, the Company granted a restricted stock award of 11,364 shares of the Company’s common stock to Adam Levy for his service as our Chief Executive Officer pursuant to the terms of his Executive Employment Agreement dated November 4, 2021, all of which shares vested monthly from January 1, 2022 through December 31, 2022. Under ASC 718, the Company has measured the value of the 11,364 shares granted based on the closing price of the Company’s stock at the grant date of the RSU Grant ($4.40 per share).

 

Effective as of January 3, 2023, the Company granted a restricted stock award of 37,037 shares of the Company’s common stock to Adam Levy for his service as our Chief Executive Officer pursuant to the terms of his Executive Employment Agreement dated December 30, 2022, all of which shares vested monthly from January 3, 2023 through December 31, 2023. Under ASC 718, the Company has measured the value of the 37,037 shares granted based on the closing price of the Company’s stock at the grant date of the RSU Grant ($1.35 per share).

       Weighted 
       Average 
   Number of   Grant Date 
   Units   Fair Value 
Outstanding at January 1, 2023   90,432   $1.43 
Granted   37,037    1.35 
Exercised and converted to common shares   (5,682)   4.40 
Forfeited   —    — 
Outstanding at June 30, 2023   121,787   $1.68 
Exercisable at June 30, 2023   30,466   $1.68 

 

Compensation expense will be recognized ratably over the total vesting schedule. The Company will periodically adjust the cumulative compensation expense for forfeited awards. As of June 30, 2023, there was $121 thousand unrecognized share-based compensation related to unvested RSUs, which the Company expects to recognize over the next 3 years.

 

Stock based compensation and restricted stock vesting of $53 thousand and $134 thousand has been recorded for the six months ended June 30, 2023, and 2022, respectively.

 

Warrants

 

The following table shows a summary of common stock warrants through June 30, 2023:

 

       Weighted   Weighted 
       Average   Average 
   Number of   Exercise   Contractual 
   Warrants   Price   Term in Years 
Outstanding at January 1, 2023   3,637,190   $5.16281    3.65 
Granted   —    —    — 
Exercised   (112,466)   0.55    — 
Forfeited   —    —    — 
Cancelled   (81,820)   0.91    — 
Expired   —    —    — 
Outstanding at June 30, 2023   3,442,904   $5.414793    3.35 
Exercisable at June 30, 2023   3,442,904   $5.414793    3.35 

 

As of June 30, 2023, vested outstanding warrants had $0 intrinsic value as the exercise price is greater than the estimated fair value of the underlying common stock.

 
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Noncontrolling Interest in Joint Venture
 6 Months Ended
Jun. 30, 2023
Equity Method Investments and Joint Ventures [Abstract]  
Noncontrolling Interest in Joint Venture

11. Noncontrolling Interest in Joint Venture

 

On March 1, 2023, the Company acquired a 50% interest in a JV, named CG Converting and Packaging, LLC, with C.G. Laboratories Inc. (“CG Labs”) for its converting and packaging business (see Note 1). The JV is owned 50% by the Company and 50% by CG Labs. CG Labs contributed its existing converting and packaging division to the JV, including, but not limited to, its facilities, equipment, employees, and customers. The Company will contribute $500,000 to the JV, on a schedule to be determined, to be used for equipment and facility upgrades as well as general corporate purposes for JV. As of June 30, 2023, the Company has contributed $350,000 of its $500,000 commitment.

 

 

The JV is considered to be a variable interest entity (“VIE”), as defined by authoritative accounting guidance. A VIE must be consolidated by a reporting entity if the reporting entity is the primary beneficiary because it has (i) the power to direct the VIE’s activities that most significantly impact the VIE’s economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE. All major decisions related to the JV that most significantly impact its economic performance, including but not limited to operating procedures with respect to business affairs. Therefore, we have consolidated the JV.

 
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Notes Payable
 6 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
Notes Payable

12. Notes Payable

 

Economic Injury Disaster Loan

 

On May 28, 2020, the Company entered into the standard loan documents required for securing a loan (the “EIDL Loan”) from the SBA under its Economic Injury Disaster Loan (“EIDL”) assistance program in light of the impact of the COVID-19 pandemic on the Company’s business. Pursuant to that certain Loan Authorization and Agreement (the “SBA Loan Agreement”), the principal amount of the EIDL Loan is up to $260,500, with proceeds to be used for working capital purposes. Interest accrues at the rate of 3.75% per annum. Installment payments, including principal and interest, are due monthly which the Company began paying in December 2022 (thirty months from the date of the SBA Note) in the amount of $1,270. The balance of principal and interest is payable thirty years from the date of the SBA Note. In connection therewith, the Company received an $8,000 advance, which does not have to be repaid. The balances of the principal and accrued interest amounted to $280 thousand and $283 thousand as of June 30, 2023 and December 31, 2022, respectively.

 

The future annual principal amounts and accrued interest to be paid as of June 30, 2023 are as follows:

 

   Amount 
For the year ending December 31 ($ in thousands):     
2023 (remainder of the year)  $3 
2024   5 
2025   5 
2026   5 
2027   6 
Thereafter   256 
Total  $280 

 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Convertible Notes Payable
 6 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
Convertible Notes Payable

13. Convertible Notes Payable

 

On March 11, 2021, the Company issued Auctus Fund, LLC, a Delaware limited liability company a one-year senior secured convertible promissory note in the principal amount of $1.68 million, which included $180 thousand of interest which was deemed fully earned as of the issuance date (the “Auctus Note”). The Auctus Note was fully repaid (including all principal and interest) on March 15, 2022 with a one-time cash payment of $1.68 million.

 

On September 2, 2021, the Company issued to certain holders one-year subordinated secured convertible promissory notes in the aggregate principal amount of $1,814 thousand, which included $194 thousand of interest which was deemed fully earned as of the issuance date (the “September 2 Notes”). On January 25, 2022, the Company repaid one of the September 2 Notes in full with a one-time cash payment of $300 thousand of outstanding principal and accrued but unpaid interest. The Company incurred pre-payment penalty of $17 thousand with respect to the repayment of the note and the remaining unamortized debt discount in the amount of $133 thousand was written off and both amounts were recorded as a loss on extinguishment of debt of $150 thousand in accompany condensed consolidated statement of operations during 2022. The repayment extinguished the note in its entirety. On September 6, 2022, the outstanding balance on the remaining September 2 Notes’ was repaid in full which consisted of principal of $1,478 thousand.

 

 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Warrant Liability
 6 Months Ended
Jun. 30, 2023
Warrant Liability  
Warrant Liability

14. Warrant Liability

 

On September 2, 2021, March 11, 2021, February 3, 2021, December 24, 2020, March 18, 2020, September 10, 2019, and November 6, 2019, the Company issued 22,019, 34,286, 7,429, 7,286, 44,286, 35,715 and 114,286 warrants, respectively, as equity issuance consideration, in connection with a private placement of the Company’s common stock. The warrants entitle the holder to purchase one share of our common stock at an exercise price equal to $0.49 to $5.25 per share at any time on or after their issuance date and on or prior to the close of business 3 or 5 years, as applicable, after the issuance date (the “Termination Date”). The Company determined that these warrants are free standing financial instruments that are legally detachable and separately exercisable from the common stock included in the public share offering. Management also determined that the warrants required classification as a liability pursuant to ASC 815. In accordance with the accounting guidance, the outstanding warrants are recognized as a warrant liability on the balance sheet and are measured at their inception date fair value and subsequently re-measured at each reporting period with changes being recorded as a component of other income in the statement of operations.

 

The warrants outstanding and fair values at each of the respective valuation dates are summarized below:

 

Warrant Liability  Warrants Outstanding   Fair Value per Share   Fair Value 
Fair value as of year ended 12/31/2022   265,305       $242 
Exercise of warrants   (194,286)             (154)
Change in fair value of warrant liability   -        77 
Fair value as of period ended 6/30/2023   71,019        $165 

 

The warrant liabilities are considered Level 3 liabilities on the fair value hierarchy as the determination of fair value includes various assumptions about of future activities and the Company’s stock prices and historical volatility of Guideline Public Companies as inputs.

 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and Contingencies
 6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

15. Commitments and Contingencies

 

Litigation

 

The Company may be subject to legal proceedings and claims that arise in the ordinary course of business. Management is not currently aware of any matters that will have a material effect on the financial position, results of operations, or cash flows of the Company.

 

Service Agreement

 

On March 21, 2023, the Company entered into a Services Agreement with GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (“Haleon”) to supply material for a consumer product to be developed and released in the future. There can be no guaranty that a consumer product will be released or, if released, that it will be successful. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC is a Haleon group company.

 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Concentrations of Risk
 6 Months Ended
Jun. 30, 2023
Risks and Uncertainties [Abstract]  
Concentrations of Risk

16. Concentrations of Risk

 

The Company’s revenues are concentrated in a small group of customers with some individually having more than 10% of total revenues.

 

Revenues from two customers that exceeded 10% of total revenues for the six months ended June 30, 2023, were 40% and 14%. The accounts receivable from those top two customers were 0% and 22% as well as 13%, 15%, and 16% from three other customers of the total accounts receivable as of June 30, 2023.

 

 

Revenues from two customers that exceeded 10% of total revenues for the six months ended June 30, 2022, were 40% and 25%. The accounts receivable from those top two customers by revenue were 6% and 46% as well as 15% and 22% from two other customers of the total accounts receivable as of June 30, 2022.

 

The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash, cash equivalents and marketable securities. Cash balances are maintained principally at major U.S. financial institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to regulatory limits. Such cash balances are currently in excess of the FDIC insurance limit of $250 thousand. As of June 30, 2023, the total amount exceeding such limit was $3 million. The Company has not experienced any credit losses associated with its cash balances in the past. The Company invests its cash equivalents in U.S. treasury bills with original maturities of three months or less.

 

Marketable securities are comprised of U.S. treasury bills with original maturities greater than three months. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents, and marketable securities and performs periodic evaluations of the credit standing of such institutions.

 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions
 6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

17. Related Party Transactions

 

Convertible Promissory Note

 

On September 2, 2021, the Company issued three Secured Convertible Promissory Notes to members of the board of directors in aggregate amounts of $150,000 to Mr. Stein, $150,000 to Mr. Stefansky (Bezalel Partners, LLC), and $50,000 to Dr. Zeldis as part of the September 2 Notes. The notes were repaid in full in 2022.

 

Advances

 

Dr. Jerome Zeldis, a member of the Company board of directors, has an outstanding balance due of $25,000 for services as of June 30, 2023 and $40,000 as of December 31, 2022, included in accounts payable in the accompanying condensed consolidated balance sheets.

 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Subsequent Events
 6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events

18. Subsequent Events

 

Management of the Company has performed a review of events and transactions occurring after the condensed consolidated balance sheet date to determine if there were any such events or transactions requiring adjustment to or disclosure in the accompanying condensed consolidated financial statements and has noted none except as follows.

 

In July 2023, the Company announced a new strategic relationship with Enigma Health, a new joint venture company, for retail distribution and marketing services in North America. In addition to the Company, Enigma Health will also be providing services for Moiety, Inc., a topical lotion and creams manufacturer.
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Significant Accounting Policies and Estimates (Policies)
 6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Use of Estimates

Use of Estimates

 

The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. These estimates and assumptions include allowances for doubtful accounts, inventory reserves, deferred taxes, share-based compensation and related valuation allowances and fair value of long-lived assets. Actual results could differ from the estimates.

 
Cash

Cash

 

Cash is comprised of cash in banks and highly liquid investments, including U.S. treasury bills purchased with an original maturity of three months or less as well as investments in money market funds for which the carrying amount approximates fair value, due to the short maturities of these investments.

 
Marketable Securities

Marketable Securities

 

The Company classifies its marketable securities as held-to-maturity, which include U.S. treasury bills with original maturities of greater than three months. These securities are carried at fair value with any change in fair value recorded as an unrealized gain (loss) in the consolidated statement of operations of the period in which such change occurs.

 

The Company had the following marketable securities as of June 30, 2023 and December 31, 2022:

Schedule of Marketable Securities  

   June 30,   December 31, 
   2023   2022 
Marketable Securities          
United States treasury bills (due February 23, 2023)  $-   $492 
United States treasury bills (due April 27, 2023)   -    20 
United States treasury bills (due June 15, 2023)   -    4,384 
United States treasury bills (due July 13, 2023)   127    127 
United States treasury bills (due August 10, 2023)   485    485 
Total  $612   $5,508 

 
Accounts Receivable, net

Accounts Receivable, net

 

Trade accounts receivable are stated at the amount the Company expects to collect and do not bear interest. The Company evaluates the collectability of accounts receivable and records a provision to the allowance for doubtful accounts based on factors including the length of time the receivables are past due, the current business environment and the Company’s historical experience. Provisions to the allowances for doubtful accounts are recorded in selling, general, and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered. The allowance for doubtful accounts was $17 thousand as of June 30, 2023, and $9 thousand as of December 31, 2022.

 
Inventory and Cost of Goods Sold

Inventory and Cost of Goods Sold

 

Inventory is stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. The Company evaluates inventories for excess quantities, obsolescence, and shelf-life expiration. This evaluation includes an analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, and a review of the shelf-life expiration dates for products. These factors determine when, and if, the Company adjusts the carrying value of inventory to estimated net realizable value.

 

 

The Company produces proprietary branded products and white label opportunities in our manufacturing of consumer products. In our contract manufacturing, the Company builds its products based on customer orders and immediately ships the products upon completion of the production process.

 

The balance is made up of raw materials, work-in-progress, and finished goods. Inventory is maintained primarily at the Company’s warehouse and at an Amazon fulfillment center.

 

The “Cost of revenues” line item in the condensed consolidated statements of operations is comprised of the book value of inventory sold to customers during the reporting period. When circumstances dictate that we use net realizable value as the basis for recording inventory, we base our estimates on expected future selling prices less expected disposal costs.

 
Research and Development

Research and Development

 

Our research and development activities focus on new and innovative products designed to support revenue growth. Research and development expenses consist primarily of contracted development and testing efforts associated with development of products.

 
Shipping and Handling Revenue and Expense

Shipping and Handling Revenue and Expense

 

Shipping and handling revenue and expense are included in our condensed consolidated statements of operations in revenues and cost of revenues, respectively. This is primarily through shipping fees incurred in the Amazon marketplace.

 
Property and Equipment, net

Property and Equipment, net

 

Property and equipment is recorded at historical cost, net of accumulated depreciation and amortization. Depreciation is provided over the assets’ useful lives on a straight-line basis. Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or lease terms. Repairs and maintenance costs are expensed as incurred.

 

Management periodically assesses the estimated useful life over which assets are depreciated or amortized. If the analysis warrants a change in the estimated useful life of property and equipment, management will reduce the estimated useful life and depreciate or amortize the carrying value prospectively over the shorter remaining useful life.

 

The carrying amounts of assets sold or retired and the related accumulated depreciation are eliminated in the period of disposal and the resulting gains and losses are included in the results of operations during the same period.

 
Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

The Company reviews its property and equipment and any identifiable intangibles for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted operating cash flow expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell.

 
Goodwill and Intangible Assets

Goodwill and Intangible Assets

 

In applying the acquisition method of accounting, amounts assigned to identifiable assets and liabilities acquired were based on estimated fair values as of the date of acquisition, with the remainder recorded as goodwill. Identifiable intangible assets are initially recorded at fair value using generally accepted valuation methods appropriate for the type of intangible asset. Identifiable intangible assets with definite lives are amortized over their estimated useful lives and are reviewed for impairment if indicators of impairment arise. Intangible assets with indefinite lives are tested for impairment within one year of acquisitions or annually as of December 31, and whenever indicators of impairment exist. The fair value of intangible assets is compared with their carrying values, and an impairment loss would be recognized for the amount by which a carrying amount exceeds its fair value.

 

 

The Company performed the annual assessment and concluded it is more likely than not that the fair value exceeds the carrying value and no impairments were recognized in the year ended December 31, 2022.

 
Prepaid Expenses and Other Current Assets

Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets are recorded at historical cost and is primarily made up of $96 thousand and $63 thousand of prepaid insurance, and $270 thousand and $109 thousand general prepaid expenses and other current assets as of June 30, 2023, and December 31, 2022, respectively.

 
Other Assets

Other Assets

 

Other assets are recorded at historical costs, and as of June 30, 2023, and December 31, 2022, the balance is primarily comprised of spare parts for manufacturing equipment. Other assets are not subject to depreciation until such time that they are placed into service and the part that is being replaced is disposed.

 
Fair Value Measurements

Fair Value Measurements

 

The Company utilizes the fair value hierarchy to apply fair value measurements. The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair values that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources, while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions. The basis for fair value measurements for each level within the hierarchy is described below:

 

Level 1 — Quoted prices for identical assets or liabilities in active markets.

 

Level 2 — Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable.

 

Level 3 — Valuations derived from valuation techniques in which one or more significant inputs to the valuation model are unobservable.

 

The Company considers the carrying amounts of its financial instruments (cash, accounts receivable and accounts payable, notes payable and convertible notes payable) in the balance sheet to approximate fair value because of the short-term or highly liquid nature of these financial instruments.

 

The following table sets forth the fair value of the Company’s financial assets within the fair value hierarchy:

 

   Level 1   Level 2   Level 3   Fair Value 
       June 30, 2023     
   Level 1   Level 2   Level 3   Fair Value 
Assets                    
Marketable securities:                          
United States treasury bills  $612   $     -   $-   $612 
Total  $612   $-   $-   $612 

 

   Level 1   Level 2   Level 3   Fair Value 
       December 31, 2022     
   Level 1   Level 2   Level 3   Fair Value 
Assets                    
Marketable securities:                    
United States treasury bills  $5,508   $      -   $     -   $5,508 
Total  $5,508   $-   $-   $5,508 

 

 
Warrant Liability

Warrant Liability

 

Warrants to purchase common stock were issued in connection with equity financing raises, which occurred during 2019 through 2021. The fair values of the warrants are estimated as of the date of issuance and again at each year end using a Black-Scholes option valuation model. At issuance, the fair values of the warrants are recognized as an equity issuance cost within additional paid-in-capital. Fair value adjustments to the warrant liability are recognized in other income (expense) in the accompanying condensed consolidated statements of operations.

 
Revenue Recognition

Revenue Recognition

 

On January 1, 2018, the Company adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted ASC 606 for all applicable contracts using the modified retrospective method, which would have required a cumulative-effect adjustment, if any, as of the date of adoption.

 

The Company currently recognizes revenue predominately from three types of revenue, contract manufacturing, custom and white label finished goods manufacturing and our branded products. Revenues from manufactured and branded products are recognized at the point where the customer obtains control of the goods and the Company satisfies its performance obligation, which generally is at the time the customer receives the product.

 

The Company’s customers consist of other life sciences companies and Amazon retail customers. Revenues are entirely concentrated in the United States. Payment terms vary by the type and location of customer and may differ by jurisdiction and customer, but payment is generally required in a term ranging from 30 to 60 days from date of shipment.

 

Estimates for product returns, allowances and discounts are recorded as a reduction of revenue and are established at the time of sale. Returns are estimated through a comparison of historical return data and are determined for each product and adjusted for known or expected changes in the marketplace specific to each product, when appropriate. Historically, sales return provisions have not been material. Amounts accrued for sales allowances and discounts are based on estimates of amounts that are expected to be claimed on the related sales and are based on historical data. Payments for allowances and discounts have historically been immaterial.

 

Disaggregated revenue by sales type:

  

   2023   2022 
   Three months ended 
   June 30, 
   2023   2022 
Contract manufacturing  $887   $324 
Custom and white label finished goods manufacturing   —    19 
NexGel branded consumer products   259    180 
Other   21    38 
Total  $1,167   $561 

 

 

   2023   2022 
   Six months ended 
   June 30, 
   2023   2022 
Contract manufacturing  $1,267   $459 
Custom and white label finished goods manufacturing   4    19 
NexGel branded consumer products   493    392 
Other   22    86 
Total  $1,786   $956 

 

As of June 30, 2023, and December 31, 2022, the Company did not have any contract assets or contract liabilities from contracts with customers. As of June 30, 2023, and December 31, 2022, there were no remaining performance obligations that the Company had not satisfied.

 

The Company has four distinct lines of business; Contract Manufacturing, Custom & White Label, Consumer Branded Products, and Medical Devices.

 

Contract Manufacturing

 

Customers order rolls of gel (“rollstock”). The rollstock is shipped to our customers, which they package into finished goods. Historically, this has been the Company’s primary source of revenue.

 

Custom & White Label

 

These products often infuse various ingredients into our base gel to develop unique product offerings to satisfy market demand (e.g. aloe infused into the gel for a beauty mask). The rollstock is converted and packaged into salable units. The finished goods are shipped to the customer, who is ultimately responsible for product distribution. Frequently these products started as development deals, in which the customer paid the Company a small fee to develop a specific product. Once completed, the customer places a large order for newly developed product.

 

Consumer Branded Products

 

These products are finished goods marketed and sold directly to the customer by the Company through online and retail channels. The Company is responsible for sales, marketing, and distribution. These products carry the Company’s brand names.

 

Medical Devices

 

Medical Devices are a hybrid business, combining elements of Custom & White Label and Consumer Branded Products. Medical Devices, which are not yet marketed, are expected to be distributed through strategic partnerships. The Company will manufacture and possibly convert/package the device while the strategic partner brings the product to market. Small market Medical Devices could be launched by the Company, but also be offered to a distributor to reach the full scale of the market.

 
Share-based Compensation

Share-based Compensation

 

On August 28, 2019, the Company adopted the 2019 Long-Term Incentive Plan, as amended (the “2019 Plan”). See Note 10 below for further details regarding the 2019 Plan.

 

The 2019 Plan provides certain employees, contractors, and outside directors with share-based compensation in the form of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalent rights and other awards. The fair values of incentive stock option award grants are estimated as of the date of grant using a Black-Scholes option valuation model. Compensation expense is recognized in the statements of operations on a straight-line basis over the requisite service period, which is generally the vesting period required to obtain full vesting. Forfeitures are accounted for when they occur.

 

 

In June 2018, FASB issued Accounting Standards Update (“ASU”) No. 2018-07, Compensation - Stock Compensation (Topic 718) - Improvements to Nonemployee Share-Based Payment Accounting. These amendments expand the scope of Topic 718, Compensation - Stock Compensation, to include share-based payments issued to non-employees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. This new standard was effective for the Company on January 1, 2020. The Company adopted this new standard early in the third quarter of 2019 and it did not have a material impact to its condensed consolidated financial statements.

 
Income Taxes

Income Taxes

 

Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax bases of assets and liabilities at the applicable tax rates. Deferred tax assets are reduced by a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates.

 

Tax benefits are recognized from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by a tax authority and based upon the technical merits of the tax position. The tax benefit recognized in the condensed consolidated financial statements for a particular tax position is based on the largest benefit that is more likely than not to be realized upon settlement. An unrecognized tax benefit, or a portion thereof, is presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed.

 
Leases

Leases

 

ASC 842, Leases, requires recognition of leases on the condensed consolidated balance sheets as right-of-use (“ROU”) assets and lease liabilities. ROU assets represent the Company’s right to use underlying assets for the lease terms and lease liabilities represent the Company’s obligation to make lease payments arising from the leases. Operating lease ROU assets and operating lease liabilities are recognized based on the present value and future minimum lease payments over the lease term at commencement date. As the Company’s leases do not provide an implicit rate, the Company used its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. A number of the lease agreements contain options to renew and options to terminate the leases early. The lease term used to calculate ROU assets and lease liabilities only includes renewal and termination options that are deemed reasonably certain to be exercised.

 

The Company recognized lease liabilities, with corresponding ROU assets, based on the present value of unpaid lease payments for existing operating leases longer than twelve months. The ROU assets were adjusted per ASC 842 transition guidance for existing lease-related balances of accrued and prepaid rent, and unamortized lease incentives provided by lessors. Operating lease cost is recognized as a single lease cost on a straight-line basis over the lease term and is recorded in selling, general and administrative expenses. Variable lease payments for common area maintenance, property taxes and other operating expenses are recognized as expense in the period when the changes in facts and circumstances on which the variable lease payments are based occur. The Company has elected not to separate lease and non-lease components for all property leases for the purposes of calculating ROU assets and lease liabilities.

 
Segment Reporting

Segment Reporting

 

The Company operates in one business segment as a contract manufacturer of aqueous polymer hydrogels. As a result, the Company’s operations are a single reportable segment, which is consistent with the Company’s internal management reporting.

 

 
Recently Issued Accounting Standards

Recently Issued Accounting Standards

 

From time to time, new accounting pronouncements are issued by FASB, or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption.

 

In June 2016, FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 significantly changes the impairment model for most financial assets and certain other instruments. ASU 2016-13 will require immediate recognition of estimated credit losses expected to occur over the remaining life of many financial assets, which will generally result in earlier recognition of allowances for credit losses on loans and other financial instruments. ASU 2016-13 is effective for the Company’s fiscal year beginning January 1, 2023 and subsequent interim periods. The Company is currently evaluating the impact the adoption of ASU 2016-13 will have on the Company’s condensed consolidated financial statements.
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Significant Accounting Policies and Estimates (Tables)
 6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Schedule of Marketable Securities

The Company had the following marketable securities as of June 30, 2023 and December 31, 2022:

Schedule of Marketable Securities  

   June 30,   December 31, 
   2023   2022 
Marketable Securities          
United States treasury bills (due February 23, 2023)  $-   $492 
United States treasury bills (due April 27, 2023)   -    20 
United States treasury bills (due June 15, 2023)   -    4,384 
United States treasury bills (due July 13, 2023)   127    127 
United States treasury bills (due August 10, 2023)   485    485 
Total  $612   $5,508 
Schedule of Fair Value of Financial Assets

The following table sets forth the fair value of the Company’s financial assets within the fair value hierarchy:

 

   Level 1   Level 2   Level 3   Fair Value 
       June 30, 2023     
   Level 1   Level 2   Level 3   Fair Value 
Assets                    
Marketable securities:                          
United States treasury bills  $612   $     -   $-   $612 
Total  $612   $-   $-   $612 

 

   Level 1   Level 2   Level 3   Fair Value 
       December 31, 2022     
   Level 1   Level 2   Level 3   Fair Value 
Assets                    
Marketable securities:                    
United States treasury bills  $5,508   $      -   $     -   $5,508 
Total  $5,508   $-   $-   $5,508 
Schedule of Disaggregated Revenue by Sales Type

Disaggregated revenue by sales type:

  

   2023   2022 
   Three months ended 
   June 30, 
   2023   2022 
Contract manufacturing  $887   $324 
Custom and white label finished goods manufacturing   —    19 
NexGel branded consumer products   259    180 
Other   21    38 
Total  $1,167   $561 

 

 

   2023   2022 
   Six months ended 
   June 30, 
   2023   2022 
Contract manufacturing  $1,267   $459 
Custom and white label finished goods manufacturing   4    19 
NexGel branded consumer products   493    392 
Other   22    86 
Total  $1,786   $956 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Leases (Tables)
 6 Months Ended
Jun. 30, 2023
Leases  
Schedule of Future Minimum Lease Payments

The following table presents information about the amount and timing of the liability arising from the Company’s operating lease as of June 30, 2023 ($ in thousands):

  

   Operating 
   Lease 
Maturity of Lease Liability  Liability 
2023  $122 
2024   245 
2025   245 
2026   301 
2027   315 
Thereafter   1,115 
Total undiscounted operating lease payments   2,343 
Less: Imputed interest   (292)
Present value of operating lease liability  $2,051 
Weighted average remaining lease term   8.6 years  
Weighted average discount rate   3.5%
Schedule of Supplemental Cash Flows Information Related to Leases

Supplemental cash flows information related to leases was as follows ($ in thousands):

  

   June 30, 
   2023 
Cash paid for amounts included in the measurement of lease liability:     
Operating cash flows from operating lease  $136 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.2
Inventory (Tables)
 6 Months Ended
Jun. 30, 2023
Inventory Disclosure [Abstract]  
Schedule of Inventory

Inventory consists of the following ($ in thousands):

  

   June 30,   December 31, 
   2023   2022 
Raw materials  $638   $295 
Work-in-progress   43    51 
Finished goods   398    156 
Inventory, gross   1,079    502 
Less: Inventory reserve for excess and slow moving inventory   —    — 
Total  $1,079   $502 

 

Inventory is maintained at the Company’s warehouse, an outsourced third-party contract manufacturing vendor, and at Amazon fulfillment centers. The Company builds its contract manufacturing products based on customer orders and immediately ships the products upon completion of the production process.

 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Property and Equipment, Net (Tables)
 6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment

Property and equipment consist of the following ($ in thousands):

  

   Useful Life   June 30,   December 31, 
   (Years)   2023   2022 
Machinery and equipment  3 - 10   $1,530   $973 
Office furniture and equipment  3 - 10    159    59 
Leasehold improvements  6    261    228 
Construction in progress  N/A    118    55 
Total property and equipment       2,068    1,315 
Less: accumulated depreciation and amortization       (655)   (594)
Property and equipment, net      $1,413   $721 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.2
Intangible Assets (Tables)
 6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Breakdown of Identifiable Intangible Assets

The following provides a breakdown of identifiable intangible assets as of June 30, 2023 and December 31, 2022:

  

   June 30,   December 31, 
   2023   2022 
Product/Technology Related          
Identifiable intangible assets, gross  $31   $31 
Accumulated amortization   (31)   (26)
Product/Technology Related identifiable intangible assets, net   -    5 
Marketing Related          
Customer related intangible asset, gross   17    17 
Tradename related intangible asset, gross   7    7 
Accumulated amortization   (11)   (9)
Marketing related identifiable intangible assets, net   13    15 
Total Identifiable intangible assets, net  $13   $20 
Schedule of Estimated Annual Amortization Expense

As of June 30, 2023, the estimated annual amortization expense for each of the next five fiscal years is as follows:

  

      
($ in thousands):     
2023  $2 
2024   2 
2025   2 
2026   2 
2027   2 
Thereafter   3 
Total  $13 
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.2
Accrued Expenses and Other Current Liabilities (Tables)
 6 Months Ended
Jun. 30, 2023
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following ($ in thousands):

 

   June 30,   December 31, 
   2023   2022 
Salaries, benefits, and incentive compensation  $72   $56 
Franchise tax accrual   64    52 
Other   66    22 
Total accrued expenses and other current liabilities  $202   $130 
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.2
Common Stock (Tables)
 6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Schedule of Reserved Common Stock For Issued Securities in Relation

At June 30, 2023, the Company has reserved common stock for issued securities in relation to the following:

 

Share-based compensation plan   528,182 
Warrants to purchase common stock   3,442,904 
Restricted stock units   121,787 
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based Compensation (Tables)
 6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Information about Incentive Plan

The following table contains information about the 2019 Plan as of June 30, 2023:

 

   Awards   Awards       Awards 
  

Reserved for

Issuance

   Issued & Outstanding  

Awards

Exercised

  

Available for

Grant

 
2019 Plan(1)   871,429    612,932    7,183    251,314 
Awards granted outside of the 2019 Plan(2)   -    37,037    11,364    - 

 

(1) Includes incentive stock options and restricted stock units discussed below.
   
(2) Includes shares of restricted common stock granted outside of the 2019 Plan to our Chief Executive Officer, Adam Levy.
Schedule of Incentive Stock Option Activity

The following table summarizes the Company’s incentive stock option activity and related information for the period ended June 30, 2023:

 

           Weighted 
       Weighted   Average 
       Average   Contractual 
   Number of   Exercise   Term in 
   Options   Price   Years 
Outstanding at January 1, 2023   524,937   $2.351416    8.38 
Granted   17,532    2.00    10.0 
Exercised   —    —    — 
Forfeited   —    —    — 
Cancelled   (10,000)   1.75    — 
Expired   (4,287)   1.40    — 
Outstanding at June 30, 2023   528,182   $2.35886    7.99 
Exercisable at June 30, 2023   337,111   $1.774915    7.21 
Schedule of Assumptions used in Share-based Compensation

 

Volatility   257.64%
Risk-free interest rate   4.21%
Dividend yield   0.0%
Expected term   5.50 years 
Schedule of Restricted Stock Units Granted

       Weighted 
       Average 
   Number of   Grant Date 
   Units   Fair Value 
Outstanding at January 1, 2023   90,432   $1.43 
Granted   37,037    1.35 
Exercised and converted to common shares   (5,682)   4.40 
Forfeited   —    — 
Outstanding at June 30, 2023   121,787   $1.68 
Exercisable at June 30, 2023   30,466   $1.68 
Summary of Common Stock Warrants

The following table shows a summary of common stock warrants through June 30, 2023:

 

       Weighted   Weighted 
       Average   Average 
   Number of   Exercise   Contractual 
   Warrants   Price   Term in Years 
Outstanding at January 1, 2023   3,637,190   $5.16281    3.65 
Granted   —    —    — 
Exercised   (112,466)   0.55    — 
Forfeited   —    —    — 
Cancelled   (81,820)   0.91    — 
Expired   —    —    — 
Outstanding at June 30, 2023   3,442,904   $5.414793    3.35 
Exercisable at June 30, 2023   3,442,904   $5.414793    3.35 
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Notes Payable (Tables)
 6 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
Schedule of Debt Instruments

The future annual principal amounts and accrued interest to be paid as of June 30, 2023 are as follows:

 

   Amount 
For the year ending December 31 ($ in thousands):     
2023 (remainder of the year)  $3 
2024   5 
2025   5 
2026   5 
2027   6 
Thereafter   256 
Total  $280 
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Warrant Liability (Tables)
 6 Months Ended
Jun. 30, 2023
Warrant Liability  
Schedule of Warrant Liability

The warrants outstanding and fair values at each of the respective valuation dates are summarized below:

 

Warrant Liability  Warrants Outstanding   Fair Value per Share   Fair Value 
Fair value as of year ended 12/31/2022   265,305       $242 
Exercise of warrants   (194,286)             (154)
Change in fair value of warrant liability   -        77 
Fair value as of period ended 6/30/2023   71,019        $165 
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.2
Description of Business, Stock Split and Basis of Presentation (Details Narrative)
Jun. 30, 2023
Mar. 01, 2023
Joint Venture [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Minority percentage 50.00% 50.00%
Joint Venture [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Acquisition percentage   50.00%
CG Labs [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Acquisition percentage   50.00%
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.2
Going Concern (Details Narrative) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]          
Cash $ 3,691   $ 3,691   $ 1,101
Marketable securities 612   612   $ 5,508
Net loss 695 $ 1,035 1,509 $ 2,871  
Net cash used in operating activities     1,926 $ 1,495  
Working capital $ 5,000   $ 5,000    
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Marketable Securities (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]    
Total $ 612 $ 5,508
US Treasury Securities [Member]    
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]    
Total 612 5,508
US Treasury Securities [Member] | February 23, 2023 [Member]    
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]    
Total 492
US Treasury Securities [Member] | April 27, 2023 [Member]    
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]    
Total 20
US Treasury Securities [Member] | June 15, 2023 [Member]    
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]    
Total 4,384
US Treasury Securities [Member] | July 13, 2023 [Member]    
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]    
Total 127 127
US Treasury Securities [Member] | August 10, 2023 [Member]    
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]    
Total $ 485 $ 485
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Fair Value of Financial Assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Platform Operator, Crypto-Asset [Line Items]    
Total $ 612 $ 5,508
US Treasury Securities [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Total 612 5,508
Fair Value, Inputs, Level 1 [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Total 612 5,508
Fair Value, Inputs, Level 1 [Member] | US Treasury Securities [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Total 612 5,508
Fair Value, Inputs, Level 2 [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Total
Fair Value, Inputs, Level 2 [Member] | US Treasury Securities [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Total
Fair Value, Inputs, Level 3 [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Total
Fair Value, Inputs, Level 3 [Member] | US Treasury Securities [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Total
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Disaggregated Revenue by Sales Type (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Accounting Policies [Abstract]        
Contract manufacturing $ 887 $ 324 $ 1,267 $ 459
Custom and white label finished goods manufacturing 19 4 19
NexGel branded consumer products 259 180 493 392
Other 21 38 22 86
Total $ 1,167 $ 561 $ 1,786 $ 956
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.2
Significant Accounting Policies and Estimates (Details Narrative)
 6 Months Ended 12 Months Ended
Jun. 30, 2023
USD ($)
Segment
Dec. 31, 2022
USD ($)
Accounting Policies [Abstract]    
Allowance for doubtful accounts $ 17,000 $ 9,000
Asset impairment charges   0
Prepaid insurance 96,000 63,000
General prepaid expenses 270,000 109,000
Remaining performance obligations $ 0 $ 0
Number of operating segments | Segment 1  
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Future Minimum Lease Payments (Details)
$ in Thousands
Jun. 30, 2023
USD ($)
Leases  
2023 $ 122
2024 245
2025 245
2026 301
2027 315
Thereafter 1,115
Total undiscounted operating lease payments 2,343
Less: Imputed interest (292)
Present value of operating lease liability $ 2,051
Weighted average remaining lease term 8 years 7 months 6 days
Weighted average discount rate 3.50%
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Supplemental Cash Flows Information Related to Leases (Details)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
USD ($)
Leases  
Operating cash flows from operating lease $ 136
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.2
Leases (Details Narrative) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Leases    
Operating lease expense $ 136 $ 103
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Inventory (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Raw materials $ 638 $ 295
Work-in-progress 43 51
Finished goods 398 156
Inventory, gross 1,079 502
Less: Inventory reserve for excess and slow moving inventory
Total $ 1,079 $ 502
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Property and Equipment (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 2,068 $ 1,315
Less: accumulated depreciation and amortization (655) (594)
Property and equipment, net 1,413 721
Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 1,530 973
Machinery and Equipment [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Useful Life (Years) 3 years  
Machinery and Equipment [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Useful Life (Years) 10 years  
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 159 59
Furniture and Fixtures [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Useful Life (Years) 3 years  
Furniture and Fixtures [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Useful Life (Years) 10 years  
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Useful Life (Years) 6 years  
Total property and equipment $ 261 228
Construction in Progress [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 118 $ 55
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.2
Property and Equipment, Net (Details Narrative) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Property, Plant and Equipment [Abstract]    
Depreciation expense $ 61 $ 49
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Breakdown of Identifiable Intangible Assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Total $ 13 $ 20
Technology-Based Intangible Assets [Member]    
Finite-Lived Intangible Assets [Line Items]    
Identifiable intangible assets, gross 31 31
Accumulated amortization (31) (26)
Total 5
Customer-Related Intangible Assets [Member]    
Finite-Lived Intangible Assets [Line Items]    
Identifiable intangible assets, gross 17 17
Trade Names [Member]    
Finite-Lived Intangible Assets [Line Items]    
Identifiable intangible assets, gross 7 7
Marketing-Related Intangible Assets [Member]    
Finite-Lived Intangible Assets [Line Items]    
Accumulated amortization (11) (9)
Total $ 13 $ 15
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Estimated Annual Amortization Expense (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
2023 $ 2  
2024 2  
2025 2  
2026 2  
2027 2  
Thereafter 3  
Total $ 13 $ 20
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.23.2
Intangible Assets (Details Narrative) - Sport Defense LLC [Member] - Technology Related and Customer Related Intangibles [Member] - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
May 29, 2020
Finite-Lived Intangible Assets [Line Items]      
Intangibles     $ 55
Expected life 5 years 8 months 12 days 5 years 8 months 12 days  
Amortization expense $ 7 $ 7  
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
Salaries, benefits, and incentive compensation $ 72 $ 56
Franchise tax accrual 64 52
Other 66 22
Total accrued expenses and other current liabilities $ 202 $ 130
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Reserved Common Stock For Issued Securities in Relation (Details)
 6 Months Ended
Jun. 30, 2023
shares
Equity [Abstract]  
Share-based compensation plan 528,182
Warrants to purchase common Stock 3,442,904
Restricted stock units 121,787
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Information about Incentive Plan (Details)
 6 Months Ended
Jun. 30, 2023
shares
2019 Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Awards Reserved For Issuance 871,429 [1]
Awards Issued 612,932 [1]
Awards Exercised 7,183 [1]
Awards Available for Grant 251,314 [1]
Awards Granted Outside Of The 2019 Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Awards Reserved For Issuance [2]
Awards Granted Outside Of The 2019 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Awards Issued 37,037 [2]
Awards Exercised 11,364 [2]
Awards Available for Grant [2]
[1] Includes incentive stock options and restricted stock units discussed below.
[2] Includes shares of restricted common stock granted outside of the 2019 Plan to our Chief Executive Officer, Adam Levy.
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Incentive Stock Option Activity (Details) - Equity Option [Member] - 2019 Plan [Member]
 6 Months Ended
Jun. 30, 2023
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of options, outstanding, beginning balance | shares 524,937
Weighted average exercise price, outstanding beginning balance | $ / shares $ 2.351416
Weighted average remaining contractual term 8 years 4 months 17 days
Number of options, granted | shares 17,532
Weighted average exercise price, granted | $ / shares $ 2.00
Weighted average remaining contractual term, Granted 10 years
Number of options, exercised | shares
Weighted average exercise price, exercised | $ / shares
Number of options, forfeited | shares
Weighted average exercise price, forfeited | $ / shares
Number of options, cancelled | shares (10,000)
Weighted average exercise price, cancelled | $ / shares $ 1.75
Number of options, expired | shares (4,287)
Weighted average exercise price, expired | $ / shares $ 1.40
Number of options, outstanding, ending balance | shares 528,182
Weighted average exercise price, outstanding ending balance | $ / shares $ 2.35886
Weighted average remaining contractual term 7 years 11 months 26 days
Number of options, exercisable | shares 337,111
Weighted average exercise price, exercisable | $ / shares $ 1.774915
Weighted average remaining contractual term, exercisable 7 years 2 months 15 days
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Assumptions used in Share-based Compensation (Details)
 6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Volatility 257.64%
Risk-free interest rate 4.21%
Dividend yield 0.00%
Expected term 5 years 6 months
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Restricted Stock Units Granted (Details)
 6 Months Ended
Jun. 30, 2023
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, exercised and converted to common shares (112,466,000)
Restricted Stock Units (RSUs) [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units outstanding beginning 90,432
Weighted average grant date fair value outstanding beginning | $ / shares $ 1.43
Number of units, granted 37,037
Weighted average grant date fair value, granted | $ / shares $ 1.35
Number of units, exercised and converted to common shares (5,682)
Weighted average grant date fair value, exercised and converted to common shares | $ / shares $ 4.40
Number of units, forfeited
Weighted average grant date fair value, forfeited | $ / shares
Number of units outstanding beginning 121,787
Weighted average grant date fair value outstanding ending | $ / shares $ 1.68
Number of units exercisable 30,466
Weighted average grant date fair value exercisable | $ / shares $ 1.68
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Common Stock Warrants (Details)
 6 Months Ended
Jun. 30, 2023
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Number of warrants, outstanding beginning balance | shares 3,637,190
Weighted average exercise price, outstanding beginning balance | $ / shares $ 5.16281
Weighted average remaining contractual term 3 years 7 months 24 days
Number of warrants, granted | shares
Weighted average exercise price, granted | $ / shares
Number of warrants, exercised | shares (112,466,000)
Weighted average exercise price, exercised | $ / shares $ 0.55
Number of warrants, forfeited | shares
Weighted average exercise price, forfeited | $ / shares
Number of warrants, cancelled | shares (81,820,000)
Weighted average exercise price, cancelled | $ / shares $ 0.91
Number of warrants, expired | shares
Weighted average exercise price, expired | $ / shares
Number of warrants, outstanding ending balance | shares 3,442,904
Weighted average exercise price, outstanding ending balance | $ / shares $ 5.414793
Weighted average remaining contractual term 3 years 4 months 6 days
Number of warrants, exercisable | shares 3,442,904
Weighted average exercise price, exercisable | $ / shares $ 5.414793
Weighted average remaining contractual term, exercisable 3 years 4 months 6 days
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based Compensation (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jan. 03, 2023
Oct. 01, 2022
Aug. 01, 2022
Jan. 01, 2022
Mar. 31, 2023
Jun. 30, 2023
Jun. 30, 2022
Mar. 08, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Restricted stock vesting, shares           121,787    
[custom:UnrecognizedShareBasedCompensationExpense]           $ 121    
Stock based compensation and restricted stock vesting           53 $ 134  
Intrinsic value of vested outstanding warrants           $ 0    
Officers and Employees [Member | Restricted Stock [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of units, granted     84,750          
Restricted stock vesting, shares     84,750          
Share price     $ 1.82          
Chief Executive Officer [Member] | Restricted Stock [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of units, granted 37,037     11,364        
Restricted stock vesting, shares 37,037     11,364        
Share price $ 1.35     $ 4.40        
Common Stock [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Restricted stock vesting, shares         5,682      
2019 Plan [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of options, granted [1]           612,932    
2019 Plan [Member] | Equity Option [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of shares granted           17,532    
Exercise price of options           $ 2.00    
Intrinsic value           $ 129    
Unrecognized share-based compensation expense           $ 17    
2019 Plan [Member] | Equity Option [Member] | Minimum [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Period of recognition of stock based compensation expense           18 months    
2019 Plan [Member] | Equity Option [Member] | Maximum [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Period of recognition of stock based compensation expense           36 months    
2019 Plan [Member] | Executive Officer [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of shares granted           14,286    
2019 Plan [Member] | Contractor [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of options, granted               17,532
Exercise price of options   $ 2.00            
2019 Plan [Member] | Common Stock [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of options, granted           871,429    
[1] Includes incentive stock options and restricted stock units discussed below.
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.23.2
Noncontrolling Interest in Joint Venture (Details Narrative) - USD ($)
 6 Months Ended
Mar. 01, 2023
Jun. 30, 2023
Payment to acquire business $ 500,000  
Joint Venture [Member]    
Minority percentage 50.00% 50.00%
CG Converting And Packaging LLC [Member]    
Minority percentage 50.00%  
CG Laboratories Inc [Member]    
Minority percentage 5000.00%  
CG Laboratories [Member]    
Payment to acquire business   $ 350,000
CG Labs [Member]    
Payment to acquire business   $ 500,000
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Debt Instruments (Details)
$ in Thousands
Jun. 30, 2023
USD ($)
Debt Disclosure [Abstract]  
2023 (remainder of the year) $ 3
2024 5
2025 5
2026 5
2027 6
Thereafter 256
Total $ 280
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.23.2
Notes Payable (Details Narrative) - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
May 28, 2020
Jun. 30, 2023
Dec. 31, 2022
Short-Term Debt [Line Items]      
Accrued interest   $ 280 $ 283
Economic Injury Disaster Loan [Member]      
Short-Term Debt [Line Items]      
Borrowing capacity $ 260,500    
Interest rate 3.75%    
DebtInstrument periodic payment $ 1,270    
Loan advance $ 8,000    
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.23.2
Convertible Notes Payable (Details Narrative) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Sep. 02, 2021
Mar. 11, 2021
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Sep. 06, 2022
Mar. 15, 2022
Jan. 25, 2022
Short-Term Debt [Line Items]                    
Principal amount of debt                 $ 1,680  
Interest expense     $ 9 $ 348 $ 10 $ 1,092        
Gains loss on extinguishment of debt     $ (150)        
Secured Convertible Promissory Note [Member]                    
Short-Term Debt [Line Items]                    
Interest expense $ 194                  
Outstanding principal and accrued unpaid interest                   $ 300
Pre payment penalty                   17
Unamortized debt discount                   $ 133
Gains loss on extinguishment of debt             $ 150      
Secured Convertible Promissory Note [Member] | Private Placement [Member]                    
Short-Term Debt [Line Items]                    
Principal amount of debt $ 1,814             $ 1,478    
Auctus Note [Member]                    
Short-Term Debt [Line Items]                    
Principal amount of debt   $ 1,680                
Debt Instrument, Periodic Payment, Interest   $ 180                
XML 73 R63.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Warrant Liability (Details) - USD ($)
$ / shares in Thousands, $ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Change in fair value of warrant liability $ (77) $ 101
Warrant [Member]    
Warrants outstanding 265,305  
Fair value $ 242  
Number of warrants, exercised (194,286,000)  
Exercise of wararnts $ (154)  
Change in fair value of warrant liability  
Change in fair value of warrant liability $ 77  
Warrants outstanding 71,019  
Fair value $ 165  
XML 74 R64.htm IDEA: XBRL DOCUMENT v3.23.2
Warrant Liability (Details Narrative) - Private Placement [Member] - $ / shares
Jun. 30, 2023
Sep. 02, 2021
Mar. 11, 2021
Feb. 03, 2021
Dec. 24, 2020
Mar. 18, 2020
Nov. 06, 2019
Sep. 10, 2019
Subsidiary, Sale of Stock [Line Items]                
Warrants outstanding   22,019 34,286 7,429 7,286 44,286 114,286 35,715
Minimum [Member]                
Subsidiary, Sale of Stock [Line Items]                
Exercise price $ 0.49              
Maximum [Member]                
Subsidiary, Sale of Stock [Line Items]                
Exercise price $ 5.25              
XML 75 R65.htm IDEA: XBRL DOCUMENT v3.23.2
Concentrations of Risk (Details Narrative) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Concentration Risk [Line Items]    
Cash, FDIC insured amount $ 250  
Cash, exceeding $ 3  
Customer One [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 40.00% 40.00%
Customer One [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 0.00% 6.00%
Customer Two [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 14.00% 25.00%
Customer Two [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 22.00% 46.00%
One Other Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 13.00% 15.00%
Two Other Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 15.00% 22.00%
Three Other Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 16.00%  
XML 76 R66.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions (Details Narrative)
$ in Thousands
Jun. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Mar. 15, 2022
USD ($)
Sep. 02, 2021
USD ($)
Integer
Related Party Transaction [Line Items]        
Debt instrument face amount     $ 1,680  
Mr. Stein [Member]        
Related Party Transaction [Line Items]        
Number Of Debt Instruments | Integer       3
Debt instrument face amount       $ 150,000
Mr.Stefansky [Member]        
Related Party Transaction [Line Items]        
Debt instrument face amount       150,000
Dr.Jerome Zeldis [Member]        
Related Party Transaction [Line Items]        
Debt instrument face amount       $ 50,000
Due from related parties, current $ 25,000 $ 40,000    
XML 77 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001468929 2023-01-01 2023-06-30 0001468929 NXGL:CommonStockParValue0.001Member 2023-01-01 2023-06-30 0001468929 NXGL:WarrantsToPurchaseCommonStockMember 2023-01-01 2023-06-30 0001468929 2023-08-11 0001468929 2023-06-30 0001468929 2022-12-31 0001468929 2023-04-01 2023-06-30 0001468929 2022-04-01 2022-06-30 0001468929 2022-01-01 2022-06-30 0001468929 us-gaap:CommonStockMember 2022-12-31 0001468929 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001468929 us-gaap:NoncontrollingInterestMember 2022-12-31 0001468929 us-gaap:RetainedEarningsMember 2022-12-31 0001468929 us-gaap:CommonStockMember 2023-03-31 0001468929 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001468929 us-gaap:NoncontrollingInterestMember 2023-03-31 0001468929 us-gaap:RetainedEarningsMember 2023-03-31 0001468929 2023-03-31 0001468929 us-gaap:CommonStockMember 2021-12-31 0001468929 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001468929 us-gaap:RetainedEarningsMember 2021-12-31 0001468929 2021-12-31 0001468929 us-gaap:CommonStockMember 2022-03-31 0001468929 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001468929 us-gaap:RetainedEarningsMember 2022-03-31 0001468929 2022-03-31 0001468929 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001468929 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001468929 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001468929 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001468929 2023-01-01 2023-03-31 0001468929 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001468929 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001468929 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001468929 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001468929 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001468929 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001468929 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001468929 2022-01-01 2022-03-31 0001468929 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001468929 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001468929 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001468929 us-gaap:CommonStockMember 2023-06-30 0001468929 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001468929 us-gaap:NoncontrollingInterestMember 2023-06-30 0001468929 us-gaap:RetainedEarningsMember 2023-06-30 0001468929 us-gaap:CommonStockMember 2022-06-30 0001468929 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001468929 us-gaap:RetainedEarningsMember 2022-06-30 0001468929 2022-06-30 0001468929 NXGL:JointVentureMember 2023-03-01 0001468929 NXGL:CGLabsMember 2023-03-01 0001468929 NXGL:JointVentureMember 2023-06-30 0001468929 NXGL:FebruraryTwentyThreeTwoThousandAndTwentyThreeMember us-gaap:USTreasurySecuritiesMember 2023-06-30 0001468929 NXGL:FebruraryTwentyThreeTwoThousandAndTwentyThreeMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0001468929 NXGL:AprilTwentySevenTwoThousandAndTwentyThreeMember us-gaap:USTreasurySecuritiesMember 2023-06-30 0001468929 NXGL:AprilTwentySevenTwoThousandAndTwentyThreeMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0001468929 NXGL:JuneFifteenTwoThousandandTwentyThreeMember us-gaap:USTreasurySecuritiesMember 2023-06-30 0001468929 NXGL:JuneFifteenTwoThousandandTwentyThreeMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0001468929 NXGL:JulyThirteenTwoThousandTwentyThreeMember us-gaap:USTreasurySecuritiesMember 2023-06-30 0001468929 NXGL:JulyThirteenTwoThousandTwentyThreeMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0001468929 NXGL:AugustTenTwoThousandTwentyThreeMember us-gaap:USTreasurySecuritiesMember 2023-06-30 0001468929 NXGL:AugustTenTwoThousandTwentyThreeMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0001468929 2022-01-01 2022-12-31 0001468929 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2023-06-30 0001468929 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasurySecuritiesMember 2023-06-30 0001468929 us-gaap:FairValueInputsLevel3Member us-gaap:USTreasurySecuritiesMember 2023-06-30 0001468929 us-gaap:USTreasurySecuritiesMember 2023-06-30 0001468929 us-gaap:FairValueInputsLevel1Member 2023-06-30 0001468929 us-gaap:FairValueInputsLevel2Member 2023-06-30 0001468929 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001468929 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2022-12-31 0001468929 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasurySecuritiesMember 2022-12-31 0001468929 us-gaap:FairValueInputsLevel3Member us-gaap:USTreasurySecuritiesMember 2022-12-31 0001468929 us-gaap:USTreasurySecuritiesMember 2022-12-31 0001468929 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001468929 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001468929 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001468929 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2023-06-30 0001468929 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2023-06-30 0001468929 us-gaap:MachineryAndEquipmentMember 2023-06-30 0001468929 us-gaap:MachineryAndEquipmentMember 2022-12-31 0001468929 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2023-06-30 0001468929 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2023-06-30 0001468929 us-gaap:FurnitureAndFixturesMember 2023-06-30 0001468929 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001468929 us-gaap:LeaseholdImprovementsMember 2023-06-30 0001468929 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001468929 us-gaap:ConstructionInProgressMember 2023-06-30 0001468929 us-gaap:ConstructionInProgressMember 2022-12-31 0001468929 us-gaap:TechnologyBasedIntangibleAssetsMember 2023-06-30 0001468929 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-12-31 0001468929 us-gaap:CustomerRelatedIntangibleAssetsMember 2023-06-30 0001468929 us-gaap:CustomerRelatedIntangibleAssetsMember 2022-12-31 0001468929 us-gaap:TradeNamesMember 2023-06-30 0001468929 us-gaap:TradeNamesMember 2022-12-31 0001468929 us-gaap:MarketingRelatedIntangibleAssetsMember 2023-06-30 0001468929 us-gaap:MarketingRelatedIntangibleAssetsMember 2022-12-31 0001468929 NXGL:SportDefenseLlcMember NXGL:TechnologyRelatedAndCustomerRelatedIntangiblesMember 2020-05-29 0001468929 NXGL:SportDefenseLlcMember NXGL:TechnologyRelatedAndCustomerRelatedIntangiblesMember 2023-01-01 2023-06-30 0001468929 NXGL:SportDefenseLlcMember NXGL:TechnologyRelatedAndCustomerRelatedIntangiblesMember 2022-01-01 2022-06-30 0001468929 NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember us-gaap:CommonStockMember 2023-06-30 0001468929 srt:ExecutiveOfficerMember NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2023-01-01 2023-06-30 0001468929 NXGL:ContractorMember NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2023-03-08 0001468929 NXGL:ContractorMember NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2022-10-01 2022-10-01 0001468929 us-gaap:StockOptionMember NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2023-06-30 0001468929 srt:MinimumMember us-gaap:StockOptionMember NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2023-01-01 2023-06-30 0001468929 srt:MaximumMember us-gaap:StockOptionMember NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2023-01-01 2023-06-30 0001468929 NXGL:OfficersAndEmployeesMember us-gaap:RestrictedStockMember 2022-08-01 2022-08-01 0001468929 NXGL:OfficersAndEmployeesMember us-gaap:RestrictedStockMember 2022-08-01 0001468929 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2022-01-01 2022-01-01 0001468929 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2022-01-01 0001468929 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2023-01-03 2023-01-03 0001468929 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2023-01-03 0001468929 NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2023-06-30 0001468929 NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2023-01-01 2023-06-30 0001468929 NXGL:AwardsGrantedOutsideOfThe2019PlanMember 2023-06-30 0001468929 NXGL:AwardsGrantedOutsideOfThe2019Member 2023-06-30 0001468929 NXGL:AwardsGrantedOutsideOfThe2019Member 2023-01-01 2023-06-30 0001468929 us-gaap:StockOptionMember NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2022-12-31 0001468929 us-gaap:StockOptionMember NXGL:TwoThousandAndNineteenLongTermIncentivePlanMember 2023-01-01 2023-06-30 0001468929 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001468929 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001468929 us-gaap:RestrictedStockUnitsRSUMember 2023-06-30 0001468929 NXGL:JointVentureMember 2023-03-01 0001468929 NXGL:CGConvertingAndPackagingLLCMember 2023-03-01 0001468929 NXGL:CGLaboratoriesIncMember 2023-03-01 0001468929 2023-03-01 2023-03-01 0001468929 NXGL:CGLaboratoriesMember 2023-01-01 2023-06-30 0001468929 NXGL:CGLabsMember 2023-01-01 2023-06-30 0001468929 NXGL:EconomicInjuryDisasterLoanMember 2020-05-28 0001468929 NXGL:EconomicInjuryDisasterLoanMember 2020-05-27 2020-05-28 0001468929 NXGL:AuctusNoteMember 2021-03-11 0001468929 NXGL:AuctusNoteMember 2021-03-10 2021-03-11 0001468929 2022-03-15 0001468929 NXGL:SecuredConvertiblePromissoryNoteMember us-gaap:PrivatePlacementMember 2021-09-02 0001468929 NXGL:SecuredConvertiblePromissoryNoteMember 2021-09-02 2021-09-02 0001468929 NXGL:SecuredConvertiblePromissoryNoteMember 2022-01-25 0001468929 NXGL:SecuredConvertiblePromissoryNoteMember 2022-01-01 2022-12-31 0001468929 NXGL:SecuredConvertiblePromissoryNoteMember us-gaap:PrivatePlacementMember 2022-09-06 0001468929 us-gaap:PrivatePlacementMember 2021-09-02 0001468929 us-gaap:PrivatePlacementMember 2021-03-11 0001468929 us-gaap:PrivatePlacementMember 2021-02-03 0001468929 us-gaap:PrivatePlacementMember 2020-12-24 0001468929 us-gaap:PrivatePlacementMember 2020-03-18 0001468929 us-gaap:PrivatePlacementMember 2019-09-10 0001468929 us-gaap:PrivatePlacementMember 2019-11-06 0001468929 srt:MinimumMember us-gaap:PrivatePlacementMember 2023-06-30 0001468929 srt:MaximumMember us-gaap:PrivatePlacementMember 2023-06-30 0001468929 us-gaap:WarrantMember 2022-12-31 0001468929 us-gaap:WarrantMember 2023-06-30 0001468929 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001468929 NXGL:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001468929 NXGL:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001468929 NXGL:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001468929 NXGL:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001468929 NXGL:OneOtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001468929 NXGL:TwoOtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001468929 NXGL:ThreeOtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001468929 NXGL:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001468929 NXGL:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001468929 NXGL:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001468929 NXGL:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001468929 NXGL:OneOtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001468929 NXGL:TwoOtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001468929 NXGL:Mr.SteinMember 2021-09-02 0001468929 NXGL:Mr.StefanskyMember 2021-09-02 0001468929 NXGL:Dr.JeromeZeldisMember 2021-09-02 0001468929 NXGL:Dr.JeromeZeldisMember 2023-06-30 0001468929 NXGL:Dr.JeromeZeldisMember 2022-12-31 iso4217:USD shares iso4217:USD shares pure NXGL:Segment NXGL:Integer 0001468929 false Q2 --12-31 10-Q true 2023-06-30 2023 false 001-41173 NexGel, Inc. DE 26-4042544 2150 Cabot Blvd West Suite B Langhorne PA 19047 (215) 702-8550 Common Stock, par value $0.001 NXGL NASDAQ Warrants to Purchase Common Stock NXGLW NASDAQ Yes Yes Non-accelerated Filer true true false false 5696064 3691000 1101000 612000 5508000 950000 222000 1079000 502000 366000 172000 6698000 7505000 311000 311000 13000 20000 1413000 721000 1967000 1737000 95000 63000 10497000 10357000 1058000 265000 202000 130000 15000 15000 165000 242000 232000 207000 1672000 859000 1819000 1593000 265000 268000 3756000 2720000 0.001 0.001 5000000 5000000 0 0 0 0 0.001 0.001 25000000 25000000 5696064 5696064 5577916 5577916 6000 6000 19242000 19189000 -13067000 -11558000 6181000 7637000 560000 6741000 7637000 10497000 10357000 1167000 561000 1786000 956000 992000 460000 1669000 884000 175000 101000 117000 72000 55000 111000 84000 135000 882000 708000 1679000 1467000 937000 819000 1763000 1602000 -762000 -718000 -1646000 -1530000 9000 348000 10000 1092000 2000 2000 -150000 2000 4000 2000 116000 124000 -11000 -29000 -77000 101000 120000 -317000 197000 -1341000 -642000 -1035000 -1449000 -2871000 -642000 -1035000 -1449000 -2871000 53000 60000 -695000 -1035000 -1509000 -2871000 -0.12 -0.19 -0.27 -0.52 -0.12 -0.19 -0.27 -0.52 5662338000 5572234000 5624275000 5572234000 5662338000 5572234000 5624275000 5572234000 5577916 6000 19189000 -11558000 7637000 5682 24000 24000 30430 500000 500000 7000 -814000 -807000 5614028 6000 19213000 507000 -12372000 7354000 29000 29000 82036 53000 -695000 -642000 5696064 6000 19242000 560000 -13067000 6741000 5572234 6000 18891000 -6812000 12085000 55000 55000 -1836000 -1836000 5572234 6000 18946000 -8648000 10304000 5572234 6000 18946000 -8648000 10304000 54000 54000 25000 25000 -1035000 -1035000 -1035000 -1035000 5572234 6000 19025000 -9683000 9348000 5572234 6000 19025000 -9683000 9348000 -1509000 -2871000 60000 68000 57000 21000 19000 53000 134000 -124000 -77000 101000 1086000 -150000 728000 91000 577000 90000 226000 286000 793000 268000 72000 28000 -1926000 -1495000 4772000 5371000 253000 31000 4519000 -5402000 3000 2033000 -3000 -2033000 2590000 -8930000 1101000 13350000 3691000 4420000 500000 334000 <p id="xdx_80B_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_zR4V2Dp39jp7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>1. <span id="xdx_820_zCatSmyjXo74">Description of Business, Stock Split and Basis of Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NexGel, Inc. (“NexGel” or the “Company”) manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. The Company specializes in custom gels by capitalizing on proprietary manufacturing technologies. NexGel has historically served as a contract manufacturer, supplying our gels to third parties who incorporate them into their own products, and has recently began producing the Company’s own consumer products using our gels focused on proprietary branded products and white label opportunities. Both the Company’s gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies. Together, these technologies enable NexGel to produce gels that can satisfy rigid tolerance specifications with respect to a wide range of physical characteristics (e.g., thickness, water content, adherence, absorption, moisture vapor transmission rate (a measure of the passage of water vapor through a substance) and release rate) while maintaining product integrity. Additionally, the Company has the manufacturing capability to offer broad choices in the selection of liners onto which the gels are coated. Consequently, NexGel and our customers are able to determine tolerances in moisture vapor transmission rate and active ingredient release rates while personalizing color and texture.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NexGel was previously known as AquaMed Technologies, Inc. (“AquaMed”) before changing its name to NexGel, Inc. on November 14, 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 1, 2023, the Company acquired a <span id="xdx_902_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20230301__us-gaap--BusinessAcquisitionAxis__custom--JointVentureMember_za1fjgGLuTGb" title="Acquisition percentage">50</span>% interest in a newly formed joint venture (“JV”), CG Converting and Packaging, LLC, with C.G. Laboratories Inc. (“CG Labs”) for its converting and packaging business. The agreement is effective March 1, 2023. <span style="background-color: white">As a result of this transaction, the Company owns <span id="xdx_904_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20230301__us-gaap--BusinessAcquisitionAxis__custom--JointVentureMember_zaIHthTjYyD9" title="Acquisition percentage">50</span>% of the JV, with the remaining<span id="xdx_904_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20230301__us-gaap--BusinessAcquisitionAxis__custom--CGLabsMember_zLzJHPdWrhq" title="Acquisition percentage"> 50</span>% held by CG Labs.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis of Presentation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying interim unaudited condensed consolidated financial statements and footnotes of NexGel have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and the instructions to Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Accordingly, they do <i>not</i> include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, these unaudited condensed consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation of the results of the interim periods, but are <i>not</i> necessarily indicative of the results of operations to be anticipated for the full year ending December 31, 2023<i>. </i>These condensed consolidated financial statements should be read in conjunction with the audited financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Principles of Consolidation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed consolidated financial statements include the accounts of the Company and its consolidated wholly-owned subsidiary, NexGelRx, Inc. and the fifty percent (<span id="xdx_902_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_c20230630__srt--OwnershipAxis__custom--JointVentureMember_zmDzDfK6dJ72" title="Minority percentage">50</span>%) owned JV (see Note 11).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.50 0.50 0.50 0.50 <p id="xdx_806_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zKDQUNCIeRH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. <span id="xdx_824_zv0DnbgV7BZc">Going Concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, the Company had a cash balance of $<span id="xdx_906_eus-gaap--Cash_iI_pn5n6_c20230630_zHNr5FLTfjl4" title="Cash">3.7</span> million (including cash equivalents) and $<span id="xdx_90F_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20230630_zOeIuIonmA2g" title="Marketable securities">612</span> thousand of marketable securities (see Note 3 for details of our marketable securities). For the six months ended June 30, 2023, the Company incurred a net loss of $<span id="xdx_902_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20230101__20230630_zKT2bY6UvnD" title="Net loss">1.5</span> million and had a net usage of cash in operating activities of $<span id="xdx_908_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20230101__20230630_zib5U9i4btGj" title="Net cash used in operating activities">1.9</span> million. In addition, the Company had a working capital of $<span id="xdx_90D_ecustom--WorkingCapitalDeficit_iI_pn5n6_c20230630_zC9c4YLax7oj" title="Working capital">5.0</span> million as of June 30, 2023. We believe we have sufficient cash and marketable securities to operate our business plan through 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management is exploring new product channel sales in adjacent industries, such as cosmetics, athletic products, and proprietary medical devices. The Company has increased its focus on sales and developing a sales pipeline for potential customers. This customer base expansion will enable us to provide financial stability for the foreseeable future, expand our current processes, and position us for long-term shareholder value creation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have sufficient capital to maintain as a going concern due to the capital raise that occurred on December 27, 2021. We intend to maintain and attempt to grow our existing contract manufacturing business. We also plan to continue building and developing our catalog of consumer products for sale to branding partners and to use our in-house capabilities to create and test market additional branded products. These products will be target marketed and sold online through social media, television and online marketplaces. Furthermore, the Company plans to develop its own proprietary medical devices and explore drug delivery programs for its technology. Additionally, the Company continues to evaluate strategic initiatives (e.g., acquisitions) and additional capital raises through debt or equity may be necessary to achieve these objectives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We expect to continue incurring losses for the near-term future. Our ability to continue to operate as a going concern in the long-term is dependent upon our ability to manage and grow our current products and to ultimately achieve profitable operations. Management may consider various options to raise capital to fund potential acquisitions through equity or debt offerings. There can be no assurances, however, that management will be able to obtain sufficient additional funds, if needed, or that such funds, if available, will be obtained on terms satisfactory to us. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets and liabilities that might be necessary should we be unable to continue as a going concern. Additionally, it is reasonably possible that estimates made in the condensed consolidated financial statements have been, or will be, materially and adversely impacted in the near term as a result of these conditions, including the recoverability of long-lived assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3700000 612000 -1500000 -1900000 5000000.0 <p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_z19W32da0NAe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. <span id="xdx_827_zutR5urTiXS">Significant Accounting Policies and Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--UseOfEstimates_z3dM8IDo7qW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zW1SWZpAvGr6">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. These estimates and assumptions include allowances for doubtful accounts, inventory reserves, deferred taxes, share-based compensation and related valuation allowances and fair value of long-lived assets. Actual results could differ from the estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_znSDKsBgJD8c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zToYWWRxJVX3">Cash</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash is comprised of cash in banks and highly liquid investments, including U.S. treasury bills purchased with an original maturity of three months or less as well as investments in money market funds for which the carrying amount approximates fair value, due to the short maturities of these investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--MarketableSecuritiesPolicy_zHCJHRc9FcUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zxrj4FoFlPCe">Marketable Securities</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company classifies its marketable securities as held-to-maturity, which include U.S. treasury bills with original maturities of greater than three months. These securities are carried at fair value with any change in fair value recorded as an unrealized gain (loss) in the consolidated statement of operations of the period in which such change occurs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--MarketableSecuritiesTextBlock_zsr0vJnJ3MVl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had the following marketable securities as of June 30, 2023 and December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span><span id="xdx_8BF_zt1KKfwoj8gl">Schedule of Marketable Securities</span></span></span> </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20230630_zwscOysCVPKi" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_494_20221231_zgzf7RSxYX67" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Marketable Securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--MarketableSecurities_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--AwardDateAxis__custom--FebruraryTwentyThreeTwoThousandAndTwentyThreeMember_zNlzxrNCHf5l" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 62%; text-align: justify">United States treasury bills (due February 23, 2023)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0584">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">492</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--MarketableSecurities_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--AwardDateAxis__custom--AprilTwentySevenTwoThousandAndTwentyThreeMember_zKuhdLYluxMg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">United States treasury bills (due April 27, 2023)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0587">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--MarketableSecurities_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--AwardDateAxis__custom--JuneFifteenTwoThousandandTwentyThreeMember_zGPINFiyhJ1a" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">United States treasury bills (due June 15, 2023)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0590">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,384</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--MarketableSecurities_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--AwardDateAxis__custom--JulyThirteenTwoThousandTwentyThreeMember_z0mUZ2Fvgfbl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">United States treasury bills (due July 13, 2023)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">127</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">127</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--MarketableSecurities_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--AwardDateAxis__custom--AugustTenTwoThousandTwentyThreeMember_zms34bk5pMI" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">United States treasury bills (due August 10, 2023)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">485</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">485</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--MarketableSecurities_iI_pn3n3_z56svfHDSLHi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">612</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,508</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_z6hJtDFMyfna" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zav8tC1Juji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zzOUNHREGag3">Accounts Receivable, net</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade accounts receivable are stated at the amount the Company expects to collect and do not bear interest. The Company evaluates the collectability of accounts receivable and records a provision to the allowance for doubtful accounts based on factors including the length of time the receivables are past due, the current business environment and the Company’s historical experience. Provisions to the allowances for doubtful accounts are recorded in selling, general, and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered. The allowance for doubtful accounts was $<span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn3n3_c20230630_zMFOkRRwQH92" title="Allowance for doubtful accounts">17</span> thousand as of June 30, 2023, and $<span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn3n3_c20221231_zshOtAzm0ZBf" title="Allowance for doubtful accounts">9</span> thousand as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--InventoryPolicyTextBlock_zFfPivGB2ITa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zSL3Xp79uLyf">Inventory and Cost of Goods Sold</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. The Company evaluates inventories for excess quantities, obsolescence, and shelf-life expiration. This evaluation includes an analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, and a review of the shelf-life expiration dates for products. These factors determine when, and if, the Company adjusts the carrying value of inventory to estimated net realizable value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company produces proprietary branded products and white label opportunities in our manufacturing of consumer products. In our contract manufacturing, the Company builds its products based on customer orders and immediately ships the products upon completion of the production process.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The balance is made up of raw materials, work-in-progress, and finished goods. Inventory is maintained primarily at the Company’s warehouse and at an Amazon fulfillment center.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The “Cost of revenues” line item in the condensed consolidated statements of operations is comprised of the book value of inventory sold to customers during the reporting period. When circumstances dictate that we use net realizable value as the basis for recording inventory, we base our estimates on expected future selling prices less expected disposal costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zTRis43yrvZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zdQ7IS7ZKmme">Research and Development</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our research and development activities focus on new and innovative products designed to support revenue growth. Research and development expenses consist primarily of contracted development and testing efforts associated with development of products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--ShippingAndHandlingRevenueAndExpensePolicyPolicyTextBlock_zPR2bf1klWs" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zC1zxwd5F9f3">Shipping and Handling Revenue and Expense</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping and handling revenue and expense are included in our condensed consolidated statements of operations in revenues and cost of revenues, respectively. This is primarily through shipping fees incurred in the Amazon marketplace.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zE67q3Pxz1le" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_ztVnwus6G3Xl">Property and Equipment, net</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment is recorded at historical cost, net of accumulated depreciation and amortization. Depreciation is provided over the assets’ useful lives on a straight-line basis. Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or lease terms. Repairs and maintenance costs are expensed as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management periodically assesses the estimated useful life over which assets are depreciated or amortized. If the analysis warrants a change in the estimated useful life of property and equipment, management will reduce the estimated useful life and depreciate or amortize the carrying value prospectively over the shorter remaining useful life.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of assets sold or retired and the related accumulated depreciation are eliminated in the period of disposal and the resulting gains and losses are included in the results of operations during the same period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zedhdlGqMUKi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zpLbCx7Y9oed">Impairment of Long-Lived Assets</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reviews its property and equipment and any identifiable intangibles for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted operating cash flow expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z2m1e97P4lof" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zJGpynNSkMee">Goodwill and Intangible Assets</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In applying the acquisition method of accounting, amounts assigned to identifiable assets and liabilities acquired were based on estimated fair values as of the date of acquisition, with the remainder recorded as goodwill. Identifiable intangible assets are initially recorded at fair value using generally accepted valuation methods appropriate for the type of intangible asset. Identifiable intangible assets with definite lives are amortized over their estimated useful lives and are reviewed for impairment if indicators of impairment arise. Intangible assets with indefinite lives are tested for impairment within one year of acquisitions or annually as of December 31, and whenever indicators of impairment exist. The fair value of intangible assets is compared with their carrying values, and an impairment loss would be recognized for the amount by which a carrying amount exceeds its fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company performed the annual assessment and concluded it is more likely than not that the fair value exceeds the carrying value and<span id="xdx_90E_eus-gaap--AssetImpairmentCharges_do_c20220101__20221231_zVkmFbQkt0da" title="Asset impairment charges"> no</span> impairments were recognized in the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_848_ecustom--PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock_ztd8j8imYTO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zy4ktuXnvVd">Prepaid Expenses and Other Current Assets</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other current assets are recorded at historical cost and is primarily made up of $<span id="xdx_909_eus-gaap--PrepaidInsurance_iI_pn3n3_c20230630_zdOJ3tFaGwag" title="Prepaid insurance">96</span> thousand and $<span id="xdx_902_eus-gaap--PrepaidInsurance_iI_pn3n3_c20221231_zN9lb2Yqwot2" title="Prepaid insurance">63</span> thousand of prepaid insurance, and $<span id="xdx_904_eus-gaap--OtherPrepaidExpenseCurrent_iI_pn3n3_c20230630_zfnwtbQB3V3" title="General prepaid expenses">270</span> thousand and $<span id="xdx_90C_eus-gaap--OtherPrepaidExpenseCurrent_iI_pn3n3_c20221231_zgqOa4IbZFM6" title="General prepaid expenses">109</span> thousand general prepaid expenses and other current assets as of June 30, 2023, and December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--OtherAssetsPolicyPolicyTextBlock_zL3iUlrG5ksc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_z7cwa8A6JKhb">Other Assets</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other assets are recorded at historical costs, and as of June 30, 2023, and December 31, 2022, the balance is primarily comprised of spare parts for manufacturing equipment. Other assets are not subject to depreciation until such time that they are placed into service and the part that is being replaced is disposed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zGFw4OekJTT7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zbQB6susExvj">Fair Value Measurements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company utilizes the fair value hierarchy to apply fair value measurements. The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair values that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources, while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions. The basis for fair value measurements for each level within the hierarchy is described below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 1</i> — Quoted prices for identical assets or liabilities in active markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 2</i> — Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 3</i> — Valuations derived from valuation techniques in which one or more significant inputs to the valuation model are unobservable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers the carrying amounts of its financial instruments (cash, accounts receivable and accounts payable, notes payable and convertible notes payable) in the balance sheet to approximate fair value because of the short-term or highly liquid nature of these financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zD0JUMudcVRi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the fair value of the Company’s financial assets within the fair value hierarchy:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> <span id="xdx_8BA_zsIejr9DSnkj" style="display: none">Schedule of Fair Value of Financial Assets</span></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zcMYrH2gtvE3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zJzra644iG38" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBnUW0xkB43c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20230630_zPrVpn9aeZN7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Marketable securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">       </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--MarketableSecurities_iI_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zfc835tS5lJ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: justify; padding-bottom: 1.5pt">United States treasury bills</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">612</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">     <span style="-sec-ix-hidden: xdx2ixbrl0639">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0640">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">612</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--MarketableSecurities_iI_zPi3fnlodfme" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">612</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0644">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0645">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">612</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMza4PFqi38a" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z5HJkEDkbopl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_znd5sqz8Mr1d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20221231_zlpKuSyHGlK5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Marketable securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--MarketableSecurities_iI_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zRZn19Ydlmed" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: justify; padding-bottom: 1.5pt">United States treasury bills</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">5,508</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">      <span style="-sec-ix-hidden: xdx2ixbrl0649">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">     <span style="-sec-ix-hidden: xdx2ixbrl0650">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">5,508</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--MarketableSecurities_iI_zayDTvf2mq2e" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,508</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0654">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0655">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,508</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zGwduUgHrOFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84E_ecustom--WarrantLiabilityPolicyPolicyTextBlock_zAD0DNvCh6R1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_z3A5dcepGnA5">Warrant Liability</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants to purchase common stock were issued in connection with equity financing raises, which occurred during 2019 through 2021. The fair values of the warrants are estimated as of the date of issuance and again at each year end using a Black-Scholes option valuation model. At issuance, the fair values of the warrants are recognized as an equity issuance cost within additional paid-in-capital. Fair value adjustments to the warrant liability are recognized in other income (expense) in the accompanying condensed consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zrbZjsU0ALG" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zRjsv9Uw9tW1">Revenue Recognition</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2018, the Company adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, <i>Revenue from Contracts with Customers</i> (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted ASC 606 for all applicable contracts using the modified retrospective method, which would have required a cumulative-effect adjustment, if any, as of the date of adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company currently recognizes revenue predominately from three types of revenue, contract manufacturing, custom and white label finished goods manufacturing and our branded products. Revenues from manufactured and branded products are recognized at the point where the customer obtains control of the goods and the Company satisfies its performance obligation, which generally is at the time the customer receives the product.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s customers consist of other life sciences companies and Amazon retail customers. Revenues are entirely concentrated in the United States. Payment terms vary by the type and location of customer and may differ by jurisdiction and customer, but payment is generally required in a term ranging from 30 to 60 days from date of shipment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates for product returns, allowances and discounts are recorded as a reduction of revenue and are established at the time of sale. Returns are estimated through a comparison of historical return data and are determined for each product and adjusted for known or expected changes in the marketplace specific to each product, when appropriate. Historically, sales return provisions have not been material. Amounts accrued for sales allowances and discounts are based on estimates of amounts that are expected to be claimed on the related sales and are based on historical data. Payments for allowances and discounts have historically been immaterial.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--DisaggregationOfRevenueTableTextBlock_zvO1uQz2x0G8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregated revenue by sales type:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zIrxxvIqTeV6" style="display: none">Schedule of Disaggregated Revenue by Sales Type</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230401__20230630_zuPmFd6PBiFl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220401__20220630_zJZfuHrc9Ol8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three months ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_ecustom--RevenueFromContractManufacturing_pn3n3_maRFCWCzE8T_zeyN9PHwaH5i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Contract manufacturing</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">887</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">324</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--RevenueFromFinishedGoods_pn3n3_maRFCWCzE8T_z2KFkj7Wudo2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Custom and white label finished goods manufacturing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0667">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--RevenueFromConsumerProducts_pn3n3_maRFCWCzE8T_z3lNEvOc5F63" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">NexGel branded consumer products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">259</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--RevenueClassifiedAsOthers_pn3n3_maRFCWCzE8T_zP2846ixapde" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">38</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_iT_pn3n3_mtRFCWCzE8T_zoHln7MON1Rj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,167</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">561</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230630_zjYECOOfYTNf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20220101__20220630_ziwx6x1WIOP6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six months ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_ecustom--RevenueFromContractManufacturing_pn3n3_maRFCWCzE8T_zpsxClqBqzpc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Contract manufacturing</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,267</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">459</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--RevenueFromFinishedGoods_pn3n3_maRFCWCzE8T_zXRn5kI0iaG9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Custom and white label finished goods manufacturing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--RevenueFromConsumerProducts_pn3n3_maRFCWCzE8T_zYNfVJI159c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">NexGel branded consumer products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">493</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">392</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--RevenueClassifiedAsOthers_pn3n3_maRFCWCzE8T_zdlbzE8qcbs9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">22</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">86</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_iT_pn3n3_mtRFCWCzE8T_zhER6mHf8cYf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,786</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">956</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zu2UP9Aiw7Lg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, and December 31, 2022, the Company did not have any contract assets or contract liabilities from contracts with customers. As of June 30, 2023, and December 31, 2022, there were <span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_iI_pn3n3_do_c20230630_znLNQLwNocnk" title="Remaining performance obligations"><span id="xdx_90D_eus-gaap--RevenueRemainingPerformanceObligation_iI_pn3n3_do_c20221231_zmeGkkvYxU53" title="Remaining performance obligations">no</span></span> remaining performance obligations that the Company had not satisfied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has four distinct lines of business; Contract Manufacturing, Custom &amp; White Label, Consumer Branded Products, and Medical Devices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contract Manufacturing</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customers order rolls of gel (“rollstock”). The rollstock is shipped to our customers, which they package into finished goods. Historically, this has been the Company’s primary source of revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Custom &amp; White Label</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These products often infuse various ingredients into our base gel to develop unique product offerings to satisfy market demand (e.g. aloe infused into the gel for a beauty mask). The rollstock is converted and packaged into salable units. The finished goods are shipped to the customer, who is ultimately responsible for product distribution. Frequently these products started as development deals, in which the customer paid the Company a small fee to develop a specific product. Once completed, the customer places a large order for newly developed product.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Consumer Branded Products</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These products are finished goods marketed and sold directly to the customer by the Company through online and retail channels. The Company is responsible for sales, marketing, and distribution. These products carry the Company’s brand names.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Medical Devices</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medical Devices are a hybrid business, combining elements of Custom &amp; White Label and Consumer Branded Products. Medical Devices, which are not yet marketed, are expected to be distributed through strategic partnerships. The Company will manufacture and possibly convert/package the device while the strategic partner brings the product to market. Small market Medical Devices could be launched by the Company, but also be offered to a distributor to reach the full scale of the market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z70076yDqvb8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_z6k89056h9j7">Share-based Compensation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 28, 2019, the Company adopted the 2019 Long-Term Incentive Plan, as amended (the “2019 Plan”). See Note 10 below for further details regarding the 2019 Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 2019 Plan provides certain employees, contractors, and outside directors with share-based compensation in the form of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalent rights and other awards. The fair values of incentive stock option award grants are estimated as of the date of grant using a Black-Scholes option valuation model. Compensation expense is recognized in the statements of operations on a straight-line basis over the requisite service period, which is generally the vesting period required to obtain full vesting. Forfeitures are accounted for when they occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2018, FASB issued Accounting Standards Update (“ASU”) No. 2018-07, <i>Compensation - Stock Compensation (Topic 718) - Improvements to Nonemployee Share-Based Payment Accounting</i>. These amendments expand the scope of Topic 718, <i>Compensation - Stock Compensation</i>, to include share-based payments issued to non-employees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. This new standard was effective for the Company on January 1, 2020. The Company adopted this new standard early in the third quarter of 2019 and it did not have a material impact to its condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zRV8xRon0Cbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zy9BIptvktwj">Income Taxes</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax bases of assets and liabilities at the applicable tax rates. Deferred tax assets are reduced by a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax benefits are recognized from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by a tax authority and based upon the technical merits of the tax position. The tax benefit recognized in the condensed consolidated financial statements for a particular tax position is based on the largest benefit that is more likely than not to be realized upon settlement. An unrecognized tax benefit, or a portion thereof, is presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--LesseeLeasesPolicyTextBlock_z12s1y3QQE51" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_z1OOTB5e8Pz6">Leases</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 842, Leases, requires recognition of leases on the condensed consolidated balance sheets as right-of-use (“ROU”) assets and lease liabilities. ROU assets represent the Company’s right to use underlying assets for the lease terms and lease liabilities represent the Company’s obligation to make lease payments arising from the leases. Operating lease ROU assets and operating lease liabilities are recognized based on the present value and future minimum lease payments over the lease term at commencement date. As the Company’s leases do not provide an implicit rate, the Company used its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. A number of the lease agreements contain options to renew and options to terminate the leases early. The lease term used to calculate ROU assets and lease liabilities only includes renewal and termination options that are deemed reasonably certain to be exercised.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognized lease liabilities, with corresponding ROU assets, based on the present value of unpaid lease payments for existing operating leases longer than twelve months. The ROU assets were adjusted per ASC 842 transition guidance for existing lease-related balances of accrued and prepaid rent, and unamortized lease incentives provided by lessors. Operating lease cost is recognized as a single lease cost on a straight-line basis over the lease term and is recorded in selling, general and administrative expenses. Variable lease payments for common area maintenance, property taxes and other operating expenses are recognized as expense in the period when the changes in facts and circumstances on which the variable lease payments are based occur. The Company has elected not to separate lease and non-lease components for all property leases for the purposes of calculating ROU assets and lease liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zvEYDiZZecib" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zrY3oc696xcg">Segment Reporting</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates in <span id="xdx_90C_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20230101__20230630_z5FmXRkA8inf" title="Number of operating segments">one</span> business segment as a contract manufacturer of aqueous polymer hydrogels. As a result, the Company’s operations are a single reportable segment, which is consistent with the Company’s internal management reporting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zv8pYgwZElx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zeYHp7gygXzg">Recently Issued Accounting Standards</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, new accounting pronouncements are issued by FASB, or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, FASB issued ASU 2016-13, <i>Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</i>. ASU 2016-13 significantly changes the impairment model for most financial assets and certain other instruments. ASU 2016-13 will require immediate recognition of estimated credit losses expected to occur over the remaining life of many financial assets, which will generally result in earlier recognition of allowances for credit losses on loans and other financial instruments. ASU 2016-13 is effective for the Company’s fiscal year beginning January 1, 2023 and subsequent interim periods. The Company is currently evaluating the impact the adoption of ASU 2016-13 will have on the Company’s condensed consolidated financial statements.</span></p> <p id="xdx_853_zd3YmFfWFdBc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--UseOfEstimates_z3dM8IDo7qW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zW1SWZpAvGr6">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. These estimates and assumptions include allowances for doubtful accounts, inventory reserves, deferred taxes, share-based compensation and related valuation allowances and fair value of long-lived assets. Actual results could differ from the estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_znSDKsBgJD8c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zToYWWRxJVX3">Cash</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash is comprised of cash in banks and highly liquid investments, including U.S. treasury bills purchased with an original maturity of three months or less as well as investments in money market funds for which the carrying amount approximates fair value, due to the short maturities of these investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--MarketableSecuritiesPolicy_zHCJHRc9FcUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zxrj4FoFlPCe">Marketable Securities</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company classifies its marketable securities as held-to-maturity, which include U.S. treasury bills with original maturities of greater than three months. These securities are carried at fair value with any change in fair value recorded as an unrealized gain (loss) in the consolidated statement of operations of the period in which such change occurs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--MarketableSecuritiesTextBlock_zsr0vJnJ3MVl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had the following marketable securities as of June 30, 2023 and December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span><span id="xdx_8BF_zt1KKfwoj8gl">Schedule of Marketable Securities</span></span></span> </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20230630_zwscOysCVPKi" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_494_20221231_zgzf7RSxYX67" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Marketable Securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--MarketableSecurities_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--AwardDateAxis__custom--FebruraryTwentyThreeTwoThousandAndTwentyThreeMember_zNlzxrNCHf5l" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 62%; text-align: justify">United States treasury bills (due February 23, 2023)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0584">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">492</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--MarketableSecurities_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--AwardDateAxis__custom--AprilTwentySevenTwoThousandAndTwentyThreeMember_zKuhdLYluxMg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">United States treasury bills (due April 27, 2023)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0587">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--MarketableSecurities_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--AwardDateAxis__custom--JuneFifteenTwoThousandandTwentyThreeMember_zGPINFiyhJ1a" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">United States treasury bills (due June 15, 2023)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0590">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,384</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--MarketableSecurities_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--AwardDateAxis__custom--JulyThirteenTwoThousandTwentyThreeMember_z0mUZ2Fvgfbl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">United States treasury bills (due July 13, 2023)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">127</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">127</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--MarketableSecurities_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--AwardDateAxis__custom--AugustTenTwoThousandTwentyThreeMember_zms34bk5pMI" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">United States treasury bills (due August 10, 2023)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">485</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">485</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--MarketableSecurities_iI_pn3n3_z56svfHDSLHi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">612</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,508</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_z6hJtDFMyfna" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--MarketableSecuritiesTextBlock_zsr0vJnJ3MVl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had the following marketable securities as of June 30, 2023 and December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span><span id="xdx_8BF_zt1KKfwoj8gl">Schedule of Marketable Securities</span></span></span> </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20230630_zwscOysCVPKi" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_494_20221231_zgzf7RSxYX67" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Marketable Securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--MarketableSecurities_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--AwardDateAxis__custom--FebruraryTwentyThreeTwoThousandAndTwentyThreeMember_zNlzxrNCHf5l" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 62%; text-align: justify">United States treasury bills (due February 23, 2023)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0584">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">492</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--MarketableSecurities_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--AwardDateAxis__custom--AprilTwentySevenTwoThousandAndTwentyThreeMember_zKuhdLYluxMg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">United States treasury bills (due April 27, 2023)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0587">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--MarketableSecurities_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--AwardDateAxis__custom--JuneFifteenTwoThousandandTwentyThreeMember_zGPINFiyhJ1a" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">United States treasury bills (due June 15, 2023)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0590">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,384</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--MarketableSecurities_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--AwardDateAxis__custom--JulyThirteenTwoThousandTwentyThreeMember_z0mUZ2Fvgfbl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">United States treasury bills (due July 13, 2023)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">127</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">127</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--MarketableSecurities_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember__us-gaap--AwardDateAxis__custom--AugustTenTwoThousandTwentyThreeMember_zms34bk5pMI" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">United States treasury bills (due August 10, 2023)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">485</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">485</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--MarketableSecurities_iI_pn3n3_z56svfHDSLHi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">612</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,508</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 492000 20000 4384000 127000 127000 485000 485000 612000 5508000 <p id="xdx_84D_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zav8tC1Juji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zzOUNHREGag3">Accounts Receivable, net</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade accounts receivable are stated at the amount the Company expects to collect and do not bear interest. The Company evaluates the collectability of accounts receivable and records a provision to the allowance for doubtful accounts based on factors including the length of time the receivables are past due, the current business environment and the Company’s historical experience. Provisions to the allowances for doubtful accounts are recorded in selling, general, and administrative expenses. Account balances are charged off against the allowance when it is probable that the receivable will not be recovered. The allowance for doubtful accounts was $<span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn3n3_c20230630_zMFOkRRwQH92" title="Allowance for doubtful accounts">17</span> thousand as of June 30, 2023, and $<span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn3n3_c20221231_zshOtAzm0ZBf" title="Allowance for doubtful accounts">9</span> thousand as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 17000 9000 <p id="xdx_84B_eus-gaap--InventoryPolicyTextBlock_zFfPivGB2ITa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zSL3Xp79uLyf">Inventory and Cost of Goods Sold</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is stated at the lower of cost, the value determined by the first-in, first-out method, or net realizable value. The Company evaluates inventories for excess quantities, obsolescence, and shelf-life expiration. This evaluation includes an analysis of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, and a review of the shelf-life expiration dates for products. These factors determine when, and if, the Company adjusts the carrying value of inventory to estimated net realizable value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company produces proprietary branded products and white label opportunities in our manufacturing of consumer products. In our contract manufacturing, the Company builds its products based on customer orders and immediately ships the products upon completion of the production process.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The balance is made up of raw materials, work-in-progress, and finished goods. Inventory is maintained primarily at the Company’s warehouse and at an Amazon fulfillment center.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The “Cost of revenues” line item in the condensed consolidated statements of operations is comprised of the book value of inventory sold to customers during the reporting period. When circumstances dictate that we use net realizable value as the basis for recording inventory, we base our estimates on expected future selling prices less expected disposal costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zTRis43yrvZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zdQ7IS7ZKmme">Research and Development</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our research and development activities focus on new and innovative products designed to support revenue growth. Research and development expenses consist primarily of contracted development and testing efforts associated with development of products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--ShippingAndHandlingRevenueAndExpensePolicyPolicyTextBlock_zPR2bf1klWs" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zC1zxwd5F9f3">Shipping and Handling Revenue and Expense</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping and handling revenue and expense are included in our condensed consolidated statements of operations in revenues and cost of revenues, respectively. This is primarily through shipping fees incurred in the Amazon marketplace.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zE67q3Pxz1le" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_ztVnwus6G3Xl">Property and Equipment, net</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment is recorded at historical cost, net of accumulated depreciation and amortization. Depreciation is provided over the assets’ useful lives on a straight-line basis. Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or lease terms. Repairs and maintenance costs are expensed as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management periodically assesses the estimated useful life over which assets are depreciated or amortized. If the analysis warrants a change in the estimated useful life of property and equipment, management will reduce the estimated useful life and depreciate or amortize the carrying value prospectively over the shorter remaining useful life.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of assets sold or retired and the related accumulated depreciation are eliminated in the period of disposal and the resulting gains and losses are included in the results of operations during the same period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zedhdlGqMUKi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zpLbCx7Y9oed">Impairment of Long-Lived Assets</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reviews its property and equipment and any identifiable intangibles for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted operating cash flow expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z2m1e97P4lof" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zJGpynNSkMee">Goodwill and Intangible Assets</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In applying the acquisition method of accounting, amounts assigned to identifiable assets and liabilities acquired were based on estimated fair values as of the date of acquisition, with the remainder recorded as goodwill. Identifiable intangible assets are initially recorded at fair value using generally accepted valuation methods appropriate for the type of intangible asset. Identifiable intangible assets with definite lives are amortized over their estimated useful lives and are reviewed for impairment if indicators of impairment arise. Intangible assets with indefinite lives are tested for impairment within one year of acquisitions or annually as of December 31, and whenever indicators of impairment exist. The fair value of intangible assets is compared with their carrying values, and an impairment loss would be recognized for the amount by which a carrying amount exceeds its fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company performed the annual assessment and concluded it is more likely than not that the fair value exceeds the carrying value and<span id="xdx_90E_eus-gaap--AssetImpairmentCharges_do_c20220101__20221231_zVkmFbQkt0da" title="Asset impairment charges"> no</span> impairments were recognized in the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> 0 <p id="xdx_848_ecustom--PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock_ztd8j8imYTO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zy4ktuXnvVd">Prepaid Expenses and Other Current Assets</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other current assets are recorded at historical cost and is primarily made up of $<span id="xdx_909_eus-gaap--PrepaidInsurance_iI_pn3n3_c20230630_zdOJ3tFaGwag" title="Prepaid insurance">96</span> thousand and $<span id="xdx_902_eus-gaap--PrepaidInsurance_iI_pn3n3_c20221231_zN9lb2Yqwot2" title="Prepaid insurance">63</span> thousand of prepaid insurance, and $<span id="xdx_904_eus-gaap--OtherPrepaidExpenseCurrent_iI_pn3n3_c20230630_zfnwtbQB3V3" title="General prepaid expenses">270</span> thousand and $<span id="xdx_90C_eus-gaap--OtherPrepaidExpenseCurrent_iI_pn3n3_c20221231_zgqOa4IbZFM6" title="General prepaid expenses">109</span> thousand general prepaid expenses and other current assets as of June 30, 2023, and December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 96000 63000 270000 109000 <p id="xdx_844_ecustom--OtherAssetsPolicyPolicyTextBlock_zL3iUlrG5ksc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_z7cwa8A6JKhb">Other Assets</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other assets are recorded at historical costs, and as of June 30, 2023, and December 31, 2022, the balance is primarily comprised of spare parts for manufacturing equipment. Other assets are not subject to depreciation until such time that they are placed into service and the part that is being replaced is disposed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zGFw4OekJTT7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zbQB6susExvj">Fair Value Measurements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company utilizes the fair value hierarchy to apply fair value measurements. The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair values that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources, while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions. The basis for fair value measurements for each level within the hierarchy is described below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 1</i> — Quoted prices for identical assets or liabilities in active markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 2</i> — Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 3</i> — Valuations derived from valuation techniques in which one or more significant inputs to the valuation model are unobservable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers the carrying amounts of its financial instruments (cash, accounts receivable and accounts payable, notes payable and convertible notes payable) in the balance sheet to approximate fair value because of the short-term or highly liquid nature of these financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zD0JUMudcVRi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the fair value of the Company’s financial assets within the fair value hierarchy:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> <span id="xdx_8BA_zsIejr9DSnkj" style="display: none">Schedule of Fair Value of Financial Assets</span></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zcMYrH2gtvE3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zJzra644iG38" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBnUW0xkB43c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20230630_zPrVpn9aeZN7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Marketable securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">       </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--MarketableSecurities_iI_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zfc835tS5lJ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: justify; padding-bottom: 1.5pt">United States treasury bills</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">612</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">     <span style="-sec-ix-hidden: xdx2ixbrl0639">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0640">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">612</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--MarketableSecurities_iI_zPi3fnlodfme" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">612</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0644">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0645">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">612</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMza4PFqi38a" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z5HJkEDkbopl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_znd5sqz8Mr1d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20221231_zlpKuSyHGlK5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Marketable securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--MarketableSecurities_iI_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zRZn19Ydlmed" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: justify; padding-bottom: 1.5pt">United States treasury bills</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">5,508</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">      <span style="-sec-ix-hidden: xdx2ixbrl0649">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">     <span style="-sec-ix-hidden: xdx2ixbrl0650">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">5,508</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--MarketableSecurities_iI_zayDTvf2mq2e" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,508</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0654">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0655">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,508</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zGwduUgHrOFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_894_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zD0JUMudcVRi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the fair value of the Company’s financial assets within the fair value hierarchy:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> <span id="xdx_8BA_zsIejr9DSnkj" style="display: none">Schedule of Fair Value of Financial Assets</span></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zcMYrH2gtvE3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zJzra644iG38" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBnUW0xkB43c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20230630_zPrVpn9aeZN7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Marketable securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">       </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--MarketableSecurities_iI_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zfc835tS5lJ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: justify; padding-bottom: 1.5pt">United States treasury bills</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">612</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">     <span style="-sec-ix-hidden: xdx2ixbrl0639">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0640">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">612</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--MarketableSecurities_iI_zPi3fnlodfme" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">612</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0644">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0645">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">612</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMza4PFqi38a" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z5HJkEDkbopl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_znd5sqz8Mr1d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20221231_zlpKuSyHGlK5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Marketable securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--MarketableSecurities_iI_hus-gaap--FinancialInstrumentAxis__us-gaap--USTreasurySecuritiesMember_zRZn19Ydlmed" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: justify; padding-bottom: 1.5pt">United States treasury bills</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">5,508</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">      <span style="-sec-ix-hidden: xdx2ixbrl0649">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">     <span style="-sec-ix-hidden: xdx2ixbrl0650">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right">5,508</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--MarketableSecurities_iI_zayDTvf2mq2e" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,508</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0654">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0655">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,508</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 612000 612000 612000 612000 5508000 5508000 5508000 5508000 <p id="xdx_84E_ecustom--WarrantLiabilityPolicyPolicyTextBlock_zAD0DNvCh6R1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_z3A5dcepGnA5">Warrant Liability</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants to purchase common stock were issued in connection with equity financing raises, which occurred during 2019 through 2021. The fair values of the warrants are estimated as of the date of issuance and again at each year end using a Black-Scholes option valuation model. At issuance, the fair values of the warrants are recognized as an equity issuance cost within additional paid-in-capital. Fair value adjustments to the warrant liability are recognized in other income (expense) in the accompanying condensed consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zrbZjsU0ALG" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zRjsv9Uw9tW1">Revenue Recognition</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2018, the Company adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, <i>Revenue from Contracts with Customers</i> (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted ASC 606 for all applicable contracts using the modified retrospective method, which would have required a cumulative-effect adjustment, if any, as of the date of adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company currently recognizes revenue predominately from three types of revenue, contract manufacturing, custom and white label finished goods manufacturing and our branded products. Revenues from manufactured and branded products are recognized at the point where the customer obtains control of the goods and the Company satisfies its performance obligation, which generally is at the time the customer receives the product.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s customers consist of other life sciences companies and Amazon retail customers. Revenues are entirely concentrated in the United States. Payment terms vary by the type and location of customer and may differ by jurisdiction and customer, but payment is generally required in a term ranging from 30 to 60 days from date of shipment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates for product returns, allowances and discounts are recorded as a reduction of revenue and are established at the time of sale. Returns are estimated through a comparison of historical return data and are determined for each product and adjusted for known or expected changes in the marketplace specific to each product, when appropriate. Historically, sales return provisions have not been material. Amounts accrued for sales allowances and discounts are based on estimates of amounts that are expected to be claimed on the related sales and are based on historical data. Payments for allowances and discounts have historically been immaterial.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--DisaggregationOfRevenueTableTextBlock_zvO1uQz2x0G8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregated revenue by sales type:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zIrxxvIqTeV6" style="display: none">Schedule of Disaggregated Revenue by Sales Type</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230401__20230630_zuPmFd6PBiFl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220401__20220630_zJZfuHrc9Ol8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three months ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_ecustom--RevenueFromContractManufacturing_pn3n3_maRFCWCzE8T_zeyN9PHwaH5i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Contract manufacturing</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">887</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">324</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--RevenueFromFinishedGoods_pn3n3_maRFCWCzE8T_z2KFkj7Wudo2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Custom and white label finished goods manufacturing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0667">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--RevenueFromConsumerProducts_pn3n3_maRFCWCzE8T_z3lNEvOc5F63" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">NexGel branded consumer products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">259</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--RevenueClassifiedAsOthers_pn3n3_maRFCWCzE8T_zP2846ixapde" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">38</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_iT_pn3n3_mtRFCWCzE8T_zoHln7MON1Rj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,167</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">561</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230630_zjYECOOfYTNf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20220101__20220630_ziwx6x1WIOP6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six months ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_ecustom--RevenueFromContractManufacturing_pn3n3_maRFCWCzE8T_zpsxClqBqzpc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Contract manufacturing</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,267</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">459</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--RevenueFromFinishedGoods_pn3n3_maRFCWCzE8T_zXRn5kI0iaG9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Custom and white label finished goods manufacturing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--RevenueFromConsumerProducts_pn3n3_maRFCWCzE8T_zYNfVJI159c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">NexGel branded consumer products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">493</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">392</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--RevenueClassifiedAsOthers_pn3n3_maRFCWCzE8T_zdlbzE8qcbs9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">22</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">86</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_iT_pn3n3_mtRFCWCzE8T_zhER6mHf8cYf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,786</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">956</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zu2UP9Aiw7Lg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, and December 31, 2022, the Company did not have any contract assets or contract liabilities from contracts with customers. As of June 30, 2023, and December 31, 2022, there were <span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_iI_pn3n3_do_c20230630_znLNQLwNocnk" title="Remaining performance obligations"><span id="xdx_90D_eus-gaap--RevenueRemainingPerformanceObligation_iI_pn3n3_do_c20221231_zmeGkkvYxU53" title="Remaining performance obligations">no</span></span> remaining performance obligations that the Company had not satisfied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has four distinct lines of business; Contract Manufacturing, Custom &amp; White Label, Consumer Branded Products, and Medical Devices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contract Manufacturing</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customers order rolls of gel (“rollstock”). The rollstock is shipped to our customers, which they package into finished goods. Historically, this has been the Company’s primary source of revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Custom &amp; White Label</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These products often infuse various ingredients into our base gel to develop unique product offerings to satisfy market demand (e.g. aloe infused into the gel for a beauty mask). The rollstock is converted and packaged into salable units. The finished goods are shipped to the customer, who is ultimately responsible for product distribution. Frequently these products started as development deals, in which the customer paid the Company a small fee to develop a specific product. Once completed, the customer places a large order for newly developed product.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Consumer Branded Products</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These products are finished goods marketed and sold directly to the customer by the Company through online and retail channels. The Company is responsible for sales, marketing, and distribution. These products carry the Company’s brand names.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Medical Devices</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medical Devices are a hybrid business, combining elements of Custom &amp; White Label and Consumer Branded Products. Medical Devices, which are not yet marketed, are expected to be distributed through strategic partnerships. The Company will manufacture and possibly convert/package the device while the strategic partner brings the product to market. Small market Medical Devices could be launched by the Company, but also be offered to a distributor to reach the full scale of the market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--DisaggregationOfRevenueTableTextBlock_zvO1uQz2x0G8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregated revenue by sales type:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zIrxxvIqTeV6" style="display: none">Schedule of Disaggregated Revenue by Sales Type</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230401__20230630_zuPmFd6PBiFl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220401__20220630_zJZfuHrc9Ol8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three months ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_ecustom--RevenueFromContractManufacturing_pn3n3_maRFCWCzE8T_zeyN9PHwaH5i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Contract manufacturing</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">887</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">324</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--RevenueFromFinishedGoods_pn3n3_maRFCWCzE8T_z2KFkj7Wudo2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Custom and white label finished goods manufacturing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0667">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--RevenueFromConsumerProducts_pn3n3_maRFCWCzE8T_z3lNEvOc5F63" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">NexGel branded consumer products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">259</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--RevenueClassifiedAsOthers_pn3n3_maRFCWCzE8T_zP2846ixapde" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">38</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_iT_pn3n3_mtRFCWCzE8T_zoHln7MON1Rj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,167</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">561</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230630_zjYECOOfYTNf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20220101__20220630_ziwx6x1WIOP6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six months ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_ecustom--RevenueFromContractManufacturing_pn3n3_maRFCWCzE8T_zpsxClqBqzpc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Contract manufacturing</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,267</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">459</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--RevenueFromFinishedGoods_pn3n3_maRFCWCzE8T_zXRn5kI0iaG9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Custom and white label finished goods manufacturing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--RevenueFromConsumerProducts_pn3n3_maRFCWCzE8T_zYNfVJI159c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">NexGel branded consumer products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">493</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">392</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--RevenueClassifiedAsOthers_pn3n3_maRFCWCzE8T_zdlbzE8qcbs9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">22</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">86</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_iT_pn3n3_mtRFCWCzE8T_zhER6mHf8cYf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,786</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">956</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 887000 324000 19000 259000 180000 21000 38000 1167000 561000 1267000 459000 4000 19000 493000 392000 22000 86000 1786000 956000 0 0 <p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z70076yDqvb8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_z6k89056h9j7">Share-based Compensation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 28, 2019, the Company adopted the 2019 Long-Term Incentive Plan, as amended (the “2019 Plan”). See Note 10 below for further details regarding the 2019 Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 2019 Plan provides certain employees, contractors, and outside directors with share-based compensation in the form of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalent rights and other awards. The fair values of incentive stock option award grants are estimated as of the date of grant using a Black-Scholes option valuation model. Compensation expense is recognized in the statements of operations on a straight-line basis over the requisite service period, which is generally the vesting period required to obtain full vesting. Forfeitures are accounted for when they occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2018, FASB issued Accounting Standards Update (“ASU”) No. 2018-07, <i>Compensation - Stock Compensation (Topic 718) - Improvements to Nonemployee Share-Based Payment Accounting</i>. These amendments expand the scope of Topic 718, <i>Compensation - Stock Compensation</i>, to include share-based payments issued to non-employees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. This new standard was effective for the Company on January 1, 2020. The Company adopted this new standard early in the third quarter of 2019 and it did not have a material impact to its condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zRV8xRon0Cbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zy9BIptvktwj">Income Taxes</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax bases of assets and liabilities at the applicable tax rates. Deferred tax assets are reduced by a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax benefits are recognized from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by a tax authority and based upon the technical merits of the tax position. The tax benefit recognized in the condensed consolidated financial statements for a particular tax position is based on the largest benefit that is more likely than not to be realized upon settlement. An unrecognized tax benefit, or a portion thereof, is presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--LesseeLeasesPolicyTextBlock_z12s1y3QQE51" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_z1OOTB5e8Pz6">Leases</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 842, Leases, requires recognition of leases on the condensed consolidated balance sheets as right-of-use (“ROU”) assets and lease liabilities. ROU assets represent the Company’s right to use underlying assets for the lease terms and lease liabilities represent the Company’s obligation to make lease payments arising from the leases. Operating lease ROU assets and operating lease liabilities are recognized based on the present value and future minimum lease payments over the lease term at commencement date. As the Company’s leases do not provide an implicit rate, the Company used its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. A number of the lease agreements contain options to renew and options to terminate the leases early. The lease term used to calculate ROU assets and lease liabilities only includes renewal and termination options that are deemed reasonably certain to be exercised.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognized lease liabilities, with corresponding ROU assets, based on the present value of unpaid lease payments for existing operating leases longer than twelve months. The ROU assets were adjusted per ASC 842 transition guidance for existing lease-related balances of accrued and prepaid rent, and unamortized lease incentives provided by lessors. Operating lease cost is recognized as a single lease cost on a straight-line basis over the lease term and is recorded in selling, general and administrative expenses. Variable lease payments for common area maintenance, property taxes and other operating expenses are recognized as expense in the period when the changes in facts and circumstances on which the variable lease payments are based occur. The Company has elected not to separate lease and non-lease components for all property leases for the purposes of calculating ROU assets and lease liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zvEYDiZZecib" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zrY3oc696xcg">Segment Reporting</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates in <span id="xdx_90C_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20230101__20230630_z5FmXRkA8inf" title="Number of operating segments">one</span> business segment as a contract manufacturer of aqueous polymer hydrogels. As a result, the Company’s operations are a single reportable segment, which is consistent with the Company’s internal management reporting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> 1 <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zv8pYgwZElx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zeYHp7gygXzg">Recently Issued Accounting Standards</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, new accounting pronouncements are issued by FASB, or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, FASB issued ASU 2016-13, <i>Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</i>. ASU 2016-13 significantly changes the impairment model for most financial assets and certain other instruments. ASU 2016-13 will require immediate recognition of estimated credit losses expected to occur over the remaining life of many financial assets, which will generally result in earlier recognition of allowances for credit losses on loans and other financial instruments. ASU 2016-13 is effective for the Company’s fiscal year beginning January 1, 2023 and subsequent interim periods. The Company is currently evaluating the impact the adoption of ASU 2016-13 will have on the Company’s condensed consolidated financial statements.</span></p> <p id="xdx_807_eus-gaap--LesseeOperatingLeasesTextBlock_zP6UlNv5wVf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. <span id="xdx_827_znUlANQPKGF">Leases</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has one operating lease for a commercial manufacturing facility and administrative offices located in Langhorne, Pennsylvania that runs through January 2031. There are two options that can extend the lease term for five years each. The exercise of the lease options to renew is solely at the Company’s discretion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z3LNBNAkvp0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents information about the amount and timing of the liability arising from the Company’s operating lease as of June 30, 2023 ($ in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zX3mY5CmC0eb" style="display: none">Schedule of Future Minimum Lease Payments</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_494_20230630_zjfzihu9J9G6" style="font-weight: bold; text-align: center">Operating</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Lease</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Maturity of Lease Liability</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_i01I_pn3n3_maLOLLPzhGc_z2DFQnSdlOY5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">122</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_i01I_pn3n3_maLOLLPzhGc_zA7djJcpknZ9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">245</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_i01I_pn3n3_maLOLLPzhGc_z9CBaOJfxmsl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">245</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_i01I_pn3n3_maLOLLPzhGc_zZVdS6K9AnKf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">301</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_i01I_pn3n3_maLOLLPzhGc_z2BmENSomDE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">315</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_i01I_pn3n3_maLOLLPzhGc_zfVgNONRX3j6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,115</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_i01TI_pn3n3_mtLOLLPzhGc_zhDh08YYCove" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total undiscounted operating lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,343</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_i01NI_pn3n3_di_zqpqNYRRjGK7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Less: Imputed interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(292</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiability_i01I_pn3n3_zRA32WNpRwP6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Present value of operating lease liability</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,051</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Weighted average remaining lease term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zJgBf2eDISE4" title="Weighted average remaining lease term">8.6</span> years </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted average discount rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230630_z7AoWmJ1aBy5" style="text-align: right" title="Weighted average discount rate">3.5</td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A7_z9cbhA6Su4Mh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total operating lease expense for the six months ended June 30, 2023, and 2022, was $<span id="xdx_90B_eus-gaap--OperatingLeaseExpense_pn3n3_c20230101__20230630_zu0uY2Z5CBH6" title="Operating lease expense">136</span> thousand and $<span id="xdx_900_eus-gaap--OperatingLeaseExpense_pn3n3_c20220101__20220630_zp21uGqh0O36" title="Operating lease expense">103</span> thousand, respectively, and is recorded in cost of goods sold and selling, general, and administrative expenses in the accompanying condensed consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--LesseeOperatingLeaseSupplementalCashFlowInformationTableTextBlock_zhl7quyYvSU9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental cash flows information related to leases was as follows ($ in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zssyz8BMCpf7" style="display: none">Schedule of Supplemental Cash Flows Information Related to Leases</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20230101__20230630_znd4I4OYhUK6" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash paid for amounts included in the measurement of lease liability:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OperatingLeasePayments_pn3n3_zSGCci5dI1mg" style="vertical-align: bottom; background-color: White"> <td style="width: 82%; text-align: left">Operating cash flows from operating lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">136</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zzWmmqnghPMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89F_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z3LNBNAkvp0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents information about the amount and timing of the liability arising from the Company’s operating lease as of June 30, 2023 ($ in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zX3mY5CmC0eb" style="display: none">Schedule of Future Minimum Lease Payments</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_494_20230630_zjfzihu9J9G6" style="font-weight: bold; text-align: center">Operating</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Lease</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Maturity of Lease Liability</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Liability</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_i01I_pn3n3_maLOLLPzhGc_z2DFQnSdlOY5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">122</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_i01I_pn3n3_maLOLLPzhGc_zA7djJcpknZ9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">245</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_i01I_pn3n3_maLOLLPzhGc_z9CBaOJfxmsl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">245</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_i01I_pn3n3_maLOLLPzhGc_zZVdS6K9AnKf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">301</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_i01I_pn3n3_maLOLLPzhGc_z2BmENSomDE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">315</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_i01I_pn3n3_maLOLLPzhGc_zfVgNONRX3j6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,115</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_i01TI_pn3n3_mtLOLLPzhGc_zhDh08YYCove" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total undiscounted operating lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,343</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_i01NI_pn3n3_di_zqpqNYRRjGK7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Less: Imputed interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(292</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiability_i01I_pn3n3_zRA32WNpRwP6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Present value of operating lease liability</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,051</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Weighted average remaining lease term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zJgBf2eDISE4" title="Weighted average remaining lease term">8.6</span> years </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted average discount rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230630_z7AoWmJ1aBy5" style="text-align: right" title="Weighted average discount rate">3.5</td><td style="text-align: left">%</td></tr> </table> 122000 245000 245000 301000 315000 1115000 2343000 292000 2051000 P8Y7M6D 0.035 136000 103000 <p id="xdx_89C_ecustom--LesseeOperatingLeaseSupplementalCashFlowInformationTableTextBlock_zhl7quyYvSU9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental cash flows information related to leases was as follows ($ in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zssyz8BMCpf7" style="display: none">Schedule of Supplemental Cash Flows Information Related to Leases</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20230101__20230630_znd4I4OYhUK6" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash paid for amounts included in the measurement of lease liability:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OperatingLeasePayments_pn3n3_zSGCci5dI1mg" style="vertical-align: bottom; background-color: White"> <td style="width: 82%; text-align: left">Operating cash flows from operating lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">136</td><td style="width: 1%; text-align: left"> </td></tr> </table> 136000 <p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_z0tlpdEaI7ug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5. <span id="xdx_82A_z3N0QsTDlcm6">Inventory</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zUSb1vJ8bND" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consists of the following ($ in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_znRJ6dLW4ULk" style="display: none">Schedule of Inventory</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_496_20230630_z383ijH5HyX7" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_498_20221231_zBg8t1bTtsG2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryRawMaterials_iI_maIGzJZx_zHaPQDAUR5V5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">638</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">295</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_maIGzJZx_zOx08w4c52E" style="vertical-align: bottom; background-color: White"> <td>Work-in-progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryFinishedGoods_iI_maIGzJZx_zDomp0j2QHP2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">398</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">156</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryGross_iI_mtIGzJZx_maINzQec_zU8HaOGCkVF1" style="vertical-align: bottom; background-color: White"> <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory, gross</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,079</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">502</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryAdjustments_iI_msINzQec_zdpTmDjmK8cf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Inventory reserve for excess and slow moving inventory</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0760">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0761">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--InventoryNet_iI_mtINzQec_zGyCltQCibj3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,079</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">502</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is maintained at the Company’s warehouse, an outsourced third-party contract manufacturing vendor, and at Amazon fulfillment centers. The Company builds its contract manufacturing products based on customer orders and immediately ships the products upon completion of the production process.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zUSb1vJ8bND" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consists of the following ($ in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_znRJ6dLW4ULk" style="display: none">Schedule of Inventory</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_496_20230630_z383ijH5HyX7" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_498_20221231_zBg8t1bTtsG2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryRawMaterials_iI_maIGzJZx_zHaPQDAUR5V5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">638</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">295</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_maIGzJZx_zOx08w4c52E" style="vertical-align: bottom; background-color: White"> <td>Work-in-progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryFinishedGoods_iI_maIGzJZx_zDomp0j2QHP2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">398</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">156</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryGross_iI_mtIGzJZx_maINzQec_zU8HaOGCkVF1" style="vertical-align: bottom; background-color: White"> <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory, gross</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,079</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">502</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryAdjustments_iI_msINzQec_zdpTmDjmK8cf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Inventory reserve for excess and slow moving inventory</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0760">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0761">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--InventoryNet_iI_mtINzQec_zGyCltQCibj3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,079</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">502</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is maintained at the Company’s warehouse, an outsourced third-party contract manufacturing vendor, and at Amazon fulfillment centers. The Company builds its contract manufacturing products based on customer orders and immediately ships the products upon completion of the production process.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 638000 295000 43000 51000 398000 156000 1079000 502000 1079000 502000 <p id="xdx_80E_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z9U2B9QSyrnb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6. <span id="xdx_829_zZglcSSQZKGc">Property and Equipment, Net</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zIH1WS4ME9Vd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of the following ($ in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zvqm0N1RU3ea" style="display: none">Schedule of Property and Equipment</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Useful Life</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_491_20230630_zSn2JNmZ2Il5" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_497_20221231_zdCaf6Ar8C77" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 49%; text-align: left">Machinery and equipment</td><td style="width: 2%"> </td> <td style="width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zUEDMYOyHiW3" title="Useful Life">3</span> - <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_z5P5EB67uHg2" title="Useful Life">10</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zL3hic2Pnzw3" style="width: 12%; text-align: right" title="Property and equipment, gross">1,530</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zv1GHetFXsw4" style="width: 14%; text-align: right" title="Property and equipment, gross">973</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Office furniture and equipment</td><td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zh06mevsN8Ak" title="Useful Life">3</span> - <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zQY9zcARUo2a" title="Useful Life">10</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zcvvFFYTU3ub" style="text-align: right" title="Property and equipment, gross">159</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zdU9t49YV7Ef" style="text-align: right" title="Property and equipment, gross">59</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Leasehold improvements</td><td> </td> <td style="text-align: center"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z1bHOBQvcsL2" title="Useful Life (Years)">6</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zAuQcgQTvByj" style="text-align: right" title="Property and equipment, gross">261</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zPIEoPUQUAKd" style="text-align: right" title="Property and equipment, gross">228</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Construction in progress</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zWtbl7mTrLS" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross">118</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zEuUa1zeMQf8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross">55</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzMfz_zMSvStlmmvGh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total property and equipment</span></span></td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,068</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,315</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzMfz_zW73zAtjr157" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(655</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(594</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzMfz_z5r60vQyiv29" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,413</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">721</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zdkBYsoOrG9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the six months ended June 30, 2023, and 2022 was $<span id="xdx_90C_eus-gaap--Depreciation_pn3n3_c20230101__20230630_zhm4gOXUtfW5" title="Depreciation expense">61</span> thousand and $<span id="xdx_90E_eus-gaap--Depreciation_pn3n3_c20220101__20220630_zqMBgNeyEewb" title="Depreciation expense">49</span> thousand, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zIH1WS4ME9Vd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of the following ($ in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zvqm0N1RU3ea" style="display: none">Schedule of Property and Equipment</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Useful Life</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_491_20230630_zSn2JNmZ2Il5" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_497_20221231_zdCaf6Ar8C77" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 49%; text-align: left">Machinery and equipment</td><td style="width: 2%"> </td> <td style="width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zUEDMYOyHiW3" title="Useful Life">3</span> - <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_z5P5EB67uHg2" title="Useful Life">10</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zL3hic2Pnzw3" style="width: 12%; text-align: right" title="Property and equipment, gross">1,530</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zv1GHetFXsw4" style="width: 14%; text-align: right" title="Property and equipment, gross">973</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Office furniture and equipment</td><td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zh06mevsN8Ak" title="Useful Life">3</span> - <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zQY9zcARUo2a" title="Useful Life">10</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zcvvFFYTU3ub" style="text-align: right" title="Property and equipment, gross">159</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zdU9t49YV7Ef" style="text-align: right" title="Property and equipment, gross">59</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Leasehold improvements</td><td> </td> <td style="text-align: center"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z1bHOBQvcsL2" title="Useful Life (Years)">6</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zAuQcgQTvByj" style="text-align: right" title="Property and equipment, gross">261</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zPIEoPUQUAKd" style="text-align: right" title="Property and equipment, gross">228</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Construction in progress</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zWtbl7mTrLS" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross">118</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zEuUa1zeMQf8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross">55</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzMfz_zMSvStlmmvGh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total property and equipment</span></span></td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,068</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,315</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzMfz_zW73zAtjr157" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(655</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(594</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzMfz_z5r60vQyiv29" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,413</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">721</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> P3Y P10Y 1530000 973000 P3Y P10Y 159000 59000 P6Y 261000 228000 118000 55000 2068000 1315000 655000 594000 1413000 721000 61000 49000 <p id="xdx_80D_eus-gaap--IntangibleAssetsDisclosureTextBlock_zfvm2bZGYqBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7. <span id="xdx_82D_zJFrmB9SAPag">Intangible Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zoY1HMR22hX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following provides a breakdown of identifiable intangible assets as of June 30, 2023 and December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zubnGrumUws9" style="display: none">Schedule of Breakdown of Identifiable Intangible Assets</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Product/Technology Related</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 62%; text-align: left">Identifiable intangible assets, gross</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zW5jurq3KUk5" style="width: 14%; text-align: right" title="Identifiable intangible assets, gross">31</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zTWK7xKYlUU1" style="width: 16%; text-align: right" title="Identifiable intangible assets, gross">31</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zWtMhSMw3JQ1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(31</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zHh82foWbxec" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(26</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Product/Technology Related identifiable intangible assets, net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zIdu1wSpUh9g" style="text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0821">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_z9gomCc22Nv5" style="text-align: right" title="Total">5</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Marketing Related</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Customer related intangible asset, gross</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelatedIntangibleAssetsMember_zRIsqAvTwrmc" style="text-align: right" title="Identifiable intangible assets, gross">17</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelatedIntangibleAssetsMember_zckvnUy6aKC8" style="text-align: right" title="Identifiable intangible assets, gross">17</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Tradename related intangible asset, gross</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zgtQZyOvIj1l" style="text-align: right" title="Identifiable intangible assets, gross">7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zsujUd238qXc" style="text-align: right" title="Identifiable intangible assets, gross">7</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zQ6yWIu6q696" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(11</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zm9O5ku5ngMc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(9</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Marketing related identifiable intangible assets, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_z6MZlINyRyA1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total">13</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zCPD6L45Sa8c" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total">15</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Identifiable intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20230630_zqCDzchn2zNg" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">13</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zE8pyBHTNHP8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">20</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zyo2OzDsMYGc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the May 29, 2020, acquisition of Sports Defense, the Company identified intangible assets of $<span id="xdx_904_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_pn3n3_c20200529__us-gaap--BusinessAcquisitionAxis__custom--SportDefenseLlcMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TechnologyRelatedAndCustomerRelatedIntangiblesMember_zdyPAYsHf0bl" title="Intangibles">55</span> thousand representing technology related and customer related intangibles. These assets are being amortized on a straight-line basis over their weighted average estimated useful life of <span id="xdx_907_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230630__us-gaap--BusinessAcquisitionAxis__custom--SportDefenseLlcMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TechnologyRelatedAndCustomerRelatedIntangiblesMember_zdNSMX5ssTj1" title="Expected life"><span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--SportDefenseLlcMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TechnologyRelatedAndCustomerRelatedIntangiblesMember_ziCpAZSMOGa6" title="Expected life">5.7</span></span> years and amortization expense amounted to $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20230630__us-gaap--BusinessAcquisitionAxis__custom--SportDefenseLlcMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TechnologyRelatedAndCustomerRelatedIntangiblesMember_zxdsKELPCyi4" title="Amortization expense"><span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--SportDefenseLlcMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TechnologyRelatedAndCustomerRelatedIntangiblesMember_zOa5GAjbkUqf" title="Amortization expense">7</span></span> thousand for the six months ended June 30, 2023, and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_z2UU5cK2LB6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, the estimated annual amortization expense for each of the next five fiscal years is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_z93FaTyJ65qj" style="display: none">Schedule of Estimated Annual Amortization Expense</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20230630_zn0QloCJVmZ9" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">($ in thousands):</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3_maFLIANzRW0_zknMGITaT5S5" style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzRW0_z13S1glwfN8b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzRW0_zjxpn0waP7Mh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzRW0_zgVl9SLnKqL7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzRW0_zLOUIosTDLOd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_iI_pn3n3_maFLIANzRW0_zzTJKnToNxXj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzRW0_zRLbUgJ1w0tj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zqfQ7XJYFg44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zoY1HMR22hX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following provides a breakdown of identifiable intangible assets as of June 30, 2023 and December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zubnGrumUws9" style="display: none">Schedule of Breakdown of Identifiable Intangible Assets</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Product/Technology Related</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 62%; text-align: left">Identifiable intangible assets, gross</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zW5jurq3KUk5" style="width: 14%; text-align: right" title="Identifiable intangible assets, gross">31</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zTWK7xKYlUU1" style="width: 16%; text-align: right" title="Identifiable intangible assets, gross">31</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zWtMhSMw3JQ1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(31</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zHh82foWbxec" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(26</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Product/Technology Related identifiable intangible assets, net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zIdu1wSpUh9g" style="text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0821">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_z9gomCc22Nv5" style="text-align: right" title="Total">5</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Marketing Related</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Customer related intangible asset, gross</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelatedIntangibleAssetsMember_zRIsqAvTwrmc" style="text-align: right" title="Identifiable intangible assets, gross">17</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelatedIntangibleAssetsMember_zckvnUy6aKC8" style="text-align: right" title="Identifiable intangible assets, gross">17</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Tradename related intangible asset, gross</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zgtQZyOvIj1l" style="text-align: right" title="Identifiable intangible assets, gross">7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zsujUd238qXc" style="text-align: right" title="Identifiable intangible assets, gross">7</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zQ6yWIu6q696" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(11</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zm9O5ku5ngMc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(9</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Marketing related identifiable intangible assets, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_z6MZlINyRyA1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total">13</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zCPD6L45Sa8c" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total">15</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Identifiable intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20230630_zqCDzchn2zNg" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">13</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20221231_zE8pyBHTNHP8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">20</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 31000 31000 -31000 -26000 5000 17000 17000 7000 7000 -11000 -9000 13000 15000 13000 20000 55000 P5Y8M12D P5Y8M12D 7000 7000 <p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_z2UU5cK2LB6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, the estimated annual amortization expense for each of the next five fiscal years is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_z93FaTyJ65qj" style="display: none">Schedule of Estimated Annual Amortization Expense</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20230630_zn0QloCJVmZ9" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">($ in thousands):</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3_maFLIANzRW0_zknMGITaT5S5" style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzRW0_z13S1glwfN8b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzRW0_zjxpn0waP7Mh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzRW0_zgVl9SLnKqL7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzRW0_zLOUIosTDLOd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_iI_pn3n3_maFLIANzRW0_zzTJKnToNxXj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzRW0_zRLbUgJ1w0tj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2000 2000 2000 2000 2000 3000 13000 <p id="xdx_809_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zOF85Ykgywml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8. <span id="xdx_824_zIcO6txlGjEc">Accrued Expenses and Other Current Liabilities</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zCMq54JQ5fKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses and other current liabilities consist of the following ($ in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zOWaYzj7kqFl" style="display: none">Schedule of Accrued Expenses and Other Current Liabilities</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_491_20230630_zAhjkNOkvxfb" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20221231_zw7fbM5mRthg" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pn3n3_maALAOLzpc8_zVanTOqfyIy1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Salaries, benefits, and incentive compensation</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">72</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">56</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_iI_pn3n3_maALAOLzpc8_zlt5y5HfuDK8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Franchise tax accrual</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_maALAOLzpc8_zqPXooAJ6qTi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">66</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">22</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iTI_pn3n3_mtALAOLzpc8_zvKkmywuNbOa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total accrued expenses and other current liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">202</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">130</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zXDwkU2HzbCi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zCMq54JQ5fKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses and other current liabilities consist of the following ($ in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zOWaYzj7kqFl" style="display: none">Schedule of Accrued Expenses and Other Current Liabilities</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_491_20230630_zAhjkNOkvxfb" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20221231_zw7fbM5mRthg" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pn3n3_maALAOLzpc8_zVanTOqfyIy1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Salaries, benefits, and incentive compensation</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">72</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">56</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_iI_pn3n3_maALAOLzpc8_zlt5y5HfuDK8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Franchise tax accrual</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_maALAOLzpc8_zqPXooAJ6qTi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">66</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">22</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iTI_pn3n3_mtALAOLzpc8_zvKkmywuNbOa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total accrued expenses and other current liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">202</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">130</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 72000 56000 64000 52000 66000 22000 202000 130000 <p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z35JC5mP6f12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9. <span id="xdx_825_zMGeVLufl6S4">Common Stock</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfStockByClassTextBlock_zrwuwCePp6dc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At June 30, 2023, the Company has reserved common stock for issued securities in relation to the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zprgksJH70da" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Reserved Common Stock For Issued Securities in Relation</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Share-based compensation plan</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_pid_c20230101__20230630_z6U2xkqitaB8" style="width: 16%; text-align: right" title="Share-based compensation plan">528,182</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants to purchase common stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--WarrantToPurchaseCommonStock_pid_c20230101__20230630_zCr305r3XjEg" style="text-align: right" title="Warrants to purchase common Stock">3,442,904</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Restricted stock units</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20230101__20230630_zRsJMbRTUll3" style="text-align: right" title="Restricted stock units">121,787</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AF_zIztr4mRApIf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfStockByClassTextBlock_zrwuwCePp6dc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At June 30, 2023, the Company has reserved common stock for issued securities in relation to the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zprgksJH70da" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Reserved Common Stock For Issued Securities in Relation</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Share-based compensation plan</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_pid_c20230101__20230630_z6U2xkqitaB8" style="width: 16%; text-align: right" title="Share-based compensation plan">528,182</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants to purchase common stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--WarrantToPurchaseCommonStock_pid_c20230101__20230630_zCr305r3XjEg" style="text-align: right" title="Warrants to purchase common Stock">3,442,904</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Restricted stock units</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20230101__20230630_zRsJMbRTUll3" style="text-align: right" title="Restricted stock units">121,787</td><td style="text-align: left"> </td></tr> </table> 528182 3442904 121787 <p id="xdx_807_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ztKpLAIEl0Ie" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10. <span id="xdx_821_zT36UPWJC7a">Share-based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 2019 Plan provides for the granting of incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights (“SARs”), restricted stock units, performance awards, dividend equivalent rights and other awards, which may be granted singly, in combination, or in tandem, and which may be paid in cash, shares of common stock of the Company or a combination of cash and shares of common stock of the Company up to an amount of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGTcjy08v1I8" title="Number of shares available for grant">871,429</span> shares of common stock, all of which may be delivered pursuant to incentive stock options. Subject to adjustments pursuant to the 2019 Plan, the maximum number of shares of common stock with respect to which stock option or SARs may be granted to an executive officer during any calendar year is <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember__srt--TitleOfIndividualAxis__srt--ExecutiveOfficerMember_ztdUtHFZkDT6" title="Number of shares granted">14,286</span> shares of common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Incentive stock options</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 8, 2023, the Company granted a contractor an option to purchase up to <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20230308__srt--TitleOfIndividualAxis__custom--ContractorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zbmcUJDmrmuc" title="Number of options, granted">17,532</span> shares of the Company’s common stock at a per share exercise price of $<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20221001__20221001__srt--TitleOfIndividualAxis__custom--ContractorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zPRcqVOTk1Yl" title="Exercise price of options">2.00</span> under the Company’s 2019 Plan. This option award vests over a period of 12 months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zFUzPzYO81Vc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table contains information about the 2019 Plan as of June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zAhMZ6UPDlv6" style="display: none">Schedule of Information about Incentive Plan</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Awards</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Awards</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Awards</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reserved for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuance</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued &amp; Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercised</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Available for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019 Plan<sup id="xdx_F49_zrECzZhctMdb">(1)</sup></span></td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_fKDEp_zH20EwaPBAk2" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Awards Reserved For Issuance">871,429</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_fKDEp_zddM3ZSmIH4" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Awards Issued">612,932</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForExercised_iI_pid_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_fKDEp_zBmZgtlEWZij" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Awards Exercised">7,183</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_pid_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_fKDEp_zGZWXglczt2i" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Awards Available for Grant">251,314</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Awards granted outside of the 2019 Plan<sup id="xdx_F2E_zezEvCQxFKP1">(2)</sup></span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20230630__us-gaap--PlanNameAxis__custom--AwardsGrantedOutsideOfThe2019PlanMember_fKDIp_zoOqkoktoj57" style="text-align: right" title="Awards Reserved For Issuance"><span style="-sec-ix-hidden: xdx2ixbrl0917">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20230630__us-gaap--PlanNameAxis__custom--AwardsGrantedOutsideOfThe2019Member_fKDIp_zr1Tx8YNfWVg" style="text-align: right" title="Awards Issued">37,037</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForExercised_iI_pid_c20230630__us-gaap--PlanNameAxis__custom--AwardsGrantedOutsideOfThe2019Member_fKDIp_zciWVsmXjqSk" style="text-align: right" title="Awards Exercised">11,364</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_pid_c20230101__20230630__us-gaap--PlanNameAxis__custom--AwardsGrantedOutsideOfThe2019Member_fKDIp_zYgpPvh8WUBa" style="text-align: right" title="Awards Available for Grant"><span style="-sec-ix-hidden: xdx2ixbrl0923">-</span></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0D_z9fIcrX835J1">(1)</sup></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F17_z2cVSWBeBSDh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes incentive stock options and restricted stock units discussed below.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F01_zPAt3gBpr0lc">(2)</sup></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1E_znfYFIQhuSg7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes shares of restricted common stock granted outside of the 2019 Plan to our Chief Executive Officer, Adam Levy.</span></td></tr> </table> <p id="xdx_8AD_zA2NlhUGVpo2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zO4Ecy4LaYrf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Company’s incentive stock option activity and related information for the period ended June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zVn7BKlPoOJl" style="display: none">Schedule of Incentive Stock Option Activity</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Term in</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 51%">Outstanding at January 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zKsqmNkAjfRl" style="width: 12%; text-align: right" title="Number of options, outstanding, beginning balance">524,937</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zrBRGCF7KNp7" style="width: 12%; text-align: right" title="Weighted average exercise price, outstanding beginning balance">2.351416</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pid_dtY_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvtvEJvVAXf2" title="Weighted average remaining contractual term">8.38</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zRn9a12kaxn7" style="text-align: right" title="Number of options, granted">17,532</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zK2Oq3GQ72R1" style="text-align: right" title="Weighted average exercise price, granted">2.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_pid_dtY_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zd5IOsEpPGn6" title="Weighted average remaining contractual term, Granted">10.0</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zI5tGbTmgU55" style="text-align: right" title="Number of options, exercised"><span style="-sec-ix-hidden: xdx2ixbrl0941">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zuW7b2VQrEpg" style="text-align: right" title="Weighted average exercise price, exercised"><span style="-sec-ix-hidden: xdx2ixbrl0943">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zvjBZSVLFQUh" style="text-align: right" title="Number of options, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0945">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zbzgksyy3Il" style="text-align: right" title="Weighted average exercise price, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0947">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zrnj2GIQ64f7" style="text-align: right" title="Number of options, cancelled">(10,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageCancelledPrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_z9nnVDd1JJna" style="text-align: right" title="Weighted average exercise price, cancelled">1.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zHtzYPMTN9Ia" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, expired">(4,287</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zO1Yg5wWKBqg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, expired">1.40</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_ztiDKfMOmwn9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options, outstanding, ending balance">528,182</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zAizfr3hswvl" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, outstanding ending balance">2.35886</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zflOAi0pf3w1" title="Weighted average remaining contractual term">7.99</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zaUTKtO12gxa" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options, exercisable">337,111</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_znhqa8VslZMk" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">1.774915</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_ztsBm0NLaU7c" title="Weighted average remaining contractual term, exercisable">7.21</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zkMpC3zvwk18" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, vested outstanding stock options had $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pn3n3_c20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zjxRIsQugLo2" title="Intrinsic value">129</span> thousand intrinsic value as the exercise price is greater than the estimated fair value of the underlying common stock, respectively. As of June 30, 2023, there was approximately $<span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zQRMbjsibnR9" title="Unrecognized share-based compensation expense">17</span> thousand of total unrecognized share-based compensation related to unvested stock options, which the Company expects to recognize over the next 11 months excluding options fully contingent upon certain sales-based milestones being achieved within <span id="xdx_904_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtM_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_z8KxTpmrtZI8" title="Period of recognition of stock based compensation expense">18</span> to<span id="xdx_90A_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtM_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_ztbkewh4i6he" title="Period of recognition of stock based compensation expense"> 36</span> months of commercial release.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes compensation expense for stock option awards on a straight-line basis over the applicable service period of the award. The service period is generally the vesting period. The following assumptions were used to calculate share-based compensation expense for the period ended June 30, 2023:</span></p> <p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zauB88iTR061" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zBRypj5AVn9f" style="display: none">Schedule of Assumptions used in Share-based Compensation</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">Volatility</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20230101__20230630_zE0kJKL1UgFd" title="Volatility">257.64</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230101__20230630_zb54091aCPf9" title="Risk-free interest rate">4.21</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_c20230101__20230630_znWquVQDZ0Cj" title="Dividend yield">0.0</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230630_zhnri6hxjTB" title="Expected term">5.50</span> years</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A8_zENRT5oKqZmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. Accordingly, the Company has elected to use the “simplified method” to estimate the expected term of its share-based awards. The simplified method computes the expected term as the sum of the award’s vesting term plus the original contractual term divided by two.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the lack of historical data of volatility for the Company’s common stock, the Company based its estimate of expected volatility on a weighted-average of the historical volatility of comparable public companies that manufacture similar products and are similar in size, stage of life cycle, and financial leverage.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restrictive Stock Awards</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective as of August 1, 2022, the Company granted a restricted stock award of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220801__20220801__srt--TitleOfIndividualAxis__custom--OfficersAndEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zaccgOgHwUxb">84,750 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company’s common stock to certain officers and employees, all of which shares vest in four equal installments on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. Under ASC 718, the Company has measured the value of the <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20220801__20220801__srt--TitleOfIndividualAxis__custom--OfficersAndEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zUFnVVZqRpR">84,750 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares granted based on a closing price of the closing price of the Company’s stock at the grant date of the RSU Grant ($<span id="xdx_900_eus-gaap--SharePrice_iI_pid_c20220801__srt--TitleOfIndividualAxis__custom--OfficersAndEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zG931AGRfEYb">1.82 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective as of January 1, 2022, the Company granted a restricted stock award of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20220101__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zPwIIC47fdPg">11,364</span> shares of the Company’s common stock to Adam Levy for his service as our Chief Executive Officer pursuant to the terms of his Executive Employment Agreement dated November 4, 2021, all of which shares vested monthly from January 1, 2022 through December 31, 2022. Under ASC 718, the Company has measured the value of the <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20220101__20220101__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zoclfR9BW6la">11,364</span> shares granted based on the closing price of the Company’s stock at the grant date of the RSU Grant ($<span id="xdx_902_eus-gaap--SharePrice_iI_pid_c20220101__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zos4wWwlUvkg">4.40</span> per share).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective as of January 3, 2023, the Company granted a restricted stock award of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230103__20230103__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z3Yg462WVlj" title="Number of units, granted">37,037</span> shares of the Company’s common stock to Adam Levy for his service as our Chief Executive Officer pursuant to the terms of his Executive Employment Agreement dated December 30, 2022, all of which shares vested monthly from January 3, 2023 through December 31, 2023. Under ASC 718, the Company has measured the value of the <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20230103__20230103__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z7l4eqJdBzAj" title="Restricted stock vesting, shares">37,037</span> shares granted based on the closing price of the Company’s stock at the grant date of the RSU Grant ($<span id="xdx_906_eus-gaap--SharePrice_iI_pid_c20230103__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zrD7NemZm7Dl" title="Share price">1.35</span> per share).</span></p> <p id="xdx_898_eus-gaap--NonvestedRestrictedStockSharesActivityTableTextBlock_zCcR6SSqOcFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zIzD4ubxprL5" style="display: none">Schedule of Restricted Stock Units Granted</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Grant Date</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Units</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Outstanding at January 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ziRtLsCEEv32" style="width: 14%; text-align: right" title="Number of units outstanding beginning">90,432</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z06Vt3yLjVsk" title="Weighted average grant date fair value outstanding beginning">1.43</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSWuCjVK5E2j" style="text-align: right" title="Number of units, granted">37,037</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zFYWsxFVel2i" style="text-align: right" title="Weighted average grant date fair value, granted">1.35</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Exercised and converted to common shares</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z4R4chxl50w4" style="text-align: right" title="Number of units, exercised and converted to common shares">(5,682</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSCZIaoP4TZ" style="text-align: right" title="Weighted average grant date fair value, exercised and converted to common shares">4.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSgt0h6q0vtb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of units, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1013">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zTi4T8dhipn4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average grant date fair value, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1015">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zgbuv7nhthg1" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of units outstanding beginning">121,787</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z8MyMGRUTbMk" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date fair value outstanding ending">1.68</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNonvestedNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKYAdVYVXGEj" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of units exercisable">30,466</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z98u0UBk7KEj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date fair value exercisable">1.68</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_znUZFkBfa0I2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation expense will be recognized ratably over the total vesting schedule. The Company will periodically adjust the cumulative compensation expense for forfeited awards. As of June 30, 2023, there was $<span id="xdx_902_ecustom--UnrecognizedShareBasedCompensationExpense_pn3n3_c20230101__20230630_zPJpE3Uwb7S6">121 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand unrecognized share-based compensation related to unvested RSUs, which the Company expects to recognize over the next 3 years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock based compensation and restricted stock vesting of $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_pn3n3_c20230101__20230630_zFqcOjavLyVl" title="Stock based compensation and restricted stock vesting">53</span> thousand and $<span id="xdx_900_eus-gaap--ShareBasedCompensation_pn3n3_c20220101__20220630_z4NWqU6bgg8i" title="Stock based compensation and restricted stock vesting">134</span> thousand has been recorded for the six months ended June 30, 2023, and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zwSdjalBbxo2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table shows a summary of common stock warrants through June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"> <span id="xdx_8B0_zl2PF49Un9Cf" style="display: none">Summary of Common Stock Warrants</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Term in Years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 51%">Outstanding at January 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20230630_zhJ0VSCt9E0e" style="width: 12%; text-align: right" title="Number of warrants, outstanding beginning balance">3,637,190</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630_zGayPgJHEwYb" style="width: 12%; text-align: right" title="Weighted average exercise price, outstanding beginning balance">5.16281</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630_zT8CKaqb8gze" title="Weighted average remaining contractual term">3.65</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230101__20230630_zaDJxT3g82N5" style="text-align: right" title="Number of warrants, granted"><span style="-sec-ix-hidden: xdx2ixbrl1038">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230630_zvdAmR8TO6M8" style="text-align: right" title="Weighted average exercise price, granted"><span style="-sec-ix-hidden: xdx2ixbrl1040">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20230101__20230630_zmRr83iidQ7k" style="text-align: right" title="Number of warrants, exercised">(112,466</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630_zQeE2RzI3nol" style="text-align: right" title="Weighted average exercise price, exercised">0.55</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20230101__20230630_zI2zKTz7RgI9" style="text-align: right" title="Number of warrants, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1046">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230630_zqPgGuXn6C1h" style="text-align: right" title="Weighted average exercise price, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1048">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelled_c20230101__20230630_zGFDI30EAJb9" style="text-align: right" title="Number of warrants, cancelled">(81,820</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageCancelledPrice_pid_c20230101__20230630_zxiUddjP63ne" style="text-align: right" title="Weighted average exercise price, cancelled">0.91</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20230101__20230630_zrXASTGzwXcf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants, expired"><span style="-sec-ix-hidden: xdx2ixbrl1054">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20230630_zWdmQkXK4LG5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, expired"><span style="-sec-ix-hidden: xdx2ixbrl1056">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20230630_zeMiBsVNEbKg" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, outstanding ending balance">3,442,904</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630_zBGkbJBuOD72" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, outstanding ending balance">5.414793</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630_zYgKPswEH3H3" title="Weighted average remaining contractual term">3.35</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber_iE_pid_c20230101__20230630_zcTSdasD0ir1" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, exercisable">3,442,904</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230630_zAgc2JDXLPT3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">5.414793</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630_zj7tA2TB2Jp9" title="Weighted average remaining contractual term, exercisable">3.35</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zcB88qBxKds2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, vested outstanding warrants had $<span id="xdx_90A_ecustom--ClassOfWarrantOrRightOutstandingIntrinsicValue_iI_pn3n3_c20230630_zok9UAB9W7Ll" title="Intrinsic value of vested outstanding warrants">0</span> intrinsic value as the exercise price is greater than the estimated fair value of the underlying common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 871429 14286 17532 2.00 <p id="xdx_895_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zFUzPzYO81Vc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table contains information about the 2019 Plan as of June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zAhMZ6UPDlv6" style="display: none">Schedule of Information about Incentive Plan</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Awards</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Awards</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Awards</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reserved for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuance</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued &amp; Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercised</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Available for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019 Plan<sup id="xdx_F49_zrECzZhctMdb">(1)</sup></span></td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_fKDEp_zH20EwaPBAk2" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Awards Reserved For Issuance">871,429</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_fKDEp_zddM3ZSmIH4" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Awards Issued">612,932</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForExercised_iI_pid_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_fKDEp_zBmZgtlEWZij" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Awards Exercised">7,183</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_pid_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_fKDEp_zGZWXglczt2i" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Awards Available for Grant">251,314</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Awards granted outside of the 2019 Plan<sup id="xdx_F2E_zezEvCQxFKP1">(2)</sup></span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20230630__us-gaap--PlanNameAxis__custom--AwardsGrantedOutsideOfThe2019PlanMember_fKDIp_zoOqkoktoj57" style="text-align: right" title="Awards Reserved For Issuance"><span style="-sec-ix-hidden: xdx2ixbrl0917">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20230630__us-gaap--PlanNameAxis__custom--AwardsGrantedOutsideOfThe2019Member_fKDIp_zr1Tx8YNfWVg" style="text-align: right" title="Awards Issued">37,037</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForExercised_iI_pid_c20230630__us-gaap--PlanNameAxis__custom--AwardsGrantedOutsideOfThe2019Member_fKDIp_zciWVsmXjqSk" style="text-align: right" title="Awards Exercised">11,364</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_pid_c20230101__20230630__us-gaap--PlanNameAxis__custom--AwardsGrantedOutsideOfThe2019Member_fKDIp_zYgpPvh8WUBa" style="text-align: right" title="Awards Available for Grant"><span style="-sec-ix-hidden: xdx2ixbrl0923">-</span></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0D_z9fIcrX835J1">(1)</sup></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F17_z2cVSWBeBSDh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes incentive stock options and restricted stock units discussed below.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F01_zPAt3gBpr0lc">(2)</sup></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1E_znfYFIQhuSg7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes shares of restricted common stock granted outside of the 2019 Plan to our Chief Executive Officer, Adam Levy.</span></td></tr> </table> 871429 612932 7183 251314 37037 11364 <p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zO4Ecy4LaYrf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Company’s incentive stock option activity and related information for the period ended June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zVn7BKlPoOJl" style="display: none">Schedule of Incentive Stock Option Activity</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Term in</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 51%">Outstanding at January 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zKsqmNkAjfRl" style="width: 12%; text-align: right" title="Number of options, outstanding, beginning balance">524,937</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zrBRGCF7KNp7" style="width: 12%; text-align: right" title="Weighted average exercise price, outstanding beginning balance">2.351416</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pid_dtY_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvtvEJvVAXf2" title="Weighted average remaining contractual term">8.38</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zRn9a12kaxn7" style="text-align: right" title="Number of options, granted">17,532</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zK2Oq3GQ72R1" style="text-align: right" title="Weighted average exercise price, granted">2.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_pid_dtY_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zd5IOsEpPGn6" title="Weighted average remaining contractual term, Granted">10.0</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zI5tGbTmgU55" style="text-align: right" title="Number of options, exercised"><span style="-sec-ix-hidden: xdx2ixbrl0941">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zuW7b2VQrEpg" style="text-align: right" title="Weighted average exercise price, exercised"><span style="-sec-ix-hidden: xdx2ixbrl0943">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zvjBZSVLFQUh" style="text-align: right" title="Number of options, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0945">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zbzgksyy3Il" style="text-align: right" title="Weighted average exercise price, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0947">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zrnj2GIQ64f7" style="text-align: right" title="Number of options, cancelled">(10,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageCancelledPrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_z9nnVDd1JJna" style="text-align: right" title="Weighted average exercise price, cancelled">1.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zHtzYPMTN9Ia" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, expired">(4,287</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zO1Yg5wWKBqg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, expired">1.40</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_ztiDKfMOmwn9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options, outstanding, ending balance">528,182</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zAizfr3hswvl" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, outstanding ending balance">2.35886</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zflOAi0pf3w1" title="Weighted average remaining contractual term">7.99</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_zaUTKtO12gxa" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options, exercisable">337,111</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_znhqa8VslZMk" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">1.774915</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenLongTermIncentivePlanMember_ztsBm0NLaU7c" title="Weighted average remaining contractual term, exercisable">7.21</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 524937 2.351416 P8Y4M17D 17532 2.00 P10Y -10000 1.75 4287 1.40 528182 2.35886 P7Y11M26D 337111 1.774915 P7Y2M15D 129000 17000 P18M P36M <p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zauB88iTR061" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zBRypj5AVn9f" style="display: none">Schedule of Assumptions used in Share-based Compensation</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">Volatility</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20230101__20230630_zE0kJKL1UgFd" title="Volatility">257.64</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230101__20230630_zb54091aCPf9" title="Risk-free interest rate">4.21</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_c20230101__20230630_znWquVQDZ0Cj" title="Dividend yield">0.0</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230630_zhnri6hxjTB" title="Expected term">5.50</span> years</span></td><td style="text-align: left"> </td></tr> </table> 2.5764 0.0421 0.000 P5Y6M 84750 84750 1.82 11364 11364 4.40 37037 37037 1.35 <p id="xdx_898_eus-gaap--NonvestedRestrictedStockSharesActivityTableTextBlock_zCcR6SSqOcFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zIzD4ubxprL5" style="display: none">Schedule of Restricted Stock Units Granted</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Grant Date</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Units</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Outstanding at January 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ziRtLsCEEv32" style="width: 14%; text-align: right" title="Number of units outstanding beginning">90,432</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z06Vt3yLjVsk" title="Weighted average grant date fair value outstanding beginning">1.43</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSWuCjVK5E2j" style="text-align: right" title="Number of units, granted">37,037</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zFYWsxFVel2i" style="text-align: right" title="Weighted average grant date fair value, granted">1.35</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Exercised and converted to common shares</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z4R4chxl50w4" style="text-align: right" title="Number of units, exercised and converted to common shares">(5,682</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSCZIaoP4TZ" style="text-align: right" title="Weighted average grant date fair value, exercised and converted to common shares">4.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSgt0h6q0vtb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of units, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1013">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zTi4T8dhipn4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average grant date fair value, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1015">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zgbuv7nhthg1" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of units outstanding beginning">121,787</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z8MyMGRUTbMk" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date fair value outstanding ending">1.68</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNonvestedNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKYAdVYVXGEj" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of units exercisable">30,466</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z98u0UBk7KEj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date fair value exercisable">1.68</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 90432 1.43 37037 1.35 5682 4.40 121787 1.68 30466 1.68 121000 53000 134000 <p id="xdx_89F_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zwSdjalBbxo2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table shows a summary of common stock warrants through June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"> <span id="xdx_8B0_zl2PF49Un9Cf" style="display: none">Summary of Common Stock Warrants</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Term in Years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 51%">Outstanding at January 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20230630_zhJ0VSCt9E0e" style="width: 12%; text-align: right" title="Number of warrants, outstanding beginning balance">3,637,190</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630_zGayPgJHEwYb" style="width: 12%; text-align: right" title="Weighted average exercise price, outstanding beginning balance">5.16281</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630_zT8CKaqb8gze" title="Weighted average remaining contractual term">3.65</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230101__20230630_zaDJxT3g82N5" style="text-align: right" title="Number of warrants, granted"><span style="-sec-ix-hidden: xdx2ixbrl1038">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230630_zvdAmR8TO6M8" style="text-align: right" title="Weighted average exercise price, granted"><span style="-sec-ix-hidden: xdx2ixbrl1040">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20230101__20230630_zmRr83iidQ7k" style="text-align: right" title="Number of warrants, exercised">(112,466</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630_zQeE2RzI3nol" style="text-align: right" title="Weighted average exercise price, exercised">0.55</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20230101__20230630_zI2zKTz7RgI9" style="text-align: right" title="Number of warrants, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1046">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230630_zqPgGuXn6C1h" style="text-align: right" title="Weighted average exercise price, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1048">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelled_c20230101__20230630_zGFDI30EAJb9" style="text-align: right" title="Number of warrants, cancelled">(81,820</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageCancelledPrice_pid_c20230101__20230630_zxiUddjP63ne" style="text-align: right" title="Weighted average exercise price, cancelled">0.91</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20230101__20230630_zrXASTGzwXcf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants, expired"><span style="-sec-ix-hidden: xdx2ixbrl1054">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20230630_zWdmQkXK4LG5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, expired"><span style="-sec-ix-hidden: xdx2ixbrl1056">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20230630_zeMiBsVNEbKg" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, outstanding ending balance">3,442,904</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630_zBGkbJBuOD72" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, outstanding ending balance">5.414793</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630_zYgKPswEH3H3" title="Weighted average remaining contractual term">3.35</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber_iE_pid_c20230101__20230630_zcTSdasD0ir1" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, exercisable">3,442,904</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230630_zAgc2JDXLPT3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">5.414793</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630_zj7tA2TB2Jp9" title="Weighted average remaining contractual term, exercisable">3.35</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3637190 5.16281 P3Y7M24D 112466000 0.55 -81820000 0.91 3442904 5.414793 P3Y4M6D 3442904 5.414793 P3Y4M6D 0 <p id="xdx_80C_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_zWZQtdpBtBG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. <span id="xdx_825_zdgx0xIOJzmb">Noncontrolling Interest in Joint Venture</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On March 1, 2023, </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Company acquired a <span id="xdx_905_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230301__srt--OwnershipAxis__custom--JointVentureMember_zb5UtZjzWLU5" title="Minority percentage">50</span>% interest in a JV, named CG Converting and Packaging, LLC, with C.G. Laboratories Inc. (“CG Labs”) for its converting and packaging business (see Note 1). The JV is owned <span id="xdx_90B_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230301__srt--OwnershipAxis__custom--CGConvertingAndPackagingLLCMember_zA5gx4zTdzx9" title="Minority percentage">50</span>% by the Company and <span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_uPure_c20230301__srt--OwnershipAxis__custom--CGLaboratoriesIncMember_zBxabjeuTkZg" title="Minority percentage">50</span>% by CG Labs. CG Labs contributed its existing converting and packaging division to the JV, including, but not limited to, its facilities, equipment, employees, and customers. The Company will contribute $<span id="xdx_906_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20230301__20230301_zlVRlOpQWWC3" title="Payment to acquire business">500,000</span> to the JV, on a schedule to be determined, to be used for equipment and facility upgrades as well as general corporate purposes for JV. As of June 30, 2023, the Company has contributed $<span id="xdx_905_eus-gaap--PaymentsToAcquireBusinessesGross_c20230101__20230630__srt--OwnershipAxis__custom--CGLaboratoriesMember_zHokyHR6Yf0c" title="Payment to acquire business">350,000</span> of its $<span id="xdx_90C_eus-gaap--PaymentsToAcquireBusinessesGross_c20230101__20230630__srt--OwnershipAxis__custom--CGLabsMember_zUpIkuednk7a" title="Payment to acquire business">500,000</span> commitment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The JV is considered to be a variable interest entity (“VIE”), as defined by authoritative accounting guidance. A VIE must be consolidated by a reporting entity if the reporting entity is the primary beneficiary because it has (i) the power to direct the VIE’s activities that most significantly impact the VIE’s economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE. All major decisions related to the JV that most significantly impact its economic performance, including but not limited to operating procedures with respect to business affairs. Therefore, we have consolidated the JV. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.50 0.50 50 500000 350000 500000 <p id="xdx_80A_eus-gaap--DebtDisclosureTextBlock_zvNbHMLuZIK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12. <span id="xdx_828_zFXUvD3HsQKd">Notes Payable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Economic Injury Disaster Loan</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 28, 2020, the Company entered into the standard loan documents required for securing a loan (the “EIDL Loan”) from the SBA under its Economic Injury Disaster Loan (“EIDL”) assistance program in light of the impact of the COVID-19 pandemic on the Company’s business. Pursuant to that certain Loan Authorization and Agreement (the “SBA Loan Agreement”), the principal amount of the EIDL Loan is up to $<span id="xdx_90B_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20200528__us-gaap--DebtInstrumentAxis__custom--EconomicInjuryDisasterLoanMember_z8NHBKxUQrp7" title="Borrowing capacity">260,500</span>, with proceeds to be used for working capital purposes. Interest accrues at the rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20200528__us-gaap--DebtInstrumentAxis__custom--EconomicInjuryDisasterLoanMember_zQSxkdGxbuUd" title="Interest rate">3.75</span>% per annum. Installment payments, including principal and interest, are due monthly which the Company began paying in December 2022 (thirty months from the date of the SBA Note) in the amount of $<span id="xdx_908_eus-gaap--DebtInstrumentPeriodicPayment_pn3n3_c20200527__20200528__us-gaap--DebtInstrumentAxis__custom--EconomicInjuryDisasterLoanMember_zpTRLgkuiU7j" title="DebtInstrument periodic payment">1,270</span>. The balance of principal and interest is payable thirty years from the date of the SBA Note. In connection therewith, the Company received an $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20200527__20200528__us-gaap--DebtInstrumentAxis__custom--EconomicInjuryDisasterLoanMember_z72wHlNf6VIe" title="Loan advance">8,000</span> advance, which does not have to be repaid. The balances of the principal and accrued interest amounted to $<span id="xdx_90A_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20230101__20230630_zbrnDklaCcGk" title="Principal">280</span> thousand and $<span id="xdx_900_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20220101__20221231_zbvVN54FKyC3" title="Accrued interest">283</span> thousand as of June 30, 2023 and December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_esrt--ContractualObligationFiscalYearMaturityScheduleTableTextBlock_z5a88XcbM7g5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The future annual principal amounts and accrued interest to be paid as of June 30, 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zruqej0RejU1" style="display: none">Schedule of Debt Instruments</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230630_zbiTNxSxxc31" style="border-bottom: Black 1.5pt solid; text-align: center">Amount</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">For the year ending December 31 ($ in thousands):</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_pn3n3_maLTDz0GY_zw3abskru8ml" style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left">2023 (remainder of the year)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pn3n3_maLTDz0GY_zgYrdUDKhsh1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pn3n3_maLTDz0GY_zEiUh0qbdICh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_pn3n3_maLTDz0GY_zlyJYBOer7Qa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_pn3n3_maLTDz0GY_zJZNKUvdO6U7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--FinanceLeaseLiabilityPaymentsDueAfterYearFour_iI_pn3n3_maLTDz0GY_zIidofCnMi52" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">256</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebt_iTI_pn3n3_mtLTDz0GY_z0jDspCPzPTc" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">280</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zIPJdNEkKAAa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 260500000 0.0375 1270000 8000000 280000 283000 <p id="xdx_89D_esrt--ContractualObligationFiscalYearMaturityScheduleTableTextBlock_z5a88XcbM7g5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The future annual principal amounts and accrued interest to be paid as of June 30, 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zruqej0RejU1" style="display: none">Schedule of Debt Instruments</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230630_zbiTNxSxxc31" style="border-bottom: Black 1.5pt solid; text-align: center">Amount</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">For the year ending December 31 ($ in thousands):</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_pn3n3_maLTDz0GY_zw3abskru8ml" style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left">2023 (remainder of the year)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pn3n3_maLTDz0GY_zgYrdUDKhsh1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pn3n3_maLTDz0GY_zEiUh0qbdICh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_pn3n3_maLTDz0GY_zlyJYBOer7Qa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_pn3n3_maLTDz0GY_zJZNKUvdO6U7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--FinanceLeaseLiabilityPaymentsDueAfterYearFour_iI_pn3n3_maLTDz0GY_zIidofCnMi52" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">256</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebt_iTI_pn3n3_mtLTDz0GY_z0jDspCPzPTc" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">280</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3000 5000 5000 5000 6000 256000 280000 <p id="xdx_809_eus-gaap--LongTermDebtTextBlock_zOTZ38GIVXt6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13. <span id="xdx_820_zso7CkHTVZA1">Convertible Notes Payable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 11, 2021, the Company issued Auctus Fund, LLC, a Delaware limited liability company a one-year senior secured convertible promissory note in the principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pn4n6_c20210311__us-gaap--ClassOfWarrantOrRightAxis__custom--AuctusNoteMember_zmGIzDHBDpt8">1.68</span> million, which included $<span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pn3n3_c20210310__20210311__us-gaap--ClassOfWarrantOrRightAxis__custom--AuctusNoteMember_zwF9DUUlEeO6">180</span> thousand of interest which was deemed fully earned as of the issuance date (the “Auctus Note”). The Auctus Note was fully repaid (including all principal and interest) on March 15, 2022 with a one-time cash payment of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pn4n6_c20220315_zjpjBvA7W1L9">1.68</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 2, 2021, the Company issued to certain holders one-year subordinated secured convertible promissory notes in the aggregate principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20210902__us-gaap--DebtInstrumentAxis__custom--SecuredConvertiblePromissoryNoteMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zXxsZGY9eezd" title="Principal amount of debt">1,814</span> thousand, which included $<span id="xdx_90A_eus-gaap--InterestExpense_pn3n3_c20210902__20210902__us-gaap--DebtInstrumentAxis__custom--SecuredConvertiblePromissoryNoteMember_zXV9QGF76ZY4" title="Interest expense">194</span> thousand of interest which was deemed fully earned as of the issuance date (the “September 2 Notes”). On January 25, 2022, the Company repaid one of the September 2 Notes in full with a one-time cash payment of $<span id="xdx_906_ecustom--OutstandingPrincipalAndAccruedUnpaidInterest_iI_pn3n3_c20220125__us-gaap--DebtInstrumentAxis__custom--SecuredConvertiblePromissoryNoteMember_zPRMke5NG2og" title="Outstanding principal and accrued unpaid interest">300</span> thousand of outstanding principal and accrued but unpaid interest. The Company incurred pre-payment penalty of $<span id="xdx_909_ecustom--PrePaymentPenalty_iI_pn3n3_c20220125__us-gaap--DebtInstrumentAxis__custom--SecuredConvertiblePromissoryNoteMember_zSTPVoDpn263" title="Pre payment penalty">17</span> thousand with respect to the repayment of the note and the remaining unamortized debt discount in the amount of $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_c20220125__us-gaap--DebtInstrumentAxis__custom--SecuredConvertiblePromissoryNoteMember_zwe2dP7n4cwj" title="Unamortized debt discount">133</span> thousand was written off and both amounts were recorded as a loss on extinguishment of debt of $<span id="xdx_906_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pn3n3_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--SecuredConvertiblePromissoryNoteMember_zmTPmxABo3B9" title="Gains loss on extinguishment of debt">150</span> thousand in accompany condensed consolidated statement of operations during 2022. The repayment extinguished the note in its entirety. On September 6, 2022, the outstanding balance on the remaining September 2 Notes’ was repaid in full which consisted of principal of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20220906__us-gaap--DebtInstrumentAxis__custom--SecuredConvertiblePromissoryNoteMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zahNIJHoCaF8">1,478</span> thousand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 1680000 180000 1680000 1814000 194000 300000 17000 133000 150000 1478000 <p id="xdx_80B_ecustom--WarrantsLiabilityDisclosureTextBlock_zAdFe75VBsl4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14. <span id="xdx_821_zZe5loJogELl">Warrant Liability</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 2, 2021, March 11, 2021, February 3, 2021, December 24, 2020, March 18, 2020, September 10, 2019, and November 6, 2019, the Company issued <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zP1Xjv48Oghh" title="Warrants outstanding">22,019</span>, <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210311__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_ziJsdAHSB9re" title="Warrants outstanding">34,286</span>, <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zoEYKLW0JDQl" title="Warrants outstanding">7,429</span>, <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20201224__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zCm3rbvry4Ih" title="Warrants outstanding">7,286</span>, <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200318__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z5LlOSStfyU7" title="Warrants outstanding">44,286</span>, <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20190910__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zNYq6Gqj9uCg" title="Warrants outstanding">35,715</span> and <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20191106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zX5m6EhkPsL" title="Warrants outstanding">114,286</span> warrants, respectively, as equity issuance consideration, in connection with a private placement of the Company’s common stock. The warrants entitle the holder to purchase one share of our common stock at an exercise price equal to $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zU7TLHoemPQa" title="Exercise price">0.49</span> to $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zrt6vzyDNfl4" title="Exercise price">5.25</span> per share at any time on or after their issuance date and on or prior to the close of business 3 or 5 years, as applicable, after the issuance date (the “Termination Date”). The Company determined that these warrants are free standing financial instruments that are legally detachable and separately exercisable from the common stock included in the public share offering. Management also determined that the warrants required classification as a liability pursuant to ASC 815. In accordance with the accounting guidance, the outstanding warrants are recognized as a warrant liability on the balance sheet and are measured at their inception date fair value and subsequently re-measured at each reporting period with changes being recorded as a component of other income in the statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_ecustom--ScheduleOfFairValueWarrantLiabilityTextBlock_zBrguAv8OMGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants outstanding and fair values at each of the respective valuation dates are summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_z07prjflrc4h" style="display: none">Schedule of Warrant Liability</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Warrant Liability</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value per Share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; font-weight: bold">Fair value as of year ended 12/31/2022</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_za2WfpMA53i8" style="width: 14%; font-weight: bold; text-align: right" title="Warrants outstanding">265,305</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstanding_iS_pn3n3_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zttLBV9qCiB" style="width: 14%; font-weight: bold; text-align: right" title="Fair value">242</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercise of warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iNE_di_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOvALk7KSA71" style="text-align: right" title="Number of warrants, exercised">(194,286</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">      </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iNE_di_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLoInE2gsyEc" style="text-align: right" title="Exercise of wararnts">(154</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--FairValueAdjustmentOfWarrantsShares_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkcwsl5LPnoc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value of warrant liability"><span style="-sec-ix-hidden: xdx2ixbrl1164">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMa4ugDoFlz3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value of warrant liability">77</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Fair value as of period ended 6/30/2023</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsRD0Qg4b3jb" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Warrants outstanding">71,019</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--WarrantsAndRightsOutstanding_iE_pn3n3_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zTbGrabQIqy2" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Fair value">165</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A9_z3Vtg2PIsYA1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrant liabilities are considered Level 3 liabilities on the fair value hierarchy as the determination of fair value includes various assumptions about of future activities and the Company’s stock prices and historical volatility of Guideline Public Companies as inputs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 22019 34286 7429 7286 44286 35715 114286 0.49 5.25 <p id="xdx_891_ecustom--ScheduleOfFairValueWarrantLiabilityTextBlock_zBrguAv8OMGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants outstanding and fair values at each of the respective valuation dates are summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_z07prjflrc4h" style="display: none">Schedule of Warrant Liability</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Warrant Liability</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value per Share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; font-weight: bold">Fair value as of year ended 12/31/2022</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_za2WfpMA53i8" style="width: 14%; font-weight: bold; text-align: right" title="Warrants outstanding">265,305</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstanding_iS_pn3n3_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zttLBV9qCiB" style="width: 14%; font-weight: bold; text-align: right" title="Fair value">242</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercise of warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iNE_di_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOvALk7KSA71" style="text-align: right" title="Number of warrants, exercised">(194,286</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">      </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iNE_di_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLoInE2gsyEc" style="text-align: right" title="Exercise of wararnts">(154</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of warrant liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--FairValueAdjustmentOfWarrantsShares_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkcwsl5LPnoc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value of warrant liability"><span style="-sec-ix-hidden: xdx2ixbrl1164">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMa4ugDoFlz3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value of warrant liability">77</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Fair value as of period ended 6/30/2023</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsRD0Qg4b3jb" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Warrants outstanding">71,019</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--WarrantsAndRightsOutstanding_iE_pn3n3_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zTbGrabQIqy2" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Fair value">165</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 265305 242000 194286000 154000 77000 71019 165000 <p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zZOGLZetgvu5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15. <span id="xdx_820_znqO4KrU1yWi">Commitments and Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Litigation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may be subject to legal proceedings and claims that arise in the ordinary course of business. Management is not currently aware of any matters that will have a material effect on the financial position, results of operations, or cash flows of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Service Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 21, 2023, the Company entered into a Services Agreement with GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (“Haleon”) to supply material for a consumer product to be developed and released in the future. There can be no guaranty that a consumer product will be released or, if released, that it will be successful. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC is a Haleon group company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_805_eus-gaap--ConcentrationRiskDisclosureTextBlock_z8FKxKntBURe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16. <span id="xdx_828_z8ZaTV3MyEf">Concentrations of Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s revenues are concentrated in a small group of customers with some individually having more than 10% of total revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues from two customers that exceeded 10% of total revenues for the six months ended June 30, 2023, were <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zUAl2WH4yxd5" title="Concentration risk, percentage">40</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z4H36Iz64DD1" title="Concentration risk, percentage">14</span>%. The accounts receivable from those top two customers were <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zuSAy1R7KaSj" title="Concentration risk, percentage">0</span>% and<span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zU5I9yVLAfIh" title="Concentration risk, percentage"> 22</span>% as well as <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--OneOtherCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zl9ZCZ7GdsQ3" title="Concentration risk, percentage">13</span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--TwoOtherCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFUkPpmNvXVe" title="Concentration risk, percentage">15</span>%, and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--ThreeOtherCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6ciyJP5YkBb" title="Concentration risk, percentage">16</span>% from three other customers of the total accounts receivable as of June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues from two customers that exceeded 10% of total revenues for the six months ended June 30, 2022, were<span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z8soV7yr1J3d" title="Concentration risk, percentage"> 40</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zG1d0LYNYck9" title="Concentration risk, percentage">25</span>%. The accounts receivable from those top two customers by revenue were<span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zoPOlA8MEMM8" title="Concentration risk, percentage"> 6</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0XyV6xUeNkb" title="Concentration risk, percentage">46</span>% as well as <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__srt--MajorCustomersAxis__custom--OneOtherCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zHnT80amGf3c" title="Concentration risk, percentage">15</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__srt--MajorCustomersAxis__custom--TwoOtherCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zgRdc8AaPs6h" title="Concentration risk, percentage">22</span>% from two other customers of the total accounts receivable as of June 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash, cash equivalents and marketable securities. Cash balances are maintained principally at major U.S. financial institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to regulatory limits. Such cash balances are currently in excess of the FDIC insurance limit of $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20230630_zFZNfNwutRZ4" title="Cash, FDIC insured amount">250</span> thousand. As of June 30, 2023, the total amount exceeding such limit was $<span id="xdx_905_eus-gaap--CashUninsuredAmount_iI_pn3n3_c20230630_zEOL685k8S5c" title="Cash, exceeding">3</span> million. The Company has not experienced any credit losses associated with its cash balances in the past. The Company invests its cash equivalents in U.S. treasury bills with original maturities of three months or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable securities are comprised of U.S. treasury bills with original maturities greater than three months. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents, and marketable securities and performs periodic evaluations of the credit standing of such institutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.40 0.14 0 0.22 0.13 0.15 0.16 0.40 0.25 0.06 0.46 0.15 0.22 250000 3000 <p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zlucwAUjfE8k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17. <span id="xdx_827_zO7cbJpAjpDl">Related Party Transactions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Convertible Promissory Note</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 2, 2021, the Company issued <span id="xdx_901_ecustom--NumberOfDebtInstruments_iI_dc_uInteger_c20210902__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Mr.SteinMember_zHcYbXbiWMWk" title="Number Of Debt Instruments">three</span> Secured Convertible Promissory Notes to members of the board of directors in aggregate amounts of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20210902__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Mr.SteinMember_zlxkPkOGyjm" title="Debt instrument face amount">150,000</span> to Mr. Stein, $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20210902__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Mr.StefanskyMember_zRtoieIqtGof" title="Debt instrument face amount">150,000</span> to Mr. Stefansky (Bezalel Partners, LLC), and $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20210902__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Dr.JeromeZeldisMember_zwhTDZob7pad" title="Debt instrument face amount">50,000</span> to Dr. Zeldis as part of the September 2 Notes. The notes were repaid in full in 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Advances</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Jerome Zeldis, a member of the Company board of directors, has an outstanding balance due of $<span id="xdx_900_eus-gaap--OtherReceivablesNetCurrent_iI_pn3n3_c20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Dr.JeromeZeldisMember_zCBfhNdqams8" title="Due from related parties, current">25,000</span> for services as of June 30, 2023 and $<span id="xdx_902_eus-gaap--OtherReceivablesNetCurrent_iI_pn3n3_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Dr.JeromeZeldisMember_zJK0Gl1t22A3" title="Due from related parties, current">40,000</span> as of December 31, 2022, included in accounts payable in the accompanying condensed consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3 150000000 150000000 50000000 25000000 40000000 <p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_znWFDbv6gOb6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18. <span id="xdx_828_zETDt9KhBNg8">Subsequent Events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management of the Company has performed a review of events and transactions occurring after the condensed consolidated balance sheet date to determine if there were any such events or transactions requiring adjustment to or disclosure in the accompanying condensed consolidated financial statements and has noted none except as follows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2023, the Company announced a new strategic relationship with Enigma Health, a new joint venture company, for retail distribution and marketing services in North America. In addition to the Company, Enigma Health will also be providing services for Moiety, Inc., a topical lotion and creams manufacturer.</span></p> Includes incentive stock options and restricted stock units discussed below. Includes shares of restricted common stock granted outside of the 2019 Plan to our Chief Executive Officer, Adam Levy. EXCEL 78 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

)SH1BOYJ7,W2QGJ<8N!IU%FBDK7 :!L/:[;JI(\6 MZ4]H>-$C;$;2]E'C> !&C+E,GA +F2GE_AVI1FO0%H:2[P)!?$V+>H&Z M*#_T.I=%^"9Y=,#XD6K#Q)NB#>0+T<$41=G*/;-NB6N-X\3FLFPTF"@B9TBX MS3M*5Y"DOP(Q8W@D/G0>% ,+QS@NV*G2+4F?:S37^4*\A(K&?G (@6?UB IEN*GDN0,KPOU.<4'W'1^!Q\!MZM:)DJG,#AI+EMRH;A,UKDED]F/D MO*0">=RALEO,\.+@#&#>"JXF-#LOMM)KQ^VV2PL9-/>*@UY3]:F)C2WV,'53 M;H:<@+VSZPPKQHW X^^WGN3.V=CV-)I3B8X4UJ M=@>]\$ N[!]:K:Z0-4*ESD5*(A#3>77W6FZE-@PYGS;(P*0*)(+S$]!2H@[< MP5R65)]CX(PB9WQ(E=.5!H.CXV*\O2B'2/GH+$VO.)=[/D]Q%.77GHQ,77/H MTIY*!QH&$:1F6QKPI!'L=$WB19[[$%[0( &C#WI9HI!OQ,=5$=#WT(-VQ-.] M'1F=]/NI:/]1ZH5&).RT#([-]WR@!9UP>$]TS23"@ 0J&A7_?^A*Y]R&R*;, M#:F9"P;UFGW@8 NIP%%@K6NTG9+1AKVX6%/V>%N._.N#RX_N-0JM-'#M^+>AOSE\ T.WU'7>?/A[OE^2/L M!4X-C4HR5,%TM7B">[7/'S9Y$%V7/B8V+N(JDQX;? N2YP5X7SF4YC#@#::O MRZN_ 5!+ P04 " #IA Y7YB8M>Z ; #D3@ & 'AL+W=OT?O\PN]&W[KDWXIV MLK#V,WUX7?YX=$($Z4H7+8_17O'7M9 MY$Y?V>H/4[;K'X\NCE2IEWE7M1_L[:_:[^<1S5?8RO&?ZE;>/3L_4D7G6KOQ M@T'!QM3R=_[%\R$9<'%RQX"Y'S!GNF4AIO*GO,U?/&_LK6KH;V+:[.JS=(4>=VJRZ*P7=V:>J7>V\H41CN5UZ7ZV;4&^]?N M^<,62]+ AX6?_J5,/[]C^G/UUM;MVJF?ZU*7P_$/06JD=Q[H?3F_=\)_=_54 MG9Y,U/QD?GK/?*=Q_Z<\WZ,[YAO;\_]<+ES;0%[^=VS#,M_I^'RD0T_=-B_T MCT=0$J>;&WWTXOM_SHELD&EW4)%VK7ZYO'P/L_!79T J5**&#:&756OQZ;-6.A) ].4.=F=+Z[NL M7>>MRI=+6 :F)-_0EAQFV]J&:,!RWTHAKP'>;+9YO2/NU!9+3VGS[CY:3%U4 M70D:*MA'3(M7L$U5VF[1+KN*YR3B)B#J!BO99J?\V> [V!_=-*"IS;_09[?. M&WU,9HIHWL!T.^$Y+=OHBNF_R:O.?QL7S>B%96X:?JKIC"I;KXXKV$PF6,/V MX_#;#MO&^C!Z#BMT5:E* TXV:MG8#7,M[G6JKG*WYC\RXYB>QA!EF+R@)V#S M(J\_"U/6L)_53E4&)UKR9EW+K*6=$X^(J9^FUU/5PONX#GQ8F*IR:MLUQ9IW MS'*10\ :L\(959"#MFM(8ECD&JVSC9@C<+C2#@L[=0N/0'\G*Q)A>%'O,$'S M&9YQV=6EG,OMVA1K$8Z\:?B@17I4OMTV]HL_Y9Z3.".P$S))8]P:\A6H@N9D MH@H0D&3UJ7K+J^:+2F?7NO#OLAI=B7RIHL*10"7QM6F=)Y,&*-^6 %DJ >5=>X'C,F\BO:*&=612 5N M$7OC@L'!%\:R<@L37(<_/ FV -VRB\CD=5[RN*4E-:&COI//6 &>24?/Q!+] MDR[T9@'5.)WQM_.GZAJ@JNPJ-I#]*:O^E+,X33HZXSEIBFQ\U*?:$ .N6Y:^ MO0-]0!+X2B^:#K!+S4^%Q!_4=^H8_Y\]F7_%\$NH;J7FC\/88_S]%<-X-[-' M_:BSR>G%V5<-A"V815)G\\?T_]<0VJV FM3L) P]NWA$_V$DG_F*6:Y8R%NO<>_,\@.?K+ M%K[%D=H#H!$"98$H+7D%M=!Y RF$'D'E6>3Z@6*;:6\LW#PVQ_:@NR0SHQ2Q M:2>=@2@J&*$;PY#9VYQHX\?]BA)G84D%"W@7EUA;&E[I>D7V "H$,$Y?9?W: MHN3;' POR=0QT1T<$OBQZ!S@!6RLKF],8VO62Z(U8=3W_[J8SQX_@YTR0+H- M$$;%O(/- ,%3]3YLQAWLQF7CVR&"H@6!JB, ,Q93=1*US (U40\< DL;0CE M45# :\+/LX?C><"52IPQ6S%XU17[+9P &2'7#HG);M>ZAB56<',X@ 6?"Z,, M>BTYJUL(JIB*FF;?&L]PAS5G +L;#&_VE(-'XJP.D9 N&&1VLBN>$%M@>$7$0WY2VGE_?@$7Q2X@ M"8*4AM>;\.'E8.$-!:_>1XWN694"*I*)@[\-2AM/3Y$H"O_,@FA23-D@\O >=$%KG)*>*+]#)!<+LM)#!?:'!P M2UB[J\6%0E%MUQ"*[VA'<&LP/RRD-:"R3O?]6E[%$X[1LL&8X887G:E*04B1 MCFCN)+@F78"I:(1 L]GHTF#?<#YN;;;"JSBVV](X3%[I-)#QS_$-PAQ+@BT, M\C:$C,(&[@3#:423WQ*H@HW+*\@')2V@8\<8"7#EG!S=DJS3FB /*?6T5VB9 M#,XC9TT%OR%8!N3F[:AAO87]6ML.(1E+&UE@=;G)_R9[WU5+F".VRY!<4"1D MT]CYR;-@5B"?NNZTXZ]GSQ0%C6"IWOQ#E)3$1D,TMA\*T!R4ME&'HI@YLF;D M1?UA0=!%-L2ND@C1)T%V4_4'F>'"-$6WP?)LOTM3$"%BC6]Q"%":,9DF%,>4 MY&0^2-7$BY".1'HF- -)$(M@']2!F^+R*3H4&^+]#IT0D<'11GRG-&YK8938 M".-X/T"5]NN>TKV%\N"B^1#AF5-1$_TE+51[U%([I[8 M!$;H)9A*AL Y6Q@6$8X#TO<@- W?7(QIR@3.C$Z:#"_VGE_Q< @, R!D^U6:S8Q M1+=::K:!#)UB]L&KJ3B.;95[0 1"6G'\/R-29KX)9AT\T^$9K=Q'5&WJ%04! MT%!!EMVFDP1!J;<88OK, 2 N%.UO[X!_2A\+XKDQ-#W!&0%&G"_P1BB#RA&2 MH50"RVBN"'A1NO28C0FKW%2] 9B'K:K(#-.4(;'2Z+"^&.[1X?W:'&,+Q,%' MTZMIN4<(I0!(E)G*?MMOT>X<7$&,900Z,.]PL#>LCZ>R> MY5B[6$;40$8F:?J,(2IV!I=^#^EB'@*A*9T<(L3DB-A6+-MKQ.%1-9H83J\G M2X@SVLNRL"YZ7K%O8#O=&E*;$%N$--?=$DUG61F@I3Q)]OGL .:/UMG/F$F^ MBZA@\,_?4Q;"AP>I01$")#TV-!N)XW+Y1D>?]7I#S/,Y/9DBWRE25U/B\B\ #()H7TJ_"!LW.=TDR6+, MSH34U(B,<9ZNX&(!< ?.J \$>O_0;R0D]8B@D@W<,B5L(M!%E)UL5ZF;0=YR MY?<,]1[7PU1N# 5![#/"%-DP7TJ9E%6(),FU%(7>#C/YPBDG66@@#:*9-)U( M;'=;#ZN'J_\3<9G'9Q2,4-S&;G//'7M3GKI9-7"S;(]8H,AT$3X>VA]#=+%9 MH3"6J.R?D8YKJ-H!UY@PXOH!:80V#Q>A]PGM 2WL*/DV/$TV>GE==]YOT^-! M[A9[R**=O)-:_<6$=-Y0_0Y/W8= >1- L+!PZ#5]* @[UB^2D=M!S$AUEZ$% M"8>];S;R XT-=H*<2$_H7DRO&RJVZ=(##N*-1S31R\#;]253R]ZZQ'>U.F;EM\, MB2]Z68A% /F_KF!H$NJPJC*5 BKX/FA99X+ QPT=U,U2O(1?8['_Y; M\8 "^U-I[$ %A/S M:T-#"*"54Y9L1-)GVZ2Z0[4LA]JDIR0J;>=N*YH63-. M_)F_.EZ>$BB-%EA"=6990J6.([ZD#;/:+H@W;&%Q+EW=?\9A],_\THU>2KF@ M+Q'[") /UQ1FRXA?3$#'E4/.,;""!\A#L8T)X"KNSJ<@X<]R4.4S2%RV)5,* M_2%O %C=-049']B/2@\(]D1FD<@D!4..I.WS3H$D69P39V1O[&TD(]FAG$Z? M>;GC$"5SG$,8.9.;>:M.0C$XSE*[HC$+@E+4=/04D26]/O-_S_W?I\.*J@=O M;@QHB:DG"F+IGXH 32=T/2#T.+FS.!._W^8[7V*BWH#PD74&R\.YM.PD!D]_ M"%%%L '2JR4"'PK.*<<6NLA)+F)"&0=T3#$N2<6PR%[G#(E#$3H;W9TXAKX& M&LJ?!1WBS?U$9#]WXL/]UL;T4/X< M-S'Z5/TAZ8CL330]_AN705Q#FP;YK0W, ?QB\5F@N($ID/ 9:E#[?CW&1>2X M,(\7'G(B.3R>"VT,7+4G$.6#Z_G)[$G,KH%/LWV['SHNDM1)DZ8X#E$_T<9Z MQYK,'0BP[VR%&$IJCE+95*B7\&^?CR&W5 Q"<,G[2#"Z+34B@LLV"Y-.]L0_ MKCX@+T%YTA+AN1))8_SB]2DOI;Z$U=F_@62HHL22 M/[O8+VE9#H02B]#WIT&VZS*GLOA+B[_4 U_9>'5Y_=)7,WX8?__*EMSOQ@ @ M#+N\OHJC/MJM*=3YR?DD)J39D5[Y/+@/4:YBV6+@:@28^GB/F>MBMAKHJ[22 MFB(X(TU5U&=#49Q+\LR3F'17>R4P*98<5-Q"32GCFM(>0F38W#4'=;MX+$YH MZ4?YC-MAH6]/8@7^;ZV19%.C?9> <"83(.)D,[8*"B T[K4+*&IF<['KR0", MJ"NX:<%'=G7HB_19_ 8F&% Z3I+PE2U033E,!O4UU>(:GYEDL@:F>JK>YSM) M(E'>&NI,5GO7!_J2G"QBJV798$JIW"%!2.P-S9*:-O&H M:VH*D?I>2,XS^X3=?G3E&(#ZTFNB&3'G +L.OR>%U%0"B):<\/<'63$;.H'@ M0/83C4DL)Z0*E ZK)0T4$:B&K4G/"9E<__1S35"8.R%\NM%G73-O2Y.RCZ+< M.=DCKLPGTTXX>YOF?*;JUTADM9M(XT.@=MMWTZSS&^V3L[J.Y6CX)H&[U/G4 M=)Y4F>/>,SG(I4F>WF/G/B(:IE:+*C<;&9?F[?UZ ,6#J1/N$]NC'DA8<"=Y MO--UPA39LMGTF_[)N'RU:O2*DX!!B!8[3PEIU1"-#@=\Z =<\X"/&)!T['U, MVB0)+F!( */)6U>CQAS8ZN+B,?X\G9]E5_?;=35FU]E\S9^IV9/L-_WE%[P> M#/9!:X6:/WJB9AR;4C+!)9441T&16,Y\ M("G[]7&.[7M5!MEH-HW%$"_T[@'H_9M21- 4AM*UW6MA)?6 7X=" .,P";5H M9^C/>Q9!"Y4R4QSA#^7[?+-]IO[@8WE#QS*A$<+FEY[O[V._$Y'X5G,1%&$+ MY82H#SPTZPQ6Z.%1QCTX"OZ_DC9C'&F 7?PEQ0H!?/D*4OB:W#L7TL6N<$4_ MS#OI:R<[N+/B<\XU4KRVWV S,)OPNL8Q[]A6C(6SDH;;^6Q)XGRF?E?9 =ND M8RN+DFF7+1FB>DG1.MRXL1W5W&!72N.[T/U^N..$>,+Y.6Z74!WGI**#L>33 M,5CJ+@R38O>ZM+,!KD]74QA*J_VB9<8K,-PB92,S2LVI74M#W>'A:I?A%_LR@FR5-1,*EUGO*M:WX)T/V^/I*=1R[)]+=N7 M)&+K@:FDH_?'Q)7R$JBM8"8-&1_ 8]AO0#^6KP?Y[F(!KT HM:[(H(H.N\:[90@D/\IX%5+6R MU(SG]7#983V'56(B,9+27VUB]Q:O-KVK,]_T/[_@',&3\1P!?<<)(JZ!?Z3( MY34'6]0D][[*J6L6$K1A)*,>T.O>!?$H>J-W0=>P!K]92,SL1++,)/C9LFL8 M9I2L,*08J[R)K?1Q&@DPX\?00 6.X@ IPZ1A0NQ.:]<'^;;QSM5V+26JO3Y3 M&9*APYTWOT*.U5(&F(J18T1T&^,TV##K\1OS!9!"NY[>49YE@$[1Q0'V**F]PZC#/,G-2R).7#U)Y M([L).3<>H59?E^'CUR2'EWUM#F\@@*&YT'?:]=DRT;@[V@CO[63+)""2$K6. MU37I&8J7N%R2Y* !-[[5TKNT.Q!;^\W605^\D7C)6A#R) EQ_[S4:TYM9A_I.F7X MP'KEK?]/=5V';-C(6N1WN&\JW6%C LWX^UU&=,0 MBGD8 14^?PQNV(; J61ZY,%"M[U1DH5+3]MM!6? M]UPPJI'4U$]C6^&<#;43LG_(QZZ?JN3^S-UM!(Z2SEQOM'4F,7_4Y9&%AW=M MY KA'23N-PHU>IBM8=;S?6%F3=\@1[(!]W=<,KW"S.===^W:\K58 M3N#V%5J>E"CO%-+W4Y?55=G$V MG_C/D][:[5FZ2MZW]]X;&=2YF8D,"([M\I@"Y>!./KSKW4FJQK1$EBCS5.'- M\$:C_/]D@/[$9?)QI;I2Q7QIPIDBFU( M:%+*.2;4XY+8RKM>0'A$LC6&2WN/!W9[:(<&&A68TO=@>?="ER0WW6:?OMC MW;."\NM4V"5G(T$V9Z,OW1BG,R\(_CZLA[^^TXU^4Z)E4SJ$\=(*C-5[+ ?T M)ZTAT+N%;1II4*"AP_V96GZ]AGW.#9 Y7ZT?HY@T(>3Q VP?(<>0&-JGJ MCC-RWE3*\WS5:&\(",.3+GD\+1&/OZF3)5_*NM)@'0Y=Z;R16R0#=H<.)!CJ M@GO<]V7A4"K%MX3+DDQ Z''WZ[)?#>2$I'U)NR PF3M;YQQI!M/ ME5_T4UA MG+_&FK2J1UD[(,6WSQ8X,LX<<(34TS^Y3SK!XZ[F),V>4,JU4DYSKK(]37#\ M8Q8LM/2[!;>ZNAG\<$'*/$ZC1N^/>>T.XZF"MPF7/L*JL=1SJ M&.$*L;^WS?44CMBE99%.H)60KJO[CEK958QKDMLU\-_47FV;$4/ '0##^(.] M#YF1R@M.)A>5_O$"3:K4TA-YWWWJ^Z]3_PY3QB!Q>%A<]O-]()"Q/+UP,^EO M-GC@'0/!_E3[=L^#_H@8C0VN=3# 9*_38[=E'BZF#J\,VC0Q>#.^@[3L)=%1 MFJFAU#'_\)0N PIQ\OLWT3IPHVM]'$X&D+U.BUD]$[P !^^S[1KJG!0="6H8P>DC@+<@1)$.^3L$"6 M@L])_,3U?*KY,@)/?0O[Q#7!#AQ*KF,4_N*>;#50YN+^HA$,>;U^D1A=2.$G MUE"S,*]<+NR!88_QFSMN"#$XY8TRQD["[?.]^O$Y:$H_5 ME4#"-W)/R8?0I_/S'YZFC;:^K<6:P;N5' MR.*W\2?<+N67R_K7Y???W@+64R-(I9<8>C)]_.A($%GXT-HM_X[9PK:MW? _ MUSH'2J,7\'QI;1L^T +QA^U>_ =02P,$% @ Z80.5T*NNY8S! 90D M !D !X;"]W;W)K&ULE59M;^)&$/[N7S'BKJ<[ M"0&V@:0<(%W21LTI4:.D[7U>[#%>W7K7W5U#^/>=61M":(ZJ4@CK99YGGGG9 M6<^WQGYW):*'YTIIM^B5WM>SX=!E)5;"#4R-FGXIC*V$IT>['KK:HL@#J%+# M9#2:#BLA=6\Y#WL/=CDWC5=2XX,%UU25L+LK5&:[Z,6]_<:C7)>>-X;+>2W6 M^(3^S_K!TM/PP)++"K631H/%8M'[$L^NQFP?#/Z2N'5':^!(5L9\YX?;?-$; ML2!4F'EF$/2UP6M4BHE(QM\=9^_@DH''ZSW[38B=8ED)A]=&?9.Y+Q>]RQ[D M6(A&^4>S_0V[>";,EQGEPG_8MK9QVH.L<=Y4'9@45%*WW^*YR\,1X'+T T#2 M 9*@NW445/XBO%C.K=F"96MBXT4(-:!)G-1>N'AG MF'6XJQ:7_ WA7NC?>G@5YUC_AH_) T'(R%5REO!KHP>0COJ0C)+T#%]Z M""P-?)/_'5B+2]_&\2&8N5IDN.A1ESNT&^PM/[R+IZ//9U2-#ZK&Y]C/J#J+ M>UO5>!"U?/!'B=&UJ6JA=U *!T8CT+FUPDN]!L5&0 <8!&2FJM!F4BCJ(MT4 M="H:RT:TDDKZ'0B=@\BIU:3S3+ AJJ*0&;E1)A,>E\9J[,,#:NUV M:B.T%)$OA0?;: >^M*99E_"5W-!QI[JF\8"56@1!'[\UI)&/)ML2*A,:\-DC M^?K#N\LDOOCL()?:.XJ\G8-AH*QHR 4Z49E& M^Y Y+RN&[?5(L>JR:J4+:;:F>E/":;F$BXB$3@4>3@5\?,^I]Z5I'/ERGV;P M1$,Z;Q2R[4U#I42XI\I5306A->!!["I6'OV^YV][)KH77'A21LC6].X@]K"* M@MOW$"<)+\>0C">\F.P74Q(7\^("TG@2A>J*@HH&<3_F#>.ITQK-">8<4?.< M!EIW"B'II^.4U#DW@]NJ;MI.(RYT'CXF/R?P*7IH"P$;H9I0]5.VEXR_)\+1 M)(Z^A<%,7&)#IFNDGN#+Z@426NQR,/VWY5XUD LJPV "/T&(*#IUB\]T2W:' MC*OKY#-4[8!$'I"O"]D/K4*KI ];.JZ4X'0*\2B%IZ:N%7(^R$DF7 D%->+K MOK.HPBFD]E;M\6<.^FN[UOU'F[QR<_VA(UI8+63> M3I70_BPR4TW>S@=.0D50ZDAVQ:4Z*=#LI27A*-)P0$[3VR;HK?D[/+KZ:+"M MPP7O()2MO04/NX=WB"_MU?EBWKZ W N[EC2,%!8$'0TNZ&JQ[:7>/GA3AXMT M93Q=RV%9TGL06C:@WPMC_/Z!'1S>K);_ %!+ P04 " #IA Y7W[?'ATX# M %!P &0 'AL+W=O7*-0ZT4X"G<+#[RLK%N( MEO.&E?B(]M_F7M,LZEER7J,T7$G06"S"J]'L^LS9>X/_.*[-P1A<)"NE?KC) MIWP1QDX0"LRL8V#T><8;%,(1D8S_MYQA[](!#\<[]H\^=HIEQ0S>*/&5Y[9: MA-,0;A #"- MWP D6T#B=7>.O,I;9MERKM4:M+,F-C?PH7HTB>/2%>71:MKEA+/+3_(9I55Z M,X\LT;G%*-M"KSMH\@9T G=*VLK !YEC_CL^(AF]EF2GY3HY2OBYE4-(XP$D M<9(>X4O[V%+/-_Y3;'#+32:4:37"MZN5L9H.P_?7(NX(T]<)W069F89EN CI M!AC4SQ@NW[\;3>++(W+/>KEGQ]B/E^(H]'5AXV&PST _"C)%-\I8 ZH 6R$4 M2M#-Y+*$OTZ 2UI3K6$R-W_/X)%Z0-X*#,AVST!U0E^G6\RP7J&&=#0(7-%< MY9+@@:WIB%K4G D#)S!)I_1.+L;!5[JAIUR>-EJ5I-/ 60KC4?"12TY'.(=2 MJ=Q >C&%T7BR5S^ 4BNR'@WB\PL8QTGPA<"SO238!DW!:,"7S%%3"& H,JC5 MLXN.]\;OWTV347*Y^P9/RC)!"COZ$^?@(%INP#4W2P\I9-8G[4;5#9,;SW!^ M:6#--+J\X8#\ C4_HUJ=D;VMN,Y/&Z;M!BCS_N01GVP+&K3:"2-'N=(#+YCH MKVKVD]I5T8J""T']ST)&+]1F&#SM7<.JY8*2Q:F2;Q!3EO,VHWW7MG(@TJZA M4,&4SHG0N^1UC3FG_Q5U]KVYMT/XH[IDDL# @N"QL-SNO>Z:[K=Q*K& M-[J5LA2E'U;TGT+M#&B_4,KN)LY!_^=;_@)02P,$% @ Z80.5R1J'#PP M P ]P8 !D !X;"]W;W)K&ULE55M;]LV$/ZN M7W'0BB$!C.C-9*M2CIIE*Z899$O8U, MJY&5WJ@141K'DZAA7(:KA3];Z]5"=59PB6L-IFL:IK_=HE"[99B$AX,/?%M; M=Q"M%BW;X@/:C^U:DQ0-*"5O4!JN)&BLEN%-,K\=.WVO\(GCSCS;@XMDH]07 M)_Q6+L/8$4*!A74(C)9'O$,A'!#1^+K'# >7SO#Y_H#^BX^=8MDP@W=*_,5+ M6R_#:0@E5JP3]H/:_8K[>'*'5RAA_!=VO>Z8/!:=L:K9&Y/<<-FO[&F?AV<& MT_@[!NG>(/6\>T>>Y1MFV6JAU0ZTTR8TM_&A>FLBQZ4KRH/5=,O)SJ[6FNJK M[3=@LH2W7SO>4L;M"-ZC7426'#BUJ-B#W?9@Z7? )G"OI*T-O)4EEB_M(R(V ML$L/[&[3LX"_=_(*LG@$:9QF9_"R(=K,X^7_$^T(UH))^S)H^'RS,5;3._GG M5.@]GT/_T2J=!3M-=7(5 MG'$"A[O W>&0L4)1=QH+J@);(U1*4)-SN86+5\ EG:G.D(6YG,,#C9.R$QB0 M[@NTP5/PT6#5"7C'*P2J//K*O\$"FPUJR))1F> M]9%9!DD,KR 9Y9E;9]=9\$=5\8)(=EIRVVD\99'D,\AGP3ND1J^5*($WK5:/ MZ#0,3""=))"FT^". K>ZZR<+14I*6\JE@??1#23)%/(\^%-9)MS-,:M';^DH MGDR)7I;DY,V8. B0]8H;?F__<'%),_A$B[RV1@N M7Y8-CV635#:7@'&2T7J=)I3*(VJ 3S37C:N9]K4S_ F:OGO1=>^Q B[9(X_N M,@X[9@B/\C">P:FG'3T;1@WJK1^YAIY*)VT_EX;38:K?],/LJ-[_$NZ9WG)I M0&!%IO'5-?6U[L=L+UC5^M&V498&I=_6]&="[13HOE+*'@3G8/C7K?X#4$L# M!!0 ( .F$#E>S#D1OH@, +T( 9 >&PO=V]R:W-H965T+)2^M&4B!:>*R'--"ZMK<=)8K(2 M*V8ZJD9))X72%;.TU,O$U!I9[D&52-)N=YA4C,MX-O%[MWHV48T57.*M!M-4 M%=/KXSJ=QUQF$ C/K&!@-3WB!0C@B,N/[AC-N53K@ M[GS+_M7[3KXLF,$+)?[DN2VG\><8'L[%I:)I=\(1#FQJ UD\02K3M,L@W%>:!(WZ$8PHV2MC1P M)7/,7^,3,J>U*=W:=)X>)/S6R [TNZ>0=M/^ ;Y^ZV/?\PW>X?M5J7S%A0 F M/93Y]Z MP^XO!WPX:WTX.\3^W^[I(,5^ T>=Z&U$'DJ,"B6H8+E<0JW5$\_1 (,%U?UC MKE825 &T)RTO.'-(_D+" @DS3HCN$MN[]!=PB1E6"]30[_G== SW]-3DC<"( M .>[*JYW5;RQ,VK)=SDCK\D11[=:Y4UFDP?,2JF$6J[A#@6SF$?7!XT_A:56 MQL 1$?I/-,^RIFH\%EBEM.7_,/^L')/$"1RG0S@YH.^#8)V"I/?W9QA$-TP_ MHG5AWUIZX1\!\DUOJ7Y ;XWMC>@7/6A&JEB%'\J/8'3 K9YWZPMY]6*2_A_. M]/K0&T0/RC(!'P7;R1\YQ!'=&]USE"DI-\_VBML2;(EPP]:0?O$I0S?.LN\- M-]R+4*+9F?-3W/4_)3DNAY%OZQFD@4XVTH;NTNVUOGH>6]"(>&COESY)+ P(+@G8[ M(WJG=6B686%5[1O40EG*=#\MZ?\%:B= YX52=KMP"MI_++-_ 5!+ P04 M" #IA Y7)0L')K@" !H!@ &0 'AL+W=O1V6ADN0\J193$\3 J&9?A=.SW%GHZ5I457.)"@ZG*DNFG.0JU MG83=<+]QS]>%=1O1=+QA:URB_;I9:%I%+4O.2Y2&*PD:5Y-PUAW-^P[O =\X M;LW!'%PEJ5(/;O$AGX2Q$X0",^L8&#T>\0J%<$0DXU?#&;8I7>#A?,]^ZVNG M6E)F\$J)[SRWQ22\#"''%:N$O5?;]]C4,W!\F1+&C["ML?V+$++*6%4VP:2@ MY+)^LEUS#@449Z>S+-,5YG"SH\]LT "3.7RV!6JXJK1&:>$39RD7W'(TX\A23A<990W_ MO.9/GN$?PIV2MC!P(W/,_XZ/2&LK.-D+GB,O>.,[AJ-S(9E. GIGAC4CQA. M7[_J#N-W)_3V6[W]4^S_X8.=Y#^N_K(3_%M>:. !'L*5AV<-7!S ,T77W%A0 M*R ,K)0@M^!R#6_.@$O:4Y4A!O-V!$ORI;P2&!!VG^5EH@+J'?2]MWSP#62ZZ8D6#+!- '/(46)*VYIYABYS(B*W(-TEBX3\XYR!A<)#8-A<*N9 MS IN$"S;D=/X+H)A'P9)4,L9#H$2?%&6]EESE"\\FS,GCL9N+X9C#10=W/X2 M]=I[G#O22MK:"-K=UD9GM7O\@=<>?,?TFDL# E<4&G&ULA51=;]HP%'WG5UB9 MM"=&/J M98 $7:=U4J4*M/5AVH-);HA5QT[MF]+^^UX[(0.)LI?8OK[G^%S' MYTYWVCS9 @#9:RF5G04%8C4)0YL64'([T!4HVLFU*3G2TFQ#6QG@F0>5,DRB MZ#(LN5#!?.IC#V8^U35*H>#!,%N7)3=O2Y!Z-POB8!]8B6V!+A#.IQ7?PAKP M5_5@:!5V+)DH05FA%3.0SX)%/%F.7+Y/^"U@9P_FS%6RT?K)+>ZR61 Y02 A M1 MT/-=?,!W^UP+?&-_%AN+AE[ WU,U-A3#TQ3.%1-;\11F 3U["^8%@OGG3_%E M]/6,P%$G<'2._;_W?Q9]6MOUH'?(RA;8HVN%[EK[# M@E%)Q]<8*;ED+S5C: MX*S'D>.9L+:FN(6T-@(%6":<%R7WED+MJ7(MR=M";2=L34TCJR7T=,Y6>]8C M->0E=M>PKH]85RUK;UUP U^F M6F'CKB[:]:9%8\E_Z4UCN^=F*Y1E$G*"1H,K>JRF:1;- G7E#;K12';WTX+Z M*QB70/NYUKA?N .ZCCU_!U!+ P04 " #IA Y7%HQV"X0) #M& &0 M 'AL+W=OO0&EF4G85+?'2 M%1]5LI.9S=1F[;(G26UM[0-$@A(V),& H&7MK]]N *1(Z_#LO%@DCD8?7W=_ MH*\V0GZOUHPI\I)G174]6"M5OA^-JGC--YDE%->#&ZN]-B#O+D2MH\IW)[RS*QN1[X@V;@D:_6"@=& M-U1JV4A.>LJ+@HB&3I]6#AO[^-<+U>\)6S3=5Y)FC)4HCO M^/(IN1YXJ!#+6*Q0 H6?9W;'L@P%@1H_K,Q!>R1N[#XWTG_5MH,M2UJQ.Y%] MXXE:7P]F Y*PE-:9>A2;OS%KSQCEQ2*K]%^R,6NC<$#BNE(BMYM!@YP7YI>^ M6#]T-LR\(QL"NR'0>IN#M)8?J*(W5U)LB,35( T?M*EZ-RC'"PS*DY(PRV&? MNGE:4\DNT*Z$W(D<8EU1=-?52(%T7#.*K:1;(RDX(FE"/HM"K2ORL4A8TM\_ M JU:U8)&M=O@I,#?ZV)(0L\E@1>$)^2%K:FAEC<^:>JM-O6!;@%9BBRDI,6* MZ>=_+9:5D@"3?Q\RWL@.#\O&U'E?E31FUP/(C8K)9S:X>?>3/_$N3V@>M9I' MIZ3_7T$Z*>FPGKXW=(X=0?Y8,R?P_#EYR&A!2BF>><(J N6 J#4C*_"?XL6* MB)3P(@8_0I(1@&W\G8@2)50N*43QHZ893SE(?S4'6BC)8]7,N'8!+4'!F!LE M).96Y9R]^VD6!-[ET^*QTH_^Y?F^!%(77('DDDE=M$ K0C=4)C"6<%2_2 C[ M4?-GFF' W)MB5+:R@> <9F6]?A!8E%ON2%UM EX \8 M4B"%Y:X6UMM>4I[@@IA6:S 1O5VAST!&#@9:IZ3:I^A_6FQ1).T>HM?#?BW= MB'#>$%&71 E83V@N:K 5IF=3WXV".?$C-YA-R*$]>8)>E=090W=\VA/0FJ@E. L=7M+[ M<1Y-,B0:V)^JJM:PP0<8>T?S\I+*8\TY:@@-_0 M/9VT.?//6[]/_,"=@RNFKC\+23#VW="/&J4:OX+:%0"U"6='4G!.+D@X=;UP M2GS8.XG(A8/RP[0VMG>0]V; M:@,"1"W)W9JS%+T6UUK!^S3E,9,N620T)W]GS]OA0708RL#_"UIT4(@EP)]> M5D<*C^GX7&VMY1E%%;OX:HH85 HNH"9@XVJAY1R"5G/.DS[GWIRSL.1W6M3 HHAO^YWH@^ISXP^FX7?#QI>02I['83/5LY+6S MKTWJ)C48-(,,":Q!,RA5T^%\WJBM8;&W)X3$\'T?]H 6TVCNCV%3X).%+I2] MM2YY!C!;S#9*]!-F31.4A+42=,?1RTQ6/TP_DJ0 F>818'X^D0JMTOSB.OOE^DDC'8J1C6)")1TPA# M_8OSH>GQ6\ZRA #681" R'3=4IABX^'8Z\4R$1#%0BB(.5:1&NL21W*PYA!" MR$*:]2H'>"AASU K2X !K42A@\7T(=266]U[TEK5$F=LAI=4@0:V&I>B4A61MZ!J0'MZU;2;6M]+QL?H$]:KX'(UM"=;$@GY;T8*KET*I0Z8;)VB&Z1V/] -B7P\J6/+7FEG II(!:4) MV;0]'*(%-&L;9\S0TQ1\6P#!SDC&C(I#\FC[.])!T^(:HI.FS P;_K6H5W W MM[*QOF1+O\\>F+H:SD##LG-%VHY8;VG0_W8M^W^"\$W])6^Q,A(SAV1GCZ M\G'\#,N0&Z(,#*+7@QYW&PW.OV@>;,G2CL@U_&W'U8R?/H#W'+/G5\HE^8J! M?(NBS3TW"@--3J*P)68=%3N<#*$%=0^.MU6]208#Z[.Q.X$PG6OO'2=JIQF6 M'_CN=#;5"DUF;S KT'TRL4O[+;KA.QL.^0=7W987)=B60=QVQVR44%CX;+VO M;$1,2VG"J^48,H%E$K;3Y#]8;33!=U!;YRZJ)CPE'ZTUPHL.,6EDM"(K7?#;J(-5VBPK6MZ)U3"O:B M2.ALD>8/+1X/''CP_M:X$LS[F8PAIF%$OE'\J@7'';Q*K<6F0@)JOL+N?8/8 M-)O56HIZM=YC)Q'93Z;VXM.]%[7JF]N/O1/]N5M0 MZ$[P"C#WT!M#?Q+,?!(.)^,VVX[=9':9=^;#!1VQ?@[4<3S^:[>AF>_. D^+ MF/M[MZ%C DYF:^A&4>#.O4B;%OG1= Z#G:IQ)'&/;?O3EZ(6$>8^Y)%#7S1' MG4_0.9,K_:$=6WA=*/,UNAUMO^4OS"?LW7+SCX#/5*[P2U#&4MCJP75R8+[1 M-2]*E/J#]E(H)7+]N&84NBXN@/E4"-6\X 'M?SAN_@=02P,$% @ Z80. M5Q9[HSJ? P !0@ !D !X;"]W;W)K&ULI55M M;^,V#/Z>7T'X@$,/"&(G:7I%FP1HNPYK@6[%W=9]&/9!MNE8.UGT271S_?>C M9"=K<6DW8$ 0ZX5\^#RD1"VWY+[X&I'A6V.L7R4U7CF<)J]XC ;'&:1=Q\HLOQ!L5HO'6W!!6M!"X,H-7H+.6U#43ZSDUTM M?KS^F6Q!EAT9V=G C65TZ!FTA5O2EN$!+7<.ERE+M."3%@/R98\\>P7Y!.X$ MN/9P;4LL7_JGPG)/=;:C>CE[$_"VLQ.89V.89;/Y&WCSO?1YQ%N\@G?]M=/\ M!'?(-96B_%%TRW%C#\J6+]5[^.,B]^SD#/UY*!-]H/GA0.%>G?E6%;A*Y.)X M=(^8K-^_FYYDYV_(.-[+.'X+_7]5\$WDP[RGT\GHOX:$7^SH3KFBAFE?M3%P MC7!%3:OLD]Q(J8##$A0LLOTO&V=9!O-%_]W-?ZUQ=/L VH-$]KK$X,<$.8KW MHW):Y0:%P,!$XH?:'KU_=SJ;9>#P#2FUIRT6<(JZNH\_MU']=; MIT,#%# K/ K=CPO5>5' 4 O!(_VA-Z4MNJ"SE$05'-<&,=./YWX4FYIFC0%9 M,30D)+W>6"W RK*1H)+L[ST!10SM(C4>_",]Q*;=XQ6&(PNM$#N#QE3L6"M(X*+./-WFJN MA8%O8W[E1'5>SH:7+E!52CL_"6=/G@IR.(8M2GE$W(M#T'.>P*'+G#YKS0VZ M37R PB&64]9WZ?WJ_HV[Z%O[/^;] RDW::,E6P8K<&PO=V]R:W-H965T8AV8-FJW[,.S#6:+M6Z4[]5[JNK^^Y,E6'2#Q/M@G MWI'//22/Y&BKS6>[073PK2J5'<<;Y^J;)+'Y!BMAKW2-BDY6VE3"D6C6B:T- MBB(85662I6D_J814\604]A[-9*2]*Z7"1P/65Y4PNQF6>CN.._%AXZ-<;QQO M))-1+=;XA.ZO^M&0E+0HA:Q06:D5&%R-XVGG9G;-^D'AD\2M/?H&]F2I]6<6 M%L4X3ID0EI@[1A"T?,4[+$L&(AI?]IAQ>R4;'G\?T-\%W\F7I;!XI\N_9>$V MXW@80X$KX4OW46]_P[T_/<;+=6G#/VP;W6P00^ZMT]7>F!A44C6K^+:/PY'! M,'W%(-L;9(%W(H<03)!TF^-Y\UYMDKYGUXT,IM+-RK HOG]@E1:?ED!SZS["3@[UY= M03>]A"S-NB?PNJU_W8#7>P5OCDL'3MFTX_O3W!]+IE>GT*_?\S<=+\97*=["IZA@OWN5:Z MDGFT4/]YL^/0".O0P'LM%'Q0T8/8038,\:H98#'W1JHUB$;MG"W?OAEF67I[OYB_#Q<' MN7-[ 2NC*\:.GF93\/2F#$A"/+"&%UF?'\&U2,):R01SA-KHM1$5$8>2BQ3T M*O"7Y%?>2G6"^4@Q 0 MX2!'XZ@1-K2FWFVTD=]%TWY4 =.U0>08/8L"N]H8'(X/3C3QKRE\N:Q%&8E* M>]42;J,'TH*OF<099/WTLI>FT+T:]*!SF0U2&%ZFM)$-^=>%/RFX*^^X%H12 M7I0_\:'!MX&KR'/CFVQ3UFWP<4EDA*0SRQRH5+$M51 ,:"GE)?5Y>P-/-#X* M7V)$FJ$(%XH*KWDAT31<%%%?#9[L4!AZ7@4_DSGF6"TIM=T.G)]QSBB*WA(E M>W$3A:O.#?*XX<>Q#P4#7)#W75:XAAXOO6;I-\L ^A&Y3G-KQ>\FZY&H'?E\ M%B+S4OTF1UVU0K,.L\-"SM2;!MONMN-IVG3EG^K-;'L09BV5A1)79)I2;F(P MS;QH!*?KT*.7VE''#Y\;&K%H6('.5YJJ>"_P!>W0GOP 4$L#!!0 ( .F$ M#E&PO=V]R:W-H965T, N*I-)=VV[*TE7H! =J%:E? ^+!2::)M8X=;&>[_7O&239; MI+82+_&,/>?,&5\FL[W2#R9'M/!4"&GF7FYM>>W[)LFQ8&:@2I2TLE.Z8)9< MG?FFU,C2&E0(/PJ"L5\P+KW%K)[;ZL5,559PB5L-IBH*I@\K%&H_]T+O>>*. M9[EU$_YB5K(,[]%^+[>:/+]C27F!TG E0>-N[BW#Z]7(Q=E](!C^UG]H]U[51+S RNE?C) M4YO/O:D'*>Y8)>R=VG_"MIXKQYHO[)O8:.)!4AFKBA9,"@HNFY$]M?MP M!)@&9P!1"XAJW4VB6N6&6;:8:;4'[:*)S1EUJ36:Q''I#N7>:EKEA+.+M9*/ MJ"V/!<)79=' EAT8>3/?$KT+\I.6:M5016>HQG"KI,T-?) IIO_B?9+5:8N> MM:VBBX1?*CF 8="'*(B&%_B&7:W#FN_J#-\&8PL;;A*A3*41?BUC8S7=B]^G MBFVXAJ>YW%NY-B5+<.[18S"H']%;O'D5CH/W%Y2..J6C2^S_=RH7J4X+#8># MWMD<\$WV;IE.<@C#>N_I:W.$M2I*)@_ C:DPA665V,K QTJF?;BY6?>!P08% MVS/:6L$+;BE(T!DA;-0$E\>T!&G0$E5VY(Z#12BG@15&I54!ZE#SU) MVH#+6D*IN4QXR02P0E72@MK!:P@'XRF$TZ Q2/T]EA:+$%PJP"A+*1XT+ M$5F?S29PJF[XQ^][@)U5O$UEJ4#(AK_=)A!?Z1S/%T?T6]\ M[!3+FAN\5N6=R&VQ"&8!Y+CA36F_J?WOV,4S=GB9*HW_A7UK&Y-QUABKJLZ9 M&%1"ME_^T.7AQ&$6_<2!=0[,\VX/\BP_<,N768-UFF'405RT$^PG$!+XH:0L#'V6.^5/_ MD.CTG-B1TQ4["_A'(T>01$-@$4O.X"5]C(G'&_^?&%N(Y&4(]S0N30_]O!,]"O$PP3D>#9]CP50Y66%NLUJB!^2S' M0_C"=59 '!_E&USKAIXI)$?-!\PZG]2KHMYI=I0?<6-?OOAB"%SF\*?:M>K) M46L+'%RKJN;R ,*8!G-@;$A;D*1#-IO =)BR"_IUZ[15)>/A-!X3QU:,1ND% MC$=L#'\1V+Z-TP!U'F/I4"&W_NP-%QIVO&S0 +> G!BKC2- 3<74Z-N"-^"^ M3^3<.DN-7:,2_Q*WM>M>E["BGI@W)0X(X%EB7TCUW9'4UQ-2-X[0=T<(:DK) MJG!G/2H'-SUAX,91/2#7@.YQ0#JX++K<(0IZDY<0%RI[ZKS"=/J="A(7*.S*3,(D&ULG57?;]LV$'[W7W%0@:(%#$N6DRQ(; .)NRW;$BRHU^UAV --G22N%*F2 M5!3_]SN2LN)AJ8'UQ=:1=]]]]Y/+7IO/MD9T\-Q(95=)[5Q[E::6U]@P.],M M*KHIM6F8(]%4J6T-LB(8-3+-L^PB;9A0R7H9SA[->JD[)X7"1P.V:QIF]K8)H43N/ *COR?B&A\&3"3T:4W//X^H/\0 M8J=8=LSB1LL_1.'J57*90($EZZ3[J/L['.(Y]WA<2QM^H8^ZYWD"O+-.-X,Q M,6B$BO_L>2$\D79 M.D.W@NS<>J.;1CC*LK/ 5 $;K9Q0%2HNT"Y31RZ\8LH'N-L(EW\%[@(>"*"V M\+TJL/BW?4K41G[Y@=]M?A+PYT[-8)%-(<_RQ0F\Q1CO(N"=?TN\\$%8+K7M M#,*?-SOK##7-7Z]E(3I9O.[$#]*5;1G'54*38M$\8;)^^V9^D5V?".%L#.'L M%/K_+]E)N-?)SL]GD].INA=.5"Q,UF\U>N66J3VUYAYV2#.^^YOF#IP&B163 MT!K-$0NRCV!<,M%8<#5SP(RP"$*1A* -*=%Z *X[0\>ZA%UGB;.U,WA@BC:% MIP3"@M*.1L08$N4>6,\,3D@]TG .S8#?"RFA9D\(S%^@$40(R](3U-%K23XI M+D]46^&CFM+*L33:UC.@'6A"K'9*!($S6T-)^RQ<>OLA_!EL*7^"X^2F,AB) M_JHF#\SP&O)Y[.+IL060"AHL*'S*%3O86W@!Z(6KX4?)GO66ZE'_X@OHBT%[ M% W<(9.NYA0[W&D9$_SNT_8]W-]OX-W;-Y=YGEW?,8E:!6%^_7Y"GFS7MG+_ MD@Y:[^2='U"I7$47ZT?5+/")MG=++'WI#*U4VH/%H6)EYVA@9KX-B 1GRILH M#57'#%-N/Q3Y/^"34!?2'0&UF8(H1WD:+<50P=!6G')CRT[.OC$CU#8,8CJ@ M,KIK)_Q0NM=&,SW:K(1=A??#^MY4+B[9\71\HF[B9GY1C^\;-4$EE*5Y*,DT MFWU'*\K$-R,*3K=A3^^THZT?/FMZ9M%X!;HOM78'P3L8'^[U/U!+ P04 M" #IA Y747JMI2,$ !Z"0 &0 'AL+W=O+F:F]DIKO+;FZ+(7= M7;$RVWE_U-]//,AUXZ+>?^L3SFO1*W\@]G^RFT\IP$O,\K%7]HVMN/3/F6U M\Z9LG<&@E+KY%R]M'@XT#@YH31)QQ_@C;M QQ'O]!V\$)8CH7-Z M0L360Z]>LJ._+I<.X6?^[V-!-YCCXYBA8]]$1CNV&^XO/GT;3Y.(# MQI..\>0C]/]0F@]QCK,<30>]XQO0[P5CJ:R$WGW^=):.OEPXM-^&=8UT"3/+N?1D0Y6QZJ3S5%F)TUBB*,% N.(D M_A)_J^5&J(B.KNG!Z)F]6"H$PUEM9>B> 5T'VZ50X-2J(]P$H;M MB@6L62 M@U\I_D$ZG@:/@^^BD+YN.(;V#!B8K,&5EKN8O5MDV,+VAA&<]+V[L!QVI&MC M*]-$2#^%'*7)Q>W-W742\"A;4?4+6$QO2URU#O-4-MPY1(12@+S&/\'A^\U[#S;IDE\89E;&0V".*@5!_K)D39!C15;R:"' M/.I=3QGG@()07 A79)FIM?_.>QDN7QA& %+,-[PH6!-+G,B.%9ORHUY+O=R7EXA-,"TS&*0\4,Z-A!.SRX M#]&JZWCK.XK!-U=C-]L]+"Z;^_35O'F5H*@HBB/%*[@F@R^X7VQSTS! M @ MP4 !D !X;"]W;W)K&ULE51=;]HP%'WG M5UC9M"=$0H"VZ@ )VDU;I6ZHW8>T:0].H+]G7. M.?=!%( M2L9IDIS%B@L=S:?A;(7SJ:F=%!I6R&RM%,?]$J39S:)A]'1P)S:E\P?Q?%KQ M#=R#^UZMD**X4RF$ FV%T0QA/8L6P\OEV.,#X(> G3W8,U])9LR##SX7LRCQ MAD!"[KP"IV4+5R"E%R(;?UO-J$OIB8?[)_6/H7:J)>,6KHS\*0I7SJ*+B!6P MYK5T=V;W"=IZ)EXO-]*&7[9KL","Y[5U1K5D$B>8&0MH0T M^&X2!9?7W/'Y%,V.H4>3FM^$4@.;S GM'^7>(7T5Q'/S.Y#<0<%6'-V>?4.N M+0_W9:>Q(WV/BO-6:]EHI2]HG;%;HUUIV0==0/&<'Y.OSESZ9&Z9GA2\J?6 MC9(^2Y-T=$)OU!4["GJ35Q?+?B\RZY"B/\?J;F1'QV5]WUS:BN&ULC55-;^,V$+W[5Q JT)-A.7(V35/;0))NL5D@1;!!VT/1 M TV-+&XHCI8PCK)7;DK(>' MH&+7-#J\W(##_2H[RUX7OMAM3;*0KY>MWL(CT!_M0^!9/J*4M@$?+7H5H%IE MUV=7-^=BGPS^M+"/!V,E2C:(3S*Y*U?97 B! T."H/FW@UMP3H"8QK:3 NY;]:/W8;2)\Z\"3^KCC;USFQ+"RF9L!XJ:'*-Z!N%#WZ*F. MZJ,OH3SVSYG.R*EXY713G 3\W/F96LRGJI@7BQ-XBU'C(N%]^%Z-ZN_K3:3 M-^*?M^3V:(NWT:1*KF*K#:PR+H,(80?9^LCYR/3^%_GWG<1KB M['(V^;_D>^VYR+B<:(*5HAK4+3:M]B^JUE&U$*3 H52:2VTGU<16T+MJ7RK. MEH\Z55)4:$P7@O5;I2N"D- ,\NG[R @\BNALJ8DG&^VT-Z#Z#B-KBI#+AMWX M-L/$)BX!U%X^0B=VIGZ-C.$X<&!-M@]2MM M:H>M\]A-WA="WYG["-%,[W"!Q(^4&1+8DRQ%38Y8^VOOZ>J^HL2AW8,7""Q+8G=7=U==>I4=35_O#?M)[O1 MNE.?MW5C?WJTZ;K=BR=/;+'1V]R>FIUN\,O*M-N\P\=V_<3N6IV7W&A;/UF< MG5T^V>95\^CEC_S=N_;ECZ;OZJK1[UIE^^TV;_>O=&WN?WHT?^2_>%^M-QU] M\>3EC[M\K6]U]W'WKL6G)Z&7LMKJQE:F4:U>_?3H>O[BU>*<&O 3_ZGTO4W^ MK6@J2V,^T8?7Y4^/SD@B7>NBHRYR_'6G;W1=4T^0XT_7Z:,P)C5,_^U[_X4G MC\DL_RES^VYEZU]#1ZHW_P M5+DUA*L:VI7;KL6O%=IU+V^K=5.MJB)O.G5=%*9ONJI9JW>FKHI*6Y4WI?J' M[2K,'Y\>^^^___%)A]&ICR>%&^F5C+1X8*1+]=8TW<:J?S2E+H?MGT#J(/K" MB_YJ,=GAO_OF5)V?S=3B;'$^T=]Y6(IS[N_B@?[&IO\_UTO;M5"=_QV;L/1W M/MX?V=,+N\L+_=,C&(S5[9U^]/+O?YM?GOTP(>W3(.W3J=Y??K1:F57%%5> M*]OA"YAO9U75T$.$(%6WAWYW&_7/Z^MW,.H_^PHC0Y\;( ]K#J#3Y^TTD$ MTL#< C5V-+[-NDW>J7RU@EFS)/F6=LVBMYUI208,]U:M/"&-(YBV U\J:T["MKEG^N[SNW;=AT(P>6.55R[^R7M2F M69_4 #P66 .Y8=Y=CVEC?""6Q0A]7:JRPDJV:M6:+:]:F.NIFE#2BZ"D%Y-* M>I/;S9AB3K8:5TSJ2M$?665Y==J*U@E3+>@7;/HR;S[)%FT Q?5>U17TJ^2E MMQUO-.T#[1AM\?];2'.K>5FMH3 VM[/J6 M])<-H-4ZVPJ<8;]K;3&P5?=P+O1W,B()A@?U'AVTG^!E5WU3BI;<;ZIB(ZJ: MMRVKG>BRRG>[UGQV.A?W%1J#S86%4!N[@;9[J0!5F1@FU#49?7(3+\,F7DYN MXEL6/%_66MWJP@TWMJN3W8SO:NP[BWTSYMR(,:JBAO["0^'KJK-N%5D8&QM@ MS3>Z+D\Z<^+W:>;6UYOHV';S)A_N,/6'M5SCT4ZW!#>-;+B2#?>HD [?RAY6 M9&U=:HE.C3 -=+.FO4E_;75AVI)-E'2M;S!F7?T77ZS!I]3CVEC[/=ID#L\B MB@7L(E%!T02"*2"WS"(L\B8ON=W*$*:0)CZXSA@! MCE<'Q\L&][,N]'8)'#F?\[>+%^H6_+'L:_8FHQJ4A6[2UAGW25UDXZT^-A4M MP&W'QG&PH8_)0'[1R[8'PU2+_6=.L'_3Y\OOJ+Y-9"E5HMGONT)_OZ* M9CR;^45L]71V?O7TJQH"JN9!U/GB&?W_-8+V:_!#-3_S39]>7=#_V0?309V_ M4Y?S!?Z\F%V<74WAP+. \\F<<#Q(ZO>8[^J.]J8F6IT-P8%DSV-0X'O/COH M7GUH\U)GWI62T;B?V>[8$MCL(AG@?WK=UI]WH J6_P'HL>XLM M@)/2S5W5FH:1@V1-%NKO?[M:S)_] "2M$'6T" EJ7CN@&@0^5>_\9.S1;&PV M/AT2*&

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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 80 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 81 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 170 320 1 true 60 0 false 6 false false R1.htm 00000001 - Document - Cover Sheet http://nexgel.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://nexgel.com/role/BalanceSheets Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://nexgel.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://nexgel.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Description of Business, Stock Split and Basis of Presentation Sheet http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentation Description of Business, Stock Split and Basis of Presentation Notes 7 false false R8.htm 00000008 - Disclosure - Going Concern Sheet http://nexgel.com/role/GoingConcern Going Concern Notes 8 false false R9.htm 00000009 - Disclosure - Significant Accounting Policies and Estimates Sheet http://nexgel.com/role/SignificantAccountingPoliciesAndEstimates Significant Accounting Policies and Estimates Notes 9 false false R10.htm 00000010 - Disclosure - Leases Sheet http://nexgel.com/role/Leases Leases Notes 10 false false R11.htm 00000011 - Disclosure - Inventory Sheet http://nexgel.com/role/Inventory Inventory Notes 11 false false R12.htm 00000012 - Disclosure - Property and Equipment, Net Sheet http://nexgel.com/role/PropertyAndEquipmentNet Property and Equipment, Net Notes 12 false false R13.htm 00000013 - Disclosure - Intangible Assets Sheet http://nexgel.com/role/IntangibleAssets Intangible Assets Notes 13 false false R14.htm 00000014 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://nexgel.com/role/AccruedExpensesAndOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 14 false false R15.htm 00000015 - Disclosure - Common Stock Sheet http://nexgel.com/role/CommonStock Common Stock Notes 15 false false R16.htm 00000016 - Disclosure - Share-based Compensation Sheet http://nexgel.com/role/Share-basedCompensation Share-based Compensation Notes 16 false false R17.htm 00000017 - Disclosure - Noncontrolling Interest in Joint Venture Sheet http://nexgel.com/role/NoncontrollingInterestInJointVenture Noncontrolling Interest in Joint Venture Notes 17 false false R18.htm 00000018 - Disclosure - Notes Payable Notes http://nexgel.com/role/NotesPayable Notes Payable Notes 18 false false R19.htm 00000019 - Disclosure - Convertible Notes Payable Notes http://nexgel.com/role/ConvertibleNotesPayable Convertible Notes Payable Notes 19 false false R20.htm 00000020 - Disclosure - Warrant Liability Sheet http://nexgel.com/role/WarrantLiability Warrant Liability Notes 20 false false R21.htm 00000021 - Disclosure - Commitments and Contingencies Sheet http://nexgel.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 21 false false R22.htm 00000022 - Disclosure - Concentrations of Risk Sheet http://nexgel.com/role/ConcentrationsOfRisk Concentrations of Risk Notes 22 false false R23.htm 00000023 - Disclosure - Related Party Transactions Sheet http://nexgel.com/role/RelatedPartyTransactions Related Party Transactions Notes 23 false false R24.htm 00000024 - Disclosure - Subsequent Events Sheet http://nexgel.com/role/SubsequentEvents Subsequent Events Notes 24 false false R25.htm 00000025 - Disclosure - Significant Accounting Policies and Estimates (Policies) Sheet http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies Significant Accounting Policies and Estimates (Policies) Policies http://nexgel.com/role/SignificantAccountingPoliciesAndEstimates 25 false false R26.htm 00000026 - Disclosure - Significant Accounting Policies and Estimates (Tables) Sheet http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesTables Significant Accounting Policies and Estimates (Tables) Tables http://nexgel.com/role/SignificantAccountingPoliciesAndEstimates 26 false false R27.htm 00000027 - Disclosure - Leases (Tables) Sheet http://nexgel.com/role/LeasesTables Leases (Tables) Tables http://nexgel.com/role/Leases 27 false false R28.htm 00000028 - Disclosure - Inventory (Tables) Sheet http://nexgel.com/role/InventoryTables Inventory (Tables) Tables http://nexgel.com/role/Inventory 28 false false R29.htm 00000029 - Disclosure - Property and Equipment, Net (Tables) Sheet http://nexgel.com/role/PropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://nexgel.com/role/PropertyAndEquipmentNet 29 false false R30.htm 00000030 - Disclosure - Intangible Assets (Tables) Sheet http://nexgel.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://nexgel.com/role/IntangibleAssets 30 false false R31.htm 00000031 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://nexgel.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://nexgel.com/role/AccruedExpensesAndOtherCurrentLiabilities 31 false false R32.htm 00000032 - Disclosure - Common Stock (Tables) Sheet http://nexgel.com/role/CommonStockTables Common Stock (Tables) Tables http://nexgel.com/role/CommonStock 32 false false R33.htm 00000033 - Disclosure - Share-based Compensation (Tables) Sheet http://nexgel.com/role/Share-basedCompensationTables Share-based Compensation (Tables) Tables http://nexgel.com/role/Share-basedCompensation 33 false false R34.htm 00000034 - Disclosure - Notes Payable (Tables) Notes http://nexgel.com/role/NotesPayableTables Notes Payable (Tables) Tables http://nexgel.com/role/NotesPayable 34 false false R35.htm 00000035 - Disclosure - Warrant Liability (Tables) Sheet http://nexgel.com/role/WarrantLiabilityTables Warrant Liability (Tables) Tables http://nexgel.com/role/WarrantLiability 35 false false R36.htm 00000036 - Disclosure - Description of Business, Stock Split and Basis of Presentation (Details Narrative) Sheet http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentationDetailsNarrative Description of Business, Stock Split and Basis of Presentation (Details Narrative) Details http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentation 36 false false R37.htm 00000037 - Disclosure - Going Concern (Details Narrative) Sheet http://nexgel.com/role/GoingConcernDetailsNarrative Going Concern (Details Narrative) Details http://nexgel.com/role/GoingConcern 37 false false R38.htm 00000038 - Disclosure - Schedule of Marketable Securities (Details) Sheet http://nexgel.com/role/ScheduleOfMarketableSecuritiesDetails Schedule of Marketable Securities (Details) Details 38 false false R39.htm 00000039 - Disclosure - Schedule of Fair Value of Financial Assets (Details) Sheet http://nexgel.com/role/ScheduleOfFairValueOfFinancialAssetsDetails Schedule of Fair Value of Financial Assets (Details) Details 39 false false R40.htm 00000040 - Disclosure - Schedule of Disaggregated Revenue by Sales Type (Details) Sheet http://nexgel.com/role/ScheduleOfDisaggregatedRevenueBySalesTypeDetails Schedule of Disaggregated Revenue by Sales Type (Details) Details 40 false false R41.htm 00000041 - Disclosure - Significant Accounting Policies and Estimates (Details Narrative) Sheet http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesDetailsNarrative Significant Accounting Policies and Estimates (Details Narrative) Details http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesTables 41 false false R42.htm 00000042 - Disclosure - Schedule of Future Minimum Lease Payments (Details) Sheet http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails Schedule of Future Minimum Lease Payments (Details) Details 42 false false R43.htm 00000043 - Disclosure - Schedule of Supplemental Cash Flows Information Related to Leases (Details) Sheet http://nexgel.com/role/ScheduleOfSupplementalCashFlowsInformationRelatedToLeasesDetails Schedule of Supplemental Cash Flows Information Related to Leases (Details) Details 43 false false R44.htm 00000044 - Disclosure - Leases (Details Narrative) Sheet http://nexgel.com/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://nexgel.com/role/LeasesTables 44 false false R45.htm 00000045 - Disclosure - Schedule of Inventory (Details) Sheet http://nexgel.com/role/ScheduleOfInventoryDetails Schedule of Inventory (Details) Details 45 false false R46.htm 00000046 - Disclosure - Schedule of Property and Equipment (Details) Sheet http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails Schedule of Property and Equipment (Details) Details 46 false false R47.htm 00000047 - Disclosure - Property and Equipment, Net (Details Narrative) Sheet http://nexgel.com/role/PropertyAndEquipmentNetDetailsNarrative Property and Equipment, Net (Details Narrative) Details http://nexgel.com/role/PropertyAndEquipmentNetTables 47 false false R48.htm 00000048 - Disclosure - Schedule of Breakdown of Identifiable Intangible Assets (Details) Sheet http://nexgel.com/role/ScheduleOfBreakdownOfIdentifiableIntangibleAssetsDetails Schedule of Breakdown of Identifiable Intangible Assets (Details) Details 48 false false R49.htm 00000049 - Disclosure - Schedule of Estimated Annual Amortization Expense (Details) Sheet http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails Schedule of Estimated Annual Amortization Expense (Details) Details 49 false false R50.htm 00000050 - Disclosure - Intangible Assets (Details Narrative) Sheet http://nexgel.com/role/IntangibleAssetsDetailsNarrative Intangible Assets (Details Narrative) Details http://nexgel.com/role/IntangibleAssetsTables 50 false false R51.htm 00000051 - Disclosure - Schedule of Accrued Expenses and Other Current Liabilities (Details) Sheet http://nexgel.com/role/ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails Schedule of Accrued Expenses and Other Current Liabilities (Details) Details 51 false false R52.htm 00000052 - Disclosure - Schedule of Reserved Common Stock For Issued Securities in Relation (Details) Sheet http://nexgel.com/role/ScheduleOfReservedCommonStockForIssuedSecuritiesInRelationDetails Schedule of Reserved Common Stock For Issued Securities in Relation (Details) Details 52 false false R53.htm 00000053 - Disclosure - Schedule of Information about Incentive Plan (Details) Sheet http://nexgel.com/role/ScheduleOfInformationAboutIncentivePlanDetails Schedule of Information about Incentive Plan (Details) Details 53 false false R54.htm 00000054 - Disclosure - Schedule of Incentive Stock Option Activity (Details) Sheet http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails Schedule of Incentive Stock Option Activity (Details) Details 54 false false R55.htm 00000055 - Disclosure - Schedule of Assumptions used in Share-based Compensation (Details) Sheet http://nexgel.com/role/ScheduleOfAssumptionsUsedInShare-basedCompensationDetails Schedule of Assumptions used in Share-based Compensation (Details) Details 55 false false R56.htm 00000056 - Disclosure - Schedule of Restricted Stock Units Granted (Details) Sheet http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails Schedule of Restricted Stock Units Granted (Details) Details 56 false false R57.htm 00000057 - Disclosure - Summary of Common Stock Warrants (Details) Sheet http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails Summary of Common Stock Warrants (Details) Details 57 false false R58.htm 00000058 - Disclosure - Share-based Compensation (Details Narrative) Sheet http://nexgel.com/role/Share-basedCompensationDetailsNarrative Share-based Compensation (Details Narrative) Details http://nexgel.com/role/Share-basedCompensationTables 58 false false R59.htm 00000059 - Disclosure - Noncontrolling Interest in Joint Venture (Details Narrative) Sheet http://nexgel.com/role/NoncontrollingInterestInJointVentureDetailsNarrative Noncontrolling Interest in Joint Venture (Details Narrative) Details http://nexgel.com/role/NoncontrollingInterestInJointVenture 59 false false R60.htm 00000060 - Disclosure - Schedule of Debt Instruments (Details) Sheet http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails Schedule of Debt Instruments (Details) Details 60 false false R61.htm 00000061 - Disclosure - Notes Payable (Details Narrative) Notes http://nexgel.com/role/NotesPayableDetailsNarrative Notes Payable (Details Narrative) Details http://nexgel.com/role/NotesPayableTables 61 false false R62.htm 00000062 - Disclosure - Convertible Notes Payable (Details Narrative) Notes http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative Convertible Notes Payable (Details Narrative) Details http://nexgel.com/role/ConvertibleNotesPayable 62 false false R63.htm 00000063 - Disclosure - Schedule of Warrant Liability (Details) Sheet http://nexgel.com/role/ScheduleOfWarrantLiabilityDetails Schedule of Warrant Liability (Details) Details 63 false false R64.htm 00000064 - Disclosure - Warrant Liability (Details Narrative) Sheet http://nexgel.com/role/WarrantLiabilityDetailsNarrative Warrant Liability (Details Narrative) Details http://nexgel.com/role/WarrantLiabilityTables 64 false false R65.htm 00000065 - Disclosure - Concentrations of Risk (Details Narrative) Sheet http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative Concentrations of Risk (Details Narrative) Details http://nexgel.com/role/ConcentrationsOfRisk 65 false false R66.htm 00000066 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://nexgel.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://nexgel.com/role/RelatedPartyTransactions 66 false false All Reports Book All Reports form10-q.htm ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm nxgl-20230630.xsd nxgl-20230630_cal.xml nxgl-20230630_def.xml nxgl-20230630_lab.xml nxgl-20230630_pre.xml http://fasb.org/srt/2023 http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 83 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 20, "baseTaxonomies": { "http://fasb.org/srt/2023": 1, "http://fasb.org/us-gaap/2023": 606, "http://xbrl.sec.gov/dei/2023": 34 }, "contextCount": 170, "dts": { "calculationLink": { "local": [ "nxgl-20230630_cal.xml" ] }, "definitionLink": { "local": [ "nxgl-20230630_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "nxgl-20230630_lab.xml" ] }, "presentationLink": { "local": [ "nxgl-20230630_pre.xml" ] }, "schema": { "local": [ "nxgl-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 503, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 79, "http://nexgel.com/20230630": 18, "http://xbrl.sec.gov/dei/2023": 4, "total": 101 }, "keyCustom": 50, "keyStandard": 270, "memberCustom": 30, "memberStandard": 28, "nsprefix": "NXGL", "nsuri": "http://nexgel.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://nexgel.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Leases", "menuCat": "Notes", "order": "10", "role": "http://nexgel.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Inventory", "menuCat": "Notes", "order": "11", "role": "http://nexgel.com/role/Inventory", "shortName": "Inventory", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Property and Equipment, Net", "menuCat": "Notes", "order": "12", "role": "http://nexgel.com/role/PropertyAndEquipmentNet", "shortName": "Property and Equipment, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Intangible Assets", "menuCat": "Notes", "order": "13", "role": "http://nexgel.com/role/IntangibleAssets", "shortName": "Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Accrued Expenses and Other Current Liabilities", "menuCat": "Notes", "order": "14", "role": "http://nexgel.com/role/AccruedExpensesAndOtherCurrentLiabilities", "shortName": "Accrued Expenses and Other Current Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Common Stock", "menuCat": "Notes", "order": "15", "role": "http://nexgel.com/role/CommonStock", "shortName": "Common Stock", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Share-based Compensation", "menuCat": "Notes", "order": "16", "role": "http://nexgel.com/role/Share-basedCompensation", "shortName": "Share-based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Noncontrolling Interest in Joint Venture", "menuCat": "Notes", "order": "17", "role": "http://nexgel.com/role/NoncontrollingInterestInJointVenture", "shortName": "Noncontrolling Interest in Joint Venture", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Notes Payable", "menuCat": "Notes", "order": "18", "role": "http://nexgel.com/role/NotesPayable", "shortName": "Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Convertible Notes Payable", "menuCat": "Notes", "order": "19", "role": "http://nexgel.com/role/ConvertibleNotesPayable", "shortName": "Convertible Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)", "menuCat": "Statements", "order": "2", "role": "http://nexgel.com/role/BalanceSheets", "shortName": "Condensed Consolidated Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "NXGL:WarrantsLiabilityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Warrant Liability", "menuCat": "Notes", "order": "20", "role": "http://nexgel.com/role/WarrantLiability", "shortName": "Warrant Liability", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "NXGL:WarrantsLiabilityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "21", "role": "http://nexgel.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Concentrations of Risk", "menuCat": "Notes", "order": "22", "role": "http://nexgel.com/role/ConcentrationsOfRisk", "shortName": "Concentrations of Risk", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "23", "role": "http://nexgel.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "24", "role": "http://nexgel.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Significant Accounting Policies and Estimates (Policies)", "menuCat": "Policies", "order": "25", "role": "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies", "shortName": "Significant Accounting Policies and Estimates (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:MarketableSecuritiesPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Significant Accounting Policies and Estimates (Tables)", "menuCat": "Tables", "order": "26", "role": "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesTables", "shortName": "Significant Accounting Policies and Estimates (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:MarketableSecuritiesPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Leases (Tables)", "menuCat": "Tables", "order": "27", "role": "http://nexgel.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Inventory (Tables)", "menuCat": "Tables", "order": "28", "role": "http://nexgel.com/role/InventoryTables", "shortName": "Inventory (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Property and Equipment, Net (Tables)", "menuCat": "Tables", "order": "29", "role": "http://nexgel.com/role/PropertyAndEquipmentNetTables", "shortName": "Property and Equipment, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://nexgel.com/role/BalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Intangible Assets (Tables)", "menuCat": "Tables", "order": "30", "role": "http://nexgel.com/role/IntangibleAssetsTables", "shortName": "Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)", "menuCat": "Tables", "order": "31", "role": "http://nexgel.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables", "shortName": "Accrued Expenses and Other Current Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Common Stock (Tables)", "menuCat": "Tables", "order": "32", "role": "http://nexgel.com/role/CommonStockTables", "shortName": "Common Stock (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Share-based Compensation (Tables)", "menuCat": "Tables", "order": "33", "role": "http://nexgel.com/role/Share-basedCompensationTables", "shortName": "Share-based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Notes Payable (Tables)", "menuCat": "Tables", "order": "34", "role": "http://nexgel.com/role/NotesPayableTables", "shortName": "Notes Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "NXGL:WarrantsLiabilityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "NXGL:ScheduleOfFairValueWarrantLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Warrant Liability (Tables)", "menuCat": "Tables", "order": "35", "role": "http://nexgel.com/role/WarrantLiabilityTables", "shortName": "Warrant Liability (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "NXGL:WarrantsLiabilityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "NXGL:ScheduleOfFairValueWarrantLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_JointVentureMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Description of Business, Stock Split and Basis of Presentation (Details Narrative)", "menuCat": "Details", "order": "36", "role": "http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentationDetailsNarrative", "shortName": "Description of Business, Stock Split and Basis of Presentation (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-01_custom_JointVentureMember", "decimals": "INF", "lang": null, "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Going Concern (Details Narrative)", "menuCat": "Details", "order": "37", "role": "http://nexgel.com/role/GoingConcernDetailsNarrative", "shortName": "Going Concern (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "us-gaap:MarketableSecuritiesPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:MarketableSecurities", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Schedule of Marketable Securities (Details)", "menuCat": "Details", "order": "38", "role": "http://nexgel.com/role/ScheduleOfMarketableSecuritiesDetails", "shortName": "Schedule of Marketable Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "us-gaap:MarketableSecuritiesPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_us-gaap_USTreasurySecuritiesMember_custom_FebruraryTwentyThreeTwoThousandAndTwentyThreeMember", "decimals": "-3", "lang": null, "name": "us-gaap:MarketableSecurities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "us-gaap:MarketableSecuritiesPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:MarketableSecurities", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - Schedule of Fair Value of Financial Assets (Details)", "menuCat": "Details", "order": "39", "role": "http://nexgel.com/role/ScheduleOfFairValueOfFinancialAssetsDetails", "shortName": "Schedule of Fair Value of Financial Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_us-gaap_FairValueInputsLevel1Member", "decimals": "-3", "lang": null, "name": "us-gaap:MarketableSecurities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "NXGL:RevenueFromContractManufacturing", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - Schedule of Disaggregated Revenue by Sales Type (Details)", "menuCat": "Details", "order": "40", "role": "http://nexgel.com/role/ScheduleOfDisaggregatedRevenueBySalesTypeDetails", "shortName": "Schedule of Disaggregated Revenue by Sales Type (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "NXGL:RevenueFromContractManufacturing", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - Significant Accounting Policies and Estimates (Details Narrative)", "menuCat": "Details", "order": "41", "role": "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesDetailsNarrative", "shortName": "Significant Accounting Policies and Estimates (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - Schedule of Future Minimum Lease Payments (Details)", "menuCat": "Details", "order": "42", "role": "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails", "shortName": "Schedule of Future Minimum Lease Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "NXGL:LesseeOperatingLeaseSupplementalCashFlowInformationTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - Schedule of Supplemental Cash Flows Information Related to Leases (Details)", "menuCat": "Details", "order": "43", "role": "http://nexgel.com/role/ScheduleOfSupplementalCashFlowsInformationRelatedToLeasesDetails", "shortName": "Schedule of Supplemental Cash Flows Information Related to Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "NXGL:LesseeOperatingLeaseSupplementalCashFlowInformationTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - Leases (Details Narrative)", "menuCat": "Details", "order": "44", "role": "http://nexgel.com/role/LeasesDetailsNarrative", "shortName": "Leases (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - Schedule of Inventory (Details)", "menuCat": "Details", "order": "45", "role": "http://nexgel.com/role/ScheduleOfInventoryDetails", "shortName": "Schedule of Inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - Schedule of Property and Equipment (Details)", "menuCat": "Details", "order": "46", "role": "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails", "shortName": "Schedule of Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - Property and Equipment, Net (Details Narrative)", "menuCat": "Details", "order": "47", "role": "http://nexgel.com/role/PropertyAndEquipmentNetDetailsNarrative", "shortName": "Property and Equipment, Net (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - Schedule of Breakdown of Identifiable Intangible Assets (Details)", "menuCat": "Details", "order": "48", "role": "http://nexgel.com/role/ScheduleOfBreakdownOfIdentifiableIntangibleAssetsDetails", "shortName": "Schedule of Breakdown of Identifiable Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_us-gaap_TechnologyBasedIntangibleAssetsMember", "decimals": "-3", "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - Schedule of Estimated Annual Amortization Expense (Details)", "menuCat": "Details", "order": "49", "role": "http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails", "shortName": "Schedule of Estimated Annual Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)", "menuCat": "Statements", "order": "5", "role": "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_us-gaap_RetainedEarningsMember", "decimals": "-3", "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-05-29_custom_SportDefenseLlcMember_custom_TechnologyRelatedAndCustomerRelatedIntangiblesMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - Intangible Assets (Details Narrative)", "menuCat": "Details", "order": "50", "role": "http://nexgel.com/role/IntangibleAssetsDetailsNarrative", "shortName": "Intangible Assets (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-05-29_custom_SportDefenseLlcMember_custom_TechnologyRelatedAndCustomerRelatedIntangiblesMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - Schedule of Accrued Expenses and Other Current Liabilities (Details)", "menuCat": "Details", "order": "51", "role": "http://nexgel.com/role/ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails", "shortName": "Schedule of Accrued Expenses and Other Current Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockByClassTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - Schedule of Reserved Common Stock For Issued Securities in Relation (Details)", "menuCat": "Details", "order": "52", "role": "http://nexgel.com/role/ScheduleOfReservedCommonStockForIssuedSecuritiesInRelationDetails", "shortName": "Schedule of Reserved Common Stock For Issued Securities in Relation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockByClassTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_TwoThousandAndNineteenLongTermIncentivePlanMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - Schedule of Information about Incentive Plan (Details)", "menuCat": "Details", "order": "53", "role": "http://nexgel.com/role/ScheduleOfInformationAboutIncentivePlanDetails", "shortName": "Schedule of Information about Incentive Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_TwoThousandAndNineteenLongTermIncentivePlanMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_us-gaap_StockOptionMember_custom_TwoThousandAndNineteenLongTermIncentivePlanMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - Schedule of Incentive Stock Option Activity (Details)", "menuCat": "Details", "order": "54", "role": "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails", "shortName": "Schedule of Incentive Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_us-gaap_StockOptionMember_custom_TwoThousandAndNineteenLongTermIncentivePlanMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - Schedule of Assumptions used in Share-based Compensation (Details)", "menuCat": "Details", "order": "55", "role": "http://nexgel.com/role/ScheduleOfAssumptionsUsedInShare-basedCompensationDetails", "shortName": "Schedule of Assumptions used in Share-based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - Schedule of Restricted Stock Units Granted (Details)", "menuCat": "Details", "order": "56", "role": "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails", "shortName": "Schedule of Restricted Stock Units Granted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - Summary of Common Stock Warrants (Details)", "menuCat": "Details", "order": "57", "role": "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails", "shortName": "Summary of Common Stock Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockByClassTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - Share-based Compensation (Details Narrative)", "menuCat": "Details", "order": "58", "role": "http://nexgel.com/role/Share-basedCompensationDetailsNarrative", "shortName": "Share-based Compensation (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "lang": null, "name": "NXGL:UnrecognizedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-03-012023-03-01", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - Noncontrolling Interest in Joint Venture (Details Narrative)", "menuCat": "Details", "order": "59", "role": "http://nexgel.com/role/NoncontrollingInterestInJointVentureDetailsNarrative", "shortName": "Noncontrolling Interest in Joint Venture (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-03-012023-03-01", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "menuCat": "Statements", "order": "6", "role": "http://nexgel.com/role/StatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "lang": null, "name": "NXGL:NoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - Schedule of Debt Instruments (Details)", "menuCat": "Details", "order": "60", "role": "http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails", "shortName": "Schedule of Debt Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentIncreaseAccruedInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - Notes Payable (Details Narrative)", "menuCat": "Details", "order": "61", "role": "http://nexgel.com/role/NotesPayableDetailsNarrative", "shortName": "Notes Payable (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentIncreaseAccruedInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-15", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - Convertible Notes Payable (Details Narrative)", "menuCat": "Details", "order": "62", "role": "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative", "shortName": "Convertible Notes Payable (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-09-022021-09-02_custom_SecuredConvertiblePromissoryNoteMember", "decimals": "-3", "lang": null, "name": "us-gaap:InterestExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueAdjustmentOfWarrants", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - Schedule of Warrant Liability (Details)", "menuCat": "Details", "order": "63", "role": "http://nexgel.com/role/ScheduleOfWarrantLiabilityDetails", "shortName": "Schedule of Warrant Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "NXGL:ScheduleOfFairValueWarrantLiabilityTextBlock", "NXGL:WarrantsLiabilityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_us-gaap_WarrantMember", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "span", "p", "NXGL:WarrantsLiabilityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-02_us-gaap_PrivatePlacementMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - Warrant Liability (Details Narrative)", "menuCat": "Details", "order": "64", "role": "http://nexgel.com/role/WarrantLiabilityDetailsNarrative", "shortName": "Warrant Liability (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "NXGL:WarrantsLiabilityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-02_us-gaap_PrivatePlacementMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - Concentrations of Risk (Details Narrative)", "menuCat": "Details", "order": "65", "role": "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative", "shortName": "Concentrations of Risk (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-15", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - Related Party Transactions (Details Narrative)", "menuCat": "Details", "order": "66", "role": "http://nexgel.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "Related Party Transactions (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-02_custom_Mr.SteinMember", "decimals": "INF", "lang": null, "name": "NXGL:NumberOfDebtInstruments", "reportCount": 1, "unique": true, "unitRef": "Integer", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Description of Business, Stock Split and Basis of Presentation", "menuCat": "Notes", "order": "7", "role": "http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentation", "shortName": "Description of Business, Stock Split and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Going Concern", "menuCat": "Notes", "order": "8", "role": "http://nexgel.com/role/GoingConcern", "shortName": "Going Concern", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Significant Accounting Policies and Estimates", "menuCat": "Notes", "order": "9", "role": "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimates", "shortName": "Significant Accounting Policies and Estimates", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 60, "tag": { "NXGL_AprilTwentySevenTwoThousandAndTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "April 27, 2023 [Member]", "label": "April 27, 2023 [Member]" } } }, "localname": "AprilTwentySevenTwoThousandAndTwentyThreeMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "NXGL_AuctusNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Auctus Note [Member]", "label": "Auctus Note [Member]" } } }, "localname": "AuctusNoteMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_AugustTenTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "August 10, 2023 [Member]", "label": "August 10, 2023 [Member]" } } }, "localname": "AugustTenTwoThousandTwentyThreeMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "NXGL_AwardsGrantedOutsideOfThe2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Awards Granted Outside Of The 2019 [Member]", "label": "Awards Granted Outside Of The 2019 [Member]" } } }, "localname": "AwardsGrantedOutsideOfThe2019Member", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfInformationAboutIncentivePlanDetails" ], "xbrltype": "domainItemType" }, "NXGL_AwardsGrantedOutsideOfThe2019PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Awards Granted Outside Of The 2019 Plan [Member]", "label": "Awards Granted Outside Of The 2019 Plan [Member]" } } }, "localname": "AwardsGrantedOutsideOfThe2019PlanMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfInformationAboutIncentivePlanDetails" ], "xbrltype": "domainItemType" }, "NXGL_CGConvertingAndPackagingLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CG Converting And Packaging LLC [Member]", "label": "CG Converting And Packaging LLC [Member]" } } }, "localname": "CGConvertingAndPackagingLLCMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/NoncontrollingInterestInJointVentureDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_CGLaboratoriesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CG Laboratories Inc [Member]", "label": "CG Laboratories Inc [Member]" } } }, "localname": "CGLaboratoriesIncMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/NoncontrollingInterestInJointVentureDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_CGLaboratoriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CG Laboratories [Member]", "label": "CG Laboratories [Member]" } } }, "localname": "CGLaboratoriesMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/NoncontrollingInterestInJointVentureDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_CGLabsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CG Labs [Member]", "label": "CG Labs [Member]" } } }, "localname": "CGLabsMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentationDetailsNarrative", "http://nexgel.com/role/NoncontrollingInterestInJointVentureDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_ChangeInFairValueOfWarrantLiability": { "auth_ref": [], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of warrant liability.", "label": "ChangeInFairValueOfWarrantLiability", "negatedLabel": "Changes in fair value of warrant liability" } } }, "localname": "ChangeInFairValueOfWarrantLiability", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "NXGL_ChangeInRightOfUseAssetAndOperatingLeaseLiability": { "auth_ref": [], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in right of use asset and operating lease liability.", "label": "Changes in ROU asset and operating lease liability" } } }, "localname": "ChangeInRightOfUseAssetAndOperatingLeaseLiability", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "NXGL_ClassOfWarrantOrRightOutstandingIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of vested outstanding warrants.", "label": "Intrinsic value of vested outstanding warrants" } } }, "localname": "ClassOfWarrantOrRightOutstandingIntrinsicValue", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "NXGL_CommonStockParValue0.001Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, par value 0.001 [Member]", "label": "Common Stock, par value 0.001 [Member]" } } }, "localname": "CommonStockParValue0.001Member", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "domainItemType" }, "NXGL_ContractorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractor [Member]", "label": "Contractor [Member]" } } }, "localname": "ContractorMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One [Member]", "label": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_CustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Two [Member]", "label": "Customer Two [Member]" } } }, "localname": "CustomerTwoMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_DisclosureLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases", "terseLabel": "Schedule Of Supplemental Cash Flows Information Related To Leases", "verboseLabel": "Schedule Of Future Minimum Lease Payments" } } }, "localname": "DisclosureLeasesAbstract", "nsuri": "http://nexgel.com/20230630", "xbrltype": "stringItemType" }, "NXGL_DisclosureWarrantLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Liability" } } }, "localname": "DisclosureWarrantLiabilityAbstract", "nsuri": "http://nexgel.com/20230630", "xbrltype": "stringItemType" }, "NXGL_Dr.JeromeZeldisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dr.Jerome Zeldis [Member]", "label": "Dr.Jerome Zeldis [Member]" } } }, "localname": "Dr.JeromeZeldisMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_EconomicInjuryDisasterLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Economic Injury Disaster Loan [Member]", "label": "Economic Injury Disaster Loan [Member]" } } }, "localname": "EconomicInjuryDisasterLoanMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_FairValueAdjustmentOfWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair Value Adjustment Of Warrants Shares", "label": "Change in fair value of warrant liability" } } }, "localname": "FairValueAdjustmentOfWarrantsShares", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfWarrantLiabilityDetails" ], "xbrltype": "sharesItemType" }, "NXGL_FebruraryTwentyThreeTwoThousandAndTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 23, 2023 [Member]", "label": "February 23, 2023 [Member]" } } }, "localname": "FebruraryTwentyThreeTwoThousandAndTwentyThreeMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "NXGL_FinanceLeaseLiabilityPaymentsDueAfterYearFour": { "auth_ref": [], "calculation": { "http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails": { "order": 6.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Finance lease liability payments due after year four.", "label": "FinanceLeaseLiabilityPaymentsDueAfterYearFour", "verboseLabel": "Thereafter" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFour", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "NXGL_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour": { "auth_ref": [], "calculation": { "http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finite lived intangible assets amortization expense after year four.", "label": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour", "verboseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "NXGL_JointVentureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Joint Venture [Member]", "label": "Joint Venture [Member]" } } }, "localname": "JointVentureMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentationDetailsNarrative", "http://nexgel.com/role/NoncontrollingInterestInJointVentureDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_JulyThirteenTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July 13, 2023 [Member]", "label": "July 13, 2023 [Member]" } } }, "localname": "JulyThirteenTwoThousandTwentyThreeMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "NXGL_JuneFifteenTwoThousandandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June 15, 2023 [Member]", "label": "June 15, 2023 [Member]" } } }, "localname": "JuneFifteenTwoThousandandTwentyThreeMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "NXGL_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": { "auth_ref": [], "calculation": { "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lessee operating lease liability payments due after year four.", "label": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "NXGL_LesseeOperatingLeaseSupplementalCashFlowInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of supplemental cash flows information related to leases.", "label": "Schedule of Supplemental Cash Flows Information Related to Leases" } } }, "localname": "LesseeOperatingLeaseSupplementalCashFlowInformationTableTextBlock", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "NXGL_Mr.StefanskyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mr.Stefansky [Member]", "label": "Mr.Stefansky [Member]" } } }, "localname": "Mr.StefanskyMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_Mr.SteinMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mr. Stein [Member]", "label": "Mr. Stein [Member]" } } }, "localname": "Mr.SteinMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_NoncontrollingInterest": { "auth_ref": [], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Noncontrolling interest.", "label": "Income attributable to non-controlling interest in joint venture" } } }, "localname": "NoncontrollingInterest", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "NXGL_NumberOfDebtInstruments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of debt instruments.", "label": "Number Of Debt Instruments" } } }, "localname": "NumberOfDebtInstruments", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "integerItemType" }, "NXGL_OfficersAndEmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Officers and Employees [Member", "label": "Officers and Employees [Member" } } }, "localname": "OfficersAndEmployeesMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_OneOtherCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Other Customer [Member]", "label": "One Other Customer [Member]" } } }, "localname": "OneOtherCustomerMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_OtherAssetsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Assets Policy [Policy Text Block]", "label": "Other Assets" } } }, "localname": "OtherAssetsPolicyPolicyTextBlock", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "NXGL_OutstandingPrincipalAndAccruedUnpaidInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Outstanding Principal And Accrued Unpaid Interest.", "label": "Outstanding principal and accrued unpaid interest" } } }, "localname": "OutstandingPrincipalAndAccruedUnpaidInterest", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "NXGL_PrePaymentPenalty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Pre Payment Penalty", "label": "Pre payment penalty" } } }, "localname": "PrePaymentPenalty", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "NXGL_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepaid Expenses And Other Current Assets Policy [Policy Text Block]", "label": "Prepaid Expenses and Other Current Assets" } } }, "localname": "PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "NXGL_PropertyAndEquipmentContributedAsCapitalInvestmentToJv": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Property and equipment contributed as capital investment to JV.", "label": "Property and equipment contributed as capital investment to JV" } } }, "localname": "PropertyAndEquipmentContributedAsCapitalInvestmentToJv", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "NXGL_RevenueClassifiedAsOthers": { "auth_ref": [], "calculation": { "http://nexgel.com/role/ScheduleOfDisaggregatedRevenueBySalesTypeDetails": { "order": 4.0, "parentTag": "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Revenue classified as others.", "label": "Other" } } }, "localname": "RevenueClassifiedAsOthers", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfDisaggregatedRevenueBySalesTypeDetails" ], "xbrltype": "monetaryItemType" }, "NXGL_RevenueFromConsumerProducts": { "auth_ref": [], "calculation": { "http://nexgel.com/role/ScheduleOfDisaggregatedRevenueBySalesTypeDetails": { "order": 3.0, "parentTag": "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Revenue from consumer products.", "label": "NexGel branded consumer products" } } }, "localname": "RevenueFromConsumerProducts", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfDisaggregatedRevenueBySalesTypeDetails" ], "xbrltype": "monetaryItemType" }, "NXGL_RevenueFromContractManufacturing": { "auth_ref": [], "calculation": { "http://nexgel.com/role/ScheduleOfDisaggregatedRevenueBySalesTypeDetails": { "order": 1.0, "parentTag": "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Revenue from contract manufacturing.", "label": "Contract manufacturing" } } }, "localname": "RevenueFromContractManufacturing", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfDisaggregatedRevenueBySalesTypeDetails" ], "xbrltype": "monetaryItemType" }, "NXGL_RevenueFromFinishedGoods": { "auth_ref": [], "calculation": { "http://nexgel.com/role/ScheduleOfDisaggregatedRevenueBySalesTypeDetails": { "order": 2.0, "parentTag": "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Revenue from finished goods.", "label": "Custom and white label finished goods manufacturing" } } }, "localname": "RevenueFromFinishedGoods", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfDisaggregatedRevenueBySalesTypeDetails" ], "xbrltype": "monetaryItemType" }, "NXGL_RouAssetAndOperatingLeaseLiabilitiesRecognizedUponConsolidationOfJv": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Rou asset and operating lease liabilities recognized upon consolidation of jv.", "label": "ROU asset and operating lease liabilities recognized upon consolidation of JV" } } }, "localname": "RouAssetAndOperatingLeaseLiabilitiesRecognizedUponConsolidationOfJv", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "NXGL_ScheduleOfFairValueWarrantLiabilityTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Fair Value Warrant Liability [Text Block]", "label": "Schedule of Warrant Liability" } } }, "localname": "ScheduleOfFairValueWarrantLiabilityTextBlock", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/WarrantLiabilityTables" ], "xbrltype": "textBlockItemType" }, "NXGL_SecuredConvertiblePromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Secured Convertible Promissory Note [Member]", "label": "Secured Convertible Promissory Note [Member]" } } }, "localname": "SecuredConvertiblePromissoryNoteMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNonvestedNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options exercisable non vested number.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNonvestedNumber", "periodEndLabel": "Number of units exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNonvestedNumber", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails" ], "xbrltype": "sharesItemType" }, "NXGL_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options exercises in period weighted average grant date fair value.", "label": "Weighted average grant date fair value, exercised and converted to common shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails" ], "xbrltype": "perShareItemType" }, "NXGL_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options non vested exercisable weighted average grant date fair value.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue", "periodEndLabel": "Weighted average grant date fair value exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails" ], "xbrltype": "perShareItemType" }, "NXGL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelled": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.", "label": "Number of warrants, cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelled", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "sharesItemType" }, "NXGL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested warrants outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber", "periodEndLabel": "Number of warrants, exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "sharesItemType" }, "NXGL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of warrants outstanding and currently exercisable under the warrants plan.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice", "periodEndLabel": "Weighted average exercise price, exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "perShareItemType" }, "NXGL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the warrants plan.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice", "periodEndLabel": "Weighted average exercise price, outstanding ending balance", "periodStartLabel": "Weighted average exercise price, outstanding beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "perShareItemType" }, "NXGL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award number of shares available for exercised.", "label": "Awards Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForExercised", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfInformationAboutIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "NXGL_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options cancelled in period.", "label": "Number of options, cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "NXGL_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their warrants into shares.", "label": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice", "verboseLabel": "Weighted average exercise price, exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "perShareItemType" }, "NXGL_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to warrants of the plan that expired.", "label": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice", "verboseLabel": "Weighted average exercise price, expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "perShareItemType" }, "NXGL_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to warrants that were terminated.", "label": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice", "verboseLabel": "Weighted average exercise price, forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "perShareItemType" }, "NXGL_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageCancelledPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to warrants that were terminated.", "label": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageCancelledPrice", "verboseLabel": "Weighted average exercise price, cancelled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageCancelledPrice", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "perShareItemType" }, "NXGL_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of warrants.", "label": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice", "verboseLabel": "Weighted average exercise price, granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "perShareItemType" }, "NXGL_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageCancelledPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options grants in period.", "label": "Weighted average exercise price, cancelled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageCancelledPrice", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "NXGL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term, exercisable.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm1", "verboseLabel": "Weighted average remaining contractual term, exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "durationItemType" }, "NXGL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award non options outstanding weighted average remaining contractual term 1.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1", "verboseLabel": "Weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "durationItemType" }, "NXGL_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for non option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2", "verboseLabel": "Weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "durationItemType" }, "NXGL_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options granted weighted average remaining contractual term 2.", "label": "Weighted average remaining contractual term, Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "NXGL_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term 1.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1", "verboseLabel": "Weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "NXGL_ShippingAndHandlingRevenueAndExpensePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shipping And Handling Revenue And Expense Policy [Policy Text Block]", "label": "Shipping and Handling Revenue and Expense" } } }, "localname": "ShippingAndHandlingRevenueAndExpensePolicyPolicyTextBlock", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "NXGL_SportDefenseLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sport Defense LLC [Member]", "label": "Sport Defense LLC [Member]" } } }, "localname": "SportDefenseLlcMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_StockIssuedDuringPeriodSharesStockWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares stock warrants exercised.", "label": "Exercise of stock warrants, shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockWarrantsExercised", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "NXGL_StockIssuedDuringPeriodValueStockWarrantsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value stock warrants exercised.", "label": "Exercise of warrants" } } }, "localname": "StockIssuedDuringPeriodValueStockWarrantsExercised", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "NXGL_TechnologyRelatedAndCustomerRelatedIntangiblesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Technology Related and Customer Related Intangibles [Member]", "label": "Technology Related and Customer Related Intangibles [Member]" } } }, "localname": "TechnologyRelatedAndCustomerRelatedIntangiblesMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_ThreeOtherCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Three Other Customer [Member]", "label": "Three Other Customer [Member]" } } }, "localname": "ThreeOtherCustomerMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_TwoOtherCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Other Customer [Member]", "label": "Two Other Customer [Member]" } } }, "localname": "TwoOtherCustomerMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_TwoThousandAndNineteenLongTermIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2019 Plan [Member]", "label": "2019 Plan [Member]" } } }, "localname": "TwoThousandAndNineteenLongTermIncentivePlanMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails", "http://nexgel.com/role/ScheduleOfInformationAboutIncentivePlanDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "NXGL_UnrecognizedShareBasedCompensationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unrecognized share based compensation expense.", "label": "[custom:UnrecognizedShareBasedCompensationExpense]" } } }, "localname": "UnrecognizedShareBasedCompensationExpense", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "NXGL_WarrantLiabilityCurrent": { "auth_ref": [], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant liability current.", "label": "Warrant liability" } } }, "localname": "WarrantLiabilityCurrent", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "NXGL_WarrantLiabilityPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Liability Policy [Policy Text Block]", "label": "Warrant Liability Policy [Policy Text Block]", "verboseLabel": "Warrant Liability" } } }, "localname": "WarrantLiabilityPolicyPolicyTextBlock", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "NXGL_WarrantToPurchaseCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant to purchase common stock.", "label": "Warrants to purchase common Stock" } } }, "localname": "WarrantToPurchaseCommonStock", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/ScheduleOfReservedCommonStockForIssuedSecuritiesInRelationDetails" ], "xbrltype": "sharesItemType" }, "NXGL_WarrantsLiabilityDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Liability Disclosure [Text Block]", "label": "WarrantsLiabilityDisclosureTextBlock", "verboseLabel": "Warrant Liability" } } }, "localname": "WarrantsLiabilityDisclosureTextBlock", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/WarrantLiability" ], "xbrltype": "textBlockItemType" }, "NXGL_WarrantsToPurchaseCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants to Purchase Common Stock [Member]", "label": "Warrants to Purchase Common Stock [Member]" } } }, "localname": "WarrantsToPurchaseCommonStockMember", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "domainItemType" }, "NXGL_WorkingCapitalDeficit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital deficit.", "label": "Working capital" } } }, "localname": "WorkingCapitalDeficit", "nsuri": "http://nexgel.com/20230630", "presentation": [ "http://nexgel.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r751" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r751" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r750" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r748", "r750", "r751" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r749" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r737" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r750" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r750" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r752" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r740" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r743" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r756" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r753" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r751" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r754" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r750" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r744" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r745" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r738" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r742" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r741" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r746" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r755" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r791" ], "lang": { "en-us": { "role": { "documentation": "Person with designation of chief executive officer.", "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [ "r784" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.", "label": "Schedule of Debt Instruments" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://nexgel.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "srt_ExecutiveOfficerMember": { "auth_ref": [ "r791" ], "lang": { "en-us": { "role": { "documentation": "Person with designation of executive officer.", "label": "Executive Officer [Member]" } } }, "localname": "ExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r265", "r713", "r808", "r857", "r858" ], "lang": { "en-us": { "role": { "documentation": "Information by name or description of a single external customer or a group of external customers.", "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r329", "r330", "r331", "r332", "r405", "r543", "r582", "r614", "r615", "r677", "r678", "r679", "r680", "r681", "r691", "r692", "r703", "r712", "r719", "r725", "r806", "r847", "r848", "r849", "r850", "r851", "r852" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative", "http://nexgel.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r329", "r330", "r331", "r332", "r405", "r543", "r582", "r614", "r615", "r677", "r678", "r679", "r680", "r681", "r691", "r692", "r703", "r712", "r719", "r725", "r806", "r847", "r848", "r849", "r850", "r851", "r852" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative", "http://nexgel.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r265", "r713", "r808", "r857", "r858" ], "lang": { "en-us": { "role": { "documentation": "Single external customer or group of external customers." } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentationDetailsNarrative", "http://nexgel.com/role/NoncontrollingInterestInJointVentureDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentationDetailsNarrative", "http://nexgel.com/role/NoncontrollingInterestInJointVentureDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_PlatformOperatorCryptoAssetLineItems": { "auth_ref": [ "r178" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Platform Operator, Crypto-Asset [Line Items]" } } }, "localname": "PlatformOperatorCryptoAssetLineItems", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFairValueOfFinancialAssetsDetails" ], "xbrltype": "stringItemType" }, "srt_PlatformOperatorCryptoAssetTable": { "auth_ref": [ "r178" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about crypto-asset held for platform user.", "label": "Platform Operator, Crypto-Asset [Table]" } } }, "localname": "PlatformOperatorCryptoAssetTable", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFairValueOfFinancialAssetsDetails" ], "xbrltype": "stringItemType" }, "srt_RangeAxis": { "auth_ref": [ "r329", "r330", "r331", "r332", "r397", "r405", "r436", "r437", "r438", "r519", "r543", "r582", "r614", "r615", "r677", "r678", "r679", "r680", "r681", "r691", "r692", "r703", "r712", "r719", "r725", "r728", "r802", "r806", "r848", "r849", "r850", "r851", "r852" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative", "http://nexgel.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r329", "r330", "r331", "r332", "r397", "r405", "r436", "r437", "r438", "r519", "r543", "r582", "r614", "r615", "r677", "r678", "r679", "r680", "r681", "r691", "r692", "r703", "r712", "r719", "r725", "r728", "r802", "r806", "r848", "r849", "r850", "r851", "r852" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative", "http://nexgel.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r791", "r843" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals." } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accrued Expenses and Other Current Liabilities" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/AccruedExpensesAndOtherCurrentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r26", "r724" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r689" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r266", "r267" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": { "auth_ref": [ "r31", "r79", "r696" ], "calculation": { "http://nexgel.com/role/ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Franchise tax accrual" } } }, "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "auth_ref": [], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://nexgel.com/role/ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.", "label": "Accrued expenses and other current liabilities", "totalLabel": "Total accrued expenses and other current liabilities" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets", "http://nexgel.com/role/ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r63", "r186", "r573" ], "calculation": { "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Expected life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r111", "r724", "r860" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r444", "r445", "r446", "r601", "r786", "r787", "r788", "r839", "r862" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r77", "r78", "r408" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r194", "r270", "r307", "r310", "r311", "r856" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r364", "r493", "r710", "r711", "r780" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of deferred financing costs" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r5", "r56", "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r5", "r61" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset impairment charges" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r151", "r190", "r216", "r243", "r257", "r261", "r303", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r466", "r470", "r485", "r564", "r637", "r724", "r736", "r804", "r805", "r845" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS:" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r182", "r197", "r216", "r303", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r466", "r470", "r485", "r724", "r804", "r805", "r845" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r834" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r834" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r411", "r412", "r413", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r435", "r436", "r437", "r438", "r439" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails", "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r463", "r717", "r718" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentationDetailsNarrative", "http://nexgel.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r80", "r82", "r463", "r717", "r718" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentationDetailsNarrative", "http://nexgel.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Acquisition percentage" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentationDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r83", "r84" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Intangibles" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r164", "r566", "r612", "r632", "r724", "r736", "r769" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets", "http://nexgel.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r41", "r128", "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash\u2009\u2013\u2009End of period", "periodStartLabel": "Cash\u2009\u2013\u2009Beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r3", "r128" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net Decrease in Cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC insured amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Non-cash Investing and Financing activities" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashUninsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.", "label": "Cash, exceeding" } } }, "localname": "CashUninsuredAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r177", "r191", "r192", "r193", "r216", "r233", "r234", "r236", "r238", "r241", "r242", "r303", "r333", "r335", "r336", "r337", "r340", "r341", "r371", "r372", "r374", "r377", "r384", "r485", "r591", "r592", "r593", "r594", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r613", "r624", "r646", "r669", "r682", "r683", "r684", "r685", "r686", "r758", "r781", "r789" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Exercise price", "negatedPeriodEndLabel": "Exercise of wararnts" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfWarrantLiabilityDetails", "http://nexgel.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "negatedPeriodEndLabel": "Number of warrants, exercised" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfWarrantLiabilityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Warrants outstanding", "periodEndLabel": "Warrants outstanding", "periodStartLabel": "Warrants outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfWarrantLiabilityDetails", "http://nexgel.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r35", "r100", "r565", "r623" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies (Note 15)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r140", "r327", "r328", "r690", "r803" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Awards Reserved For Issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfInformationAboutIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r726", "r727", "r728", "r730", "r731", "r732", "r733", "r786", "r787", "r839", "r859", "r862" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r110", "r624" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r12", "r110", "r624", "r643", "r862", "r863" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r110", "r568", "r724" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, par value $0.001 per share, 25,000,000 shares authorized; 5,696,064 and 5,577,916 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r46", "r48", "r92", "r93", "r265", "r689" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r46", "r48", "r92", "r93", "r265", "r588", "r689" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r46", "r48", "r92", "r93", "r265", "r689", "r761" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentrations of Risk" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRisk" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [ "r689" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r46", "r48", "r92", "r93", "r265" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r45", "r46", "r48", "r49", "r92", "r150", "r689" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r46", "r48", "r92", "r93", "r265", "r689" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]" } } }, "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": { "auth_ref": [ "r11", "r91" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.", "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]" } } }, "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r122", "r216", "r303", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r485", "r804" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of revenues" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r47", "r265" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelatedIntangibleAssetsMember": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.", "label": "Customer-Related Intangible Assets [Member]" } } }, "localname": "CustomerRelatedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfBreakdownOfIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r141", "r214", "r342", "r348", "r349", "r350", "r351", "r352", "r353", "r358", "r365", "r366", "r368" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Notes Payable" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/NotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r23", "r107", "r108", "r152", "r153", "r217", "r343", "r344", "r345", "r346", "r347", "r349", "r354", "r355", "r356", "r357", "r359", "r360", "r361", "r362", "r363", "r364", "r494", "r707", "r708", "r709", "r710", "r711", "r782" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative", "http://nexgel.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r95", "r97", "r343", "r494", "r708", "r709" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Principal amount of debt", "verboseLabel": "Debt instrument face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative", "http://nexgel.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r782" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Accrued interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r33", "r344" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r34", "r217", "r343", "r344", "r345", "r346", "r347", "r349", "r354", "r355", "r356", "r357", "r359", "r360", "r361", "r362", "r363", "r364", "r494", "r707", "r708", "r709", "r710", "r711", "r782" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative", "http://nexgel.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPayment": { "auth_ref": [ "r34", "r103" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments including both interest and principal payments.", "label": "DebtInstrument periodic payment" } } }, "localname": "DebtInstrumentPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentPeriodicPaymentInterest": { "auth_ref": [ "r34" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments applied to interest.", "label": "Debt Instrument, Periodic Payment, Interest" } } }, "localname": "DebtInstrumentPeriodicPaymentInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r94", "r97", "r807" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Unamortized debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": { "auth_ref": [ "r798" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]" } } }, "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": { "auth_ref": [ "r798" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]" } } }, "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r5", "r62" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/PropertyAndEquipmentNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r5", "r247" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r808" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Schedule of Disaggregated Revenue by Sales Type" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r406", "r410", "r440", "r441", "r443", "r720" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "auth_ref": [ "r8", "r75" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of share-based payment arrangement.", "label": "Schedule of Information about Incentive Plan" } } }, "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r205", "r223", "r224", "r225", "r226", "r227", "r231", "r233", "r236", "r237", "r238", "r239", "r481", "r482", "r561", "r580", "r699" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net loss per common share - basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r205", "r223", "r224", "r225", "r226", "r227", "r233", "r236", "r237", "r238", "r239", "r481", "r482", "r561", "r580", "r699" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Net loss per common share - diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r31" ], "calculation": { "http://nexgel.com/role/ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Salaries, benefits, and incentive compensation" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Period of recognition of stock based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r835" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Unrecognized share-based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r12", "r179", "r201", "r202", "r203", "r218", "r219", "r220", "r222", "r228", "r230", "r240", "r305", "r306", "r386", "r444", "r445", "r446", "r460", "r461", "r472", "r473", "r474", "r475", "r476", "r477", "r480", "r486", "r487", "r488", "r489", "r490", "r491", "r504", "r583", "r584", "r585", "r601", "r669" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://nexgel.com/role/ScheduleOfWarrantLiabilityDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r175", "r302", "r304", "r759" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Noncontrolling Interest in Joint Venture" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/NoncontrollingInterestInJointVenture" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r2", "r5" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Changes in fair value of warrant liability and warrant modification", "verboseLabel": "Change in fair value of warrant liability" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfWarrantLiabilityDetails", "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r356", "r398", "r399", "r400", "r401", "r402", "r403", "r484", "r516", "r517", "r518", "r708", "r709", "r714", "r715", "r716" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFairValueOfFinancialAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r356", "r398", "r403", "r484", "r516", "r714", "r715", "r716" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFairValueOfFinancialAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r356", "r398", "r403", "r484", "r517", "r708", "r709", "r714", "r715", "r716" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFairValueOfFinancialAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r356", "r398", "r399", "r400", "r401", "r402", "r403", "r484", "r518", "r708", "r709", "r714", "r715", "r716" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFairValueOfFinancialAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r356", "r398", "r399", "r400", "r401", "r402", "r403", "r516", "r517", "r518", "r708", "r709", "r714", "r715", "r716" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFairValueOfFinancialAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r308", "r309", "r312", "r313", "r314", "r315", "r316", "r317", "r367", "r382", "r478", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r579", "r704", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r793", "r794", "r795", "r796" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFairValueOfFinancialAssetsDetails", "http://nexgel.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r188", "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfBreakdownOfIdentifiableIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r136" ], "calculation": { "http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "verboseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "verboseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r136" ], "calculation": { "http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "verboseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r136" ], "calculation": { "http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "verboseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r136" ], "calculation": { "http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "verboseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r323", "r324", "r325", "r326", "r546", "r547" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/IntangibleAssetsDetailsNarrative", "http://nexgel.com/role/ScheduleOfBreakdownOfIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r135", "r547" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Identifiable intangible assets, gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfBreakdownOfIdentifiableIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/IntangibleAssetsDetailsNarrative", "http://nexgel.com/role/ScheduleOfBreakdownOfIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r57", "r59" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/IntangibleAssetsDetailsNarrative", "http://nexgel.com/role/ScheduleOfBreakdownOfIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r135", "r546" ], "calculation": { "http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Total", "verboseLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfBreakdownOfIdentifiableIntangibleAssetsDetails", "http://nexgel.com/role/ScheduleOfEstimatedAnnualAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r125", "r757" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Gain on investments" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r5", "r64", "r65" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 }, "http://nexgel.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Loss on debt extinguishment", "negatedLabel": "Loss on extinguishment of debt", "verboseLabel": "Gains loss on extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations", "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative", "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r187", "r321", "r560", "r706", "r724", "r800", "r801" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r9", "r54" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r121", "r216", "r243", "r256", "r260", "r262", "r303", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r485", "r701", "r804" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r0", "r139" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r1", "r119", "r156", "r243", "r256", "r260", "r262", "r562", "r575", "r701" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r163", "r174", "r229", "r230", "r248", "r455", "r462", "r581" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r200", "r453", "r454", "r456", "r457", "r458", "r459", "r590" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r43" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r4" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r4" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r779" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "verboseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r4" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r4" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r55", "r58" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangibles, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r96", "r158", "r204", "r246", "r492", "r654", "r734", "r861" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations", "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r207", "r210", "r211" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryAdjustments": { "auth_ref": [ "r53", "r774" ], "calculation": { "http://nexgel.com/role/ScheduleOfInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods.", "label": "Less: Inventory reserve for excess and slow moving inventory" } } }, "localname": "InventoryAdjustments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "verboseLabel": "Inventory" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r771" ], "calculation": { "http://nexgel.com/role/ScheduleOfInventoryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r774" ], "calculation": { "http://nexgel.com/role/ScheduleOfInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory, gross" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r196", "r694", "r724" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://nexgel.com/role/ScheduleOfInventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory", "verboseLabel": "Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets", "http://nexgel.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r165", "r184", "r195", "r318", "r319", "r320", "r544", "r697" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory and Cost of Goods Sold" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r773" ], "calculation": { "http://nexgel.com/role/ScheduleOfInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r772" ], "calculation": { "http://nexgel.com/role/ScheduleOfInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Work-in-progress" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r124", "r127" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Interest income" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "verboseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r842" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Schedule of Future Minimum Lease Payments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r503" ], "calculation": { "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total undiscounted operating lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r503" ], "calculation": { "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r503" ], "calculation": { "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r503" ], "calculation": { "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r503" ], "calculation": { "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r842" ], "calculation": { "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r503" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: Imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "verboseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r30", "r216", "r303", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r467", "r470", "r471", "r485", "r622", "r700", "r736", "r804", "r845", "r846" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r115", "r155", "r571", "r724", "r783", "r797", "r840" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r32", "r183", "r216", "r303", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r467", "r470", "r471", "r485", "r724", "r804", "r845", "r846" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r27" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r23", "r153", "r355", "r369", "r708", "r709", "r855" ], "calculation": { "http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "totalLabel": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r7", "r217", "r360" ], "calculation": { "http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "verboseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r7", "r217", "r360" ], "calculation": { "http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails": { "order": 5.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Four", "verboseLabel": "2027" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r7", "r217", "r360" ], "calculation": { "http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails": { "order": 4.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "verboseLabel": "2026" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r7", "r217", "r360" ], "calculation": { "http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "verboseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r785" ], "calculation": { "http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.", "label": "2023 (remainder of the year)" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "Convertible Notes Payable" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r34" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes payable, net of current portion" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MarketableSecurities": { "auth_ref": [ "r101", "r770" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security.", "label": "Total" } } }, "localname": "MarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFairValueOfFinancialAssetsDetails", "http://nexgel.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesCurrent": { "auth_ref": [ "r770" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as current.", "label": "Marketable securities" } } }, "localname": "MarketableSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets", "http://nexgel.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments": { "auth_ref": [], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment in marketable security.", "label": "Marketable Security, Gain (Loss)", "negatedLabel": "Gain on investment in marketable securities" } } }, "localname": "MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.", "label": "Schedule of Marketable Securities" } } }, "localname": "MarketableSecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketingRelatedIntangibleAssetsMember": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Marketing-related asset, including, but not limited to, internet domain name, newspaper mast head, and trademark.", "label": "Marketing-Related Intangible Assets [Member]" } } }, "localname": "MarketingRelatedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfBreakdownOfIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r38", "r154", "r216", "r303", "r333", "r335", "r336", "r337", "r340", "r341", "r485", "r570", "r626" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.", "label": "Non-controlling interest in joint venture" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Minority percentage" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentationDetailsNarrative", "http://nexgel.com/role/NoncontrollingInterestInJointVentureDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r209" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Used in Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r209" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Provided by Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r128", "r129", "r130" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "negatedLabel": "Net cash used in operating activities", "totalLabel": "Net Cash Used in Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/GoingConcernDetailsNarrative", "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r120", "r130", "r157", "r181", "r198", "r199", "r203", "r216", "r221", "r223", "r224", "r225", "r226", "r229", "r230", "r235", "r243", "r256", "r260", "r262", "r303", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r482", "r485", "r578", "r645", "r667", "r668", "r701", "r734", "r804" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://nexgel.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "negatedLabel": "Net loss", "totalLabel": "Net loss attributable to NexGel stockholders" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations", "http://nexgel.com/role/GoingConcernDetailsNarrative", "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r90", "r149", "r198", "r199", "r229", "r230", "r577", "r777" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Less: Income attributable to non-controlling interest in joint venture" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently Issued Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": { "auth_ref": [ "r10", "r73", "r85" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from a business combination.", "label": "Non-controlling interest in JV" } } }, "localname": "NoncontrollingInterestIncreaseFromBusinessCombination", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r87", "r386", "r786", "r787", "r788", "r862" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r126" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense), net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.", "label": "Schedule of Restricted Stock Units Granted" } } }, "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r29" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Current portion of note payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r790" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesDetailsNarrative" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r243", "r256", "r260", "r262", "r701" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses" } } }, "localname": "OperatingIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r841" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r497" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of operating lease liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r497" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease liability, current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r497" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liability, net of current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r498", "r500" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating cash flows from operating lease" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfSupplementalCashFlowsInformationRelatedToLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r496" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating lease - right of use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r502", "r723" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r501", "r723" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r105", "r131", "r132", "r148" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.", "label": "Description of Business, Stock Split and Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/DescriptionOfBusinessStockSplitAndBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r189" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r31", "r724" ], "calculation": { "http://nexgel.com/role/ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "verboseLabel": "Other" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r206" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense)" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OtherPrepaidExpenseCurrent": { "auth_ref": [ "r775", "r799" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "General prepaid expenses" } } }, "localname": "OtherPrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Due from related parties, current" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r39", "r464" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "verboseLabel": "Payment to acquire business" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/NoncontrollingInterestInJointVentureDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r39" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payment to acquire business" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/NoncontrollingInterestInJointVentureDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r792" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedLabel": "Investment in marketable securities" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r162", "r836", "r837", "r838" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Payments to Acquire Productive Assets", "negatedLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r834" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails", "http://nexgel.com/role/ScheduleOfInformationAboutIncentivePlanDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r834" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails", "http://nexgel.com/role/ScheduleOfInformationAboutIncentivePlanDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r109", "r371" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r109", "r624" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r109", "r371" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r109", "r624", "r643", "r862", "r863" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r109", "r567", "r724" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, par value $0.001 per share, 5,000,000 shares authorized, no shares issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r776" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidInsurance": { "auth_ref": [ "r695", "r705", "r799" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid insurance" } } }, "localname": "PrepaidInsurance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative", "http://nexgel.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r778" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Loan advance" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds from sales of marketable securities" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r181", "r198", "r199", "r208", "r216", "r221", "r229", "r230", "r243", "r256", "r260", "r262", "r303", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r465", "r468", "r469", "r482", "r485", "r562", "r576", "r600", "r645", "r667", "r668", "r701", "r721", "r722", "r735", "r777", "r804" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net income (loss)", "totalLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations", "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r137", "r168", "r172", "r173" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/PropertyAndEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r138", "r185", "r574" ], "calculation": { "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Total property and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r6", "r563", "r574", "r724" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets", "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r6", "r168", "r172", "r572" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule of Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/PropertyAndEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Useful Life (Years)" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r404", "r508", "r509", "r617", "r618", "r619", "r620", "r621", "r642", "r644", "r676" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [ "r649", "r650", "r653" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r404", "r508", "r509", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r617", "r618", "r619", "r620", "r621", "r642", "r644", "r676", "r844" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party, Type [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r505", "r506", "r507", "r509", "r510", "r596", "r597", "r598", "r651", "r652", "r653", "r673", "r675" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r40" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedLabel": "Principle payments of notes payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r104", "r452", "r853" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r112", "r145", "r569", "r586", "r587", "r595", "r625", "r724" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r179", "r218", "r219", "r220", "r222", "r228", "r230", "r305", "r306", "r444", "r445", "r446", "r460", "r461", "r472", "r474", "r475", "r477", "r480", "r583", "r585", "r601", "r862" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r244", "r245", "r255", "r258", "r259", "r263", "r264", "r265", "r395", "r396", "r545" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 }, "http://nexgel.com/role/ScheduleOfDisaggregatedRevenueBySalesTypeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenues, net", "totalLabel": "Total" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations", "http://nexgel.com/role/ScheduleOfDisaggregatedRevenueBySalesTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r176", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r693" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r171" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Remaining performance obligations" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative", "http://nexgel.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r265", "r760" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConcentrationsOfRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Expenses and Other Current Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r483", "r484" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value of Financial Assets" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r57", "r59", "r546" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/IntangibleAssetsDetailsNarrative", "http://nexgel.com/role/ScheduleOfBreakdownOfIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r57", "r59" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Breakdown of Identifiable Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r25", "r116", "r117", "r118" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r98", "r99", "r649", "r650", "r653" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r407", "r409", "r411", "r412", "r413", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r435", "r436", "r437", "r438", "r439" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails", "http://nexgel.com/role/ScheduleOfInformationAboutIncentivePlanDetails", "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r19", "r20", "r76" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of Incentive Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Assumptions used in Share-based Compensation" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative", "http://nexgel.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTextBlock": { "auth_ref": [ "r24", "r66", "r67", "r68", "r69", "r70", "r71", "r72", "r109", "r110", "r143", "r144", "r145" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.", "label": "Schedule of Reserved Common Stock For Issued Securities in Relation" } } }, "localname": "ScheduleOfStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CommonStockTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Summary of Common Stock Warrants" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Estimated Annual Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r249", "r250", "r251", "r252", "r253", "r254", "r264", "r702" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r123" ], "calculation": { "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r4" ], "calculation": { "http://nexgel.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based compensation and restricted stock vesting", "verboseLabel": "Stock based compensation and restricted stock vesting" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensationDetailsNarrative", "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Number of units, forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Weighted average grant date fair value, forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Number of units, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Weighted average grant date fair value, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r423", "r424" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Number of units outstanding beginning", "periodStartLabel": "Number of units outstanding beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r423", "r424" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted average grant date fair value outstanding ending", "periodStartLabel": "Weighted average grant date fair value outstanding beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfAssumptionsUsedInShare-basedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfAssumptionsUsedInShare-basedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfAssumptionsUsedInShare-basedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [ "r407", "r409", "r411", "r412", "r413", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r435", "r436", "r437", "r438", "r439" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails", "http://nexgel.com/role/ScheduleOfInformationAboutIncentivePlanDetails", "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "negatedLabel": "Number of units, exercised and converted to common shares", "negatedTerseLabel": "Number of warrants, exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails", "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.", "label": "Number of warrants, expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.", "label": "Number of warrants, forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Number of warrants, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Number of warrants, outstanding ending balance", "periodStartLabel": "Number of warrants, outstanding beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SummaryOfCommonStockWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Awards Issued", "verboseLabel": "Number of options, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfInformationAboutIncentivePlanDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "periodEndLabel": "Number of options, exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price, exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period", "negatedLabel": "Number of options, expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Number of options, forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of options, granted", "verboseLabel": "Number of shares granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r75" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r415", "r416" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Number of options, outstanding, ending balance", "periodStartLabel": "Number of options, outstanding, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r415", "r416" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price, outstanding ending balance", "periodStartLabel": "Weighted average exercise price, outstanding beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Awards Available for Grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfInformationAboutIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r411", "r412", "r413", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r435", "r436", "r437", "r438", "r439" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails", "http://nexgel.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted average exercise price, exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Weighted average exercise price, expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted average exercise price, forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted average exercise price, granted", "verboseLabel": "Exercise price of options" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r406", "r414", "r433", "r434", "r435", "r436", "r439", "r447", "r448", "r449", "r450" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]", "verboseLabel": "Share-based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfAssumptionsUsedInShare-basedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual term, exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative", "http://nexgel.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r131", "r213" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies and Estimates" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimates" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r177", "r191", "r192", "r193", "r216", "r233", "r234", "r236", "r238", "r241", "r242", "r303", "r333", "r335", "r336", "r337", "r340", "r341", "r371", "r372", "r374", "r377", "r384", "r485", "r591", "r592", "r593", "r594", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r613", "r624", "r646", "r669", "r682", "r683", "r684", "r685", "r686", "r758", "r781", "r789" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r12", "r37", "r179", "r201", "r202", "r203", "r218", "r219", "r220", "r222", "r228", "r230", "r240", "r305", "r306", "r386", "r444", "r445", "r446", "r460", "r461", "r472", "r473", "r474", "r475", "r476", "r477", "r480", "r486", "r487", "r488", "r489", "r490", "r491", "r504", "r583", "r584", "r585", "r601", "r669" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://nexgel.com/role/ScheduleOfWarrantLiabilityDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r218", "r219", "r220", "r240", "r545", "r589", "r613", "r616", "r617", "r618", "r619", "r620", "r621", "r624", "r627", "r628", "r629", "r630", "r631", "r633", "r634", "r635", "r636", "r638", "r639", "r640", "r641", "r642", "r644", "r647", "r648", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r669", "r729" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://nexgel.com/role/Cover", "http://nexgel.com/role/NoncontrollingInterestInJointVentureDetailsNarrative", "http://nexgel.com/role/ScheduleOfWarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r218", "r219", "r220", "r240", "r545", "r589", "r613", "r616", "r617", "r618", "r619", "r620", "r621", "r624", "r627", "r628", "r629", "r630", "r631", "r633", "r634", "r635", "r636", "r638", "r639", "r640", "r641", "r642", "r644", "r647", "r648", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r669", "r729" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://nexgel.com/role/Cover", "http://nexgel.com/role/NoncontrollingInterestInJointVentureDetailsNarrative", "http://nexgel.com/role/ScheduleOfWarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r12", "r145" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Restricted stock vesting, shares", "verboseLabel": "Restricted stock units" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://nexgel.com/role/ScheduleOfReservedCommonStockForIssuedSecuritiesInRelationDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r12", "r109", "r110", "r145" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Share-based compensation plan" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfReservedCommonStockForIssuedSecuritiesInRelationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r12", "r109", "r110", "r145", "r420" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedLabel": "Number of options, exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r12", "r109", "r110", "r145" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Restricted stock vesting" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [ "r728" ], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfIncentiveStockOptionActivityDetails", "http://nexgel.com/role/Share-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r110", "r113", "r114", "r133", "r626", "r643", "r670", "r671", "r724", "r736", "r783", "r797", "r840", "r862" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "totalLabel": "Total NexGel stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r87", "r88", "r89", "r179", "r180", "r202", "r218", "r219", "r220", "r222", "r228", "r305", "r306", "r386", "r444", "r445", "r446", "r460", "r461", "r472", "r473", "r474", "r475", "r476", "r477", "r480", "r486", "r487", "r491", "r504", "r584", "r585", "r599", "r626", "r643", "r670", "r671", "r687", "r735", "r783", "r797", "r840", "r862" ], "calculation": { "http://nexgel.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.", "label": "Total stockholders\u2019 equity", "periodEndLabel": "Balance", "periodStartLabel": "Balance" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/BalanceSheets", "http://nexgel.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r142", "r215", "r370", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r383", "r386", "r479", "r672", "r674", "r688" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Common Stock" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CommonStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r511", "r512" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ConvertibleNotesPayableDetailsNarrative", "http://nexgel.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Going Concern" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Disclosure of Cash Flows Information" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid during the year for:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.", "label": "Technology-Based Intangible Assets [Member]" } } }, "localname": "TechnologyBasedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfBreakdownOfIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r159", "r160", "r161", "r268", "r269", "r271" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable, net" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfBreakdownOfIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r367", "r382", "r478", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r579", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r793", "r794", "r795", "r796" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFairValueOfFinancialAssetsDetails", "http://nexgel.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasurySecuritiesMember": { "auth_ref": [ "r698", "r714", "r716", "r854" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).", "label": "US Treasury Securities [Member]" } } }, "localname": "USTreasurySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfFairValueOfFinancialAssetsDetails", "http://nexgel.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r50", "r51", "r52", "r166", "r167", "r169", "r170" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/SignificantAccountingPoliciesAndEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [ "r726", "r727", "r730", "r731", "r732", "r733" ], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfWarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Warrants and Rights Outstanding", "periodEndLabel": "Fair value", "periodStartLabel": "Fair value" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/ScheduleOfWarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r232", "r238" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted average shares used in computing net loss per common share \u2013 diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r231", "r238" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average shares used in computing net loss per common share - basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nexgel.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.4)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org//205/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org//205-40/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org//360/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org//470/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org//810/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org//323/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org//606/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Publisher": "SEC", "Section": "FF", "Subsection": "Q2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(4)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org//330/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//350-30/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org//718/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.C.Q3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//842-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(16))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(17))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "47", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r737": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r738": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r739": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r741": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r742": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r743": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r744": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r745": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r746": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r747": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r748": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r749": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r751": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r752": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r753": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r754": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r755": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r756": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(f)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481543/323-740-50-2", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r762": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r763": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r764": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r765": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r766": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r767": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r768": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(S-X 210.12-04)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "720", "URI": "https://asc.fasb.org//1943274/2147483384/720-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r803": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)(1)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "4M", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4M", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 84 0001493152-23-028564-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-028564-xbrl.zip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�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end